-- MySQL dump 10.13  Distrib 8.0.30, for Win64 (x86_64)
--
-- Host: localhost    Database: gene_info
-- ------------------------------------------------------
-- Server version	8.0.30

/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!50503 SET NAMES utf8 */;
/*!40103 SET @OLD_TIME_ZONE=@@TIME_ZONE */;
/*!40103 SET TIME_ZONE='+00:00' */;
/*!40014 SET @OLD_UNIQUE_CHECKS=@@UNIQUE_CHECKS, UNIQUE_CHECKS=0 */;
/*!40014 SET @OLD_FOREIGN_KEY_CHECKS=@@FOREIGN_KEY_CHECKS, FOREIGN_KEY_CHECKS=0 */;
/*!40101 SET @OLD_SQL_MODE=@@SQL_MODE, SQL_MODE='NO_AUTO_VALUE_ON_ZERO' */;
/*!40111 SET @OLD_SQL_NOTES=@@SQL_NOTES, SQL_NOTES=0 */;

--
-- Table structure for table `gene`
--

DROP TABLE IF EXISTS `gene`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `gene` (
  `gene_index` int NOT NULL AUTO_INCREMENT,
  `Gene_symbol` varchar(45) NOT NULL,
  `NCBI_gene_id` varchar(45) DEFAULT NULL,
  PRIMARY KEY (`gene_index`,`Gene_symbol`)
) ENGINE=InnoDB AUTO_INCREMENT=780 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_0900_ai_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `gene`
--

LOCK TABLES `gene` WRITE;
/*!40000 ALTER TABLE `gene` DISABLE KEYS */;
INSERT INTO `gene` VALUES (1,'Bacteroidetes','gm0090'),(2,'Christensenellaceae','gm0174'),(3,'Enterobacteriaceae','gm0282'),(4,'Blautia','gm0117'),(5,'Eggerthella','gm0271'),(6,'Sarcina','gm0596'),(7,'CXCL6','6372'),(8,'CCL20','6364'),(9,'ANXA10','11199'),(10,'DUOX2','50506'),(11,'EGFR','1956'),(12,'FFAR3','2865'),(13,'FFAR2','2867'),(14,'CCL2','6347'),(15,'IL10','3586'),(16,'IL12B','3593'),(17,'IL12A','3592'),(18,'CCR6','1235'),(19,'CXCR6','10663'),(20,'CXCR3','2833'),(21,'TJP2','9414'),(22,'PRKCZ','5590'),(23,'IL1B','3553'),(24,'TNF','7124'),(25,'MAPK3','5595'),(26,'MAPK1','5594'),(27,'CXCL8','3576'),(28,'FOS','2353'),(29,'JUN','3725'),(30,'MUC2','4583'),(31,'HDAC1','3065'),(32,'HDAC2','3066'),(33,'HDAC3','8841'),(34,'HDAC4','9759'),(35,'HDAC5','10014'),(36,'HDAC7','51564'),(37,'HDAC8','55869'),(38,'HDAC9','9734'),(39,'HDAC11','79885'),(40,'TLR5','7100'),(41,'TLR2','7097'),(42,'TLR4','7099'),(43,'TJP1','7082'),(44,'CLDN1','9076'),(45,'OCLN','100506658'),(46,'CGN','57530'),(47,'DEFB4A','1673'),(48,'SLC22A6','9356'),(49,'CD14','929'),(50,'CD163','9332'),(51,'ANGPTL4','51129'),(52,'CLDN4','1364'),(53,'F11R','50848'),(54,'TGFB1','7040'),(55,'FOXP3','50943'),(56,'AHR','196'),(57,'CYP1A1','1543'),(58,'Htr1a','15550'),(59,'LGR5','8549'),(60,'ALPI','248'),(61,'LYZ','4069'),(62,'CHGA','1113'),(63,'DCLK1','9201'),(64,'REG3B',''),(65,'REG3G','130120'),(66,'DEFB1','1672'),(67,'CLDN3','1365'),(68,'GHRL','51738'),(69,'IL4R','3556'),(70,'CXCR2','3579'),(71,'HCAR2','338442'),(72,'HCAR3','8843'),(73,'KITLG','4254'),(74,'SLC5A8','160728'),(75,'MAPK14','1432'),(76,'IKBKE','9641'),(77,'MIR146A','406938'),(78,'MIR155','406947'),(79,'IL6','3569'),(80,'GSK3B','2932'),(81,'TCF7L2','6934'),(82,'CCND1','595'),(83,'MYC','4609'),(84,'MTOR','2475'),(85,'CXCL10','3627'),(86,'PDCD6IP','10015'),(87,'ALG12','79087'),(88,'MCCC1','56922'),(89,'DDC','1644'),(90,'NQO1','1728'),(91,'GNMT','27232'),(92,'CYP1A2','1544'),(93,'CYP3A5','1577'),(94,'GCLC','2729'),(95,'CYP2D6','1565'),(96,'CYP3A4','1576'),(97,'NFKB1','4790'),(98,'IL1A','3552'),(99,'IL2','3558'),(100,'IL5','3567'),(101,'IL22','50616'),(102,'IFNG','3458'),(103,'IL17A','3605'),(104,'RORA','6095'),(105,'CXCL1','2919'),(106,'CXCL5','6374'),(107,'PPARG','5468'),(108,'PLIN2','123'),(109,'NR1H4','9971'),(110,'GLP1R','2740'),(111,'GJC1','10052'),(112,'NLRP6','171389'),(113,'LEP','3952'),(114,'AKT1','207'),(115,'SOD1','6647'),(116,'CAT','847'),(117,'GPX3','2878'),(118,'BCL2','596'),(119,'BAX','581'),(120,'CASP3','836'),(121,'CYP7A1','1581'),(122,'GPBAR1','151306'),(123,'TLR6','10333'),(124,'TGFBR1','7046'),(125,'SMN1','6606'),(126,'SMURF2','64750'),(127,'SSTR1','6751'),(128,'SSTR3','6753'),(129,'IGAD1','10986'),(130,'NFE2L2','4780'),(131,'HMOX1','3162'),(132,'C5AR1','728'),(133,'CCL3','6348'),(134,'PTGS2','5743'),(135,'IL18','3606'),(136,'IL4','3565'),(137,'CLGN','1047'),(138,'TJP3','27134'),(139,'CDKN1A','1026'),(140,'CDK6','1021'),(141,'HERC5','51191'),(142,'TP53','7157'),(143,'CLDN14','23562'),(144,'FABP2','2169'),(145,'tnaA','948221'),(146,'MAPK8','5599'),(147,'ADRA2A','150'),(148,'ADRB2','154'),(149,'ADRA2B','151'),(150,'RAC1','5879'),(151,'PAK1','5058'),(152,'CLDN7','1366'),(153,'TLR3','7098'),(154,'TLR9','54106'),(155,'TOLLIP','54472'),(156,'SIGIRR','59307'),(157,'SOCS5','9655'),(158,'PIK3CA','5290'),(159,'PIK3CB','5291'),(160,'PIK3CD','5293'),(161,'IL24','11009'),(162,'IFNL3','282617'),(163,'CCL25','6370'),(164,'CCL4','6351'),(165,'CCL16','6360'),(166,'XCL1','6375'),(167,'CX3CL1','6376'),(168,'DUSP1','1843'),(169,'DUSP3','1845'),(170,'DUSP10','11221'),(171,'DUSP18','150290'),(172,'DUSP22','56940'),(173,'IRS1','3667'),(174,'RHEB','6009'),(175,'DPP7','29952'),(176,'DAPK3','1613'),(177,'CORO1B','57175'),(178,'IGFBP6','3489'),(179,'FADS3','3995'),(180,'FLNA','2316'),(181,'G6PD','2539'),(182,'UPK3B','105375355'),(183,'PEMT','10400'),(184,'SFN','2810'),(185,'THEM6','51337'),(186,'AURKAIP1','54998'),(187,'CHAC1','79094'),(188,'DNPH1','10591'),(189,'FKBP2','2286'),(190,'VAMP5','10791'),(191,'BLVRB','648'),(192,'SERINC2','347735'),(193,'CTSD','1509'),(194,'SLITRK6','84189'),(195,'MGAM2','93432'),(196,'ONECUT2','9480'),(197,'SORBS2','8470'),(198,'SLC40A1','30061'),(199,'SLC17A4','10050'),(200,'PFN1P2','767846'),(201,'SESN3','143686'),(202,'RNF144B','255488'),(203,'HPGD','3248'),(204,'ASPM','259266'),(205,'NOX1','27035'),(206,'ABCC4','10257'),(207,'LINC00504','201853'),(208,'CCNB3','85417'),(209,'TPH1','7166'),(210,'IL22RA1','58985'),(211,'MUC1','4582'),(212,'MGAT3','4248'),(213,'B4GALT1','2683'),(214,'ST6GAL1','6480'),(215,'PGP','283871'),(216,'SLC19A2','10560'),(217,'SLC19A3','80704'),(218,'SLC9A3','6550'),(219,'RELA','5970'),(220,'BCL10','8915'),(221,'SLC26A3','1811'),(222,'MGAT4B','11282'),(223,'MGAT4A','11320'),(224,'IL22RA2','116379'),(225,'VDR','7421'),(226,'SULT2A1','6822'),(227,'LCN2','3934'),(228,'CD44','960'),(229,'LBP','3929'),(230,'Cldn2','12738'),(231,'Stat3','20848'),(232,'Hdac9','79221'),(233,'Dgat2','67800'),(234,'Tjp1','21872'),(235,'Il10','16153'),(236,'Il1b','16176'),(237,'Il6','16193'),(238,'Tnf','21926'),(239,'Sirt1','93759'),(240,'Mir10b','387144'),(241,'Abca1','11303'),(242,'Abcg1','11307'),(243,'Cxcl16','66102'),(244,'Hdac1','433759'),(245,'Il17a','16171'),(246,'Foxp3','20371'),(247,'Klf4','16600'),(248,'Muc2','17831'),(249,'Muc4','140474'),(250,'C1galt1','94192'),(251,'B4galt4','56375'),(252,'St3gal4','20443'),(253,'Mir21a','387140'),(254,'Slc2a1','20525'),(255,'Slc2a4','20528'),(256,'Akt1','11651'),(257,'Mmp9','17395'),(258,'Ighe','380792'),(259,'Ighg1','16017'),(260,'Il12p70',''),(261,'Prkaa1','105787'),(262,'Angptl4','57875'),(263,'Gpx2','14776'),(264,'Apob','238055'),(265,'Aqp4','11829'),(266,'Pla2g4c','232889'),(267,'Prkaa2','108079'),(268,'Cdkn1b','12576'),(269,'Map1lc3b','67443'),(270,'Srebf1','20787'),(271,'Scd1','20249'),(272,'Fasn','14104'),(273,'Adrb3','11556'),(274,'Pnpla2','66853'),(275,'Cpt2','12896'),(276,'Acox1','11430'),(277,'Ppargc1a','19017'),(278,'Cd68','12514'),(279,'Ccl2','20296'),(280,'Slco4c1','227394'),(281,'Tgfb1','21803'),(282,'Fn1','14268'),(283,'Col1a1','12842'),(284,'Cldn1','12737'),(285,'Tff3','21786'),(286,'Retnlb','57263'),(287,'B3gnt6','272411'),(288,'Gcnt1','14537'),(289,'Fut2','14344'),(290,'St6gal1','20440'),(291,'Atg16l1','77040'),(292,'Atg5','11793'),(293,'Becn1','56208'),(294,'Lamp2','16784'),(295,'Map1lc3a','66734'),(296,'Il22','50929'),(297,'Il33','77125'),(298,'Il13','16163'),(299,'Nox4','50490'),(300,'Il18','16173'),(301,'Mir181a-2','387176'),(302,'Ifng','15978'),(303,'Gzmb','14939'),(304,'Cxcl15','20309'),(305,'Mylk3','213435'),(306,'Gcg','14526'),(307,'Nlrp3','216799'),(308,'Nlrp6','101613'),(309,'Tlr4','21898'),(310,'Mapk8ip1','19099'),(311,'Sucnr1','84112'),(312,'Defa5','13239'),(313,'Acta2','11475'),(314,'Timp1','21857'),(315,'Pparg','19016'),(316,'Nos2','18126'),(317,'Chrm2','243764'),(318,'Tlr2','24088'),(319,'Ahr','11622'),(320,'Cyp1a1','13076'),(321,'Tph1','219990'),(322,'Htr2a','15558'),(323,'Htr4','15562'),(324,'Lgr5','14160'),(325,'Alpi','76768'),(326,'Lyz1','17110'),(327,'Chga','12652'),(328,'Dclk1','13175'),(329,'Reg3b','18489'),(330,'Reg3g','19695'),(331,'Defb1','13214'),(332,'Ocln','18260'),(333,'Cldn3','12739'),(334,'Cyp3a11','13112'),(335,'Cyp2b10','13088'),(336,'Abcb1a','18671'),(337,'Dao','13142'),(338,'Ly6g','546644'),(339,'Itgb1','16412'),(340,'Casp1','12362'),(341,'Ffar2','233079'),(342,'Slc5a8','216225'),(343,'Nr1h4','20186'),(344,'Fgf15','14170'),(345,'Fgfr4','14186'),(346,'Cyp7a1','13122'),(347,'Sirpa','19261'),(348,'Cpt1b','12895'),(349,'Fas','14102'),(350,'Ffar3','233080'),(351,'Nfkb1','18033'),(352,'Pdcd1lg2','58205'),(353,'Cd86','12524'),(354,'Cd40','21939'),(355,'Il12b','16160'),(356,'Hcar2','80885'),(357,'Il10ra','16154'),(358,'Mapk3','26417'),(359,'Mapk1','26413'),(360,'Pdcd6ip','18571'),(361,'Alg12','223774'),(362,'Acaa1a','113868'),(363,'Acaa1b','235674'),(364,'Acaa2','52538'),(365,'Acads','11409'),(366,'Acmsd','266645'),(367,'Acot1','26897'),(368,'Acot3','171281'),(369,'Acot7','70025'),(370,'Acot8','170789'),(371,'Acsl4','50790'),(372,'Acss2','60525'),(373,'Acyp2','75572'),(374,'Ada','11486'),(375,'Agpat2','67512'),(376,'Ahcy','269378'),(377,'Akr1b7','11997'),(378,'Alas1','11655'),(379,'Aldoc','11676'),(380,'Aox1','11761'),(381,'Arsa','11883'),(382,'Asl','109900'),(383,'Asns','27053'),(384,'Aspdh','68352'),(385,'B3galt1','26877'),(386,'B3gat3','72727'),(387,'B3gnt3','72297'),(388,'B4galnt1','14421'),(389,'Btd','26363'),(390,'Cel','12613'),(391,'Chka','12660'),(392,'Chpf','74241'),(393,'Chst7','60322'),(394,'Ckb','12709'),(395,'Csad','246277'),(396,'Cyp1a2','13077'),(397,'Cyp2a4','13086'),(398,'Cyp2a5','13087'),(399,'Cyp2b13','13089'),(400,'Cyp2b9','13094'),(401,'Cyp2c29','13095'),(402,'Cyp2c37','13096'),(403,'Cyp2c40','13099'),(404,'Cyp2c55','72082'),(405,'Cyp2d26','76279'),(406,'Cyp2d34','223706'),(407,'Cyp2d40','71754'),(408,'Cyp2j9','74519'),(409,'Cyp3a25','56388'),(410,'Cyp3a44','337924'),(411,'Cyp4a10','13117'),(412,'Cyp4a12b','13118'),(413,'Cyp4a14','13119'),(414,'Cyp4b1','13120'),(415,'Cyp7b1','13123'),(416,'Cyp8b1','13124'),(417,'Dbt','13171'),(418,'Dct','13190'),(419,'Dctpp1','66422'),(420,'Dcxr','67880'),(421,'Ddc','13195'),(422,'Dld','13382'),(423,'Echdc1','52665'),(424,'Elovl3','12686'),(425,'Elovl5','68801'),(426,'Eno1b','433182'),(427,'Ephx2','13850'),(428,'Etnppl','71760'),(429,'Fads2','56473'),(430,'Fuca1','71665'),(431,'Fxn','14297'),(432,'G6pc','14377'),(433,'Gal3st1','53897'),(434,'Gale','74246'),(435,'Galk1','14635'),(436,'Gcat','26912'),(437,'Gck','103988'),(438,'Gclc','14629'),(439,'Gfpt1','14583'),(440,'Gmds','218138'),(441,'Gmpr','66355'),(442,'Gnmt','14711'),(443,'Gnpda2','67980'),(444,'Gpcpd1','74182'),(445,'Gpd1','14555'),(446,'Gpx3','14778'),(447,'Gpx6','75512'),(448,'Gsta1','14857'),(449,'Gsta2','14858'),(450,'Gstm1','14862'),(451,'Gstm2','14863'),(452,'Gstm3','14864'),(453,'Gstm4','14865'),(454,'Gstt3','103140'),(455,'Gulo','268756'),(456,'Haao','107766'),(457,'Hao2','56185'),(458,'Hmgcs1','208715'),(459,'Hpd','15445'),(460,'Hsd17b10','15108'),(461,'Hsd3b5','15496'),(462,'Hyal2','15587'),(463,'Impa2','114663'),(464,'Isyna1','71780'),(465,'Khk','16548'),(466,'Kmt2a','214162'),(467,'Lcat','16816'),(468,'Ldha','16828'),(469,'Lpl','16956'),(470,'Man2b2','17160'),(471,'Mcat','223722'),(472,'Mgat4b','103534'),(473,'Mgll','23945'),(474,'Mif','17319'),(475,'Mlycd','56690'),(476,'Mpst','246221'),(477,'Mthfr','17769'),(478,'Nat8','68396'),(479,'Ndufs3','68349'),(480,'Ndufs8','225887'),(481,'Nos3','18127'),(482,'Nqo1','18104'),(483,'Nudt12','67993'),(484,'Ogt','108155'),(485,'Papss2','23972'),(486,'Pde2a','207728'),(487,'Pde4d','238871'),(488,'Pemt','18618'),(489,'Pfkfb3','170768'),(490,'Pgls','66171'),(491,'Pgp','67078'),(492,'Pklr','18770'),(493,'Plcb1','18795'),(494,'Pld4','104759'),(495,'Pmm1','29858'),(496,'Pnlip','69060'),(497,'Pnliprp1','18946'),(498,'Pnpt1','71701'),(499,'Pomgnt2','215494'),(500,'Ppt2','54397'),(501,'Prdx2','21672'),(502,'Prdx4','53381'),(503,'Prodh2','56189'),(504,'Ptgds','19215'),(505,'Ptges2','96979'),(506,'Ptgis','19223'),(507,'Renbp','19703'),(508,'Retsat','67442'),(509,'Rev3l','19714'),(510,'Sdhb','67680'),(511,'Smpd3','58994'),(512,'Sult1e1','20860'),(513,'Tbxas1','21391'),(514,'Tdo2','56720'),(515,'Tecr','106529'),(516,'Tm7sf2','73166'),(517,'Treh','58866'),(518,'Gfus','22122'),(519,'Uap1l1','227620'),(520,'Ugdh','22235'),(521,'Ugt2b1','71773'),(522,'Ugt2b34','100727'),(523,'Ugt2b35','243085'),(524,'Upp1','22271'),(525,'Upp2','76654'),(526,'Ace2','70008'),(527,'Il12a','16159'),(528,'Cxcl1','14825'),(529,'Cxcl2','20310'),(530,'Sult2a1','20859'),(531,'Sult2a2','100043194'),(532,'Sult2a3','629203'),(533,'Il4','16189'),(534,'Ppara','19013'),(535,'Il2','16183'),(536,'Myh7','140781'),(537,'Nppa','230899'),(538,'Trpv1','7442'),(539,'Ucp1','7350'),(540,'Ppargc1a','10891'),(541,'Cpt1b','1375'),(542,'Prdm16','63976'),(543,'Tbx1','6899'),(544,'Hdac3','15183'),(545,'Hdac5','15184'),(546,'Sim1','20464'),(547,'Stat6','20852'),(548,'Skil','20482'),(549,'Ptf1a','19213'),(550,'Rara','19401'),(551,'Arnt2','11864'),(552,'Isl1','16392'),(553,'Nr3c1','14815'),(554,'Trim24','21848'),(555,'Kdm5b','75605'),(556,'Neurod1','18012'),(557,'Sox2','20674'),(558,'Gata3','14462'),(559,'Arnt','11863'),(560,'Onecut1','15379'),(561,'Sox11','20666'),(562,'Relb','19698'),(563,'Gata4','14463'),(564,'Cdx2','12591'),(565,'Ets2','23872'),(566,'Hnf1b','21410'),(567,'Notch1','18128'),(568,'Irf6','54139'),(569,'Sin3a','20466'),(570,'Brd7','26992'),(571,'Tcf4','21413'),(572,'Mybl2','17865'),(573,'Mtpn','14489'),(574,'Esr1','13982'),(575,'Foxm1','14235'),(576,'E2f2','242705'),(577,'E2f3','13557'),(578,'Zbtb17','22642'),(579,'Bmi1','12151'),(580,'Mta1','116870'),(581,'Phf1','21652'),(582,'Foxa1','15375'),(583,'Smad2','17126'),(584,'Smad3','17127'),(585,'Smad4','17128'),(586,'Tfdp1','21781'),(587,'Pgr','18667'),(588,'Clock','12753'),(589,'Hey1','15213'),(590,'Cdx1','12590'),(591,'Mtdh','67154'),(592,'Pias2','17344'),(593,'Gfi1','14581'),(594,'Dbp','13170'),(595,'Atf3','11910'),(596,'Fbxw7','50754'),(597,'Nacc1','66830'),(598,'Rbl1','19650'),(599,'Zeb1','21417'),(600,'Zeb2','24136'),(601,'Rnf2','19821'),(602,'Rela','19697'),(603,'Nfkbia','18035'),(604,'Tonsl','72749'),(605,'Foxo3','56484'),(606,'Gata2','14461'),(607,'Crebbp','12914'),(608,'Bach1','12013'),(609,'Jun','16476'),(610,'Esr2','13983'),(611,'Ifi204','15951'),(612,'Cebpb','12608'),(613,'Stat5b','20851'),(614,'Klf15','66277'),(615,'Meox2','17286'),(616,'Sox9','20682'),(617,'Smad7','17131'),(618,'Stat5a','20850'),(619,'Sqstm1','18412'),(620,'Vdr','22337'),(621,'Nr5a1','26423'),(622,'Rest','19712'),(623,'Gabpa','14390'),(624,'Ddit3','13198'),(625,'Nrf1','18181'),(626,'Nr4a1','15370'),(627,'Nr1i2','18171'),(628,'Hif1a','29560'),(629,'Vhl','22346'),(630,'Yy1','22632'),(631,'Trp53','22059'),(632,'Pttg1','30939'),(633,'Hic1','15248'),(634,'Trp73','22062'),(635,'Rb1','19645'),(636,'Foxo4','54601'),(637,'Taf4','228980'),(638,'Lyl1','17095'),(639,'Crem','12916'),(640,'Lef1','16842'),(641,'Myc','17869'),(642,'Fos','14281'),(643,'Tfap2c','21420'),(644,'Stat1','20846'),(645,'Klf5','12224'),(646,'Ezh2','14056'),(647,'Elp1','230233'),(648,'Creb1','12912'),(649,'Nfya','18044'),(650,'E2f1','13555'),(651,'Trp63','22061'),(652,'Foxo1','56458'),(653,'Klf2','16598'),(654,'Tob1','22057'),(655,'Tcf3','21423'),(656,'Stat4','20849'),(657,'Bcl6','12053'),(658,'Hnf1a','21405'),(659,'Nfe2l2','18024'),(660,'Gli1','14632'),(661,'Neurog3','11925'),(662,'Fli1','14247'),(663,'Ctnnb1','12387'),(664,'Egr1','13653'),(665,'Ep300','328572'),(666,'Pdx1','18609'),(667,'Plag1','56711'),(668,'Mnt','17428'),(669,'Ruvbl1','56505'),(670,'Hif1a','15251'),(671,'Epas1','13819'),(672,'Arntl','11865'),(673,'Arntl','11866'),(674,'Cdkn2a','12578'),(675,'Notch2','18129'),(676,'Notch3','18131'),(677,'Notch4','18132'),(678,'Atf4','11911'),(679,'Brca1','12189'),(680,'Hnf4a','15378'),(681,'Tbx2','21385'),(682,'Nupr1','56312'),(683,'Nkx2-3','18089'),(684,'Wt1','22431'),(685,'S100a4','20198'),(686,'Col4a1','12826'),(687,'Ccl3','20302'),(688,'Kat14','228714'),(689,'Aurkc','20871'),(690,'Dot1l','208266'),(691,'Kat5','81601'),(692,'Hdac6','15185'),(693,'Nphs1','54631'),(694,'Kirrel','170643'),(695,'Synpo','104027'),(696,'Trpc5','22067'),(697,'Trpc6','22068'),(698,'Rac1','19353'),(699,'Cdc42','12540'),(700,'Orai1','109305'),(701,'Stim1','20866'),(702,'Stim2','116873'),(703,'Mir10a','723893'),(704,'Tnfrsf1b','21938'),(705,'Ffar1','233081'),(706,'Cxcr1','227288'),(707,'Cxcr2','12765'),(708,'Cdkn1a','12575'),(709,'Ptgs2','19225'),(710,'Ptger4','19219'),(711,'Abcb1b','18669'),(712,'Ugt1a1','394436'),(713,'Bbox1','64564'),(714,'Ighm','10619'),(715,'Hmox1','15368'),(716,'Gstp1','14870'),(717,'Camk2a','12322'),(718,'Calb1','12307'),(719,'H3','109741'),(720,'Mtor','56717'),(721,'Prdm1','12142'),(722,'Arg1','11846'),(723,'Casp3','12367'),(724,'Bdnf','12064'),(725,'Sod1','20655'),(726,'Cat','12359'),(727,'Itgam','16409'),(728,'Il5','16191'),(729,'Tph1','21990'),(730,'Ido1','15930'),(731,'Cpt1a','12894'),(732,'Ucp1','22227'),(733,'Il27','246779'),(734,'Cd274','60533'),(735,'Entpd1','12495'),(736,'Tjp2','21873'),(737,'F11r','16456'),(738,'Myd88','17874'),(739,'mct1','17236'),(740,'Ggt1','14598'),(741,'Slc17a5','235504'),(742,'Gpt','76282'),(743,'Cd36','12491'),(744,'Fabp2','25598'),(745,'Ccr1','12768'),(746,'Ccl4','20303'),(747,'Bcl2','12043'),(748,'Tnfrsf10b','21933'),(749,'Cnr1','12801'),(750,'Nelfcd','57314'),(751,'Slc9a3','105243'),(752,'Slc26a3','13487'),(753,'Pdia4','12304'),(754,'Car2','12349'),(755,'Pdzk1','59020'),(756,'Axin2','12006'),(757,'Cd44','12505'),(758,'Ephb2','13844'),(759,'Ccnd1','12443'),(760,'Grin1','14810'),(761,'Ifne','230405'),(762,'Cyp11a1','13070'),(763,'Cyp11b1','110115'),(764,'Hsd11b1','15483'),(765,'Hsd11b2','15484'),(766,'Gpbar1','227289'),(767,'Zglp1','100009600'),(768,'Slc10a2','20494'),(769,'Slc51a','106407'),(770,'Lcn2','16819'),(771,'Csf3','12985'),(772,'Csf2','12981'),(773,'Pnmt','18948'),(774,'Acc','104371'),(775,'Gpam','14732'),(776,'Mlxipl','58805'),(777,'Srebf2','20788'),(778,'Hmgcr','15357'),(779,'Il1','111343');
/*!40000 ALTER TABLE `gene` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `gene_kegg_info`
--

DROP TABLE IF EXISTS `gene_kegg_info`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `gene_kegg_info` (
  `Microbiota_KEGG_info_index` varchar(45) NOT NULL,
  `Gene_KEGG_pathway` longtext,
  `KEGG_brite` longtext,
  PRIMARY KEY (`Microbiota_KEGG_info_index`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_0900_ai_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `gene_kegg_info`
--

LOCK TABLES `gene_kegg_info` WRITE;
/*!40000 ALTER TABLE `gene_kegg_info` DISABLE KEYS */;
INSERT INTO `gene_kegg_info` VALUES ('3078','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04657  IL-17 signaling pathway, hsa04668  TNF signaling pathway, hsa05133  Pertussis, hsa05323  Rheumatoid arthritis','04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05133 Pertussis, 05323 Rheumatoid arthritis, 04052 Cytokines and growth factors [BR:hsa04052], Chemokines'),('3079','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04657  IL-17 signaling pathway, hsa04668  TNF signaling pathway, hsa05323  Rheumatoid arthritis','04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05323 Rheumatoid arthritis, 04052 Cytokines and growth factors [BR:hsa04052], Chemokines'),('3080',NULL,'04147 Exosome [BR:hsa04147], Exosomal proteins of ovarian cancer cells'),('3081',NULL,'04147 Exosome [BR:hsa04147], Exosomal proteins of ovarian cancer cells'),('3082',NULL,'04147 Exosome [BR:hsa04147], Exosomal proteins of ovarian cancer cells'),('3084','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04657  IL-17 signaling pathway, hsa04668  TNF signaling pathway, hsa05133  Pertussis, hsa05323  Rheumatoid arthritis','04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05133 Pertussis, 05323 Rheumatoid arthritis, 04052 Cytokines and growth factors [BR:hsa04052], Chemokines'),('3085','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04657  IL-17 signaling pathway, hsa04668  TNF signaling pathway, hsa05323  Rheumatoid arthritis','04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05323 Rheumatoid arthritis, 04052 Cytokines and growth factors [BR:hsa04052], Chemokines'),('3086','hsa04918  Thyroid hormone synthesis','04918 Thyroid hormone synthesis, 04131 Membrane trafficking [BR:hsa04131], 1.6.3.1  NAD(P)H oxidase (H2O2-forming), 1.11.1.-, NADPH oxidases'),('3087','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04657  IL-17 signaling pathway, hsa04668  TNF signaling pathway, hsa05133  Pertussis, hsa05323  Rheumatoid arthritis','04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05133 Pertussis, 05323 Rheumatoid arthritis, 04052 Cytokines and growth factors [BR:hsa04052], Chemokines'),('3109','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa04010  MAPK signaling pathway, hsa04012  ErbB signaling pathway, hsa04014  Ras signaling pathway, hsa04015  Rap1 signaling pathway, hsa04020  Calcium signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04144  Endocytosis, hsa04151  PI3K-Akt signaling pathway, hsa04510  Focal adhesion, hsa04520  Adherens junction, hsa04540  Gap junction, hsa04630  JAK-STAT signaling pathway, hsa04810  Regulation of actin cytoskeleton, hsa04912  GnRH signaling pathway, hsa04915  Estrogen signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04934  Cushing syndrome, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05131  Shigellosis, hsa05160  Hepatitis C, hsa05163  Human cytomegalovirus infection, hsa05165  Human papillomavirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05218  Melanoma, hsa05219  Bladder cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04020 Calcium signaling pathway, 04072 Phospholipase D signaling pathway, 04151 PI3K-Akt signaling pathway, 04144 Endocytosis, 04510 Focal adhesion, 04520 Adherens junction, 04540 Gap junction, 04810 Regulation of actin cytoskeleton, 04912 GnRH signaling pathway, 04915 Estrogen signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05218 Melanoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05223 Non-small cell lung cancer, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05163 Human cytomegalovirus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05131 Shigellosis, 04934 Cushing syndrome, 01521 EGFR tyrosine kinase inhibitor resistance, 01522 Endocrine resistance, 01001 Protein kinases [BR:hsa01001], 04147 Exosome [BR:hsa04147], 2.7.10.1  receptor protein-tyrosine kinase, EGFR family [OT], Exosomal proteins of colorectal cancer cells, Exosomal proteins of pancreatic cancer cells, Exosomal proteins of bladder cancer cells'),('3110','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa04010  MAPK signaling pathway, hsa04012  ErbB signaling pathway, hsa04014  Ras signaling pathway, hsa04015  Rap1 signaling pathway, hsa04020  Calcium signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04144  Endocytosis, hsa04151  PI3K-Akt signaling pathway, hsa04510  Focal adhesion, hsa04520  Adherens junction, hsa04540  Gap junction, hsa04630  JAK-STAT signaling pathway, hsa04810  Regulation of actin cytoskeleton, hsa04912  GnRH signaling pathway, hsa04915  Estrogen signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04934  Cushing syndrome, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05131  Shigellosis, hsa05160  Hepatitis C, hsa05163  Human cytomegalovirus infection, hsa05165  Human papillomavirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05218  Melanoma, hsa05219  Bladder cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04020 Calcium signaling pathway, 04072 Phospholipase D signaling pathway, 04151 PI3K-Akt signaling pathway, 04144 Endocytosis, 04510 Focal adhesion, 04520 Adherens junction, 04540 Gap junction, 04810 Regulation of actin cytoskeleton, 04912 GnRH signaling pathway, 04915 Estrogen signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05218 Melanoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05223 Non-small cell lung cancer, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05163 Human cytomegalovirus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05131 Shigellosis, 04934 Cushing syndrome, 01521 EGFR tyrosine kinase inhibitor resistance, 01522 Endocrine resistance, 01001 Protein kinases [BR:hsa01001], 04147 Exosome [BR:hsa04147], 2.7.10.1  receptor protein-tyrosine kinase, EGFR family [OT], Exosomal proteins of colorectal cancer cells, Exosomal proteins of pancreatic cancer cells, Exosomal proteins of bladder cancer cells'),('3111','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa04010  MAPK signaling pathway, hsa04012  ErbB signaling pathway, hsa04014  Ras signaling pathway, hsa04015  Rap1 signaling pathway, hsa04020  Calcium signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04144  Endocytosis, hsa04151  PI3K-Akt signaling pathway, hsa04510  Focal adhesion, hsa04520  Adherens junction, hsa04540  Gap junction, hsa04630  JAK-STAT signaling pathway, hsa04810  Regulation of actin cytoskeleton, hsa04912  GnRH signaling pathway, hsa04915  Estrogen signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04934  Cushing syndrome, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05131  Shigellosis, hsa05160  Hepatitis C, hsa05163  Human cytomegalovirus infection, hsa05165  Human papillomavirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05218  Melanoma, hsa05219  Bladder cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04020 Calcium signaling pathway, 04072 Phospholipase D signaling pathway, 04151 PI3K-Akt signaling pathway, 04144 Endocytosis, 04510 Focal adhesion, 04520 Adherens junction, 04540 Gap junction, 04810 Regulation of actin cytoskeleton, 04912 GnRH signaling pathway, 04915 Estrogen signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05218 Melanoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05223 Non-small cell lung cancer, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05163 Human cytomegalovirus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05131 Shigellosis, 04934 Cushing syndrome, 01521 EGFR tyrosine kinase inhibitor resistance, 01522 Endocrine resistance, 01001 Protein kinases [BR:hsa01001], 04147 Exosome [BR:hsa04147], 2.7.10.1  receptor protein-tyrosine kinase, EGFR family [OT], Exosomal proteins of colorectal cancer cells, Exosomal proteins of pancreatic cancer cells, Exosomal proteins of bladder cancer cells'),('3112',NULL,'04030 G protein-coupled receptors [BR:hsa04030], Free fatty acid'),('3113','hsa04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], Free fatty acid'),('3114','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04668  TNF signaling pathway, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05135 Yersinia infection, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3115',NULL,'04030 G protein-coupled receptors [BR:hsa04030], Free fatty acid'),('3116','hsa04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], Free fatty acid'),('3117','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04668  TNF signaling pathway, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05135 Yersinia infection, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3118',NULL,'04030 G protein-coupled receptors [BR:hsa04030], Free fatty acid'),('3119','hsa04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], Free fatty acid'),('3120','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04668  TNF signaling pathway, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05135 Yersinia infection, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3141','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04068  FoxO signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05150  Staphylococcus aureus infection, hsa05152  Tuberculosis, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3142','hsa04060  Cytokine-cytokine receptor interaction, hsa04620  Toll-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05205  Proteoglycans in cancer, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3143','hsa04060  Cytokine-cytokine receptor interaction, hsa04620  Toll-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3144','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04068  FoxO signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05150  Staphylococcus aureus infection, hsa05152  Tuberculosis, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3145','hsa04060  Cytokine-cytokine receptor interaction, hsa04620  Toll-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05205  Proteoglycans in cancer, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3146','hsa04060  Cytokine-cytokine receptor interaction, hsa04620  Toll-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3149','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway','04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04062 Chemokine signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], 04050 Cytokine receptors [BR:hsa04050], 04090 CD molecules [BR:hsa04090], CC Chemokine, CC Chemokine, Proteins'),('3150','hsa04060  Cytokine-cytokine receptor interaction, hsa04062  Chemokine signaling pathway','04060 Cytokine-cytokine receptor interaction, 04062 Chemokine signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], 04050 Cytokine receptors [BR:hsa04050], 04090 CD molecules [BR:hsa04090], CXC Chemokine, CXC Chemokine, Proteins'),('3151','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway','04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04062 Chemokine signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], 04050 Cytokine receptors [BR:hsa04050], 04090 CD molecules [BR:hsa04090], CXC Chemokine, CXC Chemokine, Proteins'),('3152','hsa04530  Tight junction, hsa05110  Vibrio cholerae infection','04530 Tight junction, 05110 Vibrio cholerae infection'),('3153','hsa04530  Tight junction, hsa05110  Vibrio cholerae infection','04530 Tight junction, 05110 Vibrio cholerae infection'),('3154','hsa04015  Rap1 signaling pathway, hsa04062  Chemokine signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04144  Endocytosis, hsa04360  Axon guidance, hsa04390  Hippo signaling pathway, hsa04530  Tight junction, hsa04611  Platelet activation, hsa04910  Insulin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05165  Human papillomavirus infection, hsa05415  Diabetic cardiomyopathy, hsa05418  Fluid shear stress and atherosclerosis','04015 Rap1 signaling pathway, 04390 Hippo signaling pathway, 04071 Sphingolipid signaling pathway, 04144 Endocytosis, 04530 Tight junction, 04611 Platelet activation, 04062 Chemokine signaling pathway, 04910 Insulin signaling pathway, 04926 Relaxin signaling pathway, 04360 Axon guidance, 05165 Human papillomavirus infection, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04930 Type II diabetes mellitus, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01001 Protein kinases [BR:hsa01001], 2.7.11.13  protein kinase C, PKC family [OT]'),('3155','hsa04015  Rap1 signaling pathway, hsa04062  Chemokine signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04144  Endocytosis, hsa04360  Axon guidance, hsa04390  Hippo signaling pathway, hsa04530  Tight junction, hsa04611  Platelet activation, hsa04910  Insulin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05165  Human papillomavirus infection, hsa05415  Diabetic cardiomyopathy, hsa05418  Fluid shear stress and atherosclerosis','04015 Rap1 signaling pathway, 04390 Hippo signaling pathway, 04071 Sphingolipid signaling pathway, 04144 Endocytosis, 04530 Tight junction, 04611 Platelet activation, 04062 Chemokine signaling pathway, 04910 Insulin signaling pathway, 04926 Relaxin signaling pathway, 04360 Axon guidance, 05165 Human papillomavirus infection, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04930 Type II diabetes mellitus, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01001 Protein kinases [BR:hsa01001], 2.7.11.13  protein kinase C, PKC family [OT]'),('3156','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04064  NF-kappa B signaling pathway, hsa04217  Necroptosis, hsa04380  Osteoclast differentiation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04750  Inflammatory mediator regulation of TRP channels, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3157','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04064  NF-kappa B signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04150  mTOR signaling pathway, hsa04210  Apoptosis, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05310  Asthma, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05414  Dilated cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Tumor necrosis fators, Cytokines'),('3158','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04010  MAPK signaling pathway, hsa04012  ErbB signaling pathway, hsa04014  Ras signaling pathway, hsa04015  Rap1 signaling pathway, hsa04022  cGMP-PKG signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04114  Oocyte meiosis, hsa04140  Autophagy - animal, hsa04150  mTOR signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04218  Cellular senescence, hsa04261  Adrenergic signaling in cardiomyocytes, hsa04270  Vascular smooth muscle contraction, hsa04350  TGF-beta signaling pathway, hsa04360  Axon guidance, hsa04370  VEGF signaling pathway, hsa04371  Apelin signaling pathway, hsa04380  Osteoclast differentiation, hsa04510  Focal adhesion, hsa04520  Adherens junction, hsa04540  Gap junction, hsa04550  Signaling pathways regulating pluripotency of stem cells, hsa04611  Platelet activation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04666  Fc gamma R-mediated phagocytosis, hsa04668  TNF signaling pathway, hsa04713  Circadian entrainment, hsa04720  Long-term potentiation, hsa04722  Neurotrophin signaling pathway, hsa04723  Retrograde endocannabinoid signaling, hsa04724  Glutamatergic synapse, hsa04725  Cholinergic synapse, hsa04726  Serotonergic synapse, hsa04730  Long-term depression, hsa04810  Regulation of actin cytoskeleton, hsa04910  Insulin signaling pathway, hsa04912  GnRH signaling pathway, hsa04914  Progesterone-mediated oocyte maturation, hsa04915  Estrogen signaling pathway, hsa04916  Melanogenesis, hsa04917  Prolactin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04929  GnRH secretion, hsa04930  Type II diabetes mellitus, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04934  Cushing syndrome, hsa04935  Growth hormone synthesis, secretion and action, hsa04960  Aldosterone-regulated sodium reabsorption, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05034  Alcoholism, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05216  Thyroid cancer, hsa05218  Melanoma, hsa05219  Bladder cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04350 TGF-beta signaling pathway, 04370 VEGF signaling pathway, 04371 Apelin signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04072 Phospholipase D signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04022 cGMP-PKG signaling pathway, 04151 PI3K-Akt signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04114 Oocyte meiosis, 04210 Apoptosis, 04218 Cellular senescence, 04510 Focal adhesion, 04520 Adherens junction, 04540 Gap junction, 04550 Signaling pathways regulating pluripotency of stem cells, 04810 Regulation of actin cytoskeleton, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04664 Fc epsilon RI signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04062 Chemokine signaling pathway, 04910 Insulin signaling pathway, 04929 GnRH secretion, 04912 GnRH signaling pathway, 04915 Estrogen signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 04916 Melanogenesis, 04261 Adrenergic signaling in cardiomyocytes, 04270 Vascular smooth muscle contraction, 04960 Aldosterone-regulated sodium reabsorption, 04724 Glutamatergic synapse, 04725 Cholinergic synapse, 04726 Serotonergic synapse, 04720 Long-term potentiation, 04730 Long-term depression, 04723 Retrograde endocannabinoid signaling, 04722 Neurotrophin signaling pathway, 04360 Axon guidance, 04380 Osteoclast differentiation, 04713 Circadian entrainment, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05211 Renal cell carcinoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05152 Tuberculosis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05034 Alcoholism, 05417 Lipid and atherosclerosis, 04930 Type II diabetes mellitus, 04933 AGE-RAGE signaling pathway in diabetic complications, 04934 Cushing syndrome, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01001 Protein kinases [BR:hsa01001], 03036 Chromosome and associated proteins [BR:hsa03036], 04147 Exosome [BR:hsa04147], 2.7.11.24  mitogen-activated protein kinase, MAPK family [OT], Protein kinases, Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)'),('3159','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04010  MAPK signaling pathway, hsa04012  ErbB signaling pathway, hsa04014  Ras signaling pathway, hsa04015  Rap1 signaling pathway, hsa04022  cGMP-PKG signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04114  Oocyte meiosis, hsa04140  Autophagy - animal, hsa04150  mTOR signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04218  Cellular senescence, hsa04261  Adrenergic signaling in cardiomyocytes, hsa04270  Vascular smooth muscle contraction, hsa04350  TGF-beta signaling pathway, hsa04360  Axon guidance, hsa04370  VEGF signaling pathway, hsa04371  Apelin signaling pathway, hsa04380  Osteoclast differentiation, hsa04510  Focal adhesion, hsa04520  Adherens junction, hsa04540  Gap junction, hsa04550  Signaling pathways regulating pluripotency of stem cells, hsa04611  Platelet activation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04666  Fc gamma R-mediated phagocytosis, hsa04668  TNF signaling pathway, hsa04713  Circadian entrainment, hsa04720  Long-term potentiation, hsa04722  Neurotrophin signaling pathway, hsa04723  Retrograde endocannabinoid signaling, hsa04724  Glutamatergic synapse, hsa04725  Cholinergic synapse, hsa04726  Serotonergic synapse, hsa04730  Long-term depression, hsa04810  Regulation of actin cytoskeleton, hsa04910  Insulin signaling pathway, hsa04912  GnRH signaling pathway, hsa04914  Progesterone-mediated oocyte maturation, hsa04915  Estrogen signaling pathway, hsa04916  Melanogenesis, hsa04917  Prolactin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04929  GnRH secretion, hsa04930  Type II diabetes mellitus, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04934  Cushing syndrome, hsa04935  Growth hormone synthesis, secretion and action, hsa04960  Aldosterone-regulated sodium reabsorption, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05034  Alcoholism, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05216  Thyroid cancer, hsa05218  Melanoma, hsa05219  Bladder cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04350 TGF-beta signaling pathway, 04370 VEGF signaling pathway, 04371 Apelin signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04072 Phospholipase D signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04022 cGMP-PKG signaling pathway, 04151 PI3K-Akt signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04114 Oocyte meiosis, 04210 Apoptosis, 04218 Cellular senescence, 04510 Focal adhesion, 04520 Adherens junction, 04540 Gap junction, 04550 Signaling pathways regulating pluripotency of stem cells, 04810 Regulation of actin cytoskeleton, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04664 Fc epsilon RI signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04062 Chemokine signaling pathway, 04910 Insulin signaling pathway, 04929 GnRH secretion, 04912 GnRH signaling pathway, 04915 Estrogen signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 04916 Melanogenesis, 04261 Adrenergic signaling in cardiomyocytes, 04270 Vascular smooth muscle contraction, 04960 Aldosterone-regulated sodium reabsorption, 04724 Glutamatergic synapse, 04725 Cholinergic synapse, 04726 Serotonergic synapse, 04720 Long-term potentiation, 04730 Long-term depression, 04723 Retrograde endocannabinoid signaling, 04722 Neurotrophin signaling pathway, 04360 Axon guidance, 04380 Osteoclast differentiation, 04713 Circadian entrainment, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05211 Renal cell carcinoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05152 Tuberculosis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05034 Alcoholism, 05417 Lipid and atherosclerosis, 04930 Type II diabetes mellitus, 04933 AGE-RAGE signaling pathway in diabetic complications, 04934 Cushing syndrome, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01001 Protein kinases [BR:hsa01001], 03036 Chromosome and associated proteins [BR:hsa03036], 04147 Exosome [BR:hsa04147], 2.7.11.24  mitogen-activated protein kinase, MAPK family [OT], Protein kinases, Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)'),('3160','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04668  TNF signaling pathway, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05135 Yersinia infection, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3161','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3162','hsa01522  Endocrine resistance, hsa04010  MAPK signaling pathway, hsa04024  cAMP signaling pathway, hsa04210  Apoptosis, hsa04380  Osteoclast differentiation, hsa04620  Toll-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04668  TNF signaling pathway, hsa04713  Circadian entrainment, hsa04725  Cholinergic synapse, hsa04728  Dopaminergic synapse, hsa04915  Estrogen signaling pathway, hsa04917  Prolactin signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04932  Non-alcoholic fatty liver disease, hsa04935  Growth hormone synthesis, secretion and action, hsa05031  Amphetamine addiction, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05161  Hepatitis B, hsa05162  Measles, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05224  Breast cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04668 TNF signaling pathway, 04024 cAMP signaling pathway, 04210 Apoptosis, 04620 Toll-like receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04915 Estrogen signaling pathway, 04917 Prolactin signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04928 Parathyroid hormone synthesis, secretion and action, 04725 Cholinergic synapse, 04728 Dopaminergic synapse, 04380 Osteoclast differentiation, 04713 Circadian entrainment, 05200 Pathways in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05224 Breast cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05167 Kaposi sarcoma-associated herpesvirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05031 Amphetamine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 01522 Endocrine resistance, 03000 Transcription factors [BR:hsa03000], 04131 Membrane trafficking [BR:hsa04131], AP-1(-like) components, Fos, Selective cargos'),('3163','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04010  MAPK signaling pathway, hsa04012  ErbB signaling pathway, hsa04014  Ras signaling pathway, hsa04015  Rap1 signaling pathway, hsa04022  cGMP-PKG signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04114  Oocyte meiosis, hsa04140  Autophagy - animal, hsa04150  mTOR signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04218  Cellular senescence, hsa04261  Adrenergic signaling in cardiomyocytes, hsa04270  Vascular smooth muscle contraction, hsa04350  TGF-beta signaling pathway, hsa04360  Axon guidance, hsa04370  VEGF signaling pathway, hsa04371  Apelin signaling pathway, hsa04380  Osteoclast differentiation, hsa04510  Focal adhesion, hsa04520  Adherens junction, hsa04540  Gap junction, hsa04550  Signaling pathways regulating pluripotency of stem cells, hsa04611  Platelet activation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04666  Fc gamma R-mediated phagocytosis, hsa04668  TNF signaling pathway, hsa04713  Circadian entrainment, hsa04720  Long-term potentiation, hsa04722  Neurotrophin signaling pathway, hsa04723  Retrograde endocannabinoid signaling, hsa04724  Glutamatergic synapse, hsa04725  Cholinergic synapse, hsa04726  Serotonergic synapse, hsa04730  Long-term depression, hsa04810  Regulation of actin cytoskeleton, hsa04910  Insulin signaling pathway, hsa04912  GnRH signaling pathway, hsa04914  Progesterone-mediated oocyte maturation, hsa04915  Estrogen signaling pathway, hsa04916  Melanogenesis, hsa04917  Prolactin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04929  GnRH secretion, hsa04930  Type II diabetes mellitus, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04934  Cushing syndrome, hsa04935  Growth hormone synthesis, secretion and action, hsa04960  Aldosterone-regulated sodium reabsorption, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05034  Alcoholism, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05216  Thyroid cancer, hsa05218  Melanoma, hsa05219  Bladder cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04350 TGF-beta signaling pathway, 04370 VEGF signaling pathway, 04371 Apelin signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04072 Phospholipase D signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04022 cGMP-PKG signaling pathway, 04151 PI3K-Akt signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04114 Oocyte meiosis, 04210 Apoptosis, 04218 Cellular senescence, 04510 Focal adhesion, 04520 Adherens junction, 04540 Gap junction, 04550 Signaling pathways regulating pluripotency of stem cells, 04810 Regulation of actin cytoskeleton, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04664 Fc epsilon RI signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04062 Chemokine signaling pathway, 04910 Insulin signaling pathway, 04929 GnRH secretion, 04912 GnRH signaling pathway, 04915 Estrogen signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 04916 Melanogenesis, 04261 Adrenergic signaling in cardiomyocytes, 04270 Vascular smooth muscle contraction, 04960 Aldosterone-regulated sodium reabsorption, 04724 Glutamatergic synapse, 04725 Cholinergic synapse, 04726 Serotonergic synapse, 04720 Long-term potentiation, 04730 Long-term depression, 04723 Retrograde endocannabinoid signaling, 04722 Neurotrophin signaling pathway, 04360 Axon guidance, 04380 Osteoclast differentiation, 04713 Circadian entrainment, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05211 Renal cell carcinoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05152 Tuberculosis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05034 Alcoholism, 05417 Lipid and atherosclerosis, 04930 Type II diabetes mellitus, 04933 AGE-RAGE signaling pathway in diabetic complications, 04934 Cushing syndrome, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01001 Protein kinases [BR:hsa01001], 03036 Chromosome and associated proteins [BR:hsa03036], 04147 Exosome [BR:hsa04147], 2.7.11.24  mitogen-activated protein kinase, MAPK family [OT], Protein kinases, Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)'),('3164','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04010  MAPK signaling pathway, hsa04012  ErbB signaling pathway, hsa04014  Ras signaling pathway, hsa04015  Rap1 signaling pathway, hsa04022  cGMP-PKG signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04114  Oocyte meiosis, hsa04140  Autophagy - animal, hsa04150  mTOR signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04218  Cellular senescence, hsa04261  Adrenergic signaling in cardiomyocytes, hsa04270  Vascular smooth muscle contraction, hsa04350  TGF-beta signaling pathway, hsa04360  Axon guidance, hsa04370  VEGF signaling pathway, hsa04371  Apelin signaling pathway, hsa04380  Osteoclast differentiation, hsa04510  Focal adhesion, hsa04520  Adherens junction, hsa04540  Gap junction, hsa04550  Signaling pathways regulating pluripotency of stem cells, hsa04611  Platelet activation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04666  Fc gamma R-mediated phagocytosis, hsa04668  TNF signaling pathway, hsa04713  Circadian entrainment, hsa04720  Long-term potentiation, hsa04722  Neurotrophin signaling pathway, hsa04723  Retrograde endocannabinoid signaling, hsa04724  Glutamatergic synapse, hsa04725  Cholinergic synapse, hsa04726  Serotonergic synapse, hsa04730  Long-term depression, hsa04810  Regulation of actin cytoskeleton, hsa04910  Insulin signaling pathway, hsa04912  GnRH signaling pathway, hsa04914  Progesterone-mediated oocyte maturation, hsa04915  Estrogen signaling pathway, hsa04916  Melanogenesis, hsa04917  Prolactin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04929  GnRH secretion, hsa04930  Type II diabetes mellitus, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04934  Cushing syndrome, hsa04935  Growth hormone synthesis, secretion and action, hsa04960  Aldosterone-regulated sodium reabsorption, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05034  Alcoholism, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05216  Thyroid cancer, hsa05218  Melanoma, hsa05219  Bladder cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04350 TGF-beta signaling pathway, 04370 VEGF signaling pathway, 04371 Apelin signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04072 Phospholipase D signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04022 cGMP-PKG signaling pathway, 04151 PI3K-Akt signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04114 Oocyte meiosis, 04210 Apoptosis, 04218 Cellular senescence, 04510 Focal adhesion, 04520 Adherens junction, 04540 Gap junction, 04550 Signaling pathways regulating pluripotency of stem cells, 04810 Regulation of actin cytoskeleton, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04664 Fc epsilon RI signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04062 Chemokine signaling pathway, 04910 Insulin signaling pathway, 04929 GnRH secretion, 04912 GnRH signaling pathway, 04915 Estrogen signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 04916 Melanogenesis, 04261 Adrenergic signaling in cardiomyocytes, 04270 Vascular smooth muscle contraction, 04960 Aldosterone-regulated sodium reabsorption, 04724 Glutamatergic synapse, 04725 Cholinergic synapse, 04726 Serotonergic synapse, 04720 Long-term potentiation, 04730 Long-term depression, 04723 Retrograde endocannabinoid signaling, 04722 Neurotrophin signaling pathway, 04360 Axon guidance, 04380 Osteoclast differentiation, 04713 Circadian entrainment, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05211 Renal cell carcinoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05152 Tuberculosis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05034 Alcoholism, 05417 Lipid and atherosclerosis, 04930 Type II diabetes mellitus, 04933 AGE-RAGE signaling pathway in diabetic complications, 04934 Cushing syndrome, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01001 Protein kinases [BR:hsa01001], 03036 Chromosome and associated proteins [BR:hsa03036], 04147 Exosome [BR:hsa04147], 2.7.11.24  mitogen-activated protein kinase, MAPK family [OT], Protein kinases, Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)'),('3165','hsa01522  Endocrine resistance, hsa04010  MAPK signaling pathway, hsa04012  ErbB signaling pathway, hsa04024  cAMP signaling pathway, hsa04137  Mitophagy - animal, hsa04210  Apoptosis, hsa04310  Wnt signaling pathway, hsa04380  Osteoclast differentiation, hsa04510  Focal adhesion, hsa04530  Tight junction, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04668  TNF signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04912  GnRH signaling pathway, hsa04915  Estrogen signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05030  Cocaine addiction, hsa05031  Amphetamine addiction, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05161  Hepatitis B, hsa05162  Measles, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05224  Breast cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04310 Wnt signaling pathway, 04668 TNF signaling pathway, 04024 cAMP signaling pathway, 04137 Mitophagy - animal, 04210 Apoptosis, 04510 Focal adhesion, 04530 Tight junction, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04912 GnRH signaling pathway, 04915 Estrogen signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05211 Renal cell carcinoma, 05224 Breast cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05030 Cocaine addiction, 05031 Amphetamine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01522 Endocrine resistance, 03000 Transcription factors [BR:hsa03000], AP-1(-like) components, Jun'),('3166','hsa01522  Endocrine resistance, hsa04010  MAPK signaling pathway, hsa04024  cAMP signaling pathway, hsa04210  Apoptosis, hsa04380  Osteoclast differentiation, hsa04620  Toll-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04668  TNF signaling pathway, hsa04713  Circadian entrainment, hsa04725  Cholinergic synapse, hsa04728  Dopaminergic synapse, hsa04915  Estrogen signaling pathway, hsa04917  Prolactin signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04932  Non-alcoholic fatty liver disease, hsa04935  Growth hormone synthesis, secretion and action, hsa05031  Amphetamine addiction, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05161  Hepatitis B, hsa05162  Measles, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05224  Breast cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04668 TNF signaling pathway, 04024 cAMP signaling pathway, 04210 Apoptosis, 04620 Toll-like receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04915 Estrogen signaling pathway, 04917 Prolactin signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04928 Parathyroid hormone synthesis, secretion and action, 04725 Cholinergic synapse, 04728 Dopaminergic synapse, 04380 Osteoclast differentiation, 04713 Circadian entrainment, 05200 Pathways in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05224 Breast cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05167 Kaposi sarcoma-associated herpesvirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05031 Amphetamine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 01522 Endocrine resistance, 03000 Transcription factors [BR:hsa03000], 04131 Membrane trafficking [BR:hsa04131], AP-1(-like) components, Fos, Selective cargos'),('3167','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04010  MAPK signaling pathway, hsa04012  ErbB signaling pathway, hsa04014  Ras signaling pathway, hsa04015  Rap1 signaling pathway, hsa04022  cGMP-PKG signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04114  Oocyte meiosis, hsa04140  Autophagy - animal, hsa04150  mTOR signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04218  Cellular senescence, hsa04261  Adrenergic signaling in cardiomyocytes, hsa04270  Vascular smooth muscle contraction, hsa04350  TGF-beta signaling pathway, hsa04360  Axon guidance, hsa04370  VEGF signaling pathway, hsa04371  Apelin signaling pathway, hsa04380  Osteoclast differentiation, hsa04510  Focal adhesion, hsa04520  Adherens junction, hsa04540  Gap junction, hsa04550  Signaling pathways regulating pluripotency of stem cells, hsa04611  Platelet activation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04666  Fc gamma R-mediated phagocytosis, hsa04668  TNF signaling pathway, hsa04713  Circadian entrainment, hsa04720  Long-term potentiation, hsa04722  Neurotrophin signaling pathway, hsa04723  Retrograde endocannabinoid signaling, hsa04724  Glutamatergic synapse, hsa04725  Cholinergic synapse, hsa04726  Serotonergic synapse, hsa04730  Long-term depression, hsa04810  Regulation of actin cytoskeleton, hsa04910  Insulin signaling pathway, hsa04912  GnRH signaling pathway, hsa04914  Progesterone-mediated oocyte maturation, hsa04915  Estrogen signaling pathway, hsa04916  Melanogenesis, hsa04917  Prolactin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04929  GnRH secretion, hsa04930  Type II diabetes mellitus, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04934  Cushing syndrome, hsa04935  Growth hormone synthesis, secretion and action, hsa04960  Aldosterone-regulated sodium reabsorption, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05034  Alcoholism, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05216  Thyroid cancer, hsa05218  Melanoma, hsa05219  Bladder cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04350 TGF-beta signaling pathway, 04370 VEGF signaling pathway, 04371 Apelin signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04072 Phospholipase D signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04022 cGMP-PKG signaling pathway, 04151 PI3K-Akt signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04114 Oocyte meiosis, 04210 Apoptosis, 04218 Cellular senescence, 04510 Focal adhesion, 04520 Adherens junction, 04540 Gap junction, 04550 Signaling pathways regulating pluripotency of stem cells, 04810 Regulation of actin cytoskeleton, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04664 Fc epsilon RI signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04062 Chemokine signaling pathway, 04910 Insulin signaling pathway, 04929 GnRH secretion, 04912 GnRH signaling pathway, 04915 Estrogen signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 04916 Melanogenesis, 04261 Adrenergic signaling in cardiomyocytes, 04270 Vascular smooth muscle contraction, 04960 Aldosterone-regulated sodium reabsorption, 04724 Glutamatergic synapse, 04725 Cholinergic synapse, 04726 Serotonergic synapse, 04720 Long-term potentiation, 04730 Long-term depression, 04723 Retrograde endocannabinoid signaling, 04722 Neurotrophin signaling pathway, 04360 Axon guidance, 04380 Osteoclast differentiation, 04713 Circadian entrainment, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05211 Renal cell carcinoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05152 Tuberculosis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05034 Alcoholism, 05417 Lipid and atherosclerosis, 04930 Type II diabetes mellitus, 04933 AGE-RAGE signaling pathway in diabetic complications, 04934 Cushing syndrome, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01001 Protein kinases [BR:hsa01001], 03036 Chromosome and associated proteins [BR:hsa03036], 04147 Exosome [BR:hsa04147], 2.7.11.24  mitogen-activated protein kinase, MAPK family [OT], Protein kinases, Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)'),('3168','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04010  MAPK signaling pathway, hsa04012  ErbB signaling pathway, hsa04014  Ras signaling pathway, hsa04015  Rap1 signaling pathway, hsa04022  cGMP-PKG signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04114  Oocyte meiosis, hsa04140  Autophagy - animal, hsa04150  mTOR signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04218  Cellular senescence, hsa04261  Adrenergic signaling in cardiomyocytes, hsa04270  Vascular smooth muscle contraction, hsa04350  TGF-beta signaling pathway, hsa04360  Axon guidance, hsa04370  VEGF signaling pathway, hsa04371  Apelin signaling pathway, hsa04380  Osteoclast differentiation, hsa04510  Focal adhesion, hsa04520  Adherens junction, hsa04540  Gap junction, hsa04550  Signaling pathways regulating pluripotency of stem cells, hsa04611  Platelet activation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04666  Fc gamma R-mediated phagocytosis, hsa04668  TNF signaling pathway, hsa04713  Circadian entrainment, hsa04720  Long-term potentiation, hsa04722  Neurotrophin signaling pathway, hsa04723  Retrograde endocannabinoid signaling, hsa04724  Glutamatergic synapse, hsa04725  Cholinergic synapse, hsa04726  Serotonergic synapse, hsa04730  Long-term depression, hsa04810  Regulation of actin cytoskeleton, hsa04910  Insulin signaling pathway, hsa04912  GnRH signaling pathway, hsa04914  Progesterone-mediated oocyte maturation, hsa04915  Estrogen signaling pathway, hsa04916  Melanogenesis, hsa04917  Prolactin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04929  GnRH secretion, hsa04930  Type II diabetes mellitus, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04934  Cushing syndrome, hsa04935  Growth hormone synthesis, secretion and action, hsa04960  Aldosterone-regulated sodium reabsorption, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05034  Alcoholism, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05216  Thyroid cancer, hsa05218  Melanoma, hsa05219  Bladder cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04350 TGF-beta signaling pathway, 04370 VEGF signaling pathway, 04371 Apelin signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04072 Phospholipase D signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04022 cGMP-PKG signaling pathway, 04151 PI3K-Akt signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04114 Oocyte meiosis, 04210 Apoptosis, 04218 Cellular senescence, 04510 Focal adhesion, 04520 Adherens junction, 04540 Gap junction, 04550 Signaling pathways regulating pluripotency of stem cells, 04810 Regulation of actin cytoskeleton, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04664 Fc epsilon RI signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04062 Chemokine signaling pathway, 04910 Insulin signaling pathway, 04929 GnRH secretion, 04912 GnRH signaling pathway, 04915 Estrogen signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 04916 Melanogenesis, 04261 Adrenergic signaling in cardiomyocytes, 04270 Vascular smooth muscle contraction, 04960 Aldosterone-regulated sodium reabsorption, 04724 Glutamatergic synapse, 04725 Cholinergic synapse, 04726 Serotonergic synapse, 04720 Long-term potentiation, 04730 Long-term depression, 04723 Retrograde endocannabinoid signaling, 04722 Neurotrophin signaling pathway, 04360 Axon guidance, 04380 Osteoclast differentiation, 04713 Circadian entrainment, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05211 Renal cell carcinoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05152 Tuberculosis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05034 Alcoholism, 05417 Lipid and atherosclerosis, 04930 Type II diabetes mellitus, 04933 AGE-RAGE signaling pathway in diabetic complications, 04934 Cushing syndrome, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01001 Protein kinases [BR:hsa01001], 03036 Chromosome and associated proteins [BR:hsa03036], 04147 Exosome [BR:hsa04147], 2.7.11.24  mitogen-activated protein kinase, MAPK family [OT], Protein kinases, Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)'),('3169','hsa01522  Endocrine resistance, hsa04010  MAPK signaling pathway, hsa04012  ErbB signaling pathway, hsa04024  cAMP signaling pathway, hsa04137  Mitophagy - animal, hsa04210  Apoptosis, hsa04310  Wnt signaling pathway, hsa04380  Osteoclast differentiation, hsa04510  Focal adhesion, hsa04530  Tight junction, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04668  TNF signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04912  GnRH signaling pathway, hsa04915  Estrogen signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05030  Cocaine addiction, hsa05031  Amphetamine addiction, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05161  Hepatitis B, hsa05162  Measles, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05224  Breast cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04310 Wnt signaling pathway, 04668 TNF signaling pathway, 04024 cAMP signaling pathway, 04137 Mitophagy - animal, 04210 Apoptosis, 04510 Focal adhesion, 04530 Tight junction, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04912 GnRH signaling pathway, 04915 Estrogen signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05211 Renal cell carcinoma, 05224 Breast cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05030 Cocaine addiction, 05031 Amphetamine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01522 Endocrine resistance, 03000 Transcription factors [BR:hsa03000], AP-1(-like) components, Jun'),('3170','hsa05146  Amoebiasis, hsa05226  Gastric cancer','05226 Gastric cancer, 05146 Amoebiasis, 04131 Membrane trafficking [BR:hsa04131], Secretory mucins'),('3171','hsa04110  Cell cycle, hsa04213  Longevity regulating pathway - multiple species, hsa04330  Notch signaling pathway, hsa04613  Neutrophil extracellular trap formation, hsa04919  Thyroid hormone signaling pathway, hsa05016  Huntington disease, hsa05031  Amphetamine addiction, hsa05034  Alcoholism, hsa05165  Human papillomavirus infection, hsa05169  Epstein-Barr virus infection, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05206  MicroRNAs in cancer, hsa05220  Chronic myeloid leukemia','04330 Notch signaling pathway, 04110 Cell cycle, 04613 Neutrophil extracellular trap formation, 04919 Thyroid hormone signaling pathway, 04213 Longevity regulating pathway - multiple species, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05203 Viral carcinogenesis, 05220 Chronic myeloid leukemia, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05016 Huntington disease, 05031 Amphetamine addiction, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:hsa03036], 3.5.1.98  histone deacetylase, Class I HDACs, Sin3A-HDAC complex, BRAF-HDAC complex, Other heterochromatin formation proteins, NuRD complex'),('3172','hsa04110  Cell cycle, hsa04213  Longevity regulating pathway - multiple species, hsa04330  Notch signaling pathway, hsa04613  Neutrophil extracellular trap formation, hsa04919  Thyroid hormone signaling pathway, hsa05016  Huntington disease, hsa05031  Amphetamine addiction, hsa05034  Alcoholism, hsa05165  Human papillomavirus infection, hsa05169  Epstein-Barr virus infection, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05206  MicroRNAs in cancer, hsa05220  Chronic myeloid leukemia','04330 Notch signaling pathway, 04110 Cell cycle, 04613 Neutrophil extracellular trap formation, 04919 Thyroid hormone signaling pathway, 04213 Longevity regulating pathway - multiple species, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05203 Viral carcinogenesis, 05220 Chronic myeloid leukemia, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05016 Huntington disease, 05031 Amphetamine addiction, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:hsa03036], 3.5.1.98  histone deacetylase, Class I HDACs, Sin3A-HDAC complex, BRAF-HDAC complex, Other heterochromatin formation proteins, NuRD complex'),('3174','hsa04371  Apelin signaling pathway, hsa04613  Neutrophil extracellular trap formation, hsa05034  Alcoholism, hsa05203  Viral carcinogenesis, hsa05206  MicroRNAs in cancer','04371 Apelin signaling pathway, 04613 Neutrophil extracellular trap formation, 05206 MicroRNAs in cancer, 05203 Viral carcinogenesis, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:hsa03036], 3.5.1.98  histone deacetylase, Class II HDACs'),('3175','hsa04371  Apelin signaling pathway, hsa04613  Neutrophil extracellular trap formation, hsa05034  Alcoholism, hsa05203  Viral carcinogenesis, hsa05206  MicroRNAs in cancer','04371 Apelin signaling pathway, 04613 Neutrophil extracellular trap formation, 05206 MicroRNAs in cancer, 05203 Viral carcinogenesis, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:hsa03036], 3.5.1.98  histone deacetylase, Class II HDACs'),('3176','hsa04613  Neutrophil extracellular trap formation, hsa05034  Alcoholism, hsa05203  Viral carcinogenesis','04613 Neutrophil extracellular trap formation, 05203 Viral carcinogenesis, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:hsa03036], 3.5.1.98  histone deacetylase, Class II HDACs'),('3177','hsa04613  Neutrophil extracellular trap formation, hsa05034  Alcoholism, hsa05203  Viral carcinogenesis','04613 Neutrophil extracellular trap formation, 05203 Viral carcinogenesis, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:hsa03036], 3.5.1.98  histone deacetylase, Class I HDACs'),('3178','hsa04613  Neutrophil extracellular trap formation, hsa05034  Alcoholism, hsa05203  Viral carcinogenesis','04613 Neutrophil extracellular trap formation, 05203 Viral carcinogenesis, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:hsa03036], 3.5.1.98  histone deacetylase, Class II HDACs'),('3179','hsa04613  Neutrophil extracellular trap formation, hsa05034  Alcoholism, hsa05203  Viral carcinogenesis','04613 Neutrophil extracellular trap formation, 05203 Viral carcinogenesis, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:hsa03036], 3.5.1.98  histone deacetylase, Class IV HDACs'),('3180','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3181','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04064  NF-kappa B signaling pathway, hsa04217  Necroptosis, hsa04380  Osteoclast differentiation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04750  Inflammatory mediator regulation of TRP channels, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3182','hsa04620  Toll-like receptor signaling pathway, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05134  Legionellosis, hsa05321  Inflammatory bowel disease','04620 Toll-like receptor signaling pathway, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05134 Legionellosis, 05321 Inflammatory bowel disease, 04054 Pattern recognition receptors [BR:hsa04054], Toll-like receptors'),('3183','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3184','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04064  NF-kappa B signaling pathway, hsa04217  Necroptosis, hsa04380  Osteoclast differentiation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04750  Inflammatory mediator regulation of TRP channels, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3185','hsa04620  Toll-like receptor signaling pathway, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05134  Legionellosis, hsa05321  Inflammatory bowel disease','04620 Toll-like receptor signaling pathway, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05134 Legionellosis, 05321 Inflammatory bowel disease, 04054 Pattern recognition receptors [BR:hsa04054], Toll-like receptors'),('3192','hsa04145  Phagosome, hsa04151  PI3K-Akt signaling pathway, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa05132  Salmonella infection, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04151 PI3K-Akt signaling pathway, 04145 Phagosome, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 05205 Proteoglycans in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04131 Membrane trafficking [BR:hsa04131], 04147 Exosome [BR:hsa04147], 04054 Pattern recognition receptors [BR:hsa04054], 04090 CD molecules [BR:hsa04090], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Toll-like receptors, Exosomal proteins of breast milk, Toll-like receptors, Proteins, Cell surface receptors'),('3193','hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04145  Phagosome, hsa04151  PI3K-Akt signaling pathway, hsa04217  Necroptosis, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04936  Alcoholic liver disease, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05164  Influenza A, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04066 HIF-1 signaling pathway, 04151 PI3K-Akt signaling pathway, 04145 Phagosome, 04217 Necroptosis, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 05205 Proteoglycans in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04131 Membrane trafficking [BR:hsa04131], 04054 Pattern recognition receptors [BR:hsa04054], 04090 CD molecules [BR:hsa04090], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Toll-like receptors, Toll-like receptors, Proteins, Cell surface receptors'),('3237','hsa04520  Adherens junction, hsa04530  Tight junction, hsa04540  Gap junction, hsa05110  Vibrio cholerae infection, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 05110 Vibrio cholerae infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 04812 Cytoskeleton proteins [BR:hsa04812], Others'),('3238','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 04147 Exosome [BR:hsa04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('3239','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 01009 Protein phosphatases and associated proteins [BR:hsa01009], PP1-interacting proteins (PIPs)'),('3240','hsa04530  Tight junction','04530 Tight junction'),('3241','hsa04621  NOD-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa05150  Staphylococcus aureus infection','04621 NOD-like receptor signaling pathway, 04657 IL-17 signaling pathway, 05150 Staphylococcus aureus infection, 02000 Transporters [BR:hsa02000], Pores ion channels [TC:1]'),('3341','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa04010  MAPK signaling pathway, hsa04012  ErbB signaling pathway, hsa04014  Ras signaling pathway, hsa04015  Rap1 signaling pathway, hsa04020  Calcium signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04144  Endocytosis, hsa04151  PI3K-Akt signaling pathway, hsa04510  Focal adhesion, hsa04520  Adherens junction, hsa04540  Gap junction, hsa04630  JAK-STAT signaling pathway, hsa04810  Regulation of actin cytoskeleton, hsa04912  GnRH signaling pathway, hsa04915  Estrogen signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04934  Cushing syndrome, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05131  Shigellosis, hsa05160  Hepatitis C, hsa05163  Human cytomegalovirus infection, hsa05165  Human papillomavirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05218  Melanoma, hsa05219  Bladder cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04020 Calcium signaling pathway, 04072 Phospholipase D signaling pathway, 04151 PI3K-Akt signaling pathway, 04144 Endocytosis, 04510 Focal adhesion, 04520 Adherens junction, 04540 Gap junction, 04810 Regulation of actin cytoskeleton, 04912 GnRH signaling pathway, 04915 Estrogen signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05218 Melanoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05223 Non-small cell lung cancer, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05163 Human cytomegalovirus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05131 Shigellosis, 04934 Cushing syndrome, 01521 EGFR tyrosine kinase inhibitor resistance, 01522 Endocrine resistance, 01001 Protein kinases [BR:hsa01001], 04147 Exosome [BR:hsa04147], 2.7.10.1  receptor protein-tyrosine kinase, EGFR family [OT], Exosomal proteins of colorectal cancer cells, Exosomal proteins of pancreatic cancer cells, Exosomal proteins of bladder cancer cells'),('3342',NULL,'02000 Transporters [BR:hsa02000], SLC22: Organic cation/anion/zwitterion transporter, Organic cation transporter (OCT) family [TC:2.A.1.19]'),('3343','hsa04010  MAPK signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04145  Phagosome, hsa04620  Toll-like receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04936  Alcoholic liver disease, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05202  Transcriptional misregulation in cancer, hsa05221  Acute myeloid leukemia, hsa05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04145 Phagosome, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 05202 Transcriptional misregulation in cancer, 05221 Acute myeloid leukemia, 05132 Salmonella infection, 05131 Shigellosis, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04147 Exosome [BR:hsa04147], 04090 CD molecules [BR:hsa04090], 00537 Glycosylphosphatidylinositol (GPI)-anchored proteins [BR:hsa00537], Exosomal proteins of microglial cells, Proteins, Receptors'),('3344',NULL,'04090 CD molecules [BR:hsa04090], Proteins'),('3345','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04068  FoxO signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05150  Staphylococcus aureus infection, hsa05152  Tuberculosis, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3346','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04068  FoxO signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05150  Staphylococcus aureus infection, hsa05152  Tuberculosis, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3347','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04068  FoxO signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05150  Staphylococcus aureus infection, hsa05152  Tuberculosis, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3348','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04068  FoxO signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05150  Staphylococcus aureus infection, hsa05152  Tuberculosis, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3349','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3350','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3351','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3352','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3353','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3354','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3355','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3356','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3357','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3367','hsa03320  PPAR signaling pathway, hsa04979  Cholesterol metabolism','03320 PPAR signaling pathway, 04979 Cholesterol metabolism, 04147 Exosome [BR:hsa04147], Exosomal proteins of breast milk'),('3371','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04064  NF-kappa B signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04150  mTOR signaling pathway, hsa04210  Apoptosis, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05310  Asthma, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05414  Dilated cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Tumor necrosis fators, Cytokines'),('3417','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 01009 Protein phosphatases and associated proteins [BR:hsa01009], PP1-interacting proteins (PIPs)'),('3418','hsa04520  Adherens junction, hsa04530  Tight junction, hsa04540  Gap junction, hsa05110  Vibrio cholerae infection, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 05110 Vibrio cholerae infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 04812 Cytoskeleton proteins [BR:hsa04812], Others'),('3419','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 04147 Exosome [BR:hsa04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('3420','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 04147 Exosome [BR:hsa04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('3421','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05120  Epithelial cell signaling in Helicobacter pylori infection','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05120 Epithelial cell signaling in Helicobacter pylori infection, 04090 CD molecules [BR:hsa04090], Proteins'),('3422','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04068  FoxO signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05150  Staphylococcus aureus infection, hsa05152  Tuberculosis, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3423','hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04068  FoxO signaling pathway, hsa04110  Cell cycle, hsa04218  Cellular senescence, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04390  Hippo signaling pathway, hsa04659  Th17 cell differentiation, hsa04672  Intestinal immune network for IgA production, hsa04926  Relaxin signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05166  Human T-cell leukemia virus 1 infection, hsa05200  Pathways in cancer, hsa05205  Proteoglycans in cancer, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05212  Pancreatic cancer, hsa05220  Chronic myeloid leukemia, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05410  Hypertrophic cardiomyopathy, hsa05414  Dilated cardiomyopathy, hsa05415  Diabetic cardiomyopathy','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04390 Hippo signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04110 Cell cycle, 04218 Cellular senescence, 04659 Th17 cell differentiation, 04672 Intestinal immune network for IgA production, 04926 Relaxin signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05220 Chronic myeloid leukemia, 05211 Renal cell carcinoma, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 05415 Diabetic cardiomyopathy, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 03110 Chaperones and folding catalysts [BR:hsa03110], 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Others, Transforming growth factors (RSTK binding), Growth factors/receptors'),('3424','hsa04659  Th17 cell differentiation, hsa05321  Inflammatory bowel disease','04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:hsa03000], Fork head/winged helix other regulators'),('3442','hsa04659  Th17 cell differentiation, hsa04934  Cushing syndrome, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species','04659 Th17 cell differentiation, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 04934 Cushing syndrome, 03000 Transcription factors [BR:hsa03000], Factors with PAS domain'),('3443','hsa04659  Th17 cell differentiation, hsa04934  Cushing syndrome, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species','04659 Th17 cell differentiation, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 04934 Cushing syndrome, 03000 Transcription factors [BR:hsa03000], Factors with PAS domain'),('3444','hsa04659  Th17 cell differentiation, hsa04934  Cushing syndrome, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species','04659 Th17 cell differentiation, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 04934 Cushing syndrome, 03000 Transcription factors [BR:hsa03000], Factors with PAS domain'),('3445','hsa04659  Th17 cell differentiation, hsa04934  Cushing syndrome, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species','04659 Th17 cell differentiation, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 04934 Cushing syndrome, 03000 Transcription factors [BR:hsa03000], Factors with PAS domain'),('3446','hsa00140  Steroid hormone biosynthesis, hsa00380  Tryptophan metabolism, hsa00830  Retinol metabolism, hsa00980  Metabolism of xenobiotics by cytochrome P450, hsa01100  Metabolic pathways, hsa04913  Ovarian steroidogenesis, hsa05204  Chemical carcinogenesis - DNA adducts, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05417  Lipid and atherosclerosis','00140 Steroid hormone biosynthesis, 00380 Tryptophan metabolism, 00830 Retinol metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 04913 Ovarian steroidogenesis, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05417 Lipid and atherosclerosis, 00199 Cytochrome P450 [BR:hsa00199], 1.14.14.1  unspecific monooxygenase, CYP1 family'),('3447','hsa00140  Steroid hormone biosynthesis, hsa00380  Tryptophan metabolism, hsa00830  Retinol metabolism, hsa00980  Metabolism of xenobiotics by cytochrome P450, hsa01100  Metabolic pathways, hsa04913  Ovarian steroidogenesis, hsa05204  Chemical carcinogenesis - DNA adducts, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05417  Lipid and atherosclerosis','00140 Steroid hormone biosynthesis, 00380 Tryptophan metabolism, 00830 Retinol metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 04913 Ovarian steroidogenesis, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05417 Lipid and atherosclerosis, 00199 Cytochrome P450 [BR:hsa00199], 1.14.14.1  unspecific monooxygenase, CYP1 family'),('3448','hsa00140  Steroid hormone biosynthesis, hsa00380  Tryptophan metabolism, hsa00830  Retinol metabolism, hsa00980  Metabolism of xenobiotics by cytochrome P450, hsa01100  Metabolic pathways, hsa04913  Ovarian steroidogenesis, hsa05204  Chemical carcinogenesis - DNA adducts, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05417  Lipid and atherosclerosis','00140 Steroid hormone biosynthesis, 00380 Tryptophan metabolism, 00830 Retinol metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 04913 Ovarian steroidogenesis, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05417 Lipid and atherosclerosis, 00199 Cytochrome P450 [BR:hsa00199], 1.14.14.1  unspecific monooxygenase, CYP1 family'),('3449','hsa00140  Steroid hormone biosynthesis, hsa00380  Tryptophan metabolism, hsa00830  Retinol metabolism, hsa00980  Metabolism of xenobiotics by cytochrome P450, hsa01100  Metabolic pathways, hsa04913  Ovarian steroidogenesis, hsa05204  Chemical carcinogenesis - DNA adducts, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05417  Lipid and atherosclerosis','00140 Steroid hormone biosynthesis, 00380 Tryptophan metabolism, 00830 Retinol metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 04913 Ovarian steroidogenesis, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05417 Lipid and atherosclerosis, 00199 Cytochrome P450 [BR:hsa00199], 1.14.14.1  unspecific monooxygenase, CYP1 family'),('3450','hsa00140  Steroid hormone biosynthesis, hsa00380  Tryptophan metabolism, hsa00830  Retinol metabolism, hsa00980  Metabolism of xenobiotics by cytochrome P450, hsa01100  Metabolic pathways, hsa04913  Ovarian steroidogenesis, hsa05204  Chemical carcinogenesis - DNA adducts, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05417  Lipid and atherosclerosis','00140 Steroid hormone biosynthesis, 00380 Tryptophan metabolism, 00830 Retinol metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 04913 Ovarian steroidogenesis, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05417 Lipid and atherosclerosis, 00199 Cytochrome P450 [BR:hsa00199], 1.14.14.1  unspecific monooxygenase, CYP1 family'),('3452','hsa04310  Wnt signaling pathway','04310 Wnt signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], R-spondin'),('3453','hsa04310  Wnt signaling pathway','04310 Wnt signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], R-spondin'),('3454','hsa04310  Wnt signaling pathway','04310 Wnt signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], R-spondin'),('3455','hsa00730  Thiamine metabolism, hsa00790  Folate biosynthesis, hsa01100  Metabolic pathways, hsa01240  Biosynthesis of cofactors','00730 Thiamine metabolism, 00790 Folate biosynthesis, 04147 Exosome [BR:hsa04147], 00537 Glycosylphosphatidylinositol (GPI)-anchored proteins [BR:hsa00537], 3.1.3.1  alkaline phosphatase, Exosomal proteins of other body fluids (saliva and urine), Enzymes'),('3456','hsa00730  Thiamine metabolism, hsa00790  Folate biosynthesis, hsa01100  Metabolic pathways, hsa01240  Biosynthesis of cofactors','00730 Thiamine metabolism, 00790 Folate biosynthesis, 04147 Exosome [BR:hsa04147], 00537 Glycosylphosphatidylinositol (GPI)-anchored proteins [BR:hsa00537], 3.1.3.1  alkaline phosphatase, Exosomal proteins of other body fluids (saliva and urine), Enzymes'),('3457','hsa00730  Thiamine metabolism, hsa00790  Folate biosynthesis, hsa01100  Metabolic pathways, hsa01240  Biosynthesis of cofactors','00730 Thiamine metabolism, 00790 Folate biosynthesis, 04147 Exosome [BR:hsa04147], 00537 Glycosylphosphatidylinositol (GPI)-anchored proteins [BR:hsa00537], 3.1.3.1  alkaline phosphatase, Exosomal proteins of other body fluids (saliva and urine), Enzymes'),('3458','hsa05146  Amoebiasis, hsa05226  Gastric cancer','05226 Gastric cancer, 05146 Amoebiasis, 04131 Membrane trafficking [BR:hsa04131], Secretory mucins'),('3459','hsa05146  Amoebiasis, hsa05226  Gastric cancer','05226 Gastric cancer, 05146 Amoebiasis, 04131 Membrane trafficking [BR:hsa04131], Secretory mucins'),('3460','hsa04970  Salivary secretion','04970 Salivary secretion, 04147 Exosome [BR:hsa04147], 3.2.1.17  lysozyme, Exosomal proteins of other body fluids (saliva and urine)'),('3461',NULL,'04131 Membrane trafficking [BR:hsa04131], Others'),('3462',NULL,'01001 Protein kinases [BR:hsa01001], 2.7.11.1  non-specific serine/threonine protein kinase, DCAMKL family'),('3463',NULL,'01001 Protein kinases [BR:hsa01001], 2.7.11.1  non-specific serine/threonine protein kinase, DCAMKL family'),('3464',NULL,'01001 Protein kinases [BR:hsa01001], 2.7.11.1  non-specific serine/threonine protein kinase, DCAMKL family'),('3466',NULL,NULL),('3467','hsa02010  ABC transporters, hsa05150  Staphylococcus aureus infection','02010 ABC transporters, 05150 Staphylococcus aureus infection, 02000 Transporters [BR:hsa02000], Pores ion channels [TC:1]'),('3468','hsa02010  ABC transporters, hsa05150  Staphylococcus aureus infection','02010 ABC transporters, 05150 Staphylococcus aureus infection, 02000 Transporters [BR:hsa02000], Pores ion channels [TC:1]'),('3469','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 01009 Protein phosphatases and associated proteins [BR:hsa01009], PP1-interacting proteins (PIPs)'),('3470','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 04147 Exosome [BR:hsa04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('3471','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 04147 Exosome [BR:hsa04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('3472','hsa04520  Adherens junction, hsa04530  Tight junction, hsa04540  Gap junction, hsa05110  Vibrio cholerae infection, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 05110 Vibrio cholerae infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 04812 Cytoskeleton proteins [BR:hsa04812], Others'),('3473','hsa04520  Adherens junction, hsa04530  Tight junction, hsa04540  Gap junction, hsa05110  Vibrio cholerae infection, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 05110 Vibrio cholerae infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 04812 Cytoskeleton proteins [BR:hsa04812], Others'),('3474','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 04147 Exosome [BR:hsa04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('3475','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 01009 Protein phosphatases and associated proteins [BR:hsa01009], PP1-interacting proteins (PIPs)'),('3476','hsa04024  cAMP signaling pathway, hsa04080  Neuroactive ligand-receptor interaction, hsa04935  Growth hormone synthesis, secretion and action','04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04935 Growth hormone synthesis, secretion and action'),('3477','hsa04024  cAMP signaling pathway, hsa04080  Neuroactive ligand-receptor interaction, hsa04935  Growth hormone synthesis, secretion and action','04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04935 Growth hormone synthesis, secretion and action'),('3478','hsa04024  cAMP signaling pathway, hsa04080  Neuroactive ligand-receptor interaction, hsa04935  Growth hormone synthesis, secretion and action','04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04935 Growth hormone synthesis, secretion and action'),('3479','hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04659  Th17 cell differentiation, hsa04750  Inflammatory mediator regulation of TRP channels','04010 MAPK signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 04750 Inflammatory mediator regulation of TRP channels, 04050 Cytokine receptors [BR:hsa04050], IL1 receptor family'),('3480','hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04659  Th17 cell differentiation, hsa04750  Inflammatory mediator regulation of TRP channels','04010 MAPK signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 04750 Inflammatory mediator regulation of TRP channels, 04050 Cytokine receptors [BR:hsa04050], IL1 receptor family'),('3481','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04144  Endocytosis, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05163  Human cytomegalovirus infection','04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04144 Endocytosis, 04062 Chemokine signaling pathway, 05163 Human cytomegalovirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 04030 G protein-coupled receptors [BR:hsa04030], 04050 Cytokine receptors [BR:hsa04050], 04090 CD molecules [BR:hsa04090], CXC Chemokine, CXC Chemokine, Proteins'),('3498','hsa04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], Hydroxy-carboxylic acid'),('3499','hsa04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], Hydroxy-carboxylic acid'),('3500','hsa04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], Hydroxy-carboxylic acid'),('3501','hsa04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], Hydroxy-carboxylic acid'),('3502','hsa04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], Hydroxy-carboxylic acid'),('3503','hsa04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], Hydroxy-carboxylic acid'),('3504','hsa04010  MAPK signaling pathway, hsa04014  Ras signaling pathway, hsa04015  Rap1 signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04916  Melanogenesis, hsa05200  Pathways in cancer','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04072 Phospholipase D signaling pathway, 04151 PI3K-Akt signaling pathway, 04640 Hematopoietic cell lineage, 04916 Melanogenesis, 05200 Pathways in cancer, 04052 Cytokines and growth factors [BR:hsa04052], Growth factors (RTK binding)'),('3506',NULL,'02000 Transporters [BR:hsa02000], SLC5: Sodium glucose cotransporter'),('3507',NULL,'02000 Transporters [BR:hsa02000], SLC5: Sodium glucose cotransporter'),('3508',NULL,'02000 Transporters [BR:hsa02000], SLC5: Sodium glucose cotransporter'),('3511','hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04145  Phagosome, hsa04151  PI3K-Akt signaling pathway, hsa04217  Necroptosis, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04936  Alcoholic liver disease, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05164  Influenza A, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04066 HIF-1 signaling pathway, 04151 PI3K-Akt signaling pathway, 04145 Phagosome, 04217 Necroptosis, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 05205 Proteoglycans in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04131 Membrane trafficking [BR:hsa04131], 04054 Pattern recognition receptors [BR:hsa04054], 04090 CD molecules [BR:hsa04090], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Toll-like receptors, Toll-like receptors, Proteins, Cell surface receptors'),('3512','hsa01522  Endocrine resistance, hsa04010  MAPK signaling pathway, hsa04015  Rap1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04114  Oocyte meiosis, hsa04218  Cellular senescence, hsa04261  Adrenergic signaling in cardiomyocytes, hsa04370  VEGF signaling pathway, hsa04380  Osteoclast differentiation, hsa04550  Signaling pathways regulating pluripotency of stem cells, hsa04611  Platelet activation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04670  Leukocyte transendothelial migration, hsa04714  Thermogenesis, hsa04722  Neurotrophin signaling pathway, hsa04723  Retrograde endocannabinoid signaling, hsa04728  Dopaminergic synapse, hsa04750  Inflammatory mediator regulation of TRP channels, hsa04912  GnRH signaling pathway, hsa04914  Progesterone-mediated oocyte maturation, hsa04917  Prolactin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04935  Growth hormone synthesis, secretion and action, hsa04936  Alcoholic liver disease, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04015 Rap1 signaling pathway, 04370 VEGF signaling pathway, 04668 TNF signaling pathway, 04068 FoxO signaling pathway, 04071 Sphingolipid signaling pathway, 04114 Oocyte meiosis, 04218 Cellular senescence, 04550 Signaling pathways regulating pluripotency of stem cells, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04670 Leukocyte transendothelial migration, 04912 GnRH signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04261 Adrenergic signaling in cardiomyocytes, 04728 Dopaminergic synapse, 04723 Retrograde endocannabinoid signaling, 04722 Neurotrophin signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 04714 Thermogenesis, 05205 Proteoglycans in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05152 Tuberculosis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01522 Endocrine resistance, 01001 Protein kinases [BR:hsa01001], 2.7.11.24  mitogen-activated protein kinase, MAPK family [OT]'),('3513','hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04936  Alcoholic liver disease, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05171  Coronavirus disease - COVID-19, hsa05207  Chemical carcinogenesis - receptor activation, hsa05417  Lipid and atherosclerosis','04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04657 IL-17 signaling pathway, 05207 Chemical carcinogenesis - receptor activation, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 01001 Protein kinases [BR:hsa01001], 2.7.11.10  IkappaB kinase, IKK family [OT]'),('3514','hsa05206  MicroRNAs in cancer','05206 MicroRNAs in cancer, 04147 Exosome [BR:hsa04147], 03100 Non-coding RNAs [BR:hsa03100], Exosomal RNA of breast milk, Exosomal RNA of renal carcinoma cells, Exosomal RNA of lung cancer cells, Micro RNA'),('3515','hsa05206  MicroRNAs in cancer','05206 MicroRNAs in cancer, 04147 Exosome [BR:hsa04147], 03100 Non-coding RNAs [BR:hsa03100], Exosomal RNA of breast milk, Exosomal RNA of lung cancer cells, Micro RNA'),('3520','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01523  Antifolate resistance, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3521','hsa04060  Cytokine-cytokine receptor interaction, hsa04620  Toll-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3522','hsa04060  Cytokine-cytokine receptor interaction, hsa04620  Toll-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05205  Proteoglycans in cancer, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3529','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa04012  ErbB signaling pathway, hsa04062  Chemokine signaling pathway, hsa04110  Cell cycle, hsa04150  mTOR signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04310  Wnt signaling pathway, hsa04340  Hedgehog signaling pathway, hsa04360  Axon guidance, hsa04390  Hippo signaling pathway, hsa04510  Focal adhesion, hsa04550  Signaling pathways regulating pluripotency of stem cells, hsa04657  IL-17 signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04728  Dopaminergic synapse, hsa04910  Insulin signaling pathway, hsa04916  Melanogenesis, hsa04917  Prolactin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04934  Cushing syndrome, hsa04935  Growth hormone synthesis, secretion and action, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05131  Shigellosis, hsa05135  Yersinia infection, hsa05160  Hepatitis C, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05165  Human papillomavirus infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05200  Pathways in cancer, hsa05210  Colorectal cancer, hsa05213  Endometrial cancer, hsa05215  Prostate cancer, hsa05217  Basal cell carcinoma, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis','04012 ErbB signaling pathway, 04310 Wnt signaling pathway, 04340 Hedgehog signaling pathway, 04390 Hippo signaling pathway, 04151 PI3K-Akt signaling pathway, 04150 mTOR signaling pathway, 04110 Cell cycle, 04510 Focal adhesion, 04550 Signaling pathways regulating pluripotency of stem cells, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04910 Insulin signaling pathway, 04917 Prolactin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04916 Melanogenesis, 04728 Dopaminergic synapse, 04722 Neurotrophin signaling pathway, 04360 Axon guidance, 05200 Pathways in cancer, 05210 Colorectal cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05217 Basal cell carcinoma, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05160 Hepatitis C, 05162 Measles, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05131 Shigellosis, 05135 Yersinia infection, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04934 Cushing syndrome, 01521 EGFR tyrosine kinase inhibitor resistance, 01001 Protein kinases [BR:hsa01001], 03036 Chromosome and associated proteins [BR:hsa03036], 2.7.11.26  tau-protein kinase, GSK family [OT], Kinases and associated factors'),('3530','hsa04310  Wnt signaling pathway, hsa04390  Hippo signaling pathway, hsa04520  Adherens junction, hsa04916  Melanogenesis, hsa04934  Cushing syndrome, hsa04936  Alcoholic liver disease, hsa05132  Salmonella infection, hsa05165  Human papillomavirus infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05200  Pathways in cancer, hsa05210  Colorectal cancer, hsa05213  Endometrial cancer, hsa05215  Prostate cancer, hsa05216  Thyroid cancer, hsa05217  Basal cell carcinoma, hsa05221  Acute myeloid leukemia, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05412  Arrhythmogenic right ventricular cardiomyopathy','04310 Wnt signaling pathway, 04390 Hippo signaling pathway, 04520 Adherens junction, 04916 Melanogenesis, 05200 Pathways in cancer, 05210 Colorectal cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05217 Basal cell carcinoma, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05412 Arrhythmogenic right ventricular cardiomyopathy, 04936 Alcoholic liver disease, 04934 Cushing syndrome, 03000 Transcription factors [BR:hsa03000], HMG TCF-1'),('3531','hsa01522  Endocrine resistance, hsa04068  FoxO signaling pathway, hsa04110  Cell cycle, hsa04115  p53 signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04152  AMPK signaling pathway, hsa04218  Cellular senescence, hsa04310  Wnt signaling pathway, hsa04340  Hedgehog signaling pathway, hsa04371  Apelin signaling pathway, hsa04390  Hippo signaling pathway, hsa04510  Focal adhesion, hsa04530  Tight junction, hsa04630  JAK-STAT signaling pathway, hsa04917  Prolactin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04934  Cushing syndrome, hsa04936  Alcoholic liver disease, hsa05160  Hepatitis C, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05169  Epstein-Barr virus infection, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05210  Colorectal cancer, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05216  Thyroid cancer, hsa05218  Melanoma, hsa05219  Bladder cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05222  Small cell lung cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05416  Viral myocarditis','04310 Wnt signaling pathway, 04340 Hedgehog signaling pathway, 04390 Hippo signaling pathway, 04371 Apelin signaling pathway, 04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04110 Cell cycle, 04115 p53 signaling pathway, 04218 Cellular senescence, 04510 Focal adhesion, 04530 Tight junction, 04917 Prolactin signaling pathway, 04921 Oxytocin signaling pathway, 04919 Thyroid hormone signaling pathway, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05203 Viral carcinogenesis, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05160 Hepatitis C, 05162 Measles, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05416 Viral myocarditis, 04936 Alcoholic liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04934 Cushing syndrome, 01522 Endocrine resistance'),('3532','hsa04010  MAPK signaling pathway, hsa04012  ErbB signaling pathway, hsa04110  Cell cycle, hsa04151  PI3K-Akt signaling pathway, hsa04218  Cellular senescence, hsa04310  Wnt signaling pathway, hsa04350  TGF-beta signaling pathway, hsa04390  Hippo signaling pathway, hsa04550  Signaling pathways regulating pluripotency of stem cells, hsa04630  JAK-STAT signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa05132  Salmonella infection, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05169  Epstein-Barr virus infection, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05210  Colorectal cancer, hsa05213  Endometrial cancer, hsa05216  Thyroid cancer, hsa05219  Bladder cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05222  Small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04310 Wnt signaling pathway, 04350 TGF-beta signaling pathway, 04390 Hippo signaling pathway, 04630 JAK-STAT signaling pathway, 04151 PI3K-Akt signaling pathway, 04110 Cell cycle, 04218 Cellular senescence, 04550 Signaling pathways regulating pluripotency of stem cells, 04919 Thyroid hormone signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05230 Central carbon metabolism in cancer, 05210 Colorectal cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05219 Bladder cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 03000 Transcription factors [BR:hsa03000], 03019 Messenger RNA biogenesis [BR:hsa03019], Cell cycle controlling factors, Myc, Factors that have mRNA localization signals'),('3533','hsa04659  Th17 cell differentiation, hsa05321  Inflammatory bowel disease','04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:hsa03000], Fork head/winged helix other regulators'),('3535','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa04012  ErbB signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04136  Autophagy - other, hsa04140  Autophagy - animal, hsa04150  mTOR signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04152  AMPK signaling pathway, hsa04211  Longevity regulating pathway, hsa04213  Longevity regulating pathway - multiple species, hsa04218  Cellular senescence, hsa04371  Apelin signaling pathway, hsa04613  Neutrophil extracellular trap formation, hsa04630  JAK-STAT signaling pathway, hsa04659  Th17 cell differentiation, hsa04714  Thermogenesis, hsa04910  Insulin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04935  Growth hormone synthesis, secretion and action, hsa05010  Alzheimer disease, hsa05014  Amyotrophic lateral sclerosis, hsa05016  Huntington disease, hsa05017  Spinocerebellar ataxia, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05131  Shigellosis, hsa05163  Human cytomegalovirus infection, hsa05165  Human papillomavirus infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05210  Colorectal cancer, hsa05212  Pancreatic cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05221  Acute myeloid leukemia, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05415  Diabetic cardiomyopathy','04012 ErbB signaling pathway, 04371 Apelin signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04072 Phospholipase D signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04136 Autophagy - other, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04659 Th17 cell differentiation, 04910 Insulin signaling pathway, 04920 Adipocytokine signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 04714 Thermogenesis, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05221 Acute myeloid leukemia, 05215 Prostate cancer, 05224 Breast cancer, 05170 Human immunodeficiency virus 1 infection, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05131 Shigellosis, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05017 Spinocerebellar ataxia, 05022 Pathways of neurodegeneration - multiple diseases, 05415 Diabetic cardiomyopathy, 04930 Type II diabetes mellitus, 04931 Insulin resistance, 01521 EGFR tyrosine kinase inhibitor resistance, 01522 Endocrine resistance, 01001 Protein kinases [BR:hsa01001], 04131 Membrane trafficking [BR:hsa04131], 2.7.11.1  non-specific serine/threonine protein kinase, PIKK family [OT], mTORC1 complex, mTORC2 complex'),('3540','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04620  Toll-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04657  IL-17 signaling pathway, hsa04668  TNF signaling pathway, hsa05160  Hepatitis C, hsa05164  Influenza A, hsa05169  Epstein-Barr virus infection, hsa05171  Coronavirus disease - COVID-19','04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05169 Epstein-Barr virus infection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3541','hsa03250  Viral life cycle - HIV-1, hsa04144  Endocytosis','03250 Viral life cycle - HIV-1, 04144 Endocytosis, 04131 Membrane trafficking [BR:hsa04131], 04147 Exosome [BR:hsa04147], ESCRT associated proteins, Proteins found in most exosomes'),('3555','hsa00510  N-Glycan biosynthesis, hsa00513  Various types of N-glycan biosynthesis, hsa01100  Metabolic pathways','00510 N-Glycan biosynthesis, 00513 Various types of N-glycan biosynthesis, 01003 Glycosyltransferases [BR:hsa01003], 2.4.1.260  dolichyl-P-Man:Man7GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase, Dol-linked oligosaccharide'),('3556','hsa00280  Valine, leucine and isoleucine degradation, hsa01100  Metabolic pathways','00280 Valine, leucine and isoleucine degradation, 6.4.1.4  methylcrotonoyl-CoA carboxylase'),('3557','hsa00280  Valine, leucine and isoleucine degradation, hsa01100  Metabolic pathways','00280 Valine, leucine and isoleucine degradation, 6.4.1.4  methylcrotonoyl-CoA carboxylase'),('3558','hsa00350  Tyrosine metabolism, hsa00360  Phenylalanine metabolism, hsa00380  Tryptophan metabolism, hsa01100  Metabolic pathways, hsa04726  Serotonergic synapse, hsa04728  Dopaminergic synapse, hsa05030  Cocaine addiction, hsa05031  Amphetamine addiction, hsa05034  Alcoholism','00350 Tyrosine metabolism, 00360 Phenylalanine metabolism, 00380 Tryptophan metabolism, 04728 Dopaminergic synapse, 04726 Serotonergic synapse, 05030 Cocaine addiction, 05031 Amphetamine addiction, 05034 Alcoholism, 04147 Exosome [BR:hsa04147], 4.1.1.28  aromatic-L-amino-acid decarboxylase, 4.1.1.105  L-tryptophan decarboxylase, Exosomal proteins of other body fluids (saliva and urine)'),('3559','hsa00130  Ubiquinone and other terpenoid-quinone biosynthesis, hsa01100  Metabolic pathways, hsa01240  Biosynthesis of cofactors, hsa05200  Pathways in cancer, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05225  Hepatocellular carcinoma, hsa05418  Fluid shear stress and atherosclerosis','00130 Ubiquinone and other terpenoid-quinone biosynthesis, 05200 Pathways in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05418 Fluid shear stress and atherosclerosis, 1.6.5.2  NAD(P)H dehydrogenase (quinone)'),('3560','hsa00260  Glycine, serine and threonine metabolism, hsa01100  Metabolic pathways','00260 Glycine, serine and threonine metabolism, 2.1.1.20  glycine N-methyltransferase'),('3561','hsa00140  Steroid hormone biosynthesis, hsa00232  Caffeine metabolism, hsa00380  Tryptophan metabolism, hsa00591  Linoleic acid metabolism, hsa00830  Retinol metabolism, hsa00980  Metabolism of xenobiotics by cytochrome P450, hsa00982  Drug metabolism - cytochrome P450, hsa01100  Metabolic pathways, hsa05204  Chemical carcinogenesis - DNA adducts, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species','00140 Steroid hormone biosynthesis, 00591 Linoleic acid metabolism, 00380 Tryptophan metabolism, 00830 Retinol metabolism, 00232 Caffeine metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 00199 Cytochrome P450 [BR:hsa00199], 1.14.14.1  unspecific monooxygenase, CYP1 family'),('3562','hsa00140  Steroid hormone biosynthesis, hsa00830  Retinol metabolism, hsa00980  Metabolism of xenobiotics by cytochrome P450, hsa00982  Drug metabolism - cytochrome P450, hsa01100  Metabolic pathways, hsa05204  Chemical carcinogenesis - DNA adducts','00140 Steroid hormone biosynthesis, 00830 Retinol metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 05204 Chemical carcinogenesis - DNA adducts, 00199 Cytochrome P450 [BR:hsa00199], 1.14.14.1  unspecific monooxygenase, CYP3 family'),('3563','hsa00270  Cysteine and methionine metabolism, hsa00480  Glutathione metabolism, hsa01100  Metabolic pathways, hsa01240  Biosynthesis of cofactors, hsa04216  Ferroptosis','00270 Cysteine and methionine metabolism, 00480 Glutathione metabolism, 04216 Ferroptosis, 6.3.2.2  glutamate---cysteine ligase'),('3564','hsa00980  Metabolism of xenobiotics by cytochrome P450, hsa00982  Drug metabolism - cytochrome P450, hsa01522  Endocrine resistance, hsa04726  Serotonergic synapse','00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 04726 Serotonergic synapse, 01522 Endocrine resistance, 00199 Cytochrome P450 [BR:hsa00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('3565','hsa00140  Steroid hormone biosynthesis, hsa00591  Linoleic acid metabolism, hsa00830  Retinol metabolism, hsa00980  Metabolism of xenobiotics by cytochrome P450, hsa00982  Drug metabolism - cytochrome P450, hsa00983  Drug metabolism - other enzymes, hsa01100  Metabolic pathways, hsa04976  Bile secretion, hsa05204  Chemical carcinogenesis - DNA adducts, hsa05207  Chemical carcinogenesis - receptor activation','00140 Steroid hormone biosynthesis, 00591 Linoleic acid metabolism, 00830 Retinol metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 00983 Drug metabolism - other enzymes, 04976 Bile secretion, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 00199 Cytochrome P450 [BR:hsa00199], 1.14.13.32  albendazole monooxygenase, 1.14.14.55  quinine 3-monooxygenase, 1.14.14.56  1,8-cineole 2-exo-monooxygenase, 1.14.14.57  taurochenodeoxycholate 6alpha-hydroxylase, 1.14.14.73  albendazole monooxygenase (sulfoxide-forming), 1.14.14.-, CYP3 family'),('3566','hsa04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], Free fatty acid'),('3567','hsa04659  Th17 cell differentiation, hsa05321  Inflammatory bowel disease','04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:hsa03000], Fork head/winged helix other regulators'),('3568','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04068  FoxO signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05150  Staphylococcus aureus infection, hsa05152  Tuberculosis, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3569','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04014  Ras signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04218  Cellular senescence, hsa04380  Osteoclast differentiation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04668  TNF signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04917  Prolactin signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04926  Relaxin signaling pathway, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05030  Cocaine addiction, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05212  Pancreatic cancer, hsa05215  Prostate cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05222  Small cell lung cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:hsa03000], RHR (Rel homology region) Rel/Ankyrin'),('3570','hsa04060  Cytokine-cytokine receptor interaction, hsa04620  Toll-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3571','hsa04060  Cytokine-cytokine receptor interaction, hsa04620  Toll-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05205  Proteoglycans in cancer, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3572','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04068  FoxO signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05150  Staphylococcus aureus infection, hsa05152  Tuberculosis, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3586','hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04217  Necroptosis, hsa04218  Cellular senescence, hsa04380  Osteoclast differentiation, hsa04640  Hematopoietic cell lineage, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05133  Pertussis, hsa05140  Leishmaniasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05164  Influenza A, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04380 Osteoclast differentiation, 05164 Influenza A, 05162 Measles, 05133 Pertussis, 05152 Tuberculosis, 05140 Leishmaniasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3587','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04151  PI3K-Akt signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa04940  Type I diabetes mellitus, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05162  Measles, hsa05166  Human T-cell leukemia virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease','04630 JAK-STAT signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05166 Human T-cell leukemia virus 1 infection, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05135 Yersinia infection, 05142 Chagas disease, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 04940 Type I diabetes mellitus, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3588','hsa04060  Cytokine-cytokine receptor interaction, hsa04630  JAK-STAT signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05200  Pathways in cancer, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04640 Hematopoietic cell lineage, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05310 Asthma, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3589','hsa04060  Cytokine-cytokine receptor interaction, hsa04630  JAK-STAT signaling pathway, hsa04659  Th17 cell differentiation, hsa05321  Inflammatory bowel disease','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3590','hsa03050  Proteasome, hsa04060  Cytokine-cytokine receptor interaction, hsa04066  HIF-1 signaling pathway, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04630  JAK-STAT signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04940  Type I diabetes mellitus, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05200  Pathways in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:hsa03051], 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Other assembling factors, Interferons, Cytokines'),('3591','hsa04060  Cytokine-cytokine receptor interaction, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04936  Alcoholic liver disease, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis','04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3592','hsa04060  Cytokine-cytokine receptor interaction, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04936  Alcoholic liver disease, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis','04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3593','hsa04659  Th17 cell differentiation, hsa04710  Circadian rhythm, hsa05017  Spinocerebellar ataxia, hsa05321  Inflammatory bowel disease','04659 Th17 cell differentiation, 04710 Circadian rhythm, 05321 Inflammatory bowel disease, 05017 Spinocerebellar ataxia, 03000 Transcription factors [BR:hsa03000], 03310 Nuclear receptors [BR:hsa03310], Cys4 thyroid hormone receptor-like, 1F. RAR-related orphan receptor'),('3594','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04668  TNF signaling pathway, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05134  Legionellosis, hsa05146  Amoebiasis, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05134 Legionellosis, 05146 Amoebiasis, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], Chemokines'),('3595','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04657  IL-17 signaling pathway, hsa04668  TNF signaling pathway, hsa05133  Pertussis, hsa05323  Rheumatoid arthritis','04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05133 Pertussis, 05323 Rheumatoid arthritis, 04052 Cytokines and growth factors [BR:hsa04052], Chemokines'),('3598','hsa03320  PPAR signaling pathway, hsa04152  AMPK signaling pathway, hsa04211  Longevity regulating pathway, hsa04380  Osteoclast differentiation, hsa04714  Thermogenesis, hsa04932  Non-alcoholic fatty liver disease, hsa05016  Huntington disease, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05216  Thyroid cancer, hsa05417  Lipid and atherosclerosis','04152 AMPK signaling pathway, 03320 PPAR signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04714 Thermogenesis, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05216 Thyroid cancer, 05016 Huntington disease, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 03000 Transcription factors [BR:hsa03000], 03310 Nuclear receptors [BR:hsa03310], Cys4 thyroid hormone receptor-like, 1C. Peroxisome proliferator-activated receptor (PPAR)'),('3599','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04068  FoxO signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05150  Staphylococcus aureus infection, hsa05152  Tuberculosis, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3600','hsa03320  PPAR signaling pathway, hsa04979  Cholesterol metabolism','03320 PPAR signaling pathway, 04979 Cholesterol metabolism, 04147 Exosome [BR:hsa04147], Exosomal proteins of breast milk'),('3601','hsa03320  PPAR signaling pathway','03320 PPAR signaling pathway, 04147 Exosome [BR:hsa04147], Exosomal proteins of breast milk'),('3602','hsa04976  Bile secretion','04976 Bile secretion, 03000 Transcription factors [BR:hsa03000], 03310 Nuclear receptors [BR:hsa03310], Cys4 thyroid hormone receptor-like, 1H. Liver X receptor like receptor'),('3603','hsa04024  cAMP signaling pathway, hsa04080  Neuroactive ligand-receptor interaction, hsa04911  Insulin secretion','04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04911 Insulin secretion, 04030 G protein-coupled receptors [BR:hsa04030], Glucagon'),('3604','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 01009 Protein phosphatases and associated proteins [BR:hsa01009], PP1-interacting proteins (PIPs)'),('3605','hsa04530  Tight junction','04530 Tight junction'),('3606','hsa04520  Adherens junction, hsa04530  Tight junction, hsa04540  Gap junction, hsa05110  Vibrio cholerae infection, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 05110 Vibrio cholerae infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 04812 Cytoskeleton proteins [BR:hsa04812], Others'),('3607','hsa04530  Tight junction, hsa05110  Vibrio cholerae infection','04530 Tight junction, 05110 Vibrio cholerae infection'),('3608',NULL,'02000 Transporters [BR:hsa02000], Pores ion channels [TC:1]'),('3609','hsa03320  PPAR signaling pathway, hsa04152  AMPK signaling pathway, hsa04211  Longevity regulating pathway, hsa04380  Osteoclast differentiation, hsa04714  Thermogenesis, hsa04932  Non-alcoholic fatty liver disease, hsa05016  Huntington disease, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05216  Thyroid cancer, hsa05417  Lipid and atherosclerosis','04152 AMPK signaling pathway, 03320 PPAR signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04714 Thermogenesis, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05216 Thyroid cancer, 05016 Huntington disease, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 03000 Transcription factors [BR:hsa03000], 03310 Nuclear receptors [BR:hsa03310], Cys4 thyroid hormone receptor-like, 1C. Peroxisome proliferator-activated receptor (PPAR)'),('3610','hsa04621  NOD-like receptor signaling pathway','04621 NOD-like receptor signaling pathway, 04054 Pattern recognition receptors [BR:hsa04054], NOD-like receptors'),('3611','hsa04060  Cytokine-cytokine receptor interaction, hsa04620  Toll-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3612','hsa04060  Cytokine-cytokine receptor interaction, hsa04620  Toll-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05205  Proteoglycans in cancer, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3613','hsa04060  Cytokine-cytokine receptor interaction, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04936  Alcoholic liver disease, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis','04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3614','hsa04520  Adherens junction, hsa04530  Tight junction, hsa04540  Gap junction, hsa05110  Vibrio cholerae infection, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 05110 Vibrio cholerae infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 04812 Cytoskeleton proteins [BR:hsa04812], Others'),('3615','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04014  Ras signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04218  Cellular senescence, hsa04380  Osteoclast differentiation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04668  TNF signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04917  Prolactin signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04926  Relaxin signaling pathway, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05030  Cocaine addiction, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05212  Pancreatic cancer, hsa05215  Prostate cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05222  Small cell lung cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:hsa03000], RHR (Rel homology region) Rel/Ankyrin'),('3616','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04064  NF-kappa B signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04150  mTOR signaling pathway, hsa04210  Apoptosis, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05310  Asthma, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05414  Dilated cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Tumor necrosis fators, Cytokines'),('3617','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04064  NF-kappa B signaling pathway, hsa04217  Necroptosis, hsa04380  Osteoclast differentiation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04750  Inflammatory mediator regulation of TRP channels, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3618','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01523  Antifolate resistance, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3623','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3624','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04014  Ras signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04218  Cellular senescence, hsa04380  Osteoclast differentiation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04668  TNF signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04917  Prolactin signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04926  Relaxin signaling pathway, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05030  Cocaine addiction, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05212  Pancreatic cancer, hsa05215  Prostate cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05222  Small cell lung cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:hsa03000], RHR (Rel homology region) Rel/Ankyrin'),('3625','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04068  FoxO signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05150  Staphylococcus aureus infection, hsa05152  Tuberculosis, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3629','hsa04060  Cytokine-cytokine receptor interaction, hsa04630  JAK-STAT signaling pathway, hsa04659  Th17 cell differentiation, hsa05321  Inflammatory bowel disease','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3630','hsa01522  Endocrine resistance, hsa04010  MAPK signaling pathway, hsa04015  Rap1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04114  Oocyte meiosis, hsa04218  Cellular senescence, hsa04261  Adrenergic signaling in cardiomyocytes, hsa04370  VEGF signaling pathway, hsa04380  Osteoclast differentiation, hsa04550  Signaling pathways regulating pluripotency of stem cells, hsa04611  Platelet activation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04670  Leukocyte transendothelial migration, hsa04714  Thermogenesis, hsa04722  Neurotrophin signaling pathway, hsa04723  Retrograde endocannabinoid signaling, hsa04728  Dopaminergic synapse, hsa04750  Inflammatory mediator regulation of TRP channels, hsa04912  GnRH signaling pathway, hsa04914  Progesterone-mediated oocyte maturation, hsa04917  Prolactin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04935  Growth hormone synthesis, secretion and action, hsa04936  Alcoholic liver disease, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04015 Rap1 signaling pathway, 04370 VEGF signaling pathway, 04668 TNF signaling pathway, 04068 FoxO signaling pathway, 04071 Sphingolipid signaling pathway, 04114 Oocyte meiosis, 04218 Cellular senescence, 04550 Signaling pathways regulating pluripotency of stem cells, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04670 Leukocyte transendothelial migration, 04912 GnRH signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04261 Adrenergic signaling in cardiomyocytes, 04728 Dopaminergic synapse, 04723 Retrograde endocannabinoid signaling, 04722 Neurotrophin signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 04714 Thermogenesis, 05205 Proteoglycans in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05152 Tuberculosis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01522 Endocrine resistance, 01001 Protein kinases [BR:hsa01001], 2.7.11.24  mitogen-activated protein kinase, MAPK family [OT]'),('3631','hsa04060  Cytokine-cytokine receptor interaction, hsa04080  Neuroactive ligand-receptor interaction, hsa04152  AMPK signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04932  Non-alcoholic fatty liver disease','04630 JAK-STAT signaling pathway, 04152 AMPK signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04060 Cytokine-cytokine receptor interaction, 04920 Adipocytokine signaling pathway, 04932 Non-alcoholic fatty liver disease, 04052 Cytokines and growth factors [BR:hsa04052], CSF and other factors'),('3632','hsa04060  Cytokine-cytokine receptor interaction, hsa04080  Neuroactive ligand-receptor interaction, hsa04152  AMPK signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04932  Non-alcoholic fatty liver disease','04630 JAK-STAT signaling pathway, 04152 AMPK signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04060 Cytokine-cytokine receptor interaction, 04920 Adipocytokine signaling pathway, 04932 Non-alcoholic fatty liver disease, 04052 Cytokines and growth factors [BR:hsa04052], CSF and other factors'),('3633','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04010  MAPK signaling pathway, hsa04012  ErbB signaling pathway, hsa04014  Ras signaling pathway, hsa04015  Rap1 signaling pathway, hsa04022  cGMP-PKG signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04140  Autophagy - animal, hsa04150  mTOR signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04152  AMPK signaling pathway, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04213  Longevity regulating pathway - multiple species, hsa04218  Cellular senescence, hsa04261  Adrenergic signaling in cardiomyocytes, hsa04370  VEGF signaling pathway, hsa04371  Apelin signaling pathway, hsa04380  Osteoclast differentiation, hsa04510  Focal adhesion, hsa04550  Signaling pathways regulating pluripotency of stem cells, hsa04611  Platelet activation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04666  Fc gamma R-mediated phagocytosis, hsa04668  TNF signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04725  Cholinergic synapse, hsa04728  Dopaminergic synapse, hsa04910  Insulin signaling pathway, hsa04914  Progesterone-mediated oocyte maturation, hsa04915  Estrogen signaling pathway, hsa04917  Prolactin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04922  Glucagon signaling pathway, hsa04923  Regulation of lipolysis in adipocytes, hsa04926  Relaxin signaling pathway, hsa04929  GnRH secretion, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04935  Growth hormone synthesis, secretion and action, hsa04936  Alcoholic liver disease, hsa04973  Carbohydrate digestion and absorption, hsa05010  Alzheimer disease, hsa05017  Spinocerebellar ataxia, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05205  Proteoglycans in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05218  Melanoma, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05222  Small cell lung cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04370 VEGF signaling pathway, 04371 Apelin signaling pathway, 04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04072 Phospholipase D signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04022 cGMP-PKG signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04210 Apoptosis, 04218 Cellular senescence, 04510 Focal adhesion, 04550 Signaling pathways regulating pluripotency of stem cells, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04662 B cell receptor signaling pathway, 04664 Fc epsilon RI signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04062 Chemokine signaling pathway, 04910 Insulin signaling pathway, 04922 Glucagon signaling pathway, 04923 Regulation of lipolysis in adipocytes, 04920 Adipocytokine signaling pathway, 04929 GnRH secretion, 04915 Estrogen signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04261 Adrenergic signaling in cardiomyocytes, 04973 Carbohydrate digestion and absorption, 04725 Cholinergic synapse, 04728 Dopaminergic synapse, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05211 Renal cell carcinoma, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05152 Tuberculosis, 05145 Toxoplasmosis, 05142 Chagas disease, 05010 Alzheimer disease, 05017 Spinocerebellar ataxia, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01001 Protein kinases [BR:hsa01001], 2.7.11.1  non-specific serine/threonine protein kinase, AKT/PKB family'),('3634','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04010  MAPK signaling pathway, hsa04012  ErbB signaling pathway, hsa04014  Ras signaling pathway, hsa04015  Rap1 signaling pathway, hsa04022  cGMP-PKG signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04114  Oocyte meiosis, hsa04140  Autophagy - animal, hsa04150  mTOR signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04218  Cellular senescence, hsa04261  Adrenergic signaling in cardiomyocytes, hsa04270  Vascular smooth muscle contraction, hsa04350  TGF-beta signaling pathway, hsa04360  Axon guidance, hsa04370  VEGF signaling pathway, hsa04371  Apelin signaling pathway, hsa04380  Osteoclast differentiation, hsa04510  Focal adhesion, hsa04520  Adherens junction, hsa04540  Gap junction, hsa04550  Signaling pathways regulating pluripotency of stem cells, hsa04611  Platelet activation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04666  Fc gamma R-mediated phagocytosis, hsa04668  TNF signaling pathway, hsa04713  Circadian entrainment, hsa04720  Long-term potentiation, hsa04722  Neurotrophin signaling pathway, hsa04723  Retrograde endocannabinoid signaling, hsa04724  Glutamatergic synapse, hsa04725  Cholinergic synapse, hsa04726  Serotonergic synapse, hsa04730  Long-term depression, hsa04810  Regulation of actin cytoskeleton, hsa04910  Insulin signaling pathway, hsa04912  GnRH signaling pathway, hsa04914  Progesterone-mediated oocyte maturation, hsa04915  Estrogen signaling pathway, hsa04916  Melanogenesis, hsa04917  Prolactin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04929  GnRH secretion, hsa04930  Type II diabetes mellitus, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04934  Cushing syndrome, hsa04935  Growth hormone synthesis, secretion and action, hsa04960  Aldosterone-regulated sodium reabsorption, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05034  Alcoholism, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05216  Thyroid cancer, hsa05218  Melanoma, hsa05219  Bladder cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04350 TGF-beta signaling pathway, 04370 VEGF signaling pathway, 04371 Apelin signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04072 Phospholipase D signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04022 cGMP-PKG signaling pathway, 04151 PI3K-Akt signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04114 Oocyte meiosis, 04210 Apoptosis, 04218 Cellular senescence, 04510 Focal adhesion, 04520 Adherens junction, 04540 Gap junction, 04550 Signaling pathways regulating pluripotency of stem cells, 04810 Regulation of actin cytoskeleton, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04664 Fc epsilon RI signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04062 Chemokine signaling pathway, 04910 Insulin signaling pathway, 04929 GnRH secretion, 04912 GnRH signaling pathway, 04915 Estrogen signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 04916 Melanogenesis, 04261 Adrenergic signaling in cardiomyocytes, 04270 Vascular smooth muscle contraction, 04960 Aldosterone-regulated sodium reabsorption, 04724 Glutamatergic synapse, 04725 Cholinergic synapse, 04726 Serotonergic synapse, 04720 Long-term potentiation, 04730 Long-term depression, 04723 Retrograde endocannabinoid signaling, 04722 Neurotrophin signaling pathway, 04360 Axon guidance, 04380 Osteoclast differentiation, 04713 Circadian entrainment, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05211 Renal cell carcinoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05152 Tuberculosis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05034 Alcoholism, 05417 Lipid and atherosclerosis, 04930 Type II diabetes mellitus, 04933 AGE-RAGE signaling pathway in diabetic complications, 04934 Cushing syndrome, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01001 Protein kinases [BR:hsa01001], 03036 Chromosome and associated proteins [BR:hsa03036], 04147 Exosome [BR:hsa04147], 2.7.11.24  mitogen-activated protein kinase, MAPK family [OT], Protein kinases, Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)'),('3635','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04010  MAPK signaling pathway, hsa04012  ErbB signaling pathway, hsa04014  Ras signaling pathway, hsa04015  Rap1 signaling pathway, hsa04022  cGMP-PKG signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04114  Oocyte meiosis, hsa04140  Autophagy - animal, hsa04150  mTOR signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04218  Cellular senescence, hsa04261  Adrenergic signaling in cardiomyocytes, hsa04270  Vascular smooth muscle contraction, hsa04350  TGF-beta signaling pathway, hsa04360  Axon guidance, hsa04370  VEGF signaling pathway, hsa04371  Apelin signaling pathway, hsa04380  Osteoclast differentiation, hsa04510  Focal adhesion, hsa04520  Adherens junction, hsa04540  Gap junction, hsa04550  Signaling pathways regulating pluripotency of stem cells, hsa04611  Platelet activation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04666  Fc gamma R-mediated phagocytosis, hsa04668  TNF signaling pathway, hsa04713  Circadian entrainment, hsa04720  Long-term potentiation, hsa04722  Neurotrophin signaling pathway, hsa04723  Retrograde endocannabinoid signaling, hsa04724  Glutamatergic synapse, hsa04725  Cholinergic synapse, hsa04726  Serotonergic synapse, hsa04730  Long-term depression, hsa04810  Regulation of actin cytoskeleton, hsa04910  Insulin signaling pathway, hsa04912  GnRH signaling pathway, hsa04914  Progesterone-mediated oocyte maturation, hsa04915  Estrogen signaling pathway, hsa04916  Melanogenesis, hsa04917  Prolactin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04929  GnRH secretion, hsa04930  Type II diabetes mellitus, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04934  Cushing syndrome, hsa04935  Growth hormone synthesis, secretion and action, hsa04960  Aldosterone-regulated sodium reabsorption, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05034  Alcoholism, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05216  Thyroid cancer, hsa05218  Melanoma, hsa05219  Bladder cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04350 TGF-beta signaling pathway, 04370 VEGF signaling pathway, 04371 Apelin signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04072 Phospholipase D signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04022 cGMP-PKG signaling pathway, 04151 PI3K-Akt signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04114 Oocyte meiosis, 04210 Apoptosis, 04218 Cellular senescence, 04510 Focal adhesion, 04520 Adherens junction, 04540 Gap junction, 04550 Signaling pathways regulating pluripotency of stem cells, 04810 Regulation of actin cytoskeleton, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04664 Fc epsilon RI signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04062 Chemokine signaling pathway, 04910 Insulin signaling pathway, 04929 GnRH secretion, 04912 GnRH signaling pathway, 04915 Estrogen signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 04916 Melanogenesis, 04261 Adrenergic signaling in cardiomyocytes, 04270 Vascular smooth muscle contraction, 04960 Aldosterone-regulated sodium reabsorption, 04724 Glutamatergic synapse, 04725 Cholinergic synapse, 04726 Serotonergic synapse, 04720 Long-term potentiation, 04730 Long-term depression, 04723 Retrograde endocannabinoid signaling, 04722 Neurotrophin signaling pathway, 04360 Axon guidance, 04380 Osteoclast differentiation, 04713 Circadian entrainment, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05211 Renal cell carcinoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05152 Tuberculosis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05034 Alcoholism, 05417 Lipid and atherosclerosis, 04930 Type II diabetes mellitus, 04933 AGE-RAGE signaling pathway in diabetic complications, 04934 Cushing syndrome, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01001 Protein kinases [BR:hsa01001], 03036 Chromosome and associated proteins [BR:hsa03036], 04147 Exosome [BR:hsa04147], 2.7.11.24  mitogen-activated protein kinase, MAPK family [OT], Protein kinases, Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)'),('3636','hsa01522  Endocrine resistance, hsa04010  MAPK signaling pathway, hsa04015  Rap1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04114  Oocyte meiosis, hsa04218  Cellular senescence, hsa04261  Adrenergic signaling in cardiomyocytes, hsa04370  VEGF signaling pathway, hsa04380  Osteoclast differentiation, hsa04550  Signaling pathways regulating pluripotency of stem cells, hsa04611  Platelet activation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04670  Leukocyte transendothelial migration, hsa04714  Thermogenesis, hsa04722  Neurotrophin signaling pathway, hsa04723  Retrograde endocannabinoid signaling, hsa04728  Dopaminergic synapse, hsa04750  Inflammatory mediator regulation of TRP channels, hsa04912  GnRH signaling pathway, hsa04914  Progesterone-mediated oocyte maturation, hsa04917  Prolactin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04935  Growth hormone synthesis, secretion and action, hsa04936  Alcoholic liver disease, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04015 Rap1 signaling pathway, 04370 VEGF signaling pathway, 04668 TNF signaling pathway, 04068 FoxO signaling pathway, 04071 Sphingolipid signaling pathway, 04114 Oocyte meiosis, 04218 Cellular senescence, 04550 Signaling pathways regulating pluripotency of stem cells, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04670 Leukocyte transendothelial migration, 04912 GnRH signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04261 Adrenergic signaling in cardiomyocytes, 04728 Dopaminergic synapse, 04723 Retrograde endocannabinoid signaling, 04722 Neurotrophin signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 04714 Thermogenesis, 05205 Proteoglycans in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05152 Tuberculosis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01522 Endocrine resistance, 01001 Protein kinases [BR:hsa01001], 2.7.11.24  mitogen-activated protein kinase, MAPK family [OT]'),('3639','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04064  NF-kappa B signaling pathway, hsa04217  Necroptosis, hsa04380  Osteoclast differentiation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04750  Inflammatory mediator regulation of TRP channels, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3640','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01523  Antifolate resistance, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3641','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04064  NF-kappa B signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04150  mTOR signaling pathway, hsa04210  Apoptosis, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05310  Asthma, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05414  Dilated cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Tumor necrosis fators, Cytokines'),('3642','hsa04146  Peroxisome, hsa04213  Longevity regulating pathway - multiple species, hsa05012  Parkinson disease, hsa05014  Amyotrophic lateral sclerosis, hsa05016  Huntington disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05208  Chemical carcinogenesis - reactive oxygen species','04146 Peroxisome, 04213 Longevity regulating pathway - multiple species, 05208 Chemical carcinogenesis - reactive oxygen species, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 1.15.1.1  superoxide dismutase'),('3643','hsa00380  Tryptophan metabolism, hsa00630  Glyoxylate and dicarboxylate metabolism, hsa01100  Metabolic pathways, hsa01200  Carbon metabolism, hsa04068  FoxO signaling pathway, hsa04146  Peroxisome, hsa04211  Longevity regulating pathway, hsa04213  Longevity regulating pathway - multiple species, hsa05014  Amyotrophic lateral sclerosis, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05208  Chemical carcinogenesis - reactive oxygen species','00630 Glyoxylate and dicarboxylate metabolism, 00380 Tryptophan metabolism, 04068 FoxO signaling pathway, 04146 Peroxisome, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 05208 Chemical carcinogenesis - reactive oxygen species, 05014 Amyotrophic lateral sclerosis, 05022 Pathways of neurodegeneration - multiple diseases, 1.11.1.6  catalase'),('3644','hsa00480  Glutathione metabolism, hsa00590  Arachidonic acid metabolism, hsa01100  Metabolic pathways, hsa04918  Thyroid hormone synthesis, hsa05014  Amyotrophic lateral sclerosis, hsa05016  Huntington disease, hsa05022  Pathways of neurodegeneration - multiple diseases','00590 Arachidonic acid metabolism, 00480 Glutathione metabolism, 04918 Thyroid hormone synthesis, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05022 Pathways of neurodegeneration - multiple diseases, 1.11.1.9  glutathione peroxidase'),('3645','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04115  p53 signaling pathway, hsa04140  Autophagy - animal, hsa04141  Protein processing in endoplasmic reticulum, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04215  Apoptosis - multiple species, hsa04217  Necroptosis, hsa04261  Adrenergic signaling in cardiomyocytes, hsa04340  Hedgehog signaling pathway, hsa04510  Focal adhesion, hsa04621  NOD-like receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04725  Cholinergic synapse, hsa04915  Estrogen signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05014  Amyotrophic lateral sclerosis, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05145  Toxoplasmosis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05210  Colorectal cancer, hsa05215  Prostate cancer, hsa05222  Small cell lung cancer, hsa05226  Gastric cancer, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 04340 Hedgehog signaling pathway, 04630 JAK-STAT signaling pathway, 04064 NF-kappa B signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04151 PI3K-Akt signaling pathway, 04140 Autophagy - animal, 04210 Apoptosis, 04215 Apoptosis - multiple species, 04217 Necroptosis, 04115 p53 signaling pathway, 04510 Focal adhesion, 04621 NOD-like receptor signaling pathway, 04915 Estrogen signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 04261 Adrenergic signaling in cardiomyocytes, 04725 Cholinergic synapse, 04722 Neurotrophin signaling pathway, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05210 Colorectal cancer, 05226 Gastric cancer, 05215 Prostate cancer, 05222 Small cell lung cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05131 Shigellosis, 05152 Tuberculosis, 05145 Toxoplasmosis, 05014 Amyotrophic lateral sclerosis, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01009 Protein phosphatases and associated proteins [BR:hsa01009], PP1-interacting proteins (PIPs)'),('3646','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04071  Sphingolipid signaling pathway, hsa04115  p53 signaling pathway, hsa04141  Protein processing in endoplasmic reticulum, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04215  Apoptosis - multiple species, hsa04217  Necroptosis, hsa04722  Neurotrophin signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05012  Parkinson disease, hsa05014  Amyotrophic lateral sclerosis, hsa05016  Huntington disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05210  Colorectal cancer, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05216  Thyroid cancer, hsa05217  Basal cell carcinoma, hsa05218  Melanoma, hsa05220  Chronic myeloid leukemia, hsa05222  Small cell lung cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05417  Lipid and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 04071 Sphingolipid signaling pathway, 04210 Apoptosis, 04215 Apoptosis - multiple species, 04217 Necroptosis, 04115 p53 signaling pathway, 04722 Neurotrophin signaling pathway, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05203 Viral carcinogenesis, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05220 Chronic myeloid leukemia, 05217 Basal cell carcinoma, 05218 Melanoma, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05152 Tuberculosis, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 03029 Mitochondrial biogenesis [BR:hsa03029], 02000 Transporters [BR:hsa02000], Fission and Fusion factors, Pores ion channels [TC:1]'),('3647','hsa01524  Platinum drug resistance, hsa04010  MAPK signaling pathway, hsa04115  p53 signaling pathway, hsa04210  Apoptosis, hsa04215  Apoptosis - multiple species, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04668  TNF signaling pathway, hsa04726  Serotonergic synapse, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05012  Parkinson disease, hsa05014  Amyotrophic lateral sclerosis, hsa05016  Huntington disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05210  Colorectal cancer, hsa05222  Small cell lung cancer, hsa05416  Viral myocarditis, hsa05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04668 TNF signaling pathway, 04210 Apoptosis, 04215 Apoptosis - multiple species, 04115 p53 signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04657 IL-17 signaling pathway, 04726 Serotonergic synapse, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05203 Viral carcinogenesis, 05210 Colorectal cancer, 05222 Small cell lung cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05010 Alzheimer disease, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05416 Viral myocarditis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01524 Platinum drug resistance, 01002 Peptidases and inhibitors [BR:hsa01002], 3.4.22.56  caspase-3, Family C14: caspase family'),('3648','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04115  p53 signaling pathway, hsa04140  Autophagy - animal, hsa04141  Protein processing in endoplasmic reticulum, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04215  Apoptosis - multiple species, hsa04217  Necroptosis, hsa04261  Adrenergic signaling in cardiomyocytes, hsa04340  Hedgehog signaling pathway, hsa04510  Focal adhesion, hsa04621  NOD-like receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04725  Cholinergic synapse, hsa04915  Estrogen signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05014  Amyotrophic lateral sclerosis, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05145  Toxoplasmosis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05210  Colorectal cancer, hsa05215  Prostate cancer, hsa05222  Small cell lung cancer, hsa05226  Gastric cancer, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 04340 Hedgehog signaling pathway, 04630 JAK-STAT signaling pathway, 04064 NF-kappa B signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04151 PI3K-Akt signaling pathway, 04140 Autophagy - animal, 04210 Apoptosis, 04215 Apoptosis - multiple species, 04217 Necroptosis, 04115 p53 signaling pathway, 04510 Focal adhesion, 04621 NOD-like receptor signaling pathway, 04915 Estrogen signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 04261 Adrenergic signaling in cardiomyocytes, 04725 Cholinergic synapse, 04722 Neurotrophin signaling pathway, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05210 Colorectal cancer, 05226 Gastric cancer, 05215 Prostate cancer, 05222 Small cell lung cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05131 Shigellosis, 05152 Tuberculosis, 05145 Toxoplasmosis, 05014 Amyotrophic lateral sclerosis, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01009 Protein phosphatases and associated proteins [BR:hsa01009], PP1-interacting proteins (PIPs)'),('3649','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04071  Sphingolipid signaling pathway, hsa04115  p53 signaling pathway, hsa04141  Protein processing in endoplasmic reticulum, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04215  Apoptosis - multiple species, hsa04217  Necroptosis, hsa04722  Neurotrophin signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05012  Parkinson disease, hsa05014  Amyotrophic lateral sclerosis, hsa05016  Huntington disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05210  Colorectal cancer, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05216  Thyroid cancer, hsa05217  Basal cell carcinoma, hsa05218  Melanoma, hsa05220  Chronic myeloid leukemia, hsa05222  Small cell lung cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05417  Lipid and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 04071 Sphingolipid signaling pathway, 04210 Apoptosis, 04215 Apoptosis - multiple species, 04217 Necroptosis, 04115 p53 signaling pathway, 04722 Neurotrophin signaling pathway, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05203 Viral carcinogenesis, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05220 Chronic myeloid leukemia, 05217 Basal cell carcinoma, 05218 Melanoma, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05152 Tuberculosis, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 03029 Mitochondrial biogenesis [BR:hsa03029], 02000 Transporters [BR:hsa02000], Fission and Fusion factors, Pores ion channels [TC:1]'),('3650','hsa01524  Platinum drug resistance, hsa04010  MAPK signaling pathway, hsa04115  p53 signaling pathway, hsa04210  Apoptosis, hsa04215  Apoptosis - multiple species, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04668  TNF signaling pathway, hsa04726  Serotonergic synapse, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05012  Parkinson disease, hsa05014  Amyotrophic lateral sclerosis, hsa05016  Huntington disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05210  Colorectal cancer, hsa05222  Small cell lung cancer, hsa05416  Viral myocarditis, hsa05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04668 TNF signaling pathway, 04210 Apoptosis, 04215 Apoptosis - multiple species, 04115 p53 signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04657 IL-17 signaling pathway, 04726 Serotonergic synapse, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05203 Viral carcinogenesis, 05210 Colorectal cancer, 05222 Small cell lung cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05010 Alzheimer disease, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05416 Viral myocarditis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01524 Platinum drug resistance, 01002 Peptidases and inhibitors [BR:hsa01002], 3.4.22.56  caspase-3, Family C14: caspase family'),('3651','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04115  p53 signaling pathway, hsa04140  Autophagy - animal, hsa04141  Protein processing in endoplasmic reticulum, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04215  Apoptosis - multiple species, hsa04217  Necroptosis, hsa04261  Adrenergic signaling in cardiomyocytes, hsa04340  Hedgehog signaling pathway, hsa04510  Focal adhesion, hsa04621  NOD-like receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04725  Cholinergic synapse, hsa04915  Estrogen signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05014  Amyotrophic lateral sclerosis, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05145  Toxoplasmosis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05210  Colorectal cancer, hsa05215  Prostate cancer, hsa05222  Small cell lung cancer, hsa05226  Gastric cancer, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 04340 Hedgehog signaling pathway, 04630 JAK-STAT signaling pathway, 04064 NF-kappa B signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04151 PI3K-Akt signaling pathway, 04140 Autophagy - animal, 04210 Apoptosis, 04215 Apoptosis - multiple species, 04217 Necroptosis, 04115 p53 signaling pathway, 04510 Focal adhesion, 04621 NOD-like receptor signaling pathway, 04915 Estrogen signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 04261 Adrenergic signaling in cardiomyocytes, 04725 Cholinergic synapse, 04722 Neurotrophin signaling pathway, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05210 Colorectal cancer, 05226 Gastric cancer, 05215 Prostate cancer, 05222 Small cell lung cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05131 Shigellosis, 05152 Tuberculosis, 05145 Toxoplasmosis, 05014 Amyotrophic lateral sclerosis, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01009 Protein phosphatases and associated proteins [BR:hsa01009], PP1-interacting proteins (PIPs)'),('3652','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04071  Sphingolipid signaling pathway, hsa04115  p53 signaling pathway, hsa04141  Protein processing in endoplasmic reticulum, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04215  Apoptosis - multiple species, hsa04217  Necroptosis, hsa04722  Neurotrophin signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05012  Parkinson disease, hsa05014  Amyotrophic lateral sclerosis, hsa05016  Huntington disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05210  Colorectal cancer, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05216  Thyroid cancer, hsa05217  Basal cell carcinoma, hsa05218  Melanoma, hsa05220  Chronic myeloid leukemia, hsa05222  Small cell lung cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05417  Lipid and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 04071 Sphingolipid signaling pathway, 04210 Apoptosis, 04215 Apoptosis - multiple species, 04217 Necroptosis, 04115 p53 signaling pathway, 04722 Neurotrophin signaling pathway, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05203 Viral carcinogenesis, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05220 Chronic myeloid leukemia, 05217 Basal cell carcinoma, 05218 Melanoma, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05152 Tuberculosis, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 03029 Mitochondrial biogenesis [BR:hsa03029], 02000 Transporters [BR:hsa02000], Fission and Fusion factors, Pores ion channels [TC:1]'),('3653','hsa01524  Platinum drug resistance, hsa04010  MAPK signaling pathway, hsa04115  p53 signaling pathway, hsa04210  Apoptosis, hsa04215  Apoptosis - multiple species, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04668  TNF signaling pathway, hsa04726  Serotonergic synapse, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05012  Parkinson disease, hsa05014  Amyotrophic lateral sclerosis, hsa05016  Huntington disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05210  Colorectal cancer, hsa05222  Small cell lung cancer, hsa05416  Viral myocarditis, hsa05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04668 TNF signaling pathway, 04210 Apoptosis, 04215 Apoptosis - multiple species, 04115 p53 signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04657 IL-17 signaling pathway, 04726 Serotonergic synapse, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05203 Viral carcinogenesis, 05210 Colorectal cancer, 05222 Small cell lung cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05010 Alzheimer disease, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05416 Viral myocarditis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01524 Platinum drug resistance, 01002 Peptidases and inhibitors [BR:hsa01002], 3.4.22.56  caspase-3, Family C14: caspase family'),('3654','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04115  p53 signaling pathway, hsa04140  Autophagy - animal, hsa04141  Protein processing in endoplasmic reticulum, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04215  Apoptosis - multiple species, hsa04217  Necroptosis, hsa04261  Adrenergic signaling in cardiomyocytes, hsa04340  Hedgehog signaling pathway, hsa04510  Focal adhesion, hsa04621  NOD-like receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04725  Cholinergic synapse, hsa04915  Estrogen signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05014  Amyotrophic lateral sclerosis, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05145  Toxoplasmosis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05210  Colorectal cancer, hsa05215  Prostate cancer, hsa05222  Small cell lung cancer, hsa05226  Gastric cancer, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 04340 Hedgehog signaling pathway, 04630 JAK-STAT signaling pathway, 04064 NF-kappa B signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04151 PI3K-Akt signaling pathway, 04140 Autophagy - animal, 04210 Apoptosis, 04215 Apoptosis - multiple species, 04217 Necroptosis, 04115 p53 signaling pathway, 04510 Focal adhesion, 04621 NOD-like receptor signaling pathway, 04915 Estrogen signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 04261 Adrenergic signaling in cardiomyocytes, 04725 Cholinergic synapse, 04722 Neurotrophin signaling pathway, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05210 Colorectal cancer, 05226 Gastric cancer, 05215 Prostate cancer, 05222 Small cell lung cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05131 Shigellosis, 05152 Tuberculosis, 05145 Toxoplasmosis, 05014 Amyotrophic lateral sclerosis, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01009 Protein phosphatases and associated proteins [BR:hsa01009], PP1-interacting proteins (PIPs)'),('3655','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04071  Sphingolipid signaling pathway, hsa04115  p53 signaling pathway, hsa04141  Protein processing in endoplasmic reticulum, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04215  Apoptosis - multiple species, hsa04217  Necroptosis, hsa04722  Neurotrophin signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05012  Parkinson disease, hsa05014  Amyotrophic lateral sclerosis, hsa05016  Huntington disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05210  Colorectal cancer, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05216  Thyroid cancer, hsa05217  Basal cell carcinoma, hsa05218  Melanoma, hsa05220  Chronic myeloid leukemia, hsa05222  Small cell lung cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05417  Lipid and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 04071 Sphingolipid signaling pathway, 04210 Apoptosis, 04215 Apoptosis - multiple species, 04217 Necroptosis, 04115 p53 signaling pathway, 04722 Neurotrophin signaling pathway, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05203 Viral carcinogenesis, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05220 Chronic myeloid leukemia, 05217 Basal cell carcinoma, 05218 Melanoma, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05152 Tuberculosis, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 03029 Mitochondrial biogenesis [BR:hsa03029], 02000 Transporters [BR:hsa02000], Fission and Fusion factors, Pores ion channels [TC:1]'),('3656','hsa01524  Platinum drug resistance, hsa04010  MAPK signaling pathway, hsa04115  p53 signaling pathway, hsa04210  Apoptosis, hsa04215  Apoptosis - multiple species, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04668  TNF signaling pathway, hsa04726  Serotonergic synapse, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05012  Parkinson disease, hsa05014  Amyotrophic lateral sclerosis, hsa05016  Huntington disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05210  Colorectal cancer, hsa05222  Small cell lung cancer, hsa05416  Viral myocarditis, hsa05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04668 TNF signaling pathway, 04210 Apoptosis, 04215 Apoptosis - multiple species, 04115 p53 signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04657 IL-17 signaling pathway, 04726 Serotonergic synapse, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05203 Viral carcinogenesis, 05210 Colorectal cancer, 05222 Small cell lung cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05010 Alzheimer disease, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05416 Viral myocarditis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01524 Platinum drug resistance, 01002 Peptidases and inhibitors [BR:hsa01002], 3.4.22.56  caspase-3, Family C14: caspase family'),('3657','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04068  FoxO signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05150  Staphylococcus aureus infection, hsa05152  Tuberculosis, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3658','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04064  NF-kappa B signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04150  mTOR signaling pathway, hsa04210  Apoptosis, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05310  Asthma, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05414  Dilated cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Tumor necrosis fators, Cytokines'),('3659','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04068  FoxO signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05150  Staphylococcus aureus infection, hsa05152  Tuberculosis, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3660','hsa04060  Cytokine-cytokine receptor interaction, hsa04620  Toll-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05205  Proteoglycans in cancer, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3661','hsa03050  Proteasome, hsa04060  Cytokine-cytokine receptor interaction, hsa04066  HIF-1 signaling pathway, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04630  JAK-STAT signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04940  Type I diabetes mellitus, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05200  Pathways in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:hsa03051], 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Other assembling factors, Interferons, Cytokines'),('3662','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04064  NF-kappa B signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04150  mTOR signaling pathway, hsa04210  Apoptosis, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05310  Asthma, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05414  Dilated cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Tumor necrosis fators, Cytokines'),('3663','hsa04060  Cytokine-cytokine receptor interaction, hsa04620  Toll-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05205  Proteoglycans in cancer, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3664','hsa03050  Proteasome, hsa04060  Cytokine-cytokine receptor interaction, hsa04066  HIF-1 signaling pathway, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04630  JAK-STAT signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04940  Type I diabetes mellitus, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05200  Pathways in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:hsa03051], 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Other assembling factors, Interferons, Cytokines'),('3665','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04064  NF-kappa B signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04150  mTOR signaling pathway, hsa04210  Apoptosis, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05310  Asthma, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05414  Dilated cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Tumor necrosis fators, Cytokines'),('3666','hsa00120  Primary bile acid biosynthesis, hsa00140  Steroid hormone biosynthesis, hsa01100  Metabolic pathways, hsa03320  PPAR signaling pathway, hsa04976  Bile secretion, hsa04979  Cholesterol metabolism','00120 Primary bile acid biosynthesis, 00140 Steroid hormone biosynthesis, 03320 PPAR signaling pathway, 04976 Bile secretion, 04979 Cholesterol metabolism, 00199 Cytochrome P450 [BR:hsa00199], 1.14.14.23  cholesterol 7alpha-monooxygenase, CYP7 family'),('3669','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04064  NF-kappa B signaling pathway, hsa04217  Necroptosis, hsa04380  Osteoclast differentiation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04750  Inflammatory mediator regulation of TRP channels, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3670','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01523  Antifolate resistance, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3671','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04668  TNF signaling pathway, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05135 Yersinia infection, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3672','hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04145  Phagosome, hsa04151  PI3K-Akt signaling pathway, hsa04217  Necroptosis, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04936  Alcoholic liver disease, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05164  Influenza A, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04066 HIF-1 signaling pathway, 04151 PI3K-Akt signaling pathway, 04145 Phagosome, 04217 Necroptosis, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 05205 Proteoglycans in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04131 Membrane trafficking [BR:hsa04131], 04054 Pattern recognition receptors [BR:hsa04054], 04090 CD molecules [BR:hsa04090], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Toll-like receptors, Toll-like receptors, Proteins, Cell surface receptors'),('3676',NULL,'04030 G protein-coupled receptors [BR:hsa04030], Bile acid'),('3677','hsa04145  Phagosome, hsa04151  PI3K-Akt signaling pathway, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa05132  Salmonella infection, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04151 PI3K-Akt signaling pathway, 04145 Phagosome, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 05205 Proteoglycans in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04131 Membrane trafficking [BR:hsa04131], 04147 Exosome [BR:hsa04147], 04054 Pattern recognition receptors [BR:hsa04054], 04090 CD molecules [BR:hsa04090], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Toll-like receptors, Exosomal proteins of breast milk, Toll-like receptors, Proteins, Cell surface receptors'),('3678','hsa04145  Phagosome, hsa04620  Toll-like receptor signaling pathway, hsa05132  Salmonella infection, hsa05142  Chagas disease, hsa05152  Tuberculosis, hsa05417  Lipid and atherosclerosis','04145 Phagosome, 04620 Toll-like receptor signaling pathway, 05132 Salmonella infection, 05152 Tuberculosis, 05142 Chagas disease, 05417 Lipid and atherosclerosis, 04131 Membrane trafficking [BR:hsa04131], 04054 Pattern recognition receptors [BR:hsa04054], 04090 CD molecules [BR:hsa04090], Toll-like receptors, Toll-like receptors, Proteins'),('3679','hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04145  Phagosome, hsa04151  PI3K-Akt signaling pathway, hsa04217  Necroptosis, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04936  Alcoholic liver disease, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05164  Influenza A, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04066 HIF-1 signaling pathway, 04151 PI3K-Akt signaling pathway, 04145 Phagosome, 04217 Necroptosis, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 05205 Proteoglycans in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04131 Membrane trafficking [BR:hsa04131], 04054 Pattern recognition receptors [BR:hsa04054], 04090 CD molecules [BR:hsa04090], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Toll-like receptors, Toll-like receptors, Proteins, Cell surface receptors'),('3683','hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04068  FoxO signaling pathway, hsa04144  Endocytosis, hsa04218  Cellular senescence, hsa04350  TGF-beta signaling pathway, hsa04371  Apelin signaling pathway, hsa04380  Osteoclast differentiation, hsa04390  Hippo signaling pathway, hsa04520  Adherens junction, hsa04659  Th17 cell differentiation, hsa04926  Relaxin signaling pathway, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05142  Chagas disease, hsa05161  Hepatitis B, hsa05166  Human T-cell leukemia virus 1 infection, hsa05200  Pathways in cancer, hsa05210  Colorectal cancer, hsa05212  Pancreatic cancer, hsa05220  Chronic myeloid leukemia, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05415  Diabetic cardiomyopathy','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04390 Hippo signaling pathway, 04371 Apelin signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04144 Endocytosis, 04218 Cellular senescence, 04520 Adherens junction, 04659 Th17 cell differentiation, 04926 Relaxin signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05220 Chronic myeloid leukemia, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05142 Chagas disease, 05415 Diabetic cardiomyopathy, 04933 AGE-RAGE signaling pathway in diabetic complications, 01001 Protein kinases [BR:hsa01001], 2.7.11.30  receptor protein serine/threonine kinase, TGFBR1 family [OT]'),('3684',NULL,'03041 Spliceosome [BR:hsa03041], SMN complex factors'),('3685','hsa04120  Ubiquitin mediated proteolysis, hsa04144  Endocytosis, hsa04340  Hedgehog signaling pathway, hsa04350  TGF-beta signaling pathway','04120 Ubiquitin mediated proteolysis, 04340 Hedgehog signaling pathway, 04350 TGF-beta signaling pathway, 04144 Endocytosis, 04131 Membrane trafficking [BR:hsa04131], 04121 Ubiquitin system [BR:hsa04121], 03029 Mitochondrial biogenesis [BR:hsa03029], 2.3.2.26  HECT-type E3 ubiquitin transferase, Ubiquitin E3 ligases, Other mitophagy associated  proteins, HECT type E3, Parkin-independent mechanism factors'),('3709','hsa04024  cAMP signaling pathway, hsa04080  Neuroactive ligand-receptor interaction, hsa04911  Insulin secretion','04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04911 Insulin secretion, 04030 G protein-coupled receptors [BR:hsa04030], Glucagon'),('3710','hsa04024  cAMP signaling pathway, hsa04080  Neuroactive ligand-receptor interaction, hsa04935  Growth hormone synthesis, secretion and action','04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04935 Growth hormone synthesis, secretion and action, 04030 G protein-coupled receptors [BR:hsa04030], Somatostatin'),('3711','hsa04080  Neuroactive ligand-receptor interaction, hsa04935  Growth hormone synthesis, secretion and action','04080 Neuroactive ligand-receptor interaction, 04935 Growth hormone synthesis, secretion and action, 04030 G protein-coupled receptors [BR:hsa04030], Somatostatin'),('3712','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01523  Antifolate resistance, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3713','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01523  Antifolate resistance, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3714','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01523  Antifolate resistance, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3715','hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04145  Phagosome, hsa04151  PI3K-Akt signaling pathway, hsa04217  Necroptosis, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04936  Alcoholic liver disease, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05164  Influenza A, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04066 HIF-1 signaling pathway, 04151 PI3K-Akt signaling pathway, 04145 Phagosome, 04217 Necroptosis, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 05205 Proteoglycans in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04131 Membrane trafficking [BR:hsa04131], 04054 Pattern recognition receptors [BR:hsa04054], 04090 CD molecules [BR:hsa04090], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Toll-like receptors, Toll-like receptors, Proteins, Cell surface receptors'),('3727','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04014  Ras signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04218  Cellular senescence, hsa04380  Osteoclast differentiation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04668  TNF signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04917  Prolactin signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04926  Relaxin signaling pathway, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05030  Cocaine addiction, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05212  Pancreatic cancer, hsa05215  Prostate cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05222  Small cell lung cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:hsa03000], RHR (Rel homology region) Rel/Ankyrin'),('3728','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04014  Ras signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04218  Cellular senescence, hsa04380  Osteoclast differentiation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04668  TNF signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04917  Prolactin signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04926  Relaxin signaling pathway, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05030  Cocaine addiction, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05212  Pancreatic cancer, hsa05215  Prostate cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05222  Small cell lung cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:hsa03000], RHR (Rel homology region) Rel/Ankyrin'),('3729','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3730','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04014  Ras signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04218  Cellular senescence, hsa04380  Osteoclast differentiation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04668  TNF signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04917  Prolactin signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04926  Relaxin signaling pathway, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05030  Cocaine addiction, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05212  Pancreatic cancer, hsa05215  Prostate cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05222  Small cell lung cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:hsa03000], RHR (Rel homology region) Rel/Ankyrin'),('3731','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3732','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04014  Ras signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04218  Cellular senescence, hsa04380  Osteoclast differentiation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04668  TNF signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04917  Prolactin signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04926  Relaxin signaling pathway, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05030  Cocaine addiction, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05212  Pancreatic cancer, hsa05215  Prostate cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05222  Small cell lung cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:hsa03000], RHR (Rel homology region) Rel/Ankyrin'),('3733','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3734','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04014  Ras signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04218  Cellular senescence, hsa04380  Osteoclast differentiation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04668  TNF signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04917  Prolactin signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04926  Relaxin signaling pathway, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05030  Cocaine addiction, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05212  Pancreatic cancer, hsa05215  Prostate cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05222  Small cell lung cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:hsa03000], RHR (Rel homology region) Rel/Ankyrin'),('3735','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3736','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 04147 Exosome [BR:hsa04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('3737','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 01009 Protein phosphatases and associated proteins [BR:hsa01009], PP1-interacting proteins (PIPs)'),('3738','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05120  Epithelial cell signaling in Helicobacter pylori infection','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05120 Epithelial cell signaling in Helicobacter pylori infection, 04090 CD molecules [BR:hsa04090], Proteins'),('3739','hsa04520  Adherens junction, hsa04530  Tight junction, hsa04540  Gap junction, hsa05110  Vibrio cholerae infection, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 05110 Vibrio cholerae infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 04812 Cytoskeleton proteins [BR:hsa04812], Others'),('3743','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01523  Antifolate resistance, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3744','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3745','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04064  NF-kappa B signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04150  mTOR signaling pathway, hsa04210  Apoptosis, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05310  Asthma, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05414  Dilated cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Tumor necrosis fators, Cytokines'),('3746','hsa04613  Neutrophil extracellular trap formation, hsa05034  Alcoholism, hsa05203  Viral carcinogenesis','04613 Neutrophil extracellular trap formation, 05203 Viral carcinogenesis, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:hsa03036], 3.5.1.98  histone deacetylase, Class II HDACs'),('3747','hsa04659  Th17 cell differentiation, hsa05321  Inflammatory bowel disease','04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:hsa03000], Fork head/winged helix other regulators'),('3748','hsa04060  Cytokine-cytokine receptor interaction, hsa04630  JAK-STAT signaling pathway, hsa04659  Th17 cell differentiation, hsa05321  Inflammatory bowel disease','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3749','hsa04141  Protein processing in endoplasmic reticulum, hsa05012  Parkinson disease, hsa05200  Pathways in cancer, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05225  Hepatocellular carcinoma, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 05200 Pathways in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05012 Parkinson disease, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 03000 Transcription factors [BR:hsa03000], 03029 Mitochondrial biogenesis [BR:hsa03029], AP-1(-like) components, NF-E2, Nuclear respiratory factors'),('3750','hsa00860  Porphyrin metabolism, hsa01100  Metabolic pathways, hsa04066  HIF-1 signaling pathway, hsa04216  Ferroptosis, hsa04978  Mineral absorption, hsa05200  Pathways in cancer, hsa05206  MicroRNAs in cancer, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05225  Hepatocellular carcinoma, hsa05418  Fluid shear stress and atherosclerosis','00860 Porphyrin metabolism, 04066 HIF-1 signaling pathway, 04216 Ferroptosis, 04978 Mineral absorption, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05418 Fluid shear stress and atherosclerosis, 1.14.14.18  heme oxygenase (biliverdin-producing)'),('3753','hsa04080  Neuroactive ligand-receptor interaction, hsa04610  Complement and coagulation cascades, hsa04613  Neutrophil extracellular trap formation, hsa04936  Alcoholic liver disease, hsa05150  Staphylococcus aureus infection, hsa05171  Coronavirus disease - COVID-19','04080 Neuroactive ligand-receptor interaction, 04610 Complement and coagulation cascades, 04613 Neutrophil extracellular trap formation, 05171 Coronavirus disease - COVID-19, 05150 Staphylococcus aureus infection, 04936 Alcoholic liver disease, 04030 G protein-coupled receptors [BR:hsa04030], 04090 CD molecules [BR:hsa04090], Anaphylatoxin, Proteins'),('3754','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04144  Endocytosis, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05163  Human cytomegalovirus infection','04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04144 Endocytosis, 04062 Chemokine signaling pathway, 05163 Human cytomegalovirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 04030 G protein-coupled receptors [BR:hsa04030], 04050 Cytokine receptors [BR:hsa04050], 04090 CD molecules [BR:hsa04090], CXC Chemokine, CXC Chemokine, Proteins'),('3755','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04064  NF-kappa B signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04150  mTOR signaling pathway, hsa04210  Apoptosis, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05310  Asthma, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05414  Dilated cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Tumor necrosis fators, Cytokines'),('3756','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04620  Toll-like receptor signaling pathway, hsa05142  Chagas disease, hsa05163  Human cytomegalovirus infection, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04620 Toll-like receptor signaling pathway, 04062 Chemokine signaling pathway, 05163 Human cytomegalovirus infection, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3757','hsa00590  Arachidonic acid metabolism, hsa01100  Metabolic pathways, hsa04064  NF-kappa B signaling pathway, hsa04370  VEGF signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04668  TNF signaling pathway, hsa04723  Retrograde endocannabinoid signaling, hsa04726  Serotonergic synapse, hsa04913  Ovarian steroidogenesis, hsa04921  Oxytocin signaling pathway, hsa04923  Regulation of lipolysis in adipocytes, hsa05010  Alzheimer disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05140  Leishmaniasis, hsa05163  Human cytomegalovirus infection, hsa05165  Human papillomavirus infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05200  Pathways in cancer, hsa05204  Chemical carcinogenesis - DNA adducts, hsa05206  MicroRNAs in cancer, hsa05222  Small cell lung cancer','00590 Arachidonic acid metabolism, 04370 VEGF signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04625 C-type lectin receptor signaling pathway, 04657 IL-17 signaling pathway, 04923 Regulation of lipolysis in adipocytes, 04913 Ovarian steroidogenesis, 04921 Oxytocin signaling pathway, 04726 Serotonergic synapse, 04723 Retrograde endocannabinoid signaling, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05204 Chemical carcinogenesis - DNA adducts, 05222 Small cell lung cancer, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05140 Leishmaniasis, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 1.14.99.1  prostaglandin-endoperoxide synthase'),('3758','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05152  Tuberculosis, hsa05164  Influenza A, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 05164 Influenza A, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05134 Legionellosis, 05152 Tuberculosis, 05144 Malaria, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3759','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04064  NF-kappa B signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04150  mTOR signaling pathway, hsa04210  Apoptosis, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05310  Asthma, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05414  Dilated cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Tumor necrosis fators, Cytokines'),('3760','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04064  NF-kappa B signaling pathway, hsa04217  Necroptosis, hsa04380  Osteoclast differentiation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04750  Inflammatory mediator regulation of TRP channels, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3761','hsa04060  Cytokine-cytokine receptor interaction, hsa04151  PI3K-Akt signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05140  Leishmaniasis, hsa05200  Pathways in cancer, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04640 Hematopoietic cell lineage, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05140 Leishmaniasis, 05310 Asthma, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3762','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01523  Antifolate resistance, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3765','hsa03320  PPAR signaling pathway','03320 PPAR signaling pathway, 04147 Exosome [BR:hsa04147], Exosomal proteins of breast milk'),('3766','hsa03320  PPAR signaling pathway, hsa04979  Cholesterol metabolism','03320 PPAR signaling pathway, 04979 Cholesterol metabolism, 04147 Exosome [BR:hsa04147], Exosomal proteins of breast milk'),('3767','hsa03320  PPAR signaling pathway','03320 PPAR signaling pathway, 04147 Exosome [BR:hsa04147], Exosomal proteins of breast milk'),('3768','hsa03320  PPAR signaling pathway, hsa04979  Cholesterol metabolism','03320 PPAR signaling pathway, 04979 Cholesterol metabolism, 04147 Exosome [BR:hsa04147], Exosomal proteins of breast milk'),('3779',NULL,'03110 Chaperones and folding catalysts [BR:hsa03110], 04091 Lectins [BR:hsa04091], Calnexin / calreticulin, Calnexin / calreticulin'),('3780','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 04147 Exosome [BR:hsa04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('3781','hsa04530  Tight junction, hsa05110  Vibrio cholerae infection','04530 Tight junction, 05110 Vibrio cholerae infection'),('3782','hsa04530  Tight junction','04530 Tight junction'),('3783','hsa04145  Phagosome, hsa04151  PI3K-Akt signaling pathway, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa05132  Salmonella infection, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04151 PI3K-Akt signaling pathway, 04145 Phagosome, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 05205 Proteoglycans in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04131 Membrane trafficking [BR:hsa04131], 04147 Exosome [BR:hsa04147], 04054 Pattern recognition receptors [BR:hsa04054], 04090 CD molecules [BR:hsa04090], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Toll-like receptors, Exosomal proteins of breast milk, Toll-like receptors, Proteins, Cell surface receptors'),('3784','hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04145  Phagosome, hsa04151  PI3K-Akt signaling pathway, hsa04217  Necroptosis, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04936  Alcoholic liver disease, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05164  Influenza A, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04066 HIF-1 signaling pathway, 04151 PI3K-Akt signaling pathway, 04145 Phagosome, 04217 Necroptosis, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 05205 Proteoglycans in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04131 Membrane trafficking [BR:hsa04131], 04054 Pattern recognition receptors [BR:hsa04054], 04090 CD molecules [BR:hsa04090], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Toll-like receptors, Toll-like receptors, Proteins, Cell surface receptors'),('3785','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04064  NF-kappa B signaling pathway, hsa04217  Necroptosis, hsa04380  Osteoclast differentiation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04750  Inflammatory mediator regulation of TRP channels, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3786','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01523  Antifolate resistance, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3787','hsa04060  Cytokine-cytokine receptor interaction, hsa04620  Toll-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05205  Proteoglycans in cancer, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3788','hsa03050  Proteasome, hsa04060  Cytokine-cytokine receptor interaction, hsa04066  HIF-1 signaling pathway, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04630  JAK-STAT signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04940  Type I diabetes mellitus, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05200  Pathways in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:hsa03051], 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Other assembling factors, Interferons, Cytokines'),('3789','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04064  NF-kappa B signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04150  mTOR signaling pathway, hsa04210  Apoptosis, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05310  Asthma, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05414  Dilated cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Tumor necrosis fators, Cytokines'),('3790','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04068  FoxO signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05150  Staphylococcus aureus infection, hsa05152  Tuberculosis, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3791','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04064  NF-kappa B signaling pathway, hsa04217  Necroptosis, hsa04380  Osteoclast differentiation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04750  Inflammatory mediator regulation of TRP channels, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3792','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01523  Antifolate resistance, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3793','hsa04060  Cytokine-cytokine receptor interaction, hsa04620  Toll-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05205  Proteoglycans in cancer, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3794','hsa03050  Proteasome, hsa04060  Cytokine-cytokine receptor interaction, hsa04066  HIF-1 signaling pathway, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04630  JAK-STAT signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04940  Type I diabetes mellitus, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05200  Pathways in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:hsa03051], 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Other assembling factors, Interferons, Cytokines'),('3795','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04064  NF-kappa B signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04150  mTOR signaling pathway, hsa04210  Apoptosis, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05310  Asthma, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05414  Dilated cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Tumor necrosis fators, Cytokines'),('3796','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04068  FoxO signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05150  Staphylococcus aureus infection, hsa05152  Tuberculosis, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3797','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04064  NF-kappa B signaling pathway, hsa04217  Necroptosis, hsa04380  Osteoclast differentiation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04750  Inflammatory mediator regulation of TRP channels, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3798','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01523  Antifolate resistance, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3799','hsa04060  Cytokine-cytokine receptor interaction, hsa04620  Toll-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05205  Proteoglycans in cancer, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3800','hsa03050  Proteasome, hsa04060  Cytokine-cytokine receptor interaction, hsa04066  HIF-1 signaling pathway, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04630  JAK-STAT signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04940  Type I diabetes mellitus, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05200  Pathways in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:hsa03051], 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Other assembling factors, Interferons, Cytokines'),('3801','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04064  NF-kappa B signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04150  mTOR signaling pathway, hsa04210  Apoptosis, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05310  Asthma, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05414  Dilated cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Tumor necrosis fators, Cytokines'),('3802','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04068  FoxO signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05150  Staphylococcus aureus infection, hsa05152  Tuberculosis, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3803','hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04012  ErbB signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04110  Cell cycle, hsa04115  p53 signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04218  Cellular senescence, hsa04630  JAK-STAT signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04934  Cushing syndrome, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05169  Epstein-Barr virus infection, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05216  Thyroid cancer, hsa05217  Basal cell carcinoma, hsa05218  Melanoma, hsa05219  Bladder cancer, hsa05220  Chronic myeloid leukemia, hsa05222  Small cell lung cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer','04012 ErbB signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04110 Cell cycle, 04115 p53 signaling pathway, 04218 Cellular senescence, 04921 Oxytocin signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05203 Viral carcinogenesis, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05220 Chronic myeloid leukemia, 05217 Basal cell carcinoma, 05218 Melanoma, 05211 Renal cell carcinoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 04934 Cushing syndrome, 01524 Platinum drug resistance, 01522 Endocrine resistance'),('3804','hsa04110  Cell cycle, hsa04115  p53 signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04218  Cellular senescence, hsa04934  Cushing syndrome, hsa05160  Hepatitis C, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05169  Epstein-Barr virus infection, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05206  MicroRNAs in cancer, hsa05212  Pancreatic cancer, hsa05214  Glioma, hsa05218  Melanoma, hsa05220  Chronic myeloid leukemia, hsa05222  Small cell lung cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma','04151 PI3K-Akt signaling pathway, 04110 Cell cycle, 04115 p53 signaling pathway, 04218 Cellular senescence, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05203 Viral carcinogenesis, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05214 Glioma, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 04934 Cushing syndrome, 01001 Protein kinases [BR:hsa01001], 2.7.11.22  cyclin-dependent kinase, CDK family'),('3805','hsa01522  Endocrine resistance, hsa04068  FoxO signaling pathway, hsa04110  Cell cycle, hsa04115  p53 signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04152  AMPK signaling pathway, hsa04218  Cellular senescence, hsa04310  Wnt signaling pathway, hsa04340  Hedgehog signaling pathway, hsa04371  Apelin signaling pathway, hsa04390  Hippo signaling pathway, hsa04510  Focal adhesion, hsa04530  Tight junction, hsa04630  JAK-STAT signaling pathway, hsa04917  Prolactin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04934  Cushing syndrome, hsa04936  Alcoholic liver disease, hsa05160  Hepatitis C, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05169  Epstein-Barr virus infection, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05210  Colorectal cancer, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05216  Thyroid cancer, hsa05218  Melanoma, hsa05219  Bladder cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05222  Small cell lung cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05416  Viral myocarditis','04310 Wnt signaling pathway, 04340 Hedgehog signaling pathway, 04390 Hippo signaling pathway, 04371 Apelin signaling pathway, 04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04110 Cell cycle, 04115 p53 signaling pathway, 04218 Cellular senescence, 04510 Focal adhesion, 04530 Tight junction, 04917 Prolactin signaling pathway, 04921 Oxytocin signaling pathway, 04919 Thyroid hormone signaling pathway, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05203 Viral carcinogenesis, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05160 Hepatitis C, 05162 Measles, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05416 Viral myocarditis, 04936 Alcoholic liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04934 Cushing syndrome, 01522 Endocrine resistance'),('3806',NULL,'04121 Ubiquitin system [BR:hsa04121], 2.3.2.-, UBL E3 ligases'),('3807','hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04010  MAPK signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04110  Cell cycle, hsa04115  p53 signaling pathway, hsa04137  Mitophagy - animal, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04216  Ferroptosis, hsa04218  Cellular senescence, hsa04310  Wnt signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa05012  Parkinson disease, hsa05014  Amyotrophic lateral sclerosis, hsa05016  Huntington disease, hsa05131  Shigellosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05210  Colorectal cancer, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05216  Thyroid cancer, hsa05217  Basal cell carcinoma, hsa05218  Melanoma, hsa05219  Bladder cancer, hsa05220  Chronic myeloid leukemia, hsa05222  Small cell lung cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04310 Wnt signaling pathway, 04071 Sphingolipid signaling pathway, 04151 PI3K-Akt signaling pathway, 04137 Mitophagy - animal, 04110 Cell cycle, 04210 Apoptosis, 04216 Ferroptosis, 04115 p53 signaling pathway, 04218 Cellular senescence, 04919 Thyroid hormone signaling pathway, 04722 Neurotrophin signaling pathway, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05203 Viral carcinogenesis, 05230 Central carbon metabolism in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05220 Chronic myeloid leukemia, 05217 Basal cell carcinoma, 05218 Melanoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05131 Shigellosis, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 01524 Platinum drug resistance, 01522 Endocrine resistance, 03000 Transcription factors [BR:hsa03000], 03036 Chromosome and associated proteins [BR:hsa03036], 03400 DNA repair and recombination proteins [BR:hsa03400], p53, Regulators of Aurora kinases, Other check point factors'),('3808','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04071  Sphingolipid signaling pathway, hsa04115  p53 signaling pathway, hsa04141  Protein processing in endoplasmic reticulum, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04215  Apoptosis - multiple species, hsa04217  Necroptosis, hsa04722  Neurotrophin signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05012  Parkinson disease, hsa05014  Amyotrophic lateral sclerosis, hsa05016  Huntington disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05210  Colorectal cancer, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05216  Thyroid cancer, hsa05217  Basal cell carcinoma, hsa05218  Melanoma, hsa05220  Chronic myeloid leukemia, hsa05222  Small cell lung cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05417  Lipid and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 04071 Sphingolipid signaling pathway, 04210 Apoptosis, 04215 Apoptosis - multiple species, 04217 Necroptosis, 04115 p53 signaling pathway, 04722 Neurotrophin signaling pathway, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05203 Viral carcinogenesis, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05220 Chronic myeloid leukemia, 05217 Basal cell carcinoma, 05218 Melanoma, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05152 Tuberculosis, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 03029 Mitochondrial biogenesis [BR:hsa03029], 02000 Transporters [BR:hsa02000], Fission and Fusion factors, Pores ion channels [TC:1]'),('3809','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04115  p53 signaling pathway, hsa04140  Autophagy - animal, hsa04141  Protein processing in endoplasmic reticulum, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04215  Apoptosis - multiple species, hsa04217  Necroptosis, hsa04261  Adrenergic signaling in cardiomyocytes, hsa04340  Hedgehog signaling pathway, hsa04510  Focal adhesion, hsa04621  NOD-like receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04725  Cholinergic synapse, hsa04915  Estrogen signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05014  Amyotrophic lateral sclerosis, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05145  Toxoplasmosis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05210  Colorectal cancer, hsa05215  Prostate cancer, hsa05222  Small cell lung cancer, hsa05226  Gastric cancer, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 04340 Hedgehog signaling pathway, 04630 JAK-STAT signaling pathway, 04064 NF-kappa B signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04151 PI3K-Akt signaling pathway, 04140 Autophagy - animal, 04210 Apoptosis, 04215 Apoptosis - multiple species, 04217 Necroptosis, 04115 p53 signaling pathway, 04510 Focal adhesion, 04621 NOD-like receptor signaling pathway, 04915 Estrogen signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 04261 Adrenergic signaling in cardiomyocytes, 04725 Cholinergic synapse, 04722 Neurotrophin signaling pathway, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05210 Colorectal cancer, 05226 Gastric cancer, 05215 Prostate cancer, 05222 Small cell lung cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05131 Shigellosis, 05152 Tuberculosis, 05145 Toxoplasmosis, 05014 Amyotrophic lateral sclerosis, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01009 Protein phosphatases and associated proteins [BR:hsa01009], PP1-interacting proteins (PIPs)'),('3810','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3811','hsa04530  Tight junction, hsa05110  Vibrio cholerae infection','04530 Tight junction, 05110 Vibrio cholerae infection'),('3812','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 01009 Protein phosphatases and associated proteins [BR:hsa01009], PP1-interacting proteins (PIPs)'),('3813','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 04147 Exosome [BR:hsa04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('3814','hsa04530  Tight junction, hsa05110  Vibrio cholerae infection','04530 Tight junction, 05110 Vibrio cholerae infection'),('3815','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 01009 Protein phosphatases and associated proteins [BR:hsa01009], PP1-interacting proteins (PIPs)'),('3816','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 04147 Exosome [BR:hsa04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('3824','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04014  Ras signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04218  Cellular senescence, hsa04380  Osteoclast differentiation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04668  TNF signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04917  Prolactin signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04926  Relaxin signaling pathway, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05030  Cocaine addiction, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05212  Pancreatic cancer, hsa05215  Prostate cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05222  Small cell lung cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:hsa03000], RHR (Rel homology region) Rel/Ankyrin'),('3825','hsa03320  PPAR signaling pathway, hsa04152  AMPK signaling pathway, hsa04211  Longevity regulating pathway, hsa04380  Osteoclast differentiation, hsa04714  Thermogenesis, hsa04932  Non-alcoholic fatty liver disease, hsa05016  Huntington disease, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05216  Thyroid cancer, hsa05417  Lipid and atherosclerosis','04152 AMPK signaling pathway, 03320 PPAR signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04714 Thermogenesis, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05216 Thyroid cancer, 05016 Huntington disease, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 03000 Transcription factors [BR:hsa03000], 03310 Nuclear receptors [BR:hsa03310], Cys4 thyroid hormone receptor-like, 1C. Peroxisome proliferator-activated receptor (PPAR)'),('3826','hsa03320  PPAR signaling pathway, hsa04975  Fat digestion and absorption','03320 PPAR signaling pathway, 04975 Fat digestion and absorption'),('3827','hsa03320  PPAR signaling pathway, hsa04979  Cholesterol metabolism','03320 PPAR signaling pathway, 04979 Cholesterol metabolism, 04147 Exosome [BR:hsa04147], Exosomal proteins of breast milk'),('3828','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04014  Ras signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04218  Cellular senescence, hsa04380  Osteoclast differentiation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04668  TNF signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04917  Prolactin signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04926  Relaxin signaling pathway, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05030  Cocaine addiction, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05212  Pancreatic cancer, hsa05215  Prostate cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05222  Small cell lung cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:hsa03000], RHR (Rel homology region) Rel/Ankyrin'),('3829','hsa03320  PPAR signaling pathway, hsa04152  AMPK signaling pathway, hsa04211  Longevity regulating pathway, hsa04380  Osteoclast differentiation, hsa04714  Thermogenesis, hsa04932  Non-alcoholic fatty liver disease, hsa05016  Huntington disease, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05216  Thyroid cancer, hsa05417  Lipid and atherosclerosis','04152 AMPK signaling pathway, 03320 PPAR signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04714 Thermogenesis, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05216 Thyroid cancer, 05016 Huntington disease, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 03000 Transcription factors [BR:hsa03000], 03310 Nuclear receptors [BR:hsa03310], Cys4 thyroid hormone receptor-like, 1C. Peroxisome proliferator-activated receptor (PPAR)'),('3830','hsa03320  PPAR signaling pathway, hsa04975  Fat digestion and absorption','03320 PPAR signaling pathway, 04975 Fat digestion and absorption'),('3831','hsa03320  PPAR signaling pathway, hsa04979  Cholesterol metabolism','03320 PPAR signaling pathway, 04979 Cholesterol metabolism, 04147 Exosome [BR:hsa04147], Exosomal proteins of breast milk'),('3832','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3833','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01523  Antifolate resistance, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3834','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04064  NF-kappa B signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04150  mTOR signaling pathway, hsa04210  Apoptosis, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05310  Asthma, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05414  Dilated cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Tumor necrosis fators, Cytokines'),('3835','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04068  FoxO signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05150  Staphylococcus aureus infection, hsa05152  Tuberculosis, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3836','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04064  NF-kappa B signaling pathway, hsa04217  Necroptosis, hsa04380  Osteoclast differentiation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04659  Th17 cell differentiation, hsa04668  TNF signaling pathway, hsa04750  Inflammatory mediator regulation of TRP channels, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05332  Graft-versus-host disease, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3837','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3841','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04115  p53 signaling pathway, hsa04140  Autophagy - animal, hsa04141  Protein processing in endoplasmic reticulum, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04215  Apoptosis - multiple species, hsa04217  Necroptosis, hsa04261  Adrenergic signaling in cardiomyocytes, hsa04340  Hedgehog signaling pathway, hsa04510  Focal adhesion, hsa04621  NOD-like receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04725  Cholinergic synapse, hsa04915  Estrogen signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05014  Amyotrophic lateral sclerosis, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05145  Toxoplasmosis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05210  Colorectal cancer, hsa05215  Prostate cancer, hsa05222  Small cell lung cancer, hsa05226  Gastric cancer, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 04340 Hedgehog signaling pathway, 04630 JAK-STAT signaling pathway, 04064 NF-kappa B signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04151 PI3K-Akt signaling pathway, 04140 Autophagy - animal, 04210 Apoptosis, 04215 Apoptosis - multiple species, 04217 Necroptosis, 04115 p53 signaling pathway, 04510 Focal adhesion, 04621 NOD-like receptor signaling pathway, 04915 Estrogen signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 04261 Adrenergic signaling in cardiomyocytes, 04725 Cholinergic synapse, 04722 Neurotrophin signaling pathway, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05210 Colorectal cancer, 05226 Gastric cancer, 05215 Prostate cancer, 05222 Small cell lung cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05131 Shigellosis, 05152 Tuberculosis, 05145 Toxoplasmosis, 05014 Amyotrophic lateral sclerosis, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01009 Protein phosphatases and associated proteins [BR:hsa01009], PP1-interacting proteins (PIPs)'),('3842','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04071  Sphingolipid signaling pathway, hsa04115  p53 signaling pathway, hsa04141  Protein processing in endoplasmic reticulum, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04215  Apoptosis - multiple species, hsa04217  Necroptosis, hsa04722  Neurotrophin signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05012  Parkinson disease, hsa05014  Amyotrophic lateral sclerosis, hsa05016  Huntington disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05210  Colorectal cancer, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05216  Thyroid cancer, hsa05217  Basal cell carcinoma, hsa05218  Melanoma, hsa05220  Chronic myeloid leukemia, hsa05222  Small cell lung cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05417  Lipid and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 04071 Sphingolipid signaling pathway, 04210 Apoptosis, 04215 Apoptosis - multiple species, 04217 Necroptosis, 04115 p53 signaling pathway, 04722 Neurotrophin signaling pathway, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05203 Viral carcinogenesis, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05220 Chronic myeloid leukemia, 05217 Basal cell carcinoma, 05218 Melanoma, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05152 Tuberculosis, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 03029 Mitochondrial biogenesis [BR:hsa03029], 02000 Transporters [BR:hsa02000], Fission and Fusion factors, Pores ion channels [TC:1]'),('3843','hsa01524  Platinum drug resistance, hsa04010  MAPK signaling pathway, hsa04115  p53 signaling pathway, hsa04210  Apoptosis, hsa04215  Apoptosis - multiple species, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04668  TNF signaling pathway, hsa04726  Serotonergic synapse, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05012  Parkinson disease, hsa05014  Amyotrophic lateral sclerosis, hsa05016  Huntington disease, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05210  Colorectal cancer, hsa05222  Small cell lung cancer, hsa05416  Viral myocarditis, hsa05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04668 TNF signaling pathway, 04210 Apoptosis, 04215 Apoptosis - multiple species, 04115 p53 signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04657 IL-17 signaling pathway, 04726 Serotonergic synapse, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05203 Viral carcinogenesis, 05210 Colorectal cancer, 05222 Small cell lung cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05010 Alzheimer disease, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05416 Viral myocarditis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01524 Platinum drug resistance, 01002 Peptidases and inhibitors [BR:hsa01002], 3.4.22.56  caspase-3, Family C14: caspase family'),('3844','hsa01522  Endocrine resistance, hsa04010  MAPK signaling pathway, hsa04012  ErbB signaling pathway, hsa04014  Ras signaling pathway, hsa04024  cAMP signaling pathway, hsa04068  FoxO signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04137  Mitophagy - animal, hsa04140  Autophagy - animal, hsa04141  Protein processing in endoplasmic reticulum, hsa04210  Apoptosis, hsa04215  Apoptosis - multiple species, hsa04217  Necroptosis, hsa04310  Wnt signaling pathway, hsa04380  Osteoclast differentiation, hsa04510  Focal adhesion, hsa04530  Tight junction, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04723  Retrograde endocannabinoid signaling, hsa04728  Dopaminergic synapse, hsa04750  Inflammatory mediator regulation of TRP channels, hsa04910  Insulin signaling pathway, hsa04912  GnRH signaling pathway, hsa04914  Progesterone-mediated oocyte maturation, hsa04917  Prolactin signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04926  Relaxin signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04935  Growth hormone synthesis, secretion and action, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05012  Parkinson disease, hsa05016  Huntington disease, hsa05017  Spinocerebellar ataxia, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05212  Pancreatic cancer, hsa05231  Choline metabolism in cancer, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04310 Wnt signaling pathway, 04668 TNF signaling pathway, 04068 FoxO signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04140 Autophagy - animal, 04137 Mitophagy - animal, 04210 Apoptosis, 04215 Apoptosis - multiple species, 04217 Necroptosis, 04510 Focal adhesion, 04530 Tight junction, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04910 Insulin signaling pathway, 04920 Adipocytokine signaling pathway, 04912 GnRH signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04728 Dopaminergic synapse, 04723 Retrograde endocannabinoid signaling, 04722 Neurotrophin signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05231 Choline metabolism in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05152 Tuberculosis, 05145 Toxoplasmosis, 05142 Chagas disease, 05010 Alzheimer disease, 05012 Parkinson disease, 05016 Huntington disease, 05017 Spinocerebellar ataxia, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04930 Type II diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01522 Endocrine resistance, 01001 Protein kinases [BR:hsa01001], 2.7.11.24  mitogen-activated protein kinase, MAPK family [OT]'),('3845','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3846','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04014  Ras signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04218  Cellular senescence, hsa04380  Osteoclast differentiation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04668  TNF signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04917  Prolactin signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04926  Relaxin signaling pathway, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05030  Cocaine addiction, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05212  Pancreatic cancer, hsa05215  Prostate cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05222  Small cell lung cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:hsa03000], RHR (Rel homology region) Rel/Ankyrin'),('3847','hsa04060  Cytokine-cytokine receptor interaction, hsa04620  Toll-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05205  Proteoglycans in cancer, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3848','hsa03050  Proteasome, hsa04060  Cytokine-cytokine receptor interaction, hsa04066  HIF-1 signaling pathway, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04630  JAK-STAT signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04940  Type I diabetes mellitus, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05200  Pathways in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:hsa03051], 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Other assembling factors, Interferons, Cytokines'),('3849','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04068  FoxO signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05150  Staphylococcus aureus infection, hsa05152  Tuberculosis, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3850','hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04010  MAPK signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04110  Cell cycle, hsa04115  p53 signaling pathway, hsa04137  Mitophagy - animal, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04216  Ferroptosis, hsa04218  Cellular senescence, hsa04310  Wnt signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa05012  Parkinson disease, hsa05014  Amyotrophic lateral sclerosis, hsa05016  Huntington disease, hsa05131  Shigellosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05210  Colorectal cancer, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05216  Thyroid cancer, hsa05217  Basal cell carcinoma, hsa05218  Melanoma, hsa05219  Bladder cancer, hsa05220  Chronic myeloid leukemia, hsa05222  Small cell lung cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04310 Wnt signaling pathway, 04071 Sphingolipid signaling pathway, 04151 PI3K-Akt signaling pathway, 04137 Mitophagy - animal, 04110 Cell cycle, 04210 Apoptosis, 04216 Ferroptosis, 04115 p53 signaling pathway, 04218 Cellular senescence, 04919 Thyroid hormone signaling pathway, 04722 Neurotrophin signaling pathway, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05203 Viral carcinogenesis, 05230 Central carbon metabolism in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05220 Chronic myeloid leukemia, 05217 Basal cell carcinoma, 05218 Melanoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05131 Shigellosis, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 01524 Platinum drug resistance, 01522 Endocrine resistance, 03000 Transcription factors [BR:hsa03000], 03036 Chromosome and associated proteins [BR:hsa03036], 03400 DNA repair and recombination proteins [BR:hsa03400], p53, Regulators of Aurora kinases, Other check point factors'),('3851','hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04012  ErbB signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04110  Cell cycle, hsa04115  p53 signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04218  Cellular senescence, hsa04630  JAK-STAT signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04934  Cushing syndrome, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05169  Epstein-Barr virus infection, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05216  Thyroid cancer, hsa05217  Basal cell carcinoma, hsa05218  Melanoma, hsa05219  Bladder cancer, hsa05220  Chronic myeloid leukemia, hsa05222  Small cell lung cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer','04012 ErbB signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04110 Cell cycle, 04115 p53 signaling pathway, 04218 Cellular senescence, 04921 Oxytocin signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05203 Viral carcinogenesis, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05220 Chronic myeloid leukemia, 05217 Basal cell carcinoma, 05218 Melanoma, 05211 Renal cell carcinoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 04934 Cushing syndrome, 01524 Platinum drug resistance, 01522 Endocrine resistance'),('3852','hsa04022  cGMP-PKG signaling pathway, hsa04080  Neuroactive ligand-receptor interaction','04022 cGMP-PKG signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04030 G protein-coupled receptors [BR:hsa04030], Adrenaline'),('3853','hsa04020  Calcium signaling pathway, hsa04022  cGMP-PKG signaling pathway, hsa04024  cAMP signaling pathway, hsa04080  Neuroactive ligand-receptor interaction, hsa04261  Adrenergic signaling in cardiomyocytes, hsa04923  Regulation of lipolysis in adipocytes, hsa04924  Renin secretion, hsa04970  Salivary secretion, hsa05207  Chemical carcinogenesis - receptor activation','04020 Calcium signaling pathway, 04024 cAMP signaling pathway, 04022 cGMP-PKG signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04923 Regulation of lipolysis in adipocytes, 04924 Renin secretion, 04261 Adrenergic signaling in cardiomyocytes, 04970 Salivary secretion, 05207 Chemical carcinogenesis - receptor activation, 04030 G protein-coupled receptors [BR:hsa04030], Adrenaline'),('3854','hsa04022  cGMP-PKG signaling pathway, hsa04080  Neuroactive ligand-receptor interaction','04022 cGMP-PKG signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04030 G protein-coupled receptors [BR:hsa04030], Adrenaline'),('3855','hsa04010  MAPK signaling pathway, hsa04014  Ras signaling pathway, hsa04015  Rap1 signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04145  Phagosome, hsa04151  PI3K-Akt signaling pathway, hsa04310  Wnt signaling pathway, hsa04360  Axon guidance, hsa04370  VEGF signaling pathway, hsa04380  Osteoclast differentiation, hsa04510  Focal adhesion, hsa04520  Adherens junction, hsa04530  Tight junction, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04662  B cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04666  Fc gamma R-mediated phagocytosis, hsa04670  Leukocyte transendothelial migration, hsa04722  Neurotrophin signaling pathway, hsa04810  Regulation of actin cytoskeleton, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04972  Pancreatic secretion, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05100  Bacterial invasion of epithelial cells, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05135  Yersinia infection, hsa05163  Human cytomegalovirus infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05212  Pancreatic cancer, hsa05231  Choline metabolism in cancer, hsa05415  Diabetic cardiomyopathy, hsa05416  Viral myocarditis, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04310 Wnt signaling pathway, 04370 VEGF signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04145 Phagosome, 04510 Focal adhesion, 04520 Adherens junction, 04530 Tight junction, 04810 Regulation of actin cytoskeleton, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04662 B cell receptor signaling pathway, 04664 Fc epsilon RI signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04670 Leukocyte transendothelial migration, 04062 Chemokine signaling pathway, 04972 Pancreatic secretion, 04722 Neurotrophin signaling pathway, 04360 Axon guidance, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05231 Choline metabolism in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05211 Renal cell carcinoma, 05170 Human immunodeficiency virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05100 Bacterial invasion of epithelial cells, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 05416 Viral myocarditis, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04131 Membrane trafficking [BR:hsa04131], 04147 Exosome [BR:hsa04147], 04031 GTP-binding proteins [BR:hsa04031], Rho GTPases, Arf6-dependent endocytosis, Ras GTPases, Nox associated proteins, Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell), Exosomal proteins of other body fluids (saliva and urine), Exosomal proteins of colorectal cancer cells, Exosomal proteins of bladder cancer cells, Rac/Cdc42 [OT]'),('3856','hsa04010  MAPK signaling pathway, hsa04012  ErbB signaling pathway, hsa04014  Ras signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04360  Axon guidance, hsa04392  Hippo signaling pathway - multiple species, hsa04510  Focal adhesion, hsa04625  C-type lectin receptor signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04660  T cell receptor signaling pathway, hsa04666  Fc gamma R-mediated phagocytosis, hsa04810  Regulation of actin cytoskeleton, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05205  Proteoglycans in cancer, hsa05211  Renal cell carcinoma','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04392 Hippo signaling pathway - multiple species, 04024 cAMP signaling pathway, 04510 Focal adhesion, 04810 Regulation of actin cytoskeleton, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04660 T cell receptor signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04062 Chemokine signaling pathway, 04360 Axon guidance, 05205 Proteoglycans in cancer, 05211 Renal cell carcinoma, 05170 Human immunodeficiency virus 1 infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 01001 Protein kinases [BR:hsa01001], 04131 Membrane trafficking [BR:hsa04131], 03036 Chromosome and associated proteins [BR:hsa03036], 2.7.11.1  non-specific serine/threonine protein kinase, STE20 family, Kinases and associated proteins, Kinases, Regulators of Aurora kinases'),('3870','hsa04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], Free fatty acid'),('3871','hsa04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], Hydroxy-carboxylic acid'),('3872','hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04012  ErbB signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04110  Cell cycle, hsa04115  p53 signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04218  Cellular senescence, hsa04630  JAK-STAT signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04934  Cushing syndrome, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05169  Epstein-Barr virus infection, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05216  Thyroid cancer, hsa05217  Basal cell carcinoma, hsa05218  Melanoma, hsa05219  Bladder cancer, hsa05220  Chronic myeloid leukemia, hsa05222  Small cell lung cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer','04012 ErbB signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04110 Cell cycle, 04115 p53 signaling pathway, 04218 Cellular senescence, 04921 Oxytocin signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05203 Viral carcinogenesis, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05220 Chronic myeloid leukemia, 05217 Basal cell carcinoma, 05218 Melanoma, 05211 Renal cell carcinoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 04934 Cushing syndrome, 01524 Platinum drug resistance, 01522 Endocrine resistance'),('3873','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 04147 Exosome [BR:hsa04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('3874','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 01009 Protein phosphatases and associated proteins [BR:hsa01009], PP1-interacting proteins (PIPs)'),('3875','hsa04520  Adherens junction, hsa04530  Tight junction, hsa04540  Gap junction, hsa05110  Vibrio cholerae infection, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 05110 Vibrio cholerae infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 04812 Cytoskeleton proteins [BR:hsa04812], Others'),('3876','hsa04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], Hydroxy-carboxylic acid'),('3882','hsa04217  Necroptosis, hsa04620  Toll-like receptor signaling pathway, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19','04217 Necroptosis, 04620 Toll-like receptor signaling pathway, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 04054 Pattern recognition receptors [BR:hsa04054], 04090 CD molecules [BR:hsa04090], Toll-like receptors, Proteins'),('3883','hsa04620  Toll-like receptor signaling pathway, hsa05132  Salmonella infection, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05152  Tuberculosis, hsa05162  Measles, hsa05168  Herpes simplex virus 1 infection, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer','04620 Toll-like receptor signaling pathway, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05132 Salmonella infection, 05152 Tuberculosis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 04054 Pattern recognition receptors [BR:hsa04054], 04090 CD molecules [BR:hsa04090], Toll-like receptors, Proteins'),('3884','hsa04620  Toll-like receptor signaling pathway','04620 Toll-like receptor signaling pathway, 04147 Exosome [BR:hsa04147], Exosomal proteins of colorectal cancer cells, Exosomal proteins of bladder cancer cells'),('3885',NULL,'04050 Cytokine receptors [BR:hsa04050], IL1 receptor family'),('3886','hsa04630  JAK-STAT signaling pathway, hsa04917  Prolactin signaling pathway','04630 JAK-STAT signaling pathway, 04917 Prolactin signaling pathway, 04121 Ubiquitin system [BR:hsa04121], Target recognizing subunit (SOCS box)'),('3887','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04068  FoxO signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05150  Staphylococcus aureus infection, hsa05152  Tuberculosis, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3888','hsa00562  Inositol phosphate metabolism, hsa01100  Metabolic pathways, hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04012  ErbB signaling pathway, hsa04014  Ras signaling pathway, hsa04015  Rap1 signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04070  Phosphatidylinositol signaling system, hsa04071  Sphingolipid signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04140  Autophagy - animal, hsa04150  mTOR signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04152  AMPK signaling pathway, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04213  Longevity regulating pathway - multiple species, hsa04218  Cellular senescence, hsa04360  Axon guidance, hsa04370  VEGF signaling pathway, hsa04380  Osteoclast differentiation, hsa04510  Focal adhesion, hsa04550  Signaling pathways regulating pluripotency of stem cells, hsa04611  Platelet activation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04666  Fc gamma R-mediated phagocytosis, hsa04668  TNF signaling pathway, hsa04670  Leukocyte transendothelial migration, hsa04722  Neurotrophin signaling pathway, hsa04725  Cholinergic synapse, hsa04750  Inflammatory mediator regulation of TRP channels, hsa04810  Regulation of actin cytoskeleton, hsa04910  Insulin signaling pathway, hsa04914  Progesterone-mediated oocyte maturation, hsa04915  Estrogen signaling pathway, hsa04917  Prolactin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa04923  Regulation of lipolysis in adipocytes, hsa04926  Relaxin signaling pathway, hsa04929  GnRH secretion, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04935  Growth hormone synthesis, secretion and action, hsa04960  Aldosterone-regulated sodium reabsorption, hsa04973  Carbohydrate digestion and absorption, hsa05010  Alzheimer disease, hsa05017  Spinocerebellar ataxia, hsa05020  Prion disease, hsa05100  Bacterial invasion of epithelial cells, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05146  Amoebiasis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05218  Melanoma, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05222  Small cell lung cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','00562 Inositol phosphate metabolism, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04370 VEGF signaling pathway, 04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04070 Phosphatidylinositol signaling system, 04072 Phospholipase D signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04210 Apoptosis, 04218 Cellular senescence, 04510 Focal adhesion, 04550 Signaling pathways regulating pluripotency of stem cells, 04810 Regulation of actin cytoskeleton, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04660 T cell receptor signaling pathway, 04662 B cell receptor signaling pathway, 04664 Fc epsilon RI signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04670 Leukocyte transendothelial migration, 04062 Chemokine signaling pathway, 04910 Insulin signaling pathway, 04923 Regulation of lipolysis in adipocytes, 04929 GnRH secretion, 04915 Estrogen signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04973 Carbohydrate digestion and absorption, 04960 Aldosterone-regulated sodium reabsorption, 04725 Cholinergic synapse, 04722 Neurotrophin signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04360 Axon guidance, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05211 Renal cell carcinoma, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05100 Bacterial invasion of epithelial cells, 05146 Amoebiasis, 05142 Chagas disease, 05010 Alzheimer disease, 05017 Spinocerebellar ataxia, 05020 Prion disease, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04930 Type II diabetes mellitus, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 04131 Membrane trafficking [BR:hsa04131], 2.7.1.153  phosphatidylinositol-4,5-bisphosphate 3-kinase, Rab associated proteins'),('3889','hsa00562  Inositol phosphate metabolism, hsa01100  Metabolic pathways, hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04012  ErbB signaling pathway, hsa04014  Ras signaling pathway, hsa04015  Rap1 signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04070  Phosphatidylinositol signaling system, hsa04071  Sphingolipid signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04140  Autophagy - animal, hsa04150  mTOR signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04152  AMPK signaling pathway, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04213  Longevity regulating pathway - multiple species, hsa04218  Cellular senescence, hsa04360  Axon guidance, hsa04370  VEGF signaling pathway, hsa04380  Osteoclast differentiation, hsa04510  Focal adhesion, hsa04550  Signaling pathways regulating pluripotency of stem cells, hsa04611  Platelet activation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04666  Fc gamma R-mediated phagocytosis, hsa04668  TNF signaling pathway, hsa04670  Leukocyte transendothelial migration, hsa04722  Neurotrophin signaling pathway, hsa04725  Cholinergic synapse, hsa04750  Inflammatory mediator regulation of TRP channels, hsa04810  Regulation of actin cytoskeleton, hsa04910  Insulin signaling pathway, hsa04914  Progesterone-mediated oocyte maturation, hsa04915  Estrogen signaling pathway, hsa04917  Prolactin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa04923  Regulation of lipolysis in adipocytes, hsa04926  Relaxin signaling pathway, hsa04929  GnRH secretion, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04935  Growth hormone synthesis, secretion and action, hsa04960  Aldosterone-regulated sodium reabsorption, hsa04973  Carbohydrate digestion and absorption, hsa05010  Alzheimer disease, hsa05017  Spinocerebellar ataxia, hsa05020  Prion disease, hsa05100  Bacterial invasion of epithelial cells, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05146  Amoebiasis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05218  Melanoma, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05222  Small cell lung cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','00562 Inositol phosphate metabolism, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04370 VEGF signaling pathway, 04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04070 Phosphatidylinositol signaling system, 04072 Phospholipase D signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04210 Apoptosis, 04218 Cellular senescence, 04510 Focal adhesion, 04550 Signaling pathways regulating pluripotency of stem cells, 04810 Regulation of actin cytoskeleton, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04660 T cell receptor signaling pathway, 04662 B cell receptor signaling pathway, 04664 Fc epsilon RI signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04670 Leukocyte transendothelial migration, 04062 Chemokine signaling pathway, 04910 Insulin signaling pathway, 04923 Regulation of lipolysis in adipocytes, 04929 GnRH secretion, 04915 Estrogen signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04973 Carbohydrate digestion and absorption, 04960 Aldosterone-regulated sodium reabsorption, 04725 Cholinergic synapse, 04722 Neurotrophin signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04360 Axon guidance, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05211 Renal cell carcinoma, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05100 Bacterial invasion of epithelial cells, 05146 Amoebiasis, 05142 Chagas disease, 05010 Alzheimer disease, 05017 Spinocerebellar ataxia, 05020 Prion disease, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04930 Type II diabetes mellitus, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 04131 Membrane trafficking [BR:hsa04131], 2.7.1.153  phosphatidylinositol-4,5-bisphosphate 3-kinase, Rab associated proteins'),('3890','hsa00562  Inositol phosphate metabolism, hsa01100  Metabolic pathways, hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04012  ErbB signaling pathway, hsa04014  Ras signaling pathway, hsa04015  Rap1 signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04070  Phosphatidylinositol signaling system, hsa04071  Sphingolipid signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04140  Autophagy - animal, hsa04150  mTOR signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04152  AMPK signaling pathway, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04213  Longevity regulating pathway - multiple species, hsa04218  Cellular senescence, hsa04360  Axon guidance, hsa04370  VEGF signaling pathway, hsa04380  Osteoclast differentiation, hsa04510  Focal adhesion, hsa04550  Signaling pathways regulating pluripotency of stem cells, hsa04611  Platelet activation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04666  Fc gamma R-mediated phagocytosis, hsa04668  TNF signaling pathway, hsa04670  Leukocyte transendothelial migration, hsa04722  Neurotrophin signaling pathway, hsa04725  Cholinergic synapse, hsa04750  Inflammatory mediator regulation of TRP channels, hsa04810  Regulation of actin cytoskeleton, hsa04910  Insulin signaling pathway, hsa04914  Progesterone-mediated oocyte maturation, hsa04915  Estrogen signaling pathway, hsa04917  Prolactin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa04923  Regulation of lipolysis in adipocytes, hsa04926  Relaxin signaling pathway, hsa04929  GnRH secretion, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04935  Growth hormone synthesis, secretion and action, hsa04960  Aldosterone-regulated sodium reabsorption, hsa04973  Carbohydrate digestion and absorption, hsa05010  Alzheimer disease, hsa05017  Spinocerebellar ataxia, hsa05020  Prion disease, hsa05100  Bacterial invasion of epithelial cells, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05146  Amoebiasis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05218  Melanoma, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05222  Small cell lung cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','00562 Inositol phosphate metabolism, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04370 VEGF signaling pathway, 04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04070 Phosphatidylinositol signaling system, 04072 Phospholipase D signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04210 Apoptosis, 04218 Cellular senescence, 04510 Focal adhesion, 04550 Signaling pathways regulating pluripotency of stem cells, 04810 Regulation of actin cytoskeleton, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04660 T cell receptor signaling pathway, 04662 B cell receptor signaling pathway, 04664 Fc epsilon RI signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04670 Leukocyte transendothelial migration, 04062 Chemokine signaling pathway, 04910 Insulin signaling pathway, 04923 Regulation of lipolysis in adipocytes, 04929 GnRH secretion, 04915 Estrogen signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04973 Carbohydrate digestion and absorption, 04960 Aldosterone-regulated sodium reabsorption, 04725 Cholinergic synapse, 04722 Neurotrophin signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04360 Axon guidance, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05211 Renal cell carcinoma, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05100 Bacterial invasion of epithelial cells, 05146 Amoebiasis, 05142 Chagas disease, 05010 Alzheimer disease, 05017 Spinocerebellar ataxia, 05020 Prion disease, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04930 Type II diabetes mellitus, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 04131 Membrane trafficking [BR:hsa04131], 2.7.1.153  phosphatidylinositol-4,5-bisphosphate 3-kinase, Rab associated proteins'),('3891','hsa01521  EGFR tyrosine kinase inhibitor resistance, hsa01522  Endocrine resistance, hsa01524  Platinum drug resistance, hsa04010  MAPK signaling pathway, hsa04012  ErbB signaling pathway, hsa04014  Ras signaling pathway, hsa04015  Rap1 signaling pathway, hsa04022  cGMP-PKG signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04068  FoxO signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04140  Autophagy - animal, hsa04150  mTOR signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04152  AMPK signaling pathway, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04213  Longevity regulating pathway - multiple species, hsa04218  Cellular senescence, hsa04261  Adrenergic signaling in cardiomyocytes, hsa04370  VEGF signaling pathway, hsa04371  Apelin signaling pathway, hsa04380  Osteoclast differentiation, hsa04510  Focal adhesion, hsa04550  Signaling pathways regulating pluripotency of stem cells, hsa04611  Platelet activation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04666  Fc gamma R-mediated phagocytosis, hsa04668  TNF signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04725  Cholinergic synapse, hsa04728  Dopaminergic synapse, hsa04910  Insulin signaling pathway, hsa04914  Progesterone-mediated oocyte maturation, hsa04915  Estrogen signaling pathway, hsa04917  Prolactin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04922  Glucagon signaling pathway, hsa04923  Regulation of lipolysis in adipocytes, hsa04926  Relaxin signaling pathway, hsa04929  GnRH secretion, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04935  Growth hormone synthesis, secretion and action, hsa04936  Alcoholic liver disease, hsa04973  Carbohydrate digestion and absorption, hsa05010  Alzheimer disease, hsa05017  Spinocerebellar ataxia, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05200  Pathways in cancer, hsa05205  Proteoglycans in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05212  Pancreatic cancer, hsa05213  Endometrial cancer, hsa05214  Glioma, hsa05215  Prostate cancer, hsa05218  Melanoma, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05222  Small cell lung cancer, hsa05223  Non-small cell lung cancer, hsa05224  Breast cancer, hsa05225  Hepatocellular carcinoma, hsa05226  Gastric cancer, hsa05230  Central carbon metabolism in cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04370 VEGF signaling pathway, 04371 Apelin signaling pathway, 04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04072 Phospholipase D signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04022 cGMP-PKG signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04210 Apoptosis, 04218 Cellular senescence, 04510 Focal adhesion, 04550 Signaling pathways regulating pluripotency of stem cells, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04662 B cell receptor signaling pathway, 04664 Fc epsilon RI signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04062 Chemokine signaling pathway, 04910 Insulin signaling pathway, 04922 Glucagon signaling pathway, 04923 Regulation of lipolysis in adipocytes, 04920 Adipocytokine signaling pathway, 04929 GnRH secretion, 04915 Estrogen signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04261 Adrenergic signaling in cardiomyocytes, 04973 Carbohydrate digestion and absorption, 04725 Cholinergic synapse, 04728 Dopaminergic synapse, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05211 Renal cell carcinoma, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05152 Tuberculosis, 05145 Toxoplasmosis, 05142 Chagas disease, 05010 Alzheimer disease, 05017 Spinocerebellar ataxia, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01001 Protein kinases [BR:hsa01001], 2.7.11.1  non-specific serine/threonine protein kinase, AKT/PKB family'),('3892','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04151  PI3K-Akt signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa04940  Type I diabetes mellitus, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05162  Measles, hsa05166  Human T-cell leukemia virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease','04630 JAK-STAT signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05166 Human T-cell leukemia virus 1 infection, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05135 Yersinia infection, 05142 Chagas disease, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 04940 Type I diabetes mellitus, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3893','hsa04060  Cytokine-cytokine receptor interaction, hsa04151  PI3K-Akt signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05140  Leishmaniasis, hsa05200  Pathways in cancer, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04640 Hematopoietic cell lineage, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05140 Leishmaniasis, 05310 Asthma, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('3894','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04621  NOD-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05152  Tuberculosis, hsa05164  Influenza A, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 05164 Influenza A, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05134 Legionellosis, 05152 Tuberculosis, 05144 Malaria, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3895','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04630  JAK-STAT signaling pathway','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04052 Cytokines and growth factors [BR:hsa04052], Interleukins'),('3896','hsa04060  Cytokine-cytokine receptor interaction, hsa04630  JAK-STAT signaling pathway','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04052 Cytokines and growth factors [BR:hsa04052], Interferons'),('3897','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04672  Intestinal immune network for IgA production','04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04672 Intestinal immune network for IgA production, 04062 Chemokine signaling pathway, 04052 Cytokines and growth factors [BR:hsa04052], Chemokines'),('3898','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04620  Toll-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa05163  Human cytomegalovirus infection','04064 NF-kappa B signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04620 Toll-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04062 Chemokine signaling pathway, 05163 Human cytomegalovirus infection, 04052 Cytokines and growth factors [BR:hsa04052], Chemokines'),('3899','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway','04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04062 Chemokine signaling pathway, 04052 Cytokines and growth factors [BR:hsa04052], Chemokines'),('3900','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04620  Toll-like receptor signaling pathway, hsa05142  Chagas disease, hsa05163  Human cytomegalovirus infection, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04620 Toll-like receptor signaling pathway, 04062 Chemokine signaling pathway, 05163 Human cytomegalovirus infection, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('3901','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway','04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04062 Chemokine signaling pathway, 04052 Cytokines and growth factors [BR:hsa04052], Chemokines'),('3902','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04668  TNF signaling pathway, hsa05163  Human cytomegalovirus infection','04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04062 Chemokine signaling pathway, 05163 Human cytomegalovirus infection, 04052 Cytokines and growth factors [BR:hsa04052], Chemokines'),('3903','hsa04010  MAPK signaling pathway, hsa04726  Serotonergic synapse, hsa05012  Parkinson disease, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04726 Serotonergic synapse, 05012 Parkinson disease, 05418 Fluid shear stress and atherosclerosis, 01009 Protein phosphatases and associated proteins [BR:hsa01009], 3.1.3.16  protein-serine/threonine phosphatase, 3.1.3.48  protein-tyrosine-phosphatase, MAPK phosphatases'),('3904','hsa04010  MAPK signaling pathway','04010 MAPK signaling pathway, 01009 Protein phosphatases and associated proteins [BR:hsa01009], 3.1.3.16  protein-serine/threonine phosphatase, 3.1.3.48  protein-tyrosine-phosphatase, Atypical DSPs'),('3905','hsa04010  MAPK signaling pathway','04010 MAPK signaling pathway, 01009 Protein phosphatases and associated proteins [BR:hsa01009], 3.1.3.16  protein-serine/threonine phosphatase, 3.1.3.48  protein-tyrosine-phosphatase, MAPK phosphatases'),('3906',NULL,'01009 Protein phosphatases and associated proteins [BR:hsa01009], 3.1.3.16  protein-serine/threonine phosphatase, 3.1.3.48  protein-tyrosine-phosphatase, Atypical DSPs'),('3907',NULL,'01009 Protein phosphatases and associated proteins [BR:hsa01009], 3.1.3.16  protein-serine/threonine phosphatase, 3.1.3.48  protein-tyrosine-phosphatase, Atypical DSPs'),('3936','hsa04022  cGMP-PKG signaling pathway, hsa04068  FoxO signaling pathway, hsa04140  Autophagy - animal, hsa04150  mTOR signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04152  AMPK signaling pathway, hsa04211  Longevity regulating pathway, hsa04213  Longevity regulating pathway - multiple species, hsa04722  Neurotrophin signaling pathway, hsa04910  Insulin signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04923  Regulation of lipolysis in adipocytes, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04935  Growth hormone synthesis, secretion and action, hsa04960  Aldosterone-regulated sodium reabsorption, hsa05010  Alzheimer disease, hsa05206  MicroRNAs in cancer, hsa05415  Diabetic cardiomyopathy','04068 FoxO signaling pathway, 04022 cGMP-PKG signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04910 Insulin signaling pathway, 04923 Regulation of lipolysis in adipocytes, 04920 Adipocytokine signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04960 Aldosterone-regulated sodium reabsorption, 04722 Neurotrophin signaling pathway, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 05206 MicroRNAs in cancer, 05010 Alzheimer disease, 05415 Diabetic cardiomyopathy, 04930 Type II diabetes mellitus, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance'),('3937','hsa04072  Phospholipase D signaling pathway, hsa04140  Autophagy - animal, hsa04150  mTOR signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04152  AMPK signaling pathway, hsa04211  Longevity regulating pathway, hsa04218  Cellular senescence, hsa04714  Thermogenesis, hsa04910  Insulin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa05163  Human cytomegalovirus infection, hsa05165  Human papillomavirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05231  Choline metabolism in cancer','04072 Phospholipase D signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04218 Cellular senescence, 04910 Insulin signaling pathway, 04919 Thyroid hormone signaling pathway, 04211 Longevity regulating pathway, 04714 Thermogenesis, 05231 Choline metabolism in cancer, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05165 Human papillomavirus infection, 04031 GTP-binding proteins [BR:hsa04031], Rheb'),('3938','hsa04022  cGMP-PKG signaling pathway, hsa04068  FoxO signaling pathway, hsa04140  Autophagy - animal, hsa04150  mTOR signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04152  AMPK signaling pathway, hsa04211  Longevity regulating pathway, hsa04213  Longevity regulating pathway - multiple species, hsa04722  Neurotrophin signaling pathway, hsa04910  Insulin signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04923  Regulation of lipolysis in adipocytes, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04935  Growth hormone synthesis, secretion and action, hsa04960  Aldosterone-regulated sodium reabsorption, hsa05010  Alzheimer disease, hsa05206  MicroRNAs in cancer, hsa05415  Diabetic cardiomyopathy','04068 FoxO signaling pathway, 04022 cGMP-PKG signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04910 Insulin signaling pathway, 04923 Regulation of lipolysis in adipocytes, 04920 Adipocytokine signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04960 Aldosterone-regulated sodium reabsorption, 04722 Neurotrophin signaling pathway, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 05206 MicroRNAs in cancer, 05010 Alzheimer disease, 05415 Diabetic cardiomyopathy, 04930 Type II diabetes mellitus, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance'),('3939','hsa04072  Phospholipase D signaling pathway, hsa04140  Autophagy - animal, hsa04150  mTOR signaling pathway, hsa04151  PI3K-Akt signaling pathway, hsa04152  AMPK signaling pathway, hsa04211  Longevity regulating pathway, hsa04218  Cellular senescence, hsa04714  Thermogenesis, hsa04910  Insulin signaling pathway, hsa04919  Thyroid hormone signaling pathway, hsa05163  Human cytomegalovirus infection, hsa05165  Human papillomavirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05231  Choline metabolism in cancer','04072 Phospholipase D signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04218 Cellular senescence, 04910 Insulin signaling pathway, 04919 Thyroid hormone signaling pathway, 04211 Longevity regulating pathway, 04714 Thermogenesis, 05231 Choline metabolism in cancer, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05165 Human papillomavirus infection, 04031 GTP-binding proteins [BR:hsa04031], Rheb'),('3940',NULL,'04030 G protein-coupled receptors [BR:hsa04030], Free fatty acid'),('3941','hsa04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], Free fatty acid'),('3942','hsa04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:hsa04030], Free fatty acid'),('3943',NULL,'04030 G protein-coupled receptors [BR:hsa04030], Free fatty acid'),('3944','hsa04520  Adherens junction, hsa04530  Tight junction, hsa04540  Gap junction, hsa05110  Vibrio cholerae infection, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 05110 Vibrio cholerae infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 04812 Cytoskeleton proteins [BR:hsa04812], Others'),('3945','hsa04530  Tight junction, hsa05110  Vibrio cholerae infection','04530 Tight junction, 05110 Vibrio cholerae infection'),('3946','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 04147 Exosome [BR:hsa04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('3947','hsa04145  Phagosome, hsa04151  PI3K-Akt signaling pathway, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa05132  Salmonella infection, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04151 PI3K-Akt signaling pathway, 04145 Phagosome, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 05205 Proteoglycans in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04131 Membrane trafficking [BR:hsa04131], 04147 Exosome [BR:hsa04147], 04054 Pattern recognition receptors [BR:hsa04054], 04090 CD molecules [BR:hsa04090], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Toll-like receptors, Exosomal proteins of breast milk, Toll-like receptors, Proteins, Cell surface receptors'),('3948','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 01009 Protein phosphatases and associated proteins [BR:hsa01009], PP1-interacting proteins (PIPs)'),('3959','hsa00140  Steroid hormone biosynthesis, hsa00380  Tryptophan metabolism, hsa00830  Retinol metabolism, hsa00980  Metabolism of xenobiotics by cytochrome P450, hsa01100  Metabolic pathways, hsa04913  Ovarian steroidogenesis, hsa05204  Chemical carcinogenesis - DNA adducts, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05417  Lipid and atherosclerosis','00140 Steroid hormone biosynthesis, 00380 Tryptophan metabolism, 00830 Retinol metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 04913 Ovarian steroidogenesis, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05417 Lipid and atherosclerosis, 00199 Cytochrome P450 [BR:hsa00199], 1.14.14.1  unspecific monooxygenase, CYP1 family'),('3960',NULL,'01002 Peptidases and inhibitors [BR:hsa01002], 3.4.14.2  dipeptidyl-peptidase II, Family S28'),('3961','hsa04140  Autophagy - animal, hsa05200  Pathways in cancer, hsa05219  Bladder cancer','04140 Autophagy - animal, 05200 Pathways in cancer, 05219 Bladder cancer, 01001 Protein kinases [BR:hsa01001], 2.7.11.1  non-specific serine/threonine protein kinase, DAPK family'),('3962',NULL,'04812 Cytoskeleton proteins [BR:hsa04812], Cross-linking proteins'),('3963',NULL,'04131 Membrane trafficking [BR:hsa04131], Insulin-like growth factor-binding proteins'),('3964',NULL,'01004 Lipid biosynthesis proteins [BR:hsa01004], 1.14.19.-, Omega'),('3965','hsa04010  MAPK signaling pathway, hsa04510  Focal adhesion, hsa05132  Salmonella infection, hsa05205  Proteoglycans in cancer','04010 MAPK signaling pathway, 04510 Focal adhesion, 05205 Proteoglycans in cancer, 05132 Salmonella infection, 04812 Cytoskeleton proteins [BR:hsa04812], 04147 Exosome [BR:hsa04147], Cross-linking proteins, Intermediate filament-binding proteins, Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)'),('3966','hsa00030  Pentose phosphate pathway, hsa00480  Glutathione metabolism, hsa01100  Metabolic pathways, hsa01200  Carbon metabolism, hsa05230  Central carbon metabolism in cancer, hsa05415  Diabetic cardiomyopathy','00030 Pentose phosphate pathway, 00480 Glutathione metabolism, 05230 Central carbon metabolism in cancer, 05415 Diabetic cardiomyopathy, 04147 Exosome [BR:hsa04147], 1.1.1.49  glucose-6-phosphate dehydrogenase (NADP+), 1.1.1.363  glucose-6-phosphate dehydrogenase [NAD(P)+], Exosomal proteins of breast cancer cells, Exosomal proteins of colorectal cancer cells, Exosomal proteins of bladder cancer cells'),('3967',NULL,NULL),('3968','hsa00564  Glycerophospholipid metabolism, hsa01100  Metabolic pathways','00564 Glycerophospholipid metabolism, 2.1.1.17  phosphatidylethanolamine N-methyltransferase, 2.1.1.71  phosphatidyl-N-methylethanolamine N-methyltransferase'),('3969','hsa04110  Cell cycle, hsa04115  p53 signaling pathway, hsa04960  Aldosterone-regulated sodium reabsorption','04110 Cell cycle, 04115 p53 signaling pathway, 04960 Aldosterone-regulated sodium reabsorption, 04147 Exosome [BR:hsa04147], Exosomal proteins of other body fluids (saliva and urine), Exosomal proteins of colorectal cancer cells, Exosomal proteins of bladder cancer cells'),('3970',NULL,NULL),('3971',NULL,'03036 Chromosome and associated proteins [BR:hsa03036], Regulators of Aurora kinases'),('3972','hsa00480  Glutathione metabolism, hsa01100  Metabolic pathways','00480 Glutathione metabolism, 4.3.2.7  glutathione-specific gamma-glutamylcyclotransferase'),('3973',NULL,'99980 Enzymes with EC numbers, 3.2.2.-'),('3974',NULL,'03110 Chaperones and folding catalysts [BR:hsa03110], 5.2.1.8  peptidylprolyl isomerase, FKBP'),('3975','hsa04130  SNARE interactions in vesicular transport','04130 SNARE interactions in vesicular transport, 04131 Membrane trafficking [BR:hsa04131], VAMP'),('3976','hsa04550  Signaling pathways regulating pluripotency of stem cells, hsa05202  Transcriptional misregulation in cancer, hsa05206  MicroRNAs in cancer','04550 Signaling pathways regulating pluripotency of stem cells, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 03036 Chromosome and associated proteins [BR:hsa03036], PRC1 (polycomb repressive complex 1)'),('3977',NULL,'04131 Membrane trafficking [BR:hsa04131], Others'),('3978','hsa04071  Sphingolipid signaling pathway, hsa04140  Autophagy - animal, hsa04142  Lysosome, hsa04210  Apoptosis, hsa04915  Estrogen signaling pathway, hsa05152  Tuberculosis, hsa05415  Diabetic cardiomyopathy','04071 Sphingolipid signaling pathway, 04142 Lysosome, 04140 Autophagy - animal, 04210 Apoptosis, 04915 Estrogen signaling pathway, 05152 Tuberculosis, 05415 Diabetic cardiomyopathy, 01002 Peptidases and inhibitors [BR:hsa01002], 04147 Exosome [BR:hsa04147], 3.4.23.5  cathepsin D, Family A1: pepsin family, Exosomal proteins of other body fluids (saliva and urine)'),('3979',NULL,NULL),('3980','hsa00052  Galactose metabolism, hsa00500  Starch and sucrose metabolism, hsa01100  Metabolic pathways, hsa04973  Carbohydrate digestion and absorption','00052 Galactose metabolism, 00500 Starch and sucrose metabolism, 04973 Carbohydrate digestion and absorption, 3.2.1.3  glucan 1,4-alpha-glucosidase, 3.2.1.20  alpha-glucosidase'),('3981',NULL,'03000 Transcription factors [BR:hsa03000], Homeo domain CUT'),('3982',NULL,'04990 Domain-containing proteins not elsewhere classified [BR:hsa04990], Other SH2 and SH3-containing proteins'),('3983','hsa04216  Ferroptosis, hsa04978  Mineral absorption','04216 Ferroptosis, 04978 Mineral absorption, 02000 Transporters [BR:hsa02000], SLC40: Basolateral iron transporter'),('3984',NULL,'02000 Transporters [BR:hsa02000], SLC17: Vesicular glutamate transporter, Anion:cation symporter (ACS) family [TC:2.A.1.14]'),('3986','hsa04115  p53 signaling pathway, hsa04211  Longevity regulating pathway','04115 p53 signaling pathway, 04211 Longevity regulating pathway'),('3987',NULL,'04121 Ubiquitin system [BR:hsa04121], 2.3.2.31  RBR-type E3 ubiquitin transferase, RBR proteins'),('3988','hsa05202  Transcriptional misregulation in cancer','05202 Transcriptional misregulation in cancer, 04147 Exosome [BR:hsa04147], 1.1.1.141  15-hydroxyprostaglandin dehydrogenase (NAD+), Exosomal proteins of other body fluids (saliva and urine)'),('3989',NULL,'03036 Chromosome and associated proteins [BR:hsa03036], Other centriole associated proteins'),('3990','hsa04380  Osteoclast differentiation, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05010  Alzheimer disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04380 Osteoclast differentiation, 05208 Chemical carcinogenesis - reactive oxygen species, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04933 AGE-RAGE signaling pathway in diabetic complications, 04131 Membrane trafficking [BR:hsa04131], NADPH oxidases'),('3991','hsa01523  Antifolate resistance, hsa02010  ABC transporters, hsa04024  cAMP signaling pathway, hsa04976  Bile secretion','02010 ABC transporters, 04024 cAMP signaling pathway, 04976 Bile secretion, 01523 Antifolate resistance, 02000 Transporters [BR:hsa02000], ABCC1, 2, 3, 4, 5, 6, 10, 11, 12, 13 subgroups'),('3993','hsa04068  FoxO signaling pathway, hsa04110  Cell cycle, hsa04218  Cellular senescence, hsa04914  Progesterone-mediated oocyte maturation, hsa05170  Human immunodeficiency virus 1 infection','04068 FoxO signaling pathway, 04110 Cell cycle, 04218 Cellular senescence, 04914 Progesterone-mediated oocyte maturation, 05170 Human immunodeficiency virus 1 infection, 03032 DNA replication proteins [BR:hsa03032], 03036 Chromosome and associated proteins [BR:hsa03036], Prevention of re-replication factors, Cyclins'),('3994','hsa04659  Th17 cell differentiation, hsa04934  Cushing syndrome, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species','04659 Th17 cell differentiation, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 04934 Cushing syndrome, 03000 Transcription factors [BR:hsa03000], Factors with PAS domain'),('3995','hsa04141  Protein processing in endoplasmic reticulum, hsa05012  Parkinson disease, hsa05200  Pathways in cancer, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05225  Hepatocellular carcinoma, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 05200 Pathways in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05012 Parkinson disease, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 03000 Transcription factors [BR:hsa03000], 03029 Mitochondrial biogenesis [BR:hsa03029], AP-1(-like) components, NF-E2, Nuclear respiratory factors'),('3996','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 04147 Exosome [BR:hsa04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('3997','hsa04514  Cell adhesion molecules, hsa04530  Tight junction, hsa04670  Leukocyte transendothelial migration, hsa05130  Pathogenic Escherichia coli infection, hsa05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 05130 Pathogenic Escherichia coli infection, 01009 Protein phosphatases and associated proteins [BR:hsa01009], PP1-interacting proteins (PIPs)'),('3998','hsa04520  Adherens junction, hsa04530  Tight junction, hsa04540  Gap junction, hsa05110  Vibrio cholerae infection, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 05110 Vibrio cholerae infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 04812 Cytoskeleton proteins [BR:hsa04812], Others'),('3999','hsa00130  Ubiquinone and other terpenoid-quinone biosynthesis, hsa01100  Metabolic pathways, hsa01240  Biosynthesis of cofactors, hsa05200  Pathways in cancer, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05225  Hepatocellular carcinoma, hsa05418  Fluid shear stress and atherosclerosis','00130 Ubiquinone and other terpenoid-quinone biosynthesis, 05200 Pathways in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05418 Fluid shear stress and atherosclerosis, 1.6.5.2  NAD(P)H dehydrogenase (quinone)'),('4017','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04064  NF-kappa B signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04150  mTOR signaling pathway, hsa04210  Apoptosis, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05310  Asthma, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05414  Dilated cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Tumor necrosis fators, Cytokines'),('4018','hsa04145  Phagosome, hsa04151  PI3K-Akt signaling pathway, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa05132  Salmonella infection, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04151 PI3K-Akt signaling pathway, 04145 Phagosome, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 05205 Proteoglycans in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04131 Membrane trafficking [BR:hsa04131], 04147 Exosome [BR:hsa04147], 04054 Pattern recognition receptors [BR:hsa04054], 04090 CD molecules [BR:hsa04090], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Toll-like receptors, Exosomal proteins of breast milk, Toll-like receptors, Proteins, Cell surface receptors'),('4019','hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04145  Phagosome, hsa04151  PI3K-Akt signaling pathway, hsa04217  Necroptosis, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04936  Alcoholic liver disease, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05161  Hepatitis B, hsa05162  Measles, hsa05164  Influenza A, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04066 HIF-1 signaling pathway, 04151 PI3K-Akt signaling pathway, 04145 Phagosome, 04217 Necroptosis, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 05205 Proteoglycans in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04131 Membrane trafficking [BR:hsa04131], 04054 Pattern recognition receptors [BR:hsa04054], 04090 CD molecules [BR:hsa04090], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Toll-like receptors, Toll-like receptors, Proteins, Cell surface receptors'),('4020','hsa03050  Proteasome, hsa04060  Cytokine-cytokine receptor interaction, hsa04066  HIF-1 signaling pathway, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04630  JAK-STAT signaling pathway, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04940  Type I diabetes mellitus, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05200  Pathways in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:hsa03051], 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Other assembling factors, Interferons, Cytokines'),('4021','hsa04060  Cytokine-cytokine receptor interaction, hsa04151  PI3K-Akt signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05140  Leishmaniasis, hsa05200  Pathways in cancer, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04640 Hematopoietic cell lineage, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05140 Leishmaniasis, 05310 Asthma, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('4022','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04068  FoxO signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04672  Intestinal immune network for IgA production, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05150  Staphylococcus aureus infection, hsa05152  Tuberculosis, hsa05310  Asthma, hsa05320  Autoimmune thyroid disease, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('4034','hsa00380  Tryptophan metabolism, hsa00790  Folate biosynthesis, hsa01100  Metabolic pathways, hsa04726  Serotonergic synapse','00380 Tryptophan metabolism, 00790 Folate biosynthesis, 04726 Serotonergic synapse, 1.14.16.4  tryptophan 5-monooxygenase'),('4044','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04630  JAK-STAT signaling pathway','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04050 Cytokine receptors [BR:hsa04050], IL10/28 receptor family'),('4074',NULL,'02000 Transporters [BR:hsa02000], SLC5: Sodium glucose cotransporter'),('4078',NULL,'04131 Membrane trafficking [BR:hsa04131], 04147 Exosome [BR:hsa04147], 04090 CD molecules [BR:hsa04090], Membrane bound mucins, Exosomal proteins of breast milk, Exosomal proteins of breast cancer cells, Exosomal proteins of bladder cancer cells, Proteins'),('4079','hsa05146  Amoebiasis, hsa05226  Gastric cancer','05226 Gastric cancer, 05146 Amoebiasis, 04131 Membrane trafficking [BR:hsa04131], Secretory mucins'),('4080','hsa00510  N-Glycan biosynthesis, hsa01100  Metabolic pathways','00510 N-Glycan biosynthesis, 01003 Glycosyltransferases [BR:hsa01003], 2.4.1.144  beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase, N-Glycan'),('4081','hsa00052  Galactose metabolism, hsa00510  N-Glycan biosynthesis, hsa00513  Various types of N-glycan biosynthesis, hsa00514  Other types of O-glycan biosynthesis, hsa00515  Mannose type O-glycan biosynthesis, hsa00533  Glycosaminoglycan biosynthesis - keratan sulfate, hsa00601  Glycosphingolipid biosynthesis - lacto and neolacto series, hsa01100  Metabolic pathways','00052 Galactose metabolism, 00510 N-Glycan biosynthesis, 00513 Various types of N-glycan biosynthesis, 00515 Mannose type O-glycan biosynthesis, 00514 Other types of O-glycan biosynthesis, 00533 Glycosaminoglycan biosynthesis - keratan sulfate, 00601 Glycosphingolipid biosynthesis - lacto and neolacto series, 01003 Glycosyltransferases [BR:hsa01003], 04131 Membrane trafficking [BR:hsa04131], 04147 Exosome [BR:hsa04147], 2.4.1.22  lactose synthase, 2.4.1.38  beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase, 2.4.1.90  N-acetyllactosamine synthase, 2.4.1.-, Type 2 chain/Poly-N-acetyllactosamine, Acrosomal exocytosis proteins, Exosomal proteins of breast milk'),('4082','hsa00510  N-Glycan biosynthesis, hsa00514  Other types of O-glycan biosynthesis, hsa01100  Metabolic pathways','00510 N-Glycan biosynthesis, 00514 Other types of O-glycan biosynthesis, 01003 Glycosyltransferases [BR:hsa01003], 2.4.99.1  beta-galactoside alpha-(2,6)-sialyltransferase, Sialyltransferase'),('4086','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04064  NF-kappa B signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04150  mTOR signaling pathway, hsa04210  Apoptosis, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05310  Asthma, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05414  Dilated cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Tumor necrosis fators, Cytokines'),('4087','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('4088','hsa01522  Endocrine resistance, hsa04010  MAPK signaling pathway, hsa04024  cAMP signaling pathway, hsa04210  Apoptosis, hsa04380  Osteoclast differentiation, hsa04620  Toll-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04668  TNF signaling pathway, hsa04713  Circadian entrainment, hsa04725  Cholinergic synapse, hsa04728  Dopaminergic synapse, hsa04915  Estrogen signaling pathway, hsa04917  Prolactin signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04932  Non-alcoholic fatty liver disease, hsa04935  Growth hormone synthesis, secretion and action, hsa05031  Amphetamine addiction, hsa05130  Pathogenic Escherichia coli infection, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05161  Hepatitis B, hsa05162  Measles, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05224  Breast cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04668 TNF signaling pathway, 04024 cAMP signaling pathway, 04210 Apoptosis, 04620 Toll-like receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04915 Estrogen signaling pathway, 04917 Prolactin signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04928 Parathyroid hormone synthesis, secretion and action, 04725 Cholinergic synapse, 04728 Dopaminergic synapse, 04380 Osteoclast differentiation, 04713 Circadian entrainment, 05200 Pathways in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05224 Breast cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05167 Kaposi sarcoma-associated herpesvirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05031 Amphetamine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 01522 Endocrine resistance, 03000 Transcription factors [BR:hsa03000], 04131 Membrane trafficking [BR:hsa04131], AP-1(-like) components, Fos, Selective cargos'),('4089','hsa01522  Endocrine resistance, hsa04010  MAPK signaling pathway, hsa04012  ErbB signaling pathway, hsa04024  cAMP signaling pathway, hsa04137  Mitophagy - animal, hsa04210  Apoptosis, hsa04310  Wnt signaling pathway, hsa04380  Osteoclast differentiation, hsa04510  Focal adhesion, hsa04530  Tight junction, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04668  TNF signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04912  GnRH signaling pathway, hsa04915  Estrogen signaling pathway, hsa04921  Oxytocin signaling pathway, hsa04926  Relaxin signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa05030  Cocaine addiction, hsa05031  Amphetamine addiction, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05161  Hepatitis B, hsa05162  Measles, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05203  Viral carcinogenesis, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05210  Colorectal cancer, hsa05211  Renal cell carcinoma, hsa05224  Breast cancer, hsa05231  Choline metabolism in cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04310 Wnt signaling pathway, 04668 TNF signaling pathway, 04024 cAMP signaling pathway, 04137 Mitophagy - animal, 04210 Apoptosis, 04510 Focal adhesion, 04530 Tight junction, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04912 GnRH signaling pathway, 04915 Estrogen signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05211 Renal cell carcinoma, 05224 Breast cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05030 Cocaine addiction, 05031 Amphetamine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01522 Endocrine resistance, 03000 Transcription factors [BR:hsa03000], AP-1(-like) components, Jun'),('4090','hsa00630  Glyoxylate and dicarboxylate metabolism, hsa01100  Metabolic pathways, hsa01200  Carbon metabolism','00630 Glyoxylate and dicarboxylate metabolism, 01009 Protein phosphatases and associated proteins [BR:hsa01009], 3.1.3.18  phosphoglycolate phosphatase, 3.1.3.48  protein-tyrosine-phosphatase, Other HAD phosphatases'),('4097','hsa04977  Vitamin digestion and absorption','04977 Vitamin digestion and absorption, 02000 Transporters [BR:hsa02000], SLC19: Folate/thiamine transporter'),('4098','hsa04977  Vitamin digestion and absorption','04977 Vitamin digestion and absorption, 02000 Transporters [BR:hsa02000], SLC19: Folate/thiamine transporter'),('4105','hsa04964  Proximal tubule bicarbonate reclamation, hsa04974  Protein digestion and absorption, hsa04976  Bile secretion, hsa04978  Mineral absorption','04976 Bile secretion, 04974 Protein digestion and absorption, 04978 Mineral absorption, 04964 Proximal tubule bicarbonate reclamation, 02000 Transporters [BR:hsa02000], SLC9: Na+/H+ exchanger'),('4108','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04014  Ras signaling pathway, hsa04024  cAMP signaling pathway, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04066  HIF-1 signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04137  Mitophagy - animal, hsa04151  PI3K-Akt signaling pathway, hsa04210  Apoptosis, hsa04211  Longevity regulating pathway, hsa04218  Cellular senescence, hsa04380  Osteoclast differentiation, hsa04613  Neutrophil extracellular trap formation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04623  Cytosolic DNA-sensing pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04659  Th17 cell differentiation, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa04668  TNF signaling pathway, hsa04722  Neurotrophin signaling pathway, hsa04917  Prolactin signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04926  Relaxin signaling pathway, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05010  Alzheimer disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05030  Cocaine addiction, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05162  Measles, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05203  Viral carcinogenesis, hsa05207  Chemical carcinogenesis - receptor activation, hsa05208  Chemical carcinogenesis - reactive oxygen species, hsa05212  Pancreatic cancer, hsa05215  Prostate cancer, hsa05220  Chronic myeloid leukemia, hsa05221  Acute myeloid leukemia, hsa05222  Small cell lung cancer, hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, hsa05321  Inflammatory bowel disease, hsa05415  Diabetic cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04137 Mitophagy - animal, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:hsa03000], RHR (Rel homology region) Rel/Ankyrin'),('4109','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('4110','hsa04064  NF-kappa B signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04662  B cell receptor signaling pathway, hsa05131  Shigellosis, hsa05152  Tuberculosis','04064 NF-kappa B signaling pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04662 B cell receptor signaling pathway, 05131 Shigellosis, 05152 Tuberculosis'),('4111','hsa04972  Pancreatic secretion, hsa04978  Mineral absorption','04972 Pancreatic secretion, 04978 Mineral absorption, 02000 Transporters [BR:hsa02000], SLC26: Multifunctional anion exchanger'),('4128','hsa00510  N-Glycan biosynthesis, hsa00513  Various types of N-glycan biosynthesis, hsa01100  Metabolic pathways','00510 N-Glycan biosynthesis, 00513 Various types of N-glycan biosynthesis, 01003 Glycosyltransferases [BR:hsa01003], 2.4.1.145  alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase, N-Glycan'),('4129','hsa00510  N-Glycan biosynthesis, hsa00513  Various types of N-glycan biosynthesis, hsa01100  Metabolic pathways','00510 N-Glycan biosynthesis, 00513 Various types of N-glycan biosynthesis, 01003 Glycosyltransferases [BR:hsa01003], 2.4.1.145  alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase, N-Glycan'),('4130','hsa04630  JAK-STAT signaling pathway','04630 JAK-STAT signaling pathway, 04050 Cytokine receptors [BR:hsa04050], IL10/28 receptor family'),('4135','hsa04928  Parathyroid hormone synthesis, secretion and action, hsa04961  Endocrine and other factor-regulated calcium reabsorption, hsa04978  Mineral absorption, hsa05152  Tuberculosis, hsa05207  Chemical carcinogenesis - receptor activation','04928 Parathyroid hormone synthesis, secretion and action, 04978 Mineral absorption, 04961 Endocrine and other factor-regulated calcium reabsorption, 05207 Chemical carcinogenesis - receptor activation, 05152 Tuberculosis, 01009 Protein phosphatases and associated proteins [BR:hsa01009], 03000 Transcription factors [BR:hsa03000], 03310 Nuclear receptors [BR:hsa03310], PP1-interacting proteins (PIPs), Cys4 thyroid hormone receptor-like, 1I. Vitamin D3 like receptor'),('4136','hsa00980  Metabolism of xenobiotics by cytochrome P450, hsa04976  Bile secretion, hsa05204  Chemical carcinogenesis - DNA adducts','00980 Metabolism of xenobiotics by cytochrome P450, 04976 Bile secretion, 05204 Chemical carcinogenesis - DNA adducts, 2.8.2.14  bile-salt sulfotransferase'),('4137','hsa04657  IL-17 signaling pathway','04657 IL-17 signaling pathway'),('4138','hsa04512  ECM-receptor interaction, hsa04640  Hematopoietic cell lineage, hsa05131  Shigellosis, hsa05169  Epstein-Barr virus infection, hsa05205  Proteoglycans in cancer, hsa05206  MicroRNAs in cancer','04512 ECM-receptor interaction, 04640 Hematopoietic cell lineage, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05169 Epstein-Barr virus infection, 05131 Shigellosis, 04147 Exosome [BR:hsa04147], 04090 CD molecules [BR:hsa04090], 00535 Proteoglycans [BR:hsa00535], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell), Exosomal proteins of other body fluids (saliva and urine), Exosomal proteins of colorectal cancer cells, Exosomal proteins of bladder cancer cells, Proteins, Others, Cell surface receptors'),('4139','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('4140','hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04062  Chemokine signaling pathway, hsa04064  NF-kappa B signaling pathway, hsa04072  Phospholipase D signaling pathway, hsa04218  Cellular senescence, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04657  IL-17 signaling pathway, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa05120  Epithelial cell signaling in Helicobacter pylori infection, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05142  Chagas disease, hsa05144  Malaria, hsa05146  Amoebiasis, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05167  Kaposi sarcoma-associated herpesvirus infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05202  Transcriptional misregulation in cancer, hsa05219  Bladder cancer, hsa05323  Rheumatoid arthritis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05219 Bladder cancer, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05120 Epithelial cell signaling in Helicobacter pylori infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Chemokines, Chemokines'),('4141','hsa01523  Antifolate resistance, hsa04010  MAPK signaling pathway, hsa04060  Cytokine-cytokine receptor interaction, hsa04061  Viral protein interaction with cytokine and cytokine receptor, hsa04064  NF-kappa B signaling pathway, hsa04071  Sphingolipid signaling pathway, hsa04150  mTOR signaling pathway, hsa04210  Apoptosis, hsa04217  Necroptosis, hsa04350  TGF-beta signaling pathway, hsa04380  Osteoclast differentiation, hsa04612  Antigen processing and presentation, hsa04620  Toll-like receptor signaling pathway, hsa04621  NOD-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04640  Hematopoietic cell lineage, hsa04650  Natural killer cell mediated cytotoxicity, hsa04657  IL-17 signaling pathway, hsa04660  T cell receptor signaling pathway, hsa04664  Fc epsilon RI signaling pathway, hsa04668  TNF signaling pathway, hsa04920  Adipocytokine signaling pathway, hsa04930  Type II diabetes mellitus, hsa04931  Insulin resistance, hsa04932  Non-alcoholic fatty liver disease, hsa04933  AGE-RAGE signaling pathway in diabetic complications, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05010  Alzheimer disease, hsa05014  Amyotrophic lateral sclerosis, hsa05020  Prion disease, hsa05022  Pathways of neurodegeneration - multiple diseases, hsa05130  Pathogenic Escherichia coli infection, hsa05131  Shigellosis, hsa05132  Salmonella infection, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05135  Yersinia infection, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05160  Hepatitis C, hsa05161  Hepatitis B, hsa05163  Human cytomegalovirus infection, hsa05164  Influenza A, hsa05165  Human papillomavirus infection, hsa05166  Human T-cell leukemia virus 1 infection, hsa05168  Herpes simplex virus 1 infection, hsa05169  Epstein-Barr virus infection, hsa05170  Human immunodeficiency virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05205  Proteoglycans in cancer, hsa05310  Asthma, hsa05321  Inflammatory bowel disease, hsa05322  Systemic lupus erythematosus, hsa05323  Rheumatoid arthritis, hsa05330  Allograft rejection, hsa05332  Graft-versus-host disease, hsa05410  Hypertrophic cardiomyopathy, hsa05414  Dilated cardiomyopathy, hsa05417  Lipid and atherosclerosis, hsa05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05130 Pathogenic Escherichia coli infection, 05132 Salmonella infection, 05131 Shigellosis, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Tumor necrosis fators, Cytokines'),('4142','hsa04060  Cytokine-cytokine receptor interaction, hsa04620  Toll-like receptor signaling pathway, hsa04622  RIG-I-like receptor signaling pathway, hsa04625  C-type lectin receptor signaling pathway, hsa04630  JAK-STAT signaling pathway, hsa04658  Th1 and Th2 cell differentiation, hsa04936  Alcoholic liver disease, hsa04940  Type I diabetes mellitus, hsa05133  Pertussis, hsa05134  Legionellosis, hsa05140  Leishmaniasis, hsa05142  Chagas disease, hsa05143  African trypanosomiasis, hsa05144  Malaria, hsa05145  Toxoplasmosis, hsa05146  Amoebiasis, hsa05152  Tuberculosis, hsa05162  Measles, hsa05164  Influenza A, hsa05168  Herpes simplex virus 1 infection, hsa05171  Coronavirus disease - COVID-19, hsa05200  Pathways in cancer, hsa05321  Inflammatory bowel disease, hsa05330  Allograft rejection, hsa05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:hsa04052], 00536 Glycosaminoglycan binding proteins [BR:hsa00536], Interleukins, Cytokines'),('4143','hsa04064  NF-kappa B signaling pathway, hsa04620  Toll-like receptor signaling pathway, hsa04936  Alcoholic liver disease, hsa05152  Tuberculosis, hsa05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04620 Toll-like receptor signaling pathway, 05152 Tuberculosis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04147 Exosome [BR:hsa04147], Exosomal proteins of other cancer cells'),('4230','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 04147 Exosome [BR:mmu04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('4231','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu04062  Chemokine signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04217  Necroptosis, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04630  JAK-STAT signaling pathway, mmu04659  Th17 cell differentiation, mmu04917  Prolactin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04931  Insulin resistance, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04935  Growth hormone synthesis, secretion and action, mmu05145  Toxoplasmosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05212  Pancreatic cancer, mmu05221  Acute myeloid leukemia, mmu05223  Non-small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04217 Necroptosis, 04550 Signaling pathways regulating pluripotency of stem cells, 04659 Th17 cell differentiation, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05223 Non-small cell lung cancer, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05145 Toxoplasmosis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 03000 Transcription factors [BR:mmu03000], STAT'),('4232','mmu04613  Neutrophil extracellular trap formation, mmu05034  Alcoholism, mmu05203  Viral carcinogenesis','04613 Neutrophil extracellular trap formation, 05203 Viral carcinogenesis, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:mmu03036], 3.5.1.98  histone deacetylase, Class II HDACs'),('4243','mmu00561  Glycerolipid metabolism, mmu01100  Metabolic pathways, mmu04975  Fat digestion and absorption','00561 Glycerolipid metabolism, 04975 Fat digestion and absorption, 2.3.1.20  diacylglycerol O-acyltransferase, 2.3.1.75  long-chain-alcohol O-fatty-acyltransferase'),('4244','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('4245','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04068  FoxO signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4246','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4247','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4248','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('4249','mmu00760  Nicotinate and nicotinamide metabolism, mmu01100  Metabolic pathways, mmu04068  FoxO signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04213  Longevity regulating pathway - multiple species, mmu04218  Cellular senescence, mmu04922  Glucagon signaling pathway, mmu04936  Alcoholic liver disease, mmu05031  Amphetamine addiction, mmu05206  MicroRNAs in cancer','00760 Nicotinate and nicotinamide metabolism, 04068 FoxO signaling pathway, 04152 AMPK signaling pathway, 04218 Cellular senescence, 04922 Glucagon signaling pathway, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 05206 MicroRNAs in cancer, 05031 Amphetamine addiction, 04936 Alcoholic liver disease, 03036 Chromosome and associated proteins [BR:mmu03036], 03029 Mitochondrial biogenesis [BR:mmu03029], 2.3.1.286  protein acetyllysine N-acetyltransferase, SIRTs (sirtuins, class III HDACs), Other regulator of mitochondrial biogenesis'),('4250','mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer','05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 03100 Non-coding RNAs [BR:mmu03100], Micro RNA'),('4251','mmu02010  ABC transporters, mmu04975  Fat digestion and absorption, mmu04979  Cholesterol metabolism, mmu05417  Lipid and atherosclerosis','02010 ABC transporters, 04975 Fat digestion and absorption, 04979 Cholesterol metabolism, 05417 Lipid and atherosclerosis, 02000 Transporters [BR:mmu02000], ABCA1, 2, 3, 4, 7, 12, 13 subgroups'),('4252','mmu02010  ABC transporters, mmu05417  Lipid and atherosclerosis','02010 ABC transporters, 05417 Lipid and atherosclerosis, 02000 Transporters [BR:mmu02000], ABCG1, 4 subgroups'),('4253','mmu04060  Cytokine-cytokine receptor interaction, mmu04062  Chemokine signaling pathway','04060 Cytokine-cytokine receptor interaction, 04062 Chemokine signaling pathway, 04052 Cytokines and growth factors [BR:mmu04052], Chemokines'),('4254','mmu04110  Cell cycle, mmu04213  Longevity regulating pathway - multiple species, mmu04330  Notch signaling pathway, mmu04613  Neutrophil extracellular trap formation, mmu04919  Thyroid hormone signaling pathway, mmu05016  Huntington disease, mmu05031  Amphetamine addiction, mmu05034  Alcoholism, mmu05165  Human papillomavirus infection, mmu05169  Epstein-Barr virus infection, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05220  Chronic myeloid leukemia','04330 Notch signaling pathway, 04110 Cell cycle, 04613 Neutrophil extracellular trap formation, 04919 Thyroid hormone signaling pathway, 04213 Longevity regulating pathway - multiple species, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05203 Viral carcinogenesis, 05220 Chronic myeloid leukemia, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05016 Huntington disease, 05031 Amphetamine addiction, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:mmu03036], 3.5.1.98  histone deacetylase, Class I HDACs, Sin3A-HDAC complex, BRAF-HDAC complex, Other heterochromatin formation proteins, NuRD complex'),('4255','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu04062  Chemokine signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04217  Necroptosis, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04630  JAK-STAT signaling pathway, mmu04659  Th17 cell differentiation, mmu04917  Prolactin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04931  Insulin resistance, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04935  Growth hormone synthesis, secretion and action, mmu05145  Toxoplasmosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05212  Pancreatic cancer, mmu05221  Acute myeloid leukemia, mmu05223  Non-small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04217 Necroptosis, 04550 Signaling pathways regulating pluripotency of stem cells, 04659 Th17 cell differentiation, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05223 Non-small cell lung cancer, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05145 Toxoplasmosis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 03000 Transcription factors [BR:mmu03000], STAT'),('4256','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4257','mmu04060  Cytokine-cytokine receptor interaction, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04936  Alcoholic liver disease, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis','04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4258','mmu04659  Th17 cell differentiation, mmu05321  Inflammatory bowel disease','04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix other regulators'),('4350','mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu05207  Chemical carcinogenesis - receptor activation','04550 Signaling pathways regulating pluripotency of stem cells, 05207 Chemical carcinogenesis - receptor activation, 03000 Transcription factors [BR:mmu03000], Cys2His2 SP/KLF family and related proteins'),('4352','mmu05146  Amoebiasis, mmu05226  Gastric cancer','05226 Gastric cancer, 05146 Amoebiasis, 04131 Membrane trafficking [BR:mmu04131], Secretory mucins'),('4353',NULL,'04131 Membrane trafficking [BR:mmu04131], Membrane bound mucins'),('4354','mmu00512  Mucin type O-glycan biosynthesis, mmu00514  Other types of O-glycan biosynthesis, mmu01100  Metabolic pathways','00512 Mucin type O-glycan biosynthesis, 00514 Other types of O-glycan biosynthesis, 01003 Glycosyltransferases [BR:mmu01003], 2.4.1.122  N-acetylgalactosaminide beta-1,3-galactosyltransferase, Type 3 chain'),('4355','mmu00533  Glycosaminoglycan biosynthesis - keratan sulfate, mmu00601  Glycosphingolipid biosynthesis - lacto and neolacto series, mmu01100  Metabolic pathways','00533 Glycosaminoglycan biosynthesis - keratan sulfate, 00601 Glycosphingolipid biosynthesis - lacto and neolacto series, 01003 Glycosyltransferases [BR:mmu01003], 2.4.1.90  N-acetyllactosamine synthase, 2.4.1.275  neolactotriaosylceramide beta-1,4-galactosyltransferase, 2.4.1.-, Type 2 chain/Poly-N-acetyllactosamine'),('4356','mmu00601  Glycosphingolipid biosynthesis - lacto and neolacto series, mmu01100  Metabolic pathways','00601 Glycosphingolipid biosynthesis - lacto and neolacto series, 01003 Glycosyltransferases [BR:mmu01003], 2.4.99.4  beta-galactoside alpha-2,3-sialyltransferase, Sialyltransferase'),('4357','mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu05207  Chemical carcinogenesis - receptor activation','04550 Signaling pathways regulating pluripotency of stem cells, 05207 Chemical carcinogenesis - receptor activation, 03000 Transcription factors [BR:mmu03000], Cys2His2 SP/KLF family and related proteins'),('4358','mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer','05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 04147 Exosome [BR:mmu04147], 03100 Non-coding RNAs [BR:mmu03100], Exosomal RNA of breast milk, Exosomal RNA of ovarian cancer cells, Exosomal RNA of lung cancer cells, Exosomal RNA of other cancer cells, Micro RNA'),('4359','mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer','05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 04147 Exosome [BR:mmu04147], 03100 Non-coding RNAs [BR:mmu03100], Exosomal RNA of breast milk, Exosomal RNA of ovarian cancer cells, Exosomal RNA of lung cancer cells, Exosomal RNA of other cancer cells, Micro RNA'),('4360','mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer','05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 04147 Exosome [BR:mmu04147], 03100 Non-coding RNAs [BR:mmu03100], Exosomal RNA of breast milk, Exosomal RNA of ovarian cancer cells, Exosomal RNA of lung cancer cells, Exosomal RNA of other cancer cells, Micro RNA'),('4418','mmu04066  HIF-1 signaling pathway, mmu04911  Insulin secretion, mmu04919  Thyroid hormone signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04976  Bile secretion, mmu05166  Human T-cell leukemia virus 1 infection, mmu05200  Pathways in cancer, mmu05211  Renal cell carcinoma, mmu05230  Central carbon metabolism in cancer, mmu05415  Diabetic cardiomyopathy','04066 HIF-1 signaling pathway, 04911 Insulin secretion, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 04919 Thyroid hormone signaling pathway, 04976 Bile secretion, 05200 Pathways in cancer, 05230 Central carbon metabolism in cancer, 05211 Renal cell carcinoma, 05166 Human T-cell leukemia virus 1 infection, 05415 Diabetic cardiomyopathy, 04931 Insulin resistance, 02000 Transporters [BR:mmu02000], SLC2: Facilitative GLUT transporter, Sugar porter (SP) family [TC:2.A.1.1]'),('4419','mmu04068  FoxO signaling pathway, mmu04152  AMPK signaling pathway, mmu04910  Insulin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu05415  Diabetic cardiomyopathy','04068 FoxO signaling pathway, 04152 AMPK signaling pathway, 04910 Insulin signaling pathway, 04920 Adipocytokine signaling pathway, 05415 Diabetic cardiomyopathy, 04930 Type II diabetes mellitus, 04931 Insulin resistance, 02000 Transporters [BR:mmu02000], SLC2: Facilitative GLUT transporter, Sugar porter (SP) family [TC:2.A.1.1]'),('4420','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01522  Endocrine resistance, mmu01524  Platinum drug resistance, mmu04010  MAPK signaling pathway, mmu04012  ErbB signaling pathway, mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04022  cGMP-PKG signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04072  Phospholipase D signaling pathway, mmu04140  Autophagy - animal, mmu04150  mTOR signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04152  AMPK signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04213  Longevity regulating pathway - multiple species, mmu04218  Cellular senescence, mmu04261  Adrenergic signaling in cardiomyocytes, mmu04370  VEGF signaling pathway, mmu04371  Apelin signaling pathway, mmu04380  Osteoclast differentiation, mmu04510  Focal adhesion, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04611  Platelet activation, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04666  Fc gamma R-mediated phagocytosis, mmu04668  TNF signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04725  Cholinergic synapse, mmu04728  Dopaminergic synapse, mmu04910  Insulin signaling pathway, mmu04914  Progesterone-mediated oocyte maturation, mmu04915  Estrogen signaling pathway, mmu04917  Prolactin signaling pathway, mmu04919  Thyroid hormone signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04922  Glucagon signaling pathway, mmu04923  Regulation of lipolysis in adipocytes, mmu04926  Relaxin signaling pathway, mmu04929  GnRH secretion, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04935  Growth hormone synthesis, secretion and action, mmu04936  Alcoholic liver disease, mmu04973  Carbohydrate digestion and absorption, mmu05010  Alzheimer disease, mmu05017  Spinocerebellar ataxia, mmu05132  Salmonella infection, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05210  Colorectal cancer, mmu05211  Renal cell carcinoma, mmu05212  Pancreatic cancer, mmu05213  Endometrial cancer, mmu05214  Glioma, mmu05215  Prostate cancer, mmu05218  Melanoma, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05223  Non-small cell lung cancer, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05230  Central carbon metabolism in cancer, mmu05231  Choline metabolism in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04370 VEGF signaling pathway, 04371 Apelin signaling pathway, 04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04072 Phospholipase D signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04022 cGMP-PKG signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04210 Apoptosis, 04218 Cellular senescence, 04510 Focal adhesion, 04550 Signaling pathways regulating pluripotency of stem cells, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04662 B cell receptor signaling pathway, 04664 Fc epsilon RI signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04062 Chemokine signaling pathway, 04910 Insulin signaling pathway, 04922 Glucagon signaling pathway, 04923 Regulation of lipolysis in adipocytes, 04920 Adipocytokine signaling pathway, 04929 GnRH secretion, 04915 Estrogen signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04261 Adrenergic signaling in cardiomyocytes, 04973 Carbohydrate digestion and absorption, 04725 Cholinergic synapse, 04728 Dopaminergic synapse, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05211 Renal cell carcinoma, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05152 Tuberculosis, 05145 Toxoplasmosis, 05142 Chagas disease, 05010 Alzheimer disease, 05017 Spinocerebellar ataxia, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01001 Protein kinases [BR:mmu01001], 2.7.11.1  non-specific serine/threonine protein kinase, AKT/PKB family'),('4421','mmu01522  Endocrine resistance, mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu04670  Leukocyte transendothelial migration, mmu04915  Estrogen signaling pathway, mmu04926  Relaxin signaling pathway, mmu05161  Hepatitis B, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05215  Prostate cancer, mmu05219  Bladder cancer, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04668 TNF signaling pathway, 04657 IL-17 signaling pathway, 04670 Leukocyte transendothelial migration, 04915 Estrogen signaling pathway, 04926 Relaxin signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05219 Bladder cancer, 05215 Prostate cancer, 05161 Hepatitis B, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 01522 Endocrine resistance, 01002 Peptidases and inhibitors [BR:mmu01002], 3.4.24.35  gelatinase B, Family M10'),('4423','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('4462','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04068  FoxO signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4463','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04068  FoxO signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4464','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04068  FoxO signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4465','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04068  FoxO signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4466','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04068  FoxO signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4467','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('4468','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('4469','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('4470','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('4471','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('4472','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4473','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4474','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4475','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4476','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4477','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4478','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4479','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4480','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4481','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4482','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04068  FoxO signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4483','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4484','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4485','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('4487','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4488','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4489','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04068  FoxO signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4490','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('4493','mmu01522  Endocrine resistance, mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu04670  Leukocyte transendothelial migration, mmu04915  Estrogen signaling pathway, mmu04926  Relaxin signaling pathway, mmu05161  Hepatitis B, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05215  Prostate cancer, mmu05219  Bladder cancer, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04668 TNF signaling pathway, 04657 IL-17 signaling pathway, 04670 Leukocyte transendothelial migration, 04915 Estrogen signaling pathway, 04926 Relaxin signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05219 Bladder cancer, 05215 Prostate cancer, 05161 Hepatitis B, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 01522 Endocrine resistance, 01002 Peptidases and inhibitors [BR:mmu01002], 3.4.24.35  gelatinase B, Family M10'),('4494','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('4495','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4496','mmu04068  FoxO signaling pathway, mmu04140  Autophagy - animal, mmu04150  mTOR signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04213  Longevity regulating pathway - multiple species, mmu04371  Apelin signaling pathway, mmu04530  Tight junction, mmu04710  Circadian rhythm, mmu04714  Thermogenesis, mmu04910  Insulin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04921  Oxytocin signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease, mmu05410  Hypertrophic cardiomyopathy, mmu05418  Fluid shear stress and atherosclerosis','04371 Apelin signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04530 Tight junction, 04910 Insulin signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 04921 Oxytocin signaling pathway, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 04710 Circadian rhythm, 04714 Thermogenesis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 01001 Protein kinases [BR:mmu01001], 04131 Membrane trafficking [BR:mmu04131], 03029 Mitochondrial biogenesis [BR:mmu03029], 2.7.11.11  cAMP-dependent protein kinase, CAMKL family, Others, Other regulator of mitochondrial biogenesis, Other mitophagy factors'),('4497','mmu03320  PPAR signaling pathway, mmu04979  Cholesterol metabolism','03320 PPAR signaling pathway, 04979 Cholesterol metabolism, 04147 Exosome [BR:mmu04147], Exosomal proteins of breast milk'),('4498','mmu00480  Glutathione metabolism, mmu00590  Arachidonic acid metabolism, mmu01100  Metabolic pathways, mmu04918  Thyroid hormone synthesis, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05022  Pathways of neurodegeneration - multiple diseases','00590 Arachidonic acid metabolism, 00480 Glutathione metabolism, 04918 Thyroid hormone synthesis, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05022 Pathways of neurodegeneration - multiple diseases, 1.11.1.9  glutathione peroxidase'),('4499','mmu04975  Fat digestion and absorption, mmu04977  Vitamin digestion and absorption, mmu04979  Cholesterol metabolism, mmu05417  Lipid and atherosclerosis','04975 Fat digestion and absorption, 04979 Cholesterol metabolism, 04977 Vitamin digestion and absorption, 05417 Lipid and atherosclerosis, 04147 Exosome [BR:mmu04147], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Exosomal proteins of other cancer cells, Others'),('4500','mmu04962  Vasopressin-regulated water reabsorption, mmu04976  Bile secretion','04976 Bile secretion, 04962 Vasopressin-regulated water reabsorption, 02000 Transporters [BR:mmu02000], Aquaporins'),('4501','mmu00564  Glycerophospholipid metabolism, mmu00565  Ether lipid metabolism, mmu00590  Arachidonic acid metabolism, mmu00591  Linoleic acid metabolism, mmu00592  alpha-Linolenic acid metabolism, mmu01100  Metabolic pathways, mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04072  Phospholipase D signaling pathway, mmu04217  Necroptosis, mmu04270  Vascular smooth muscle contraction, mmu04370  VEGF signaling pathway, mmu04611  Platelet activation, mmu04664  Fc epsilon RI signaling pathway, mmu04666  Fc gamma R-mediated phagocytosis, mmu04724  Glutamatergic synapse, mmu04726  Serotonergic synapse, mmu04730  Long-term depression, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04912  GnRH signaling pathway, mmu04913  Ovarian steroidogenesis, mmu04921  Oxytocin signaling pathway, mmu05231  Choline metabolism in cancer','00564 Glycerophospholipid metabolism, 00565 Ether lipid metabolism, 00590 Arachidonic acid metabolism, 00591 Linoleic acid metabolism, 00592 alpha-Linolenic acid metabolism, 04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04370 VEGF signaling pathway, 04072 Phospholipase D signaling pathway, 04217 Necroptosis, 04611 Platelet activation, 04664 Fc epsilon RI signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04912 GnRH signaling pathway, 04913 Ovarian steroidogenesis, 04921 Oxytocin signaling pathway, 04270 Vascular smooth muscle contraction, 04724 Glutamatergic synapse, 04726 Serotonergic synapse, 04730 Long-term depression, 04750 Inflammatory mediator regulation of TRP channels, 05231 Choline metabolism in cancer, 3.1.1.4  phospholipase A2'),('4502','mmu04068  FoxO signaling pathway, mmu04140  Autophagy - animal, mmu04150  mTOR signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04213  Longevity regulating pathway - multiple species, mmu04371  Apelin signaling pathway, mmu04530  Tight junction, mmu04710  Circadian rhythm, mmu04714  Thermogenesis, mmu04910  Insulin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04921  Oxytocin signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease, mmu05410  Hypertrophic cardiomyopathy, mmu05418  Fluid shear stress and atherosclerosis','04371 Apelin signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04530 Tight junction, 04910 Insulin signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 04921 Oxytocin signaling pathway, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 04710 Circadian rhythm, 04714 Thermogenesis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 01001 Protein kinases [BR:mmu01001], 04131 Membrane trafficking [BR:mmu04131], 03029 Mitochondrial biogenesis [BR:mmu03029], 2.7.11.11  cAMP-dependent protein kinase, CAMKL family, Others, Other regulator of mitochondrial biogenesis, Other mitophagy factors'),('4503','mmu04068  FoxO signaling pathway, mmu04140  Autophagy - animal, mmu04150  mTOR signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04213  Longevity regulating pathway - multiple species, mmu04371  Apelin signaling pathway, mmu04530  Tight junction, mmu04710  Circadian rhythm, mmu04714  Thermogenesis, mmu04910  Insulin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04921  Oxytocin signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease, mmu05410  Hypertrophic cardiomyopathy, mmu05418  Fluid shear stress and atherosclerosis','04371 Apelin signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04530 Tight junction, 04910 Insulin signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 04921 Oxytocin signaling pathway, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 04710 Circadian rhythm, 04714 Thermogenesis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 01001 Protein kinases [BR:mmu01001], 04131 Membrane trafficking [BR:mmu04131], 03029 Mitochondrial biogenesis [BR:mmu03029], 2.7.11.11  cAMP-dependent protein kinase, CAMKL family, Others, Other regulator of mitochondrial biogenesis, Other mitophagy factors'),('4504','mmu04068  FoxO signaling pathway, mmu04140  Autophagy - animal, mmu04150  mTOR signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04213  Longevity regulating pathway - multiple species, mmu04371  Apelin signaling pathway, mmu04530  Tight junction, mmu04710  Circadian rhythm, mmu04714  Thermogenesis, mmu04910  Insulin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04921  Oxytocin signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease, mmu05410  Hypertrophic cardiomyopathy, mmu05418  Fluid shear stress and atherosclerosis','04371 Apelin signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04530 Tight junction, 04910 Insulin signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 04921 Oxytocin signaling pathway, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 04710 Circadian rhythm, 04714 Thermogenesis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 01001 Protein kinases [BR:mmu01001], 04131 Membrane trafficking [BR:mmu04131], 03029 Mitochondrial biogenesis [BR:mmu03029], 2.7.11.11  cAMP-dependent protein kinase, CAMKL family, Others, Other regulator of mitochondrial biogenesis, Other mitophagy factors'),('4505','mmu04068  FoxO signaling pathway, mmu04140  Autophagy - animal, mmu04150  mTOR signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04213  Longevity regulating pathway - multiple species, mmu04371  Apelin signaling pathway, mmu04530  Tight junction, mmu04710  Circadian rhythm, mmu04714  Thermogenesis, mmu04910  Insulin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04921  Oxytocin signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease, mmu05410  Hypertrophic cardiomyopathy, mmu05418  Fluid shear stress and atherosclerosis','04371 Apelin signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04530 Tight junction, 04910 Insulin signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 04921 Oxytocin signaling pathway, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 04710 Circadian rhythm, 04714 Thermogenesis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 01001 Protein kinases [BR:mmu01001], 04131 Membrane trafficking [BR:mmu04131], 03029 Mitochondrial biogenesis [BR:mmu03029], 2.7.11.11  cAMP-dependent protein kinase, CAMKL family, Others, Other regulator of mitochondrial biogenesis, Other mitophagy factors'),('4506','mmu04068  FoxO signaling pathway, mmu04140  Autophagy - animal, mmu04150  mTOR signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04213  Longevity regulating pathway - multiple species, mmu04371  Apelin signaling pathway, mmu04530  Tight junction, mmu04710  Circadian rhythm, mmu04714  Thermogenesis, mmu04910  Insulin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04921  Oxytocin signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease, mmu05410  Hypertrophic cardiomyopathy, mmu05418  Fluid shear stress and atherosclerosis','04371 Apelin signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04530 Tight junction, 04910 Insulin signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 04921 Oxytocin signaling pathway, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 04710 Circadian rhythm, 04714 Thermogenesis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 01001 Protein kinases [BR:mmu01001], 04131 Membrane trafficking [BR:mmu04131], 03029 Mitochondrial biogenesis [BR:mmu03029], 2.7.11.11  cAMP-dependent protein kinase, CAMKL family, Others, Other regulator of mitochondrial biogenesis, Other mitophagy factors'),('4507','mmu01522  Endocrine resistance, mmu04012  ErbB signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04110  Cell cycle, mmu04151  PI3K-Akt signaling pathway, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04934  Cushing syndrome, mmu05162  Measles, mmu05165  Human papillomavirus infection, mmu05169  Epstein-Barr virus infection, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05215  Prostate cancer, mmu05220  Chronic myeloid leukemia, mmu05222  Small cell lung cancer, mmu05226  Gastric cancer','04012 ErbB signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04110 Cell cycle, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05203 Viral carcinogenesis, 05226 Gastric cancer, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05162 Measles, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 04933 AGE-RAGE signaling pathway in diabetic complications, 04934 Cushing syndrome, 01522 Endocrine resistance'),('4508','mmu04137  Mitophagy - animal, mmu04140  Autophagy - animal, mmu04216  Ferroptosis, mmu04371  Apelin signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu05014  Amyotrophic lateral sclerosis, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05167  Kaposi sarcoma-associated herpesvirus infection','04371 Apelin signaling pathway, 04140 Autophagy - animal, 04137 Mitophagy - animal, 04216 Ferroptosis, 04621 NOD-like receptor signaling pathway, 05167 Kaposi sarcoma-associated herpesvirus infection, 05014 Amyotrophic lateral sclerosis, 05022 Pathways of neurodegeneration - multiple diseases, 04131 Membrane trafficking [BR:mmu04131], 03029 Mitochondrial biogenesis [BR:mmu03029], 04812 Cytoskeleton proteins [BR:mmu04812], Other mitophagy associated  proteins, Other mitophagy factors, Microtubule-associated proteins (MAPs)'),('4509','mmu04152  AMPK signaling pathway, mmu04910  Insulin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease','04152 AMPK signaling pathway, 04910 Insulin signaling pathway, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 03000 Transcription factors [BR:mmu03000], 04131 Membrane trafficking [BR:mmu04131], Ubiquitous bHLH-ZIP factors, Other mitophagy associated  proteins'),('4510','mmu01040  Biosynthesis of unsaturated fatty acids, mmu01100  Metabolic pathways, mmu01212  Fatty acid metabolism, mmu03320  PPAR signaling pathway, mmu04152  AMPK signaling pathway, mmu04936  Alcoholic liver disease','01040 Biosynthesis of unsaturated fatty acids, 04152 AMPK signaling pathway, 03320 PPAR signaling pathway, 04936 Alcoholic liver disease, 01004 Lipid biosynthesis proteins [BR:mmu01004], 1.14.19.1  stearoyl-CoA 9-desaturase, First'),('4511','mmu00061  Fatty acid biosynthesis, mmu01100  Metabolic pathways, mmu01212  Fatty acid metabolism, mmu04152  AMPK signaling pathway, mmu04910  Insulin signaling pathway, mmu04936  Alcoholic liver disease','00061 Fatty acid biosynthesis, 04152 AMPK signaling pathway, 04910 Insulin signaling pathway, 04936 Alcoholic liver disease, 01004 Lipid biosynthesis proteins [BR:mmu01004], 04147 Exosome [BR:mmu04147], 2.3.1.85  fatty-acid synthase system, Animal type, Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell), Exosomal proteins of breast milk, Exosomal proteins of colorectal cancer cells, Exosomal proteins of bladder cancer cells'),('4514','mmu04020  Calcium signaling pathway, mmu04022  cGMP-PKG signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04714  Thermogenesis, mmu04923  Regulation of lipolysis in adipocytes, mmu04924  Renin secretion, mmu04970  Salivary secretion, mmu05207  Chemical carcinogenesis - receptor activation','04020 Calcium signaling pathway, 04022 cGMP-PKG signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04923 Regulation of lipolysis in adipocytes, 04924 Renin secretion, 04970 Salivary secretion, 04714 Thermogenesis, 05207 Chemical carcinogenesis - receptor activation, 04030 G protein-coupled receptors [BR:mmu04030], Adrenaline'),('4515','mmu00561  Glycerolipid metabolism, mmu01100  Metabolic pathways, mmu04714  Thermogenesis, mmu04923  Regulation of lipolysis in adipocytes','00561 Glycerolipid metabolism, 04923 Regulation of lipolysis in adipocytes, 04714 Thermogenesis, 3.1.1.3  triacylglycerol lipase'),('4516','mmu00071  Fatty acid degradation, mmu01212  Fatty acid metabolism, mmu03320  PPAR signaling pathway, mmu04714  Thermogenesis, mmu05415  Diabetic cardiomyopathy','00071 Fatty acid degradation, 03320 PPAR signaling pathway, 04714 Thermogenesis, 05415 Diabetic cardiomyopathy, 2.3.1.21  carnitine O-palmitoyltransferase'),('4517','mmu00071  Fatty acid degradation, mmu00410  beta-Alanine metabolism, mmu00592  alpha-Linolenic acid metabolism, mmu00640  Propanoate metabolism, mmu01040  Biosynthesis of unsaturated fatty acids, mmu01100  Metabolic pathways, mmu01200  Carbon metabolism, mmu01212  Fatty acid metabolism, mmu03320  PPAR signaling pathway, mmu04024  cAMP signaling pathway, mmu04146  Peroxisome, mmu04936  Alcoholic liver disease','00640 Propanoate metabolism, 00071 Fatty acid degradation, 00592 alpha-Linolenic acid metabolism, 01040 Biosynthesis of unsaturated fatty acids, 00410 beta-Alanine metabolism, 04024 cAMP signaling pathway, 04146 Peroxisome, 03320 PPAR signaling pathway, 04936 Alcoholic liver disease, 1.3.3.6  acyl-CoA oxidase'),('4518','mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04371  Apelin signaling pathway, mmu04714  Thermogenesis, mmu04910  Insulin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04936  Alcoholic liver disease, mmu05016  Huntington disease','04371 Apelin signaling pathway, 04152 AMPK signaling pathway, 04910 Insulin signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 04211 Longevity regulating pathway, 04714 Thermogenesis, 05016 Huntington disease, 04936 Alcoholic liver disease, 04931 Insulin resistance, 03029 Mitochondrial biogenesis [BR:mmu03029], Coactivators'),('4519','mmu04142  Lysosome','04142 Lysosome, 04090 CD molecules [BR:mmu04090], Proteins'),('4520','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04062  Chemokine signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05144  Malaria, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05135 Yersinia infection, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Chemokines, Chemokines'),('4521','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4522','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4523',NULL,'02000 Transporters [BR:mmu02000], SLC21/ASLCO: Organic anion transporter'),('4524','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('4525','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04062  Chemokine signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05144  Malaria, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05135 Yersinia infection, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Chemokines, Chemokines'),('4526','mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04068  FoxO signaling pathway, mmu04110  Cell cycle, mmu04218  Cellular senescence, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04390  Hippo signaling pathway, mmu04659  Th17 cell differentiation, mmu04672  Intestinal immune network for IgA production, mmu04926  Relaxin signaling pathway, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05166  Human T-cell leukemia virus 1 infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05210  Colorectal cancer, mmu05211  Renal cell carcinoma, mmu05212  Pancreatic cancer, mmu05220  Chronic myeloid leukemia, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05415  Diabetic cardiomyopathy','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04390 Hippo signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04110 Cell cycle, 04218 Cellular senescence, 04659 Th17 cell differentiation, 04672 Intestinal immune network for IgA production, 04926 Relaxin signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05220 Chronic myeloid leukemia, 05211 Renal cell carcinoma, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 05415 Diabetic cardiomyopathy, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 03110 Chaperones and folding catalysts [BR:mmu03110], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Others, Transforming growth factors (RSTK binding), Growth factors/receptors'),('4527','mmu04151  PI3K-Akt signaling pathway, mmu04510  Focal adhesion, mmu04512  ECM-receptor interaction, mmu04810  Regulation of actin cytoskeleton, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05100  Bacterial invasion of epithelial cells, mmu05135  Yersinia infection, mmu05146  Amoebiasis, mmu05165  Human papillomavirus infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05222  Small cell lung cancer','04151 PI3K-Akt signaling pathway, 04512 ECM-receptor interaction, 04510 Focal adhesion, 04810 Regulation of actin cytoskeleton, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05222 Small cell lung cancer, 05165 Human papillomavirus infection, 05135 Yersinia infection, 05100 Bacterial invasion of epithelial cells, 05146 Amoebiasis, 04933 AGE-RAGE signaling pathway in diabetic complications, 04131 Membrane trafficking [BR:mmu04131], 04147 Exosome [BR:mmu04147], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], 04990 Domain-containing proteins not elsewhere classified [BR:mmu04990], ER-Golgi intermediate compartment (ERGIC) proteins, Exosomal proteins of bladder cancer cells, Extracellular matrix molecules, Fibronectin type I domain-containing proteins'),('4528','mmu04151  PI3K-Akt signaling pathway, mmu04510  Focal adhesion, mmu04512  ECM-receptor interaction, mmu04611  Platelet activation, mmu04926  Relaxin signaling pathway, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04974  Protein digestion and absorption, mmu05146  Amoebiasis, mmu05165  Human papillomavirus infection, mmu05205  Proteoglycans in cancer, mmu05415  Diabetic cardiomyopathy','04151 PI3K-Akt signaling pathway, 04512 ECM-receptor interaction, 04510 Focal adhesion, 04611 Platelet activation, 04926 Relaxin signaling pathway, 04974 Protein digestion and absorption, 05205 Proteoglycans in cancer, 05165 Human papillomavirus infection, 05146 Amoebiasis, 05415 Diabetic cardiomyopathy, 04933 AGE-RAGE signaling pathway in diabetic complications, 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Extracellular matrix molecules'),('4529','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 04147 Exosome [BR:mmu04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('4531','mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu05207  Chemical carcinogenesis - receptor activation','04550 Signaling pathways regulating pluripotency of stem cells, 05207 Chemical carcinogenesis - receptor activation, 03000 Transcription factors [BR:mmu03000], Cys2His2 SP/KLF family and related proteins'),('4532',NULL,'99992 Structural proteins'),('4533',NULL,NULL),('4534','mmu05146  Amoebiasis, mmu05226  Gastric cancer','05226 Gastric cancer, 05146 Amoebiasis, 04131 Membrane trafficking [BR:mmu04131], Secretory mucins'),('4535','mmu00512  Mucin type O-glycan biosynthesis, mmu01100  Metabolic pathways','00512 Mucin type O-glycan biosynthesis, 01003 Glycosyltransferases [BR:mmu01003], 2.4.1.147  acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase, Type 2 chain/Poly-N-acetyllactosamine'),('4536','mmu00512  Mucin type O-glycan biosynthesis, mmu00514  Other types of O-glycan biosynthesis, mmu01100  Metabolic pathways','00512 Mucin type O-glycan biosynthesis, 00514 Other types of O-glycan biosynthesis, 01003 Glycosyltransferases [BR:mmu01003], 2.4.1.122  N-acetylgalactosaminide beta-1,3-galactosyltransferase, Type 3 chain'),('4537','mmu00512  Mucin type O-glycan biosynthesis, mmu01100  Metabolic pathways','00512 Mucin type O-glycan biosynthesis, 01003 Glycosyltransferases [BR:mmu01003], 2.4.1.102  beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase, O-Glycan'),('4538','mmu00601  Glycosphingolipid biosynthesis - lacto and neolacto series, mmu00603  Glycosphingolipid biosynthesis - globo and isoglobo series, mmu01100  Metabolic pathways','00601 Glycosphingolipid biosynthesis - lacto and neolacto series, 00603 Glycosphingolipid biosynthesis - globo and isoglobo series, 01003 Glycosyltransferases [BR:mmu01003], 04131 Membrane trafficking [BR:mmu04131], 2.4.1.69  type 1 galactoside alpha-(1,2)-fucosyltransferase, ABO blood group, Fucosyltransferase'),('4539','mmu00510  N-Glycan biosynthesis, mmu00514  Other types of O-glycan biosynthesis, mmu01100  Metabolic pathways','00510 N-Glycan biosynthesis, 00514 Other types of O-glycan biosynthesis, 01003 Glycosyltransferases [BR:mmu01003], 2.4.99.1  beta-galactoside alpha-(2,6)-sialyltransferase, Sialyltransferase'),('4540','mmu04136  Autophagy - other, mmu04140  Autophagy - animal, mmu04621  NOD-like receptor signaling pathway','04140 Autophagy - animal, 04136 Autophagy - other, 04621 NOD-like receptor signaling pathway, 04131 Membrane trafficking [BR:mmu04131], 03029 Mitochondrial biogenesis [BR:mmu03029], Atg12 conjugation proteins, Auto phagosome, Autophagy-related proteins'),('4541','mmu04136  Autophagy - other, mmu04137  Mitophagy - animal, mmu04140  Autophagy - animal, mmu04211  Longevity regulating pathway, mmu04213  Longevity regulating pathway - multiple species, mmu04216  Ferroptosis, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway','04140 Autophagy - animal, 04136 Autophagy - other, 04137 Mitophagy - animal, 04216 Ferroptosis, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 04131 Membrane trafficking [BR:mmu04131], 03029 Mitochondrial biogenesis [BR:mmu03029], Atg12 conjugation proteins, Autophagy-related proteins'),('4542','mmu04136  Autophagy - other, mmu04137  Mitophagy - animal, mmu04140  Autophagy - animal, mmu04215  Apoptosis - multiple species, mmu04371  Apelin signaling pathway, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05017  Spinocerebellar ataxia, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05167  Kaposi sarcoma-associated herpesvirus infection','04371 Apelin signaling pathway, 04140 Autophagy - animal, 04136 Autophagy - other, 04137 Mitophagy - animal, 04215 Apoptosis - multiple species, 05167 Kaposi sarcoma-associated herpesvirus infection, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05017 Spinocerebellar ataxia, 05022 Pathways of neurodegeneration - multiple diseases, 04131 Membrane trafficking [BR:mmu04131], 03029 Mitochondrial biogenesis [BR:mmu03029], PI3K complex, Autophagy-related proteins'),('4543','mmu04140  Autophagy - animal, mmu04142  Lysosome, mmu04145  Phagosome, mmu05152  Tuberculosis','04145 Phagosome, 04142 Lysosome, 04140 Autophagy - animal, 05152 Tuberculosis, 04131 Membrane trafficking [BR:mmu04131], 04147 Exosome [BR:mmu04147], 04090 CD molecules [BR:mmu04090], Cargo receptors, Exosomal proteins of hepatic cells, Proteins'),('4544','mmu04137  Mitophagy - animal, mmu04140  Autophagy - animal, mmu04216  Ferroptosis, mmu04371  Apelin signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu05014  Amyotrophic lateral sclerosis, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05167  Kaposi sarcoma-associated herpesvirus infection','04371 Apelin signaling pathway, 04140 Autophagy - animal, 04137 Mitophagy - animal, 04216 Ferroptosis, 04621 NOD-like receptor signaling pathway, 05167 Kaposi sarcoma-associated herpesvirus infection, 05014 Amyotrophic lateral sclerosis, 05022 Pathways of neurodegeneration - multiple diseases, 04131 Membrane trafficking [BR:mmu04131], 03029 Mitochondrial biogenesis [BR:mmu03029], 04812 Cytoskeleton proteins [BR:mmu04812], Other mitophagy associated  proteins, Other mitophagy factors, Microtubule-associated proteins (MAPs)'),('4545','mmu05146  Amoebiasis, mmu05226  Gastric cancer','05226 Gastric cancer, 05146 Amoebiasis, 04131 Membrane trafficking [BR:mmu04131], Secretory mucins'),('4546','mmu04060  Cytokine-cytokine receptor interaction, mmu04630  JAK-STAT signaling pathway, mmu04659  Th17 cell differentiation, mmu05321  Inflammatory bowel disease','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4547','mmu04060  Cytokine-cytokine receptor interaction, mmu04217  Necroptosis, mmu04623  Cytosolic DNA-sensing pathway, mmu05164  Influenza A','04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04623 Cytosolic DNA-sensing pathway, 05164 Influenza A, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4548','mmu04060  Cytokine-cytokine receptor interaction, mmu04630  JAK-STAT signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04664  Fc epsilon RI signaling pathway, mmu05200  Pathways in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04658 Th1 and Th2 cell differentiation, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 05200 Pathways in cancer, 05310 Asthma, 05321 Inflammatory bowel disease, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4550','mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05208  Chemical carcinogenesis - reactive oxygen species','05208 Chemical carcinogenesis - reactive oxygen species, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 04936 Alcoholic liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 1.6.3.-'),('4551','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('4552','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4553','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu05132  Salmonella infection, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05152  Tuberculosis, mmu05164  Influenza A, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis','04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 05164 Influenza A, 05132 Salmonella infection, 05135 Yersinia infection, 05134 Legionellosis, 05152 Tuberculosis, 05144 Malaria, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4554','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu05132  Salmonella infection, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05152  Tuberculosis, mmu05164  Influenza A, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis','04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 05164 Influenza A, 05132 Salmonella infection, 05135 Yersinia infection, 05134 Legionellosis, 05152 Tuberculosis, 05144 Malaria, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4555','mmu05206  MicroRNAs in cancer','05206 MicroRNAs in cancer, 04147 Exosome [BR:mmu04147], 03100 Non-coding RNAs [BR:mmu03100], Exosomal RNA of breast milk, Micro RNA'),('4556','mmu05206  MicroRNAs in cancer','05206 MicroRNAs in cancer, 04147 Exosome [BR:mmu04147], 03100 Non-coding RNAs [BR:mmu03100], Exosomal RNA of breast milk, Micro RNA'),('4557','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('4558','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4559','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4560','mmu04060  Cytokine-cytokine receptor interaction, mmu04630  JAK-STAT signaling pathway, mmu04659  Th17 cell differentiation, mmu05321  Inflammatory bowel disease','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4563','mmu03050  Proteasome, mmu04060  Cytokine-cytokine receptor interaction, mmu04066  HIF-1 signaling pathway, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04630  JAK-STAT signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04940  Type I diabetes mellitus, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05200  Pathways in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:mmu03051], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Other assembling factors, Interferons, Cytokines'),('4564','mmu04210  Apoptosis, mmu04650  Natural killer cell mediated cytotoxicity, mmu04940  Type I diabetes mellitus, mmu05202  Transcriptional misregulation in cancer, mmu05320  Autoimmune thyroid disease, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease','04210 Apoptosis, 04650 Natural killer cell mediated cytotoxicity, 05202 Transcriptional misregulation in cancer, 05320 Autoimmune thyroid disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 04940 Type I diabetes mellitus, 01002 Peptidases and inhibitors [BR:mmu01002], 3.4.21.79  granzyme B, Family S1: chymotrypsin family'),('4565','mmu04060  Cytokine-cytokine receptor interaction, mmu04062  Chemokine signaling pathway','04060 Cytokine-cytokine receptor interaction, 04062 Chemokine signaling pathway, 04052 Cytokines and growth factors [BR:mmu04052], Chemokines'),('4566','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('4567','mmu04020  Calcium signaling pathway, mmu04022  cGMP-PKG signaling pathway, mmu04270  Vascular smooth muscle contraction, mmu04371  Apelin signaling pathway, mmu04510  Focal adhesion, mmu04611  Platelet activation, mmu04810  Regulation of actin cytoskeleton, mmu04921  Oxytocin signaling pathway, mmu04971  Gastric acid secretion','04371 Apelin signaling pathway, 04020 Calcium signaling pathway, 04022 cGMP-PKG signaling pathway, 04510 Focal adhesion, 04810 Regulation of actin cytoskeleton, 04611 Platelet activation, 04921 Oxytocin signaling pathway, 04270 Vascular smooth muscle contraction, 04971 Gastric acid secretion, 01001 Protein kinases [BR:mmu01001], 2.7.11.18  myosin-light-chain kinase, MLCK family'),('4570','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4571','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4572','mmu04060  Cytokine-cytokine receptor interaction, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04936  Alcoholic liver disease, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis','04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4573','mmu03050  Proteasome, mmu04060  Cytokine-cytokine receptor interaction, mmu04066  HIF-1 signaling pathway, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04630  JAK-STAT signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04940  Type I diabetes mellitus, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05200  Pathways in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:mmu03051], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Other assembling factors, Interferons, Cytokines'),('4574','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04068  FoxO signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4576','mmu04024  cAMP signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04714  Thermogenesis, mmu04911  Insulin secretion, mmu04922  Glucagon signaling pathway','04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04911 Insulin secretion, 04922 Glucagon signaling pathway, 04714 Thermogenesis'),('4577','mmu04024  cAMP signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04714  Thermogenesis, mmu04911  Insulin secretion, mmu04922  Glucagon signaling pathway','04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04911 Insulin secretion, 04922 Glucagon signaling pathway, 04714 Thermogenesis'),('4578','mmu04024  cAMP signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04714  Thermogenesis, mmu04911  Insulin secretion, mmu04922  Glucagon signaling pathway','04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04911 Insulin secretion, 04922 Glucagon signaling pathway, 04714 Thermogenesis'),('4587','mmu04217  Necroptosis, mmu04621  NOD-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05164  Influenza A, mmu05171  Coronavirus disease - COVID-19, mmu05417  Lipid and atherosclerosis','04217 Necroptosis, 04621 NOD-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05417 Lipid and atherosclerosis, 04131 Membrane trafficking [BR:mmu04131], 04054 Pattern recognition receptors [BR:mmu04054], TRIM-directed selective autophagy, NOD-like receptors'),('4588','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('4589','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('4590','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('4591','mmu04621  NOD-like receptor signaling pathway','04621 NOD-like receptor signaling pathway, 04054 Pattern recognition receptors [BR:mmu04054], NOD-like receptors'),('4592','mmu04621  NOD-like receptor signaling pathway','04621 NOD-like receptor signaling pathway, 04054 Pattern recognition receptors [BR:mmu04054], NOD-like receptors'),('4593','mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04145  Phagosome, mmu04151  PI3K-Akt signaling pathway, mmu04217  Necroptosis, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04936  Alcoholic liver disease, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05164  Influenza A, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04066 HIF-1 signaling pathway, 04151 PI3K-Akt signaling pathway, 04145 Phagosome, 04217 Necroptosis, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 05205 Proteoglycans in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04131 Membrane trafficking [BR:mmu04131], 04054 Pattern recognition receptors [BR:mmu04054], 04090 CD molecules [BR:mmu04090], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Toll-like receptors, Toll-like receptors, Proteins, Cell surface receptors'),('4594','mmu04010  MAPK signaling pathway','04010 MAPK signaling pathway, 04131 Membrane trafficking [BR:mmu04131], LDLR adaptor proteins'),('4595','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('4596','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4597','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Purine / pyrimidine'),('4598','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Purine / pyrimidine'),('4599','mmu04024  cAMP signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04714  Thermogenesis, mmu04911  Insulin secretion, mmu04922  Glucagon signaling pathway','04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04911 Insulin secretion, 04922 Glucagon signaling pathway, 04714 Thermogenesis'),('4600','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('4614','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04068  FoxO signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines');
INSERT INTO `gene_kegg_info` VALUES ('4615','mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04068  FoxO signaling pathway, mmu04110  Cell cycle, mmu04218  Cellular senescence, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04390  Hippo signaling pathway, mmu04659  Th17 cell differentiation, mmu04672  Intestinal immune network for IgA production, mmu04926  Relaxin signaling pathway, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05166  Human T-cell leukemia virus 1 infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05210  Colorectal cancer, mmu05211  Renal cell carcinoma, mmu05212  Pancreatic cancer, mmu05220  Chronic myeloid leukemia, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05415  Diabetic cardiomyopathy','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04390 Hippo signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04110 Cell cycle, 04218 Cellular senescence, 04659 Th17 cell differentiation, 04672 Intestinal immune network for IgA production, 04926 Relaxin signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05220 Chronic myeloid leukemia, 05211 Renal cell carcinoma, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 05415 Diabetic cardiomyopathy, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 03110 Chaperones and folding catalysts [BR:mmu03110], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Others, Transforming growth factors (RSTK binding), Growth factors/receptors'),('4617','mmu04068  FoxO signaling pathway, mmu04140  Autophagy - animal, mmu04150  mTOR signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04213  Longevity regulating pathway - multiple species, mmu04371  Apelin signaling pathway, mmu04530  Tight junction, mmu04710  Circadian rhythm, mmu04714  Thermogenesis, mmu04910  Insulin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04921  Oxytocin signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease, mmu05410  Hypertrophic cardiomyopathy, mmu05418  Fluid shear stress and atherosclerosis','04371 Apelin signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04530 Tight junction, 04910 Insulin signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 04921 Oxytocin signaling pathway, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 04710 Circadian rhythm, 04714 Thermogenesis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 01001 Protein kinases [BR:mmu01001], 04131 Membrane trafficking [BR:mmu04131], 03029 Mitochondrial biogenesis [BR:mmu03029], 2.7.11.11  cAMP-dependent protein kinase, CAMKL family, Others, Other regulator of mitochondrial biogenesis, Other mitophagy factors'),('4618','mmu04068  FoxO signaling pathway, mmu04152  AMPK signaling pathway, mmu04910  Insulin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu05415  Diabetic cardiomyopathy','04068 FoxO signaling pathway, 04152 AMPK signaling pathway, 04910 Insulin signaling pathway, 04920 Adipocytokine signaling pathway, 05415 Diabetic cardiomyopathy, 04930 Type II diabetes mellitus, 04931 Insulin resistance, 02000 Transporters [BR:mmu02000], SLC2: Facilitative GLUT transporter, Sugar porter (SP) family [TC:2.A.1.1]'),('4619','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4620','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('4621','mmu04621  NOD-like receptor signaling pathway, mmu05150  Staphylococcus aureus infection, mmu05202  Transcriptional misregulation in cancer','04621 NOD-like receptor signaling pathway, 05202 Transcriptional misregulation in cancer, 05150 Staphylococcus aureus infection'),('4623','mmu04060  Cytokine-cytokine receptor interaction, mmu04630  JAK-STAT signaling pathway, mmu04659  Th17 cell differentiation, mmu05321  Inflammatory bowel disease','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4631','mmu04270  Vascular smooth muscle contraction, mmu04371  Apelin signaling pathway, mmu04926  Relaxin signaling pathway','04371 Apelin signaling pathway, 04926 Relaxin signaling pathway, 04270 Vascular smooth muscle contraction, 04812 Cytoskeleton proteins [BR:mmu04812], 04147 Exosome [BR:mmu04147], Actins, Exosomal proteins of colorectal cancer cells'),('4632','mmu04066  HIF-1 signaling pathway','04066 HIF-1 signaling pathway, 01002 Peptidases and inhibitors [BR:mmu01002], Family I35: timp family'),('4633','mmu03320  PPAR signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04380  Osteoclast differentiation, mmu04714  Thermogenesis, mmu04932  Non-alcoholic fatty liver disease, mmu05016  Huntington disease, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05216  Thyroid cancer, mmu05417  Lipid and atherosclerosis','04152 AMPK signaling pathway, 03320 PPAR signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04714 Thermogenesis, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05216 Thyroid cancer, 05016 Huntington disease, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 thyroid hormone receptor-like, 1C. Peroxisome proliferator-activated receptor (PPAR)'),('4634','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('4635','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4636','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('4637','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4638','mmu00220  Arginine biosynthesis, mmu00330  Arginine and proline metabolism, mmu01100  Metabolic pathways, mmu04020  Calcium signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04146  Peroxisome, mmu04371  Apelin signaling pathway, mmu04926  Relaxin signaling pathway, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05133  Pertussis, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05200  Pathways in cancer, mmu05222  Small cell lung cancer','00220 Arginine biosynthesis, 00330 Arginine and proline metabolism, 04371 Apelin signaling pathway, 04066 HIF-1 signaling pathway, 04020 Calcium signaling pathway, 04146 Peroxisome, 04926 Relaxin signaling pathway, 05200 Pathways in cancer, 05222 Small cell lung cancer, 05133 Pertussis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05022 Pathways of neurodegeneration - multiple diseases, 1.14.13.39  nitric-oxide synthase (NADPH)'),('4639','mmu04020  Calcium signaling pathway, mmu04024  cAMP signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04151  PI3K-Akt signaling pathway, mmu04725  Cholinergic synapse, mmu04810  Regulation of actin cytoskeleton','04020 Calcium signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04810 Regulation of actin cytoskeleton, 04725 Cholinergic synapse, 04030 G protein-coupled receptors [BR:mmu04030], Acetylcholine (muscarinic)'),('4640','mmu04145  Phagosome, mmu04151  PI3K-Akt signaling pathway, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu05132  Salmonella infection, mmu05134  Legionellosis, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis','04151 PI3K-Akt signaling pathway, 04145 Phagosome, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 05205 Proteoglycans in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04131 Membrane trafficking [BR:mmu04131], 04147 Exosome [BR:mmu04147], 04054 Pattern recognition receptors [BR:mmu04054], 04090 CD molecules [BR:mmu04090], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Toll-like receptors, Exosomal proteins of breast milk, Toll-like receptors, Proteins, Cell surface receptors'),('4641','mmu04659  Th17 cell differentiation, mmu04934  Cushing syndrome, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species','04659 Th17 cell differentiation, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 04934 Cushing syndrome, 03000 Transcription factors [BR:mmu03000], Factors with PAS domain'),('4642','mmu04659  Th17 cell differentiation, mmu04934  Cushing syndrome, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species','04659 Th17 cell differentiation, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 04934 Cushing syndrome, 03000 Transcription factors [BR:mmu03000], Factors with PAS domain'),('4643','mmu04659  Th17 cell differentiation, mmu04934  Cushing syndrome, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species','04659 Th17 cell differentiation, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 04934 Cushing syndrome, 03000 Transcription factors [BR:mmu03000], Factors with PAS domain'),('4644','mmu04659  Th17 cell differentiation, mmu04934  Cushing syndrome, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species','04659 Th17 cell differentiation, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 04934 Cushing syndrome, 03000 Transcription factors [BR:mmu03000], Factors with PAS domain'),('4645','mmu00140  Steroid hormone biosynthesis, mmu00380  Tryptophan metabolism, mmu00830  Retinol metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu01100  Metabolic pathways, mmu04913  Ovarian steroidogenesis, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05417  Lipid and atherosclerosis','00140 Steroid hormone biosynthesis, 00380 Tryptophan metabolism, 00830 Retinol metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 04913 Ovarian steroidogenesis, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05417 Lipid and atherosclerosis, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP1 family'),('4646','mmu00140  Steroid hormone biosynthesis, mmu00380  Tryptophan metabolism, mmu00830  Retinol metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu01100  Metabolic pathways, mmu04913  Ovarian steroidogenesis, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05417  Lipid and atherosclerosis','00140 Steroid hormone biosynthesis, 00380 Tryptophan metabolism, 00830 Retinol metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 04913 Ovarian steroidogenesis, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05417 Lipid and atherosclerosis, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP1 family'),('4647','mmu00140  Steroid hormone biosynthesis, mmu00380  Tryptophan metabolism, mmu00830  Retinol metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu01100  Metabolic pathways, mmu04913  Ovarian steroidogenesis, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05417  Lipid and atherosclerosis','00140 Steroid hormone biosynthesis, 00380 Tryptophan metabolism, 00830 Retinol metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 04913 Ovarian steroidogenesis, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05417 Lipid and atherosclerosis, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP1 family'),('4648','mmu00140  Steroid hormone biosynthesis, mmu00380  Tryptophan metabolism, mmu00830  Retinol metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu01100  Metabolic pathways, mmu04913  Ovarian steroidogenesis, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05417  Lipid and atherosclerosis','00140 Steroid hormone biosynthesis, 00380 Tryptophan metabolism, 00830 Retinol metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 04913 Ovarian steroidogenesis, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05417 Lipid and atherosclerosis, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP1 family'),('4649','mmu00140  Steroid hormone biosynthesis, mmu00380  Tryptophan metabolism, mmu00830  Retinol metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu01100  Metabolic pathways, mmu04913  Ovarian steroidogenesis, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05417  Lipid and atherosclerosis','00140 Steroid hormone biosynthesis, 00380 Tryptophan metabolism, 00830 Retinol metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 04913 Ovarian steroidogenesis, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05417 Lipid and atherosclerosis, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP1 family'),('4650','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4652','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04068  FoxO signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4653','mmu00380  Tryptophan metabolism, mmu00790  Folate biosynthesis, mmu01100  Metabolic pathways, mmu04726  Serotonergic synapse','00380 Tryptophan metabolism, 00790 Folate biosynthesis, 04726 Serotonergic synapse, 1.14.16.4  tryptophan 5-monooxygenase'),('4654','mmu04020  Calcium signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04540  Gap junction, mmu04726  Serotonergic synapse, mmu04750  Inflammatory mediator regulation of TRP channels','04020 Calcium signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04540 Gap junction, 04726 Serotonergic synapse, 04750 Inflammatory mediator regulation of TRP channels, 04030 G protein-coupled receptors [BR:mmu04030], Serotonin'),('4655','mmu04020  Calcium signaling pathway, mmu04024  cAMP signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04726  Serotonergic synapse','04020 Calcium signaling pathway, 04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04726 Serotonergic synapse, 04030 G protein-coupled receptors [BR:mmu04030], Serotonin'),('4656','mmu04310  Wnt signaling pathway','04310 Wnt signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], R-spondin'),('4657','mmu04310  Wnt signaling pathway','04310 Wnt signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], R-spondin'),('4658','mmu04310  Wnt signaling pathway','04310 Wnt signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], R-spondin'),('4659','mmu00730  Thiamine metabolism, mmu00790  Folate biosynthesis, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors','00730 Thiamine metabolism, 00790 Folate biosynthesis, 04147 Exosome [BR:mmu04147], 00537 Glycosylphosphatidylinositol (GPI)-anchored proteins [BR:mmu00537], 3.1.3.1  alkaline phosphatase, Exosomal proteins of other body fluids (saliva and urine), Enzymes'),('4660','mmu00730  Thiamine metabolism, mmu00790  Folate biosynthesis, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors','00730 Thiamine metabolism, 00790 Folate biosynthesis, 04147 Exosome [BR:mmu04147], 00537 Glycosylphosphatidylinositol (GPI)-anchored proteins [BR:mmu00537], 3.1.3.1  alkaline phosphatase, Exosomal proteins of other body fluids (saliva and urine), Enzymes'),('4661','mmu00730  Thiamine metabolism, mmu00790  Folate biosynthesis, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors','00730 Thiamine metabolism, 00790 Folate biosynthesis, 04147 Exosome [BR:mmu04147], 00537 Glycosylphosphatidylinositol (GPI)-anchored proteins [BR:mmu00537], 3.1.3.1  alkaline phosphatase, Exosomal proteins of other body fluids (saliva and urine), Enzymes'),('4662','mmu05146  Amoebiasis, mmu05226  Gastric cancer','05226 Gastric cancer, 05146 Amoebiasis, 04131 Membrane trafficking [BR:mmu04131], Secretory mucins'),('4663','mmu05146  Amoebiasis, mmu05226  Gastric cancer','05226 Gastric cancer, 05146 Amoebiasis, 04131 Membrane trafficking [BR:mmu04131], Secretory mucins'),('4664','mmu04970  Salivary secretion','04970 Salivary secretion, 04147 Exosome [BR:mmu04147], 3.2.1.17  lysozyme, Exosomal proteins of other body fluids (saliva and urine)'),('4665',NULL,'04131 Membrane trafficking [BR:mmu04131], Others'),('4666',NULL,'01001 Protein kinases [BR:mmu01001], 2.7.11.1  non-specific serine/threonine protein kinase, DCAMKL family'),('4667',NULL,'01001 Protein kinases [BR:mmu01001], 2.7.11.1  non-specific serine/threonine protein kinase, DCAMKL family'),('4668',NULL,NULL),('4669',NULL,NULL),('4670','mmu02010  ABC transporters, mmu05150  Staphylococcus aureus infection','02010 ABC transporters, 05150 Staphylococcus aureus infection, 02000 Transporters [BR:mmu02000], Pores ion channels [TC:1]'),('4671','mmu02010  ABC transporters, mmu05150  Staphylococcus aureus infection','02010 ABC transporters, 05150 Staphylococcus aureus infection, 02000 Transporters [BR:mmu02000], Pores ion channels [TC:1]'),('4672','mmu02010  ABC transporters, mmu05150  Staphylococcus aureus infection','02010 ABC transporters, 05150 Staphylococcus aureus infection, 02000 Transporters [BR:mmu02000], Pores ion channels [TC:1]'),('4673','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 01009 Protein phosphatases and associated proteins [BR:mmu01009], PP1-interacting proteins (PIPs)'),('4674','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 04147 Exosome [BR:mmu04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('4675','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 04147 Exosome [BR:mmu04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('4676','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 04147 Exosome [BR:mmu04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('4677','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('4678','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('4680','mmu00140  Steroid hormone biosynthesis, mmu00591  Linoleic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation','00140 Steroid hormone biosynthesis, 00591 Linoleic acid metabolism, 00830 Retinol metabolism, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP3 family'),('4681','mmu00140  Steroid hormone biosynthesis, mmu00590  Arachidonic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu05207  Chemical carcinogenesis - receptor activation','00140 Steroid hormone biosynthesis, 00590 Arachidonic acid metabolism, 00830 Retinol metabolism, 05207 Chemical carcinogenesis - receptor activation, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('4682','mmu02010  ABC transporters, mmu04976  Bile secretion, mmu05206  MicroRNAs in cancer, mmu05226  Gastric cancer','02010 ABC transporters, 04976 Bile secretion, 05206 MicroRNAs in cancer, 05226 Gastric cancer, 02000 Transporters [BR:mmu02000], 04147 Exosome [BR:mmu04147], 04090 CD molecules [BR:mmu04090], 7.6.2.2  ABC-type xenobiotic transporter, ABCB1, 4, 5 subgroups, Exosomal proteins of other body fluids (saliva and urine), Proteins'),('4683','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('4684','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 04147 Exosome [BR:mmu04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('4685','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 04147 Exosome [BR:mmu04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('4686','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 01009 Protein phosphatases and associated proteins [BR:mmu01009], PP1-interacting proteins (PIPs)'),('4687','mmu01522  Endocrine resistance, mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu04670  Leukocyte transendothelial migration, mmu04915  Estrogen signaling pathway, mmu04926  Relaxin signaling pathway, mmu05161  Hepatitis B, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05215  Prostate cancer, mmu05219  Bladder cancer, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04668 TNF signaling pathway, 04657 IL-17 signaling pathway, 04670 Leukocyte transendothelial migration, 04915 Estrogen signaling pathway, 04926 Relaxin signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05219 Bladder cancer, 05215 Prostate cancer, 05161 Hepatitis B, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 01522 Endocrine resistance, 01002 Peptidases and inhibitors [BR:mmu01002], 3.4.24.35  gelatinase B, Family M10'),('4688','mmu00260  Glycine, serine and threonine metabolism, mmu00330  Arginine and proline metabolism, mmu00470  D-Amino acid metabolism, mmu01100  Metabolic pathways, mmu04146  Peroxisome','00260 Glycine, serine and threonine metabolism, 00330 Arginine and proline metabolism, 00470 D-Amino acid metabolism, 00311 Penicillin and cephalosporin biosynthesis, 04146 Peroxisome, 1.4.3.3  D-amino-acid oxidase'),('4689','mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04145  Phagosome, mmu04151  PI3K-Akt signaling pathway, mmu04217  Necroptosis, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04936  Alcoholic liver disease, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05164  Influenza A, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04066 HIF-1 signaling pathway, 04151 PI3K-Akt signaling pathway, 04145 Phagosome, 04217 Necroptosis, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 05205 Proteoglycans in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04131 Membrane trafficking [BR:mmu04131], 04054 Pattern recognition receptors [BR:mmu04054], 04090 CD molecules [BR:mmu04090], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Toll-like receptors, Toll-like receptors, Proteins, Cell surface receptors'),('4690',NULL,'00537 Glycosylphosphatidylinositol (GPI)-anchored proteins [BR:mmu00537], Antigens'),('4691','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('4692','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('4693','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 04147 Exosome [BR:mmu04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('4694','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 01009 Protein phosphatases and associated proteins [BR:mmu01009], PP1-interacting proteins (PIPs)'),('4695','mmu04015  Rap1 signaling pathway, mmu04145  Phagosome, mmu04151  PI3K-Akt signaling pathway, mmu04360  Axon guidance, mmu04510  Focal adhesion, mmu04512  ECM-receptor interaction, mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04611  Platelet activation, mmu04670  Leukocyte transendothelial migration, mmu04810  Regulation of actin cytoskeleton, mmu05100  Bacterial invasion of epithelial cells, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05145  Toxoplasmosis, mmu05165  Human papillomavirus infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05222  Small cell lung cancer, mmu05410  Hypertrophic cardiomyopathy, mmu05412  Arrhythmogenic right ventricular cardiomyopathy, mmu05414  Dilated cardiomyopathy','04015 Rap1 signaling pathway, 04151 PI3K-Akt signaling pathway, 04512 ECM-receptor interaction, 04514 Cell adhesion molecules, 04145 Phagosome, 04510 Focal adhesion, 04530 Tight junction, 04810 Regulation of actin cytoskeleton, 04611 Platelet activation, 04670 Leukocyte transendothelial migration, 04360 Axon guidance, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05222 Small cell lung cancer, 05165 Human papillomavirus infection, 05135 Yersinia infection, 05133 Pertussis, 05100 Bacterial invasion of epithelial cells, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05410 Hypertrophic cardiomyopathy, 05412 Arrhythmogenic right ventricular cardiomyopathy, 05414 Dilated cardiomyopathy, 04131 Membrane trafficking [BR:mmu04131], 04147 Exosome [BR:mmu04147], 04515 Cell adhesion molecules [BR:mmu04515], 04090 CD molecules [BR:mmu04090], Integrins (complement receptors), Proteins found in most exosomes, Integrin beta subunits, Proteins'),('4696','mmu04217  Necroptosis, mmu04621  NOD-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05164  Influenza A, mmu05171  Coronavirus disease - COVID-19, mmu05417  Lipid and atherosclerosis','04217 Necroptosis, 04621 NOD-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05417 Lipid and atherosclerosis, 04131 Membrane trafficking [BR:mmu04131], 04054 Pattern recognition receptors [BR:mmu04054], TRIM-directed selective autophagy, NOD-like receptors'),('4697','mmu04217  Necroptosis, mmu04613  Neutrophil extracellular trap formation, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu05014  Amyotrophic lateral sclerosis, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05164  Influenza A, mmu05171  Coronavirus disease - COVID-19, mmu05417  Lipid and atherosclerosis','04217 Necroptosis, 04613 Neutrophil extracellular trap formation, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05014 Amyotrophic lateral sclerosis, 05417 Lipid and atherosclerosis, 01002 Peptidases and inhibitors [BR:mmu01002], 04131 Membrane trafficking [BR:mmu04131], 3.4.22.36  caspase-1, Family C14: caspase family, TRIM-directed selective autophagy'),('4698','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4699','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu05132  Salmonella infection, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05152  Tuberculosis, mmu05164  Influenza A, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis','04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 05164 Influenza A, 05132 Salmonella infection, 05135 Yersinia infection, 05134 Legionellosis, 05152 Tuberculosis, 05144 Malaria, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4700','mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04145  Phagosome, mmu04151  PI3K-Akt signaling pathway, mmu04217  Necroptosis, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04936  Alcoholic liver disease, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05164  Influenza A, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04066 HIF-1 signaling pathway, 04151 PI3K-Akt signaling pathway, 04145 Phagosome, 04217 Necroptosis, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 05205 Proteoglycans in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04131 Membrane trafficking [BR:mmu04131], 04054 Pattern recognition receptors [BR:mmu04054], 04090 CD molecules [BR:mmu04090], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Toll-like receptors, Toll-like receptors, Proteins, Cell surface receptors'),('4701','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('4702',NULL,'02000 Transporters [BR:mmu02000], SLC5: Sodium glucose cotransporter'),('4703','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('4704','mmu04976  Bile secretion','04976 Bile secretion, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 thyroid hormone receptor-like, 1H. Liver X receptor like receptor'),('4705','mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04020  Calcium signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04810  Regulation of actin cytoskeleton, mmu05200  Pathways in cancer, mmu05218  Melanoma, mmu05224  Breast cancer, mmu05226  Gastric cancer','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04020 Calcium signaling pathway, 04151 PI3K-Akt signaling pathway, 04810 Regulation of actin cytoskeleton, 05200 Pathways in cancer, 05226 Gastric cancer, 05218 Melanoma, 05224 Breast cancer, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Growth factors (RTK binding), Growth factors/receptors'),('4706','mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04020  Calcium signaling pathway, mmu04144  Endocytosis, mmu04151  PI3K-Akt signaling pathway, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04810  Regulation of actin cytoskeleton, mmu05200  Pathways in cancer','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04020 Calcium signaling pathway, 04151 PI3K-Akt signaling pathway, 04144 Endocytosis, 04550 Signaling pathways regulating pluripotency of stem cells, 04810 Regulation of actin cytoskeleton, 05200 Pathways in cancer, 01001 Protein kinases [BR:mmu01001], 04090 CD molecules [BR:mmu04090], 2.7.10.1  receptor protein-tyrosine kinase, FGFR family [OT], Proteins'),('4707','mmu00120  Primary bile acid biosynthesis, mmu00140  Steroid hormone biosynthesis, mmu01100  Metabolic pathways, mmu03320  PPAR signaling pathway, mmu04976  Bile secretion, mmu04979  Cholesterol metabolism','00120 Primary bile acid biosynthesis, 00140 Steroid hormone biosynthesis, 03320 PPAR signaling pathway, 04976 Bile secretion, 04979 Cholesterol metabolism, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.23  cholesterol 7alpha-monooxygenase, CYP7 family'),('4708','mmu04380  Osteoclast differentiation','04380 Osteoclast differentiation, 04515 Cell adhesion molecules [BR:mmu04515], 04090 CD molecules [BR:mmu04090], SIRP family, Proteins'),('4709','mmu00071  Fatty acid degradation, mmu01212  Fatty acid metabolism, mmu03320  PPAR signaling pathway, mmu04152  AMPK signaling pathway, mmu04714  Thermogenesis, mmu04920  Adipocytokine signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04936  Alcoholic liver disease, mmu05415  Diabetic cardiomyopathy','00071 Fatty acid degradation, 04152 AMPK signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 03320 PPAR signaling pathway, 04714 Thermogenesis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04931 Insulin resistance, 03029 Mitochondrial biogenesis [BR:mmu03029], 2.3.1.21  carnitine O-palmitoyltransferase, Other regulator of mitochondrial biogenesis'),('4710','mmu01524  Platinum drug resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04115  p53 signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04650  Natural killer cell mediated cytotoxicity, mmu04668  TNF signaling pathway, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05320  Autoimmune thyroid disease, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04210 Apoptosis, 04217 Necroptosis, 04115 p53 signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05142 Chagas disease, 05143 African trypanosomiasis, 05320 Autoimmune thyroid disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 01524 Platinum drug resistance, 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], TNF receptor superfamily, Proteins'),('4711','mmu04976  Bile secretion','04976 Bile secretion, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 thyroid hormone receptor-like, 1H. Liver X receptor like receptor'),('4712','mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04020  Calcium signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04810  Regulation of actin cytoskeleton, mmu05200  Pathways in cancer, mmu05218  Melanoma, mmu05224  Breast cancer, mmu05226  Gastric cancer','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04020 Calcium signaling pathway, 04151 PI3K-Akt signaling pathway, 04810 Regulation of actin cytoskeleton, 05200 Pathways in cancer, 05226 Gastric cancer, 05218 Melanoma, 05224 Breast cancer, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Growth factors (RTK binding), Growth factors/receptors'),('4713','mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04020  Calcium signaling pathway, mmu04144  Endocytosis, mmu04151  PI3K-Akt signaling pathway, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04810  Regulation of actin cytoskeleton, mmu05200  Pathways in cancer','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04020 Calcium signaling pathway, 04151 PI3K-Akt signaling pathway, 04144 Endocytosis, 04550 Signaling pathways regulating pluripotency of stem cells, 04810 Regulation of actin cytoskeleton, 05200 Pathways in cancer, 01001 Protein kinases [BR:mmu01001], 04090 CD molecules [BR:mmu04090], 2.7.10.1  receptor protein-tyrosine kinase, FGFR family [OT], Proteins'),('4714','mmu00120  Primary bile acid biosynthesis, mmu00140  Steroid hormone biosynthesis, mmu01100  Metabolic pathways, mmu03320  PPAR signaling pathway, mmu04976  Bile secretion, mmu04979  Cholesterol metabolism','00120 Primary bile acid biosynthesis, 00140 Steroid hormone biosynthesis, 03320 PPAR signaling pathway, 04976 Bile secretion, 04979 Cholesterol metabolism, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.23  cholesterol 7alpha-monooxygenase, CYP7 family'),('4715','mmu04380  Osteoclast differentiation','04380 Osteoclast differentiation, 04515 Cell adhesion molecules [BR:mmu04515], 04090 CD molecules [BR:mmu04090], SIRP family, Proteins'),('4716','mmu00071  Fatty acid degradation, mmu01212  Fatty acid metabolism, mmu03320  PPAR signaling pathway, mmu04152  AMPK signaling pathway, mmu04714  Thermogenesis, mmu04920  Adipocytokine signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04936  Alcoholic liver disease, mmu05415  Diabetic cardiomyopathy','00071 Fatty acid degradation, 04152 AMPK signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 03320 PPAR signaling pathway, 04714 Thermogenesis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04931 Insulin resistance, 03029 Mitochondrial biogenesis [BR:mmu03029], 2.3.1.21  carnitine O-palmitoyltransferase, Other regulator of mitochondrial biogenesis'),('4717','mmu01524  Platinum drug resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04115  p53 signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04650  Natural killer cell mediated cytotoxicity, mmu04668  TNF signaling pathway, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05320  Autoimmune thyroid disease, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04210 Apoptosis, 04217 Necroptosis, 04115 p53 signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05142 Chagas disease, 05143 African trypanosomiasis, 05320 Autoimmune thyroid disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 01524 Platinum drug resistance, 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], TNF receptor superfamily, Proteins'),('4718','mmu04976  Bile secretion','04976 Bile secretion, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 thyroid hormone receptor-like, 1H. Liver X receptor like receptor'),('4719','mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04020  Calcium signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04810  Regulation of actin cytoskeleton, mmu05200  Pathways in cancer, mmu05218  Melanoma, mmu05224  Breast cancer, mmu05226  Gastric cancer','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04020 Calcium signaling pathway, 04151 PI3K-Akt signaling pathway, 04810 Regulation of actin cytoskeleton, 05200 Pathways in cancer, 05226 Gastric cancer, 05218 Melanoma, 05224 Breast cancer, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Growth factors (RTK binding), Growth factors/receptors'),('4720','mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04020  Calcium signaling pathway, mmu04144  Endocytosis, mmu04151  PI3K-Akt signaling pathway, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04810  Regulation of actin cytoskeleton, mmu05200  Pathways in cancer','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04020 Calcium signaling pathway, 04151 PI3K-Akt signaling pathway, 04144 Endocytosis, 04550 Signaling pathways regulating pluripotency of stem cells, 04810 Regulation of actin cytoskeleton, 05200 Pathways in cancer, 01001 Protein kinases [BR:mmu01001], 04090 CD molecules [BR:mmu04090], 2.7.10.1  receptor protein-tyrosine kinase, FGFR family [OT], Proteins'),('4721','mmu00120  Primary bile acid biosynthesis, mmu00140  Steroid hormone biosynthesis, mmu01100  Metabolic pathways, mmu03320  PPAR signaling pathway, mmu04976  Bile secretion, mmu04979  Cholesterol metabolism','00120 Primary bile acid biosynthesis, 00140 Steroid hormone biosynthesis, 03320 PPAR signaling pathway, 04976 Bile secretion, 04979 Cholesterol metabolism, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.23  cholesterol 7alpha-monooxygenase, CYP7 family'),('4722','mmu04380  Osteoclast differentiation','04380 Osteoclast differentiation, 04515 Cell adhesion molecules [BR:mmu04515], 04090 CD molecules [BR:mmu04090], SIRP family, Proteins'),('4723','mmu00071  Fatty acid degradation, mmu01212  Fatty acid metabolism, mmu03320  PPAR signaling pathway, mmu04152  AMPK signaling pathway, mmu04714  Thermogenesis, mmu04920  Adipocytokine signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04936  Alcoholic liver disease, mmu05415  Diabetic cardiomyopathy','00071 Fatty acid degradation, 04152 AMPK signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 03320 PPAR signaling pathway, 04714 Thermogenesis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04931 Insulin resistance, 03029 Mitochondrial biogenesis [BR:mmu03029], 2.3.1.21  carnitine O-palmitoyltransferase, Other regulator of mitochondrial biogenesis'),('4724','mmu01524  Platinum drug resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04115  p53 signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04650  Natural killer cell mediated cytotoxicity, mmu04668  TNF signaling pathway, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05320  Autoimmune thyroid disease, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04210 Apoptosis, 04217 Necroptosis, 04115 p53 signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05142 Chagas disease, 05143 African trypanosomiasis, 05320 Autoimmune thyroid disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 01524 Platinum drug resistance, 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], TNF receptor superfamily, Proteins'),('4739','mmu04659  Th17 cell differentiation, mmu05321  Inflammatory bowel disease','04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix other regulators'),('4740','mmu04659  Th17 cell differentiation, mmu05321  Inflammatory bowel disease','04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix other regulators'),('4741','mmu04659  Th17 cell differentiation, mmu05321  Inflammatory bowel disease','04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix other regulators'),('4742','mmu04659  Th17 cell differentiation, mmu05321  Inflammatory bowel disease','04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix other regulators'),('4743','mmu04659  Th17 cell differentiation, mmu05321  Inflammatory bowel disease','04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix other regulators'),('4744','mmu04659  Th17 cell differentiation, mmu05321  Inflammatory bowel disease','04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix other regulators'),('4745','mmu04659  Th17 cell differentiation, mmu05321  Inflammatory bowel disease','04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix other regulators'),('4746','mmu04659  Th17 cell differentiation, mmu05321  Inflammatory bowel disease','04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix other regulators'),('4760',NULL,'04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('4761','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('4762','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04218  Cellular senescence, mmu04380  Osteoclast differentiation, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04668  TNF signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04917  Prolactin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04926  Relaxin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05212  Pancreatic cancer, mmu05215  Prostate cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:mmu03000], RHR (Rel homology region) Rel/Ankyrin'),('4763','mmu04514  Cell adhesion molecules','04514 Cell adhesion molecules, 04090 CD molecules [BR:mmu04090], Proteins'),('4764','mmu04514  Cell adhesion molecules, mmu04620  Toll-like receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04940  Type I diabetes mellitus, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05202  Transcriptional misregulation in cancer, mmu05320  Autoimmune thyroid disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05416  Viral myocarditis','04514 Cell adhesion molecules, 04620 Toll-like receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05202 Transcriptional misregulation in cancer, 05167 Kaposi sarcoma-associated herpesvirus infection, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05320 Autoimmune thyroid disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05416 Viral myocarditis, 04940 Type I diabetes mellitus, 04147 Exosome [BR:mmu04147], 04090 CD molecules [BR:mmu04090], Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell), Proteins'),('4765','mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04514  Cell adhesion molecules, mmu04620  Toll-like receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05166  Human T-cell leukemia virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05202  Transcriptional misregulation in cancer, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection, mmu05340  Primary immunodeficiency, mmu05416  Viral myocarditis, mmu05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04514 Cell adhesion molecules, 04620 Toll-like receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05169 Epstein-Barr virus infection, 05144 Malaria, 05145 Toxoplasmosis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05330 Allograft rejection, 05340 Primary immunodeficiency, 05417 Lipid and atherosclerosis, 05416 Viral myocarditis, 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], TNF receptor superfamily, Proteins'),('4766','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4767','mmu04060  Cytokine-cytokine receptor interaction, mmu04620  Toll-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4768',NULL,'04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('4769','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('4770','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04218  Cellular senescence, mmu04380  Osteoclast differentiation, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04668  TNF signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04917  Prolactin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04926  Relaxin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05212  Pancreatic cancer, mmu05215  Prostate cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:mmu03000], RHR (Rel homology region) Rel/Ankyrin'),('4771',NULL,'04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('4772','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('4773','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04218  Cellular senescence, mmu04380  Osteoclast differentiation, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04668  TNF signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04917  Prolactin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04926  Relaxin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05212  Pancreatic cancer, mmu05215  Prostate cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:mmu03000], RHR (Rel homology region) Rel/Ankyrin'),('4774','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Hydroxy-carboxylic acid'),('4775','mmu04659  Th17 cell differentiation, mmu05321  Inflammatory bowel disease','04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix other regulators'),('4776','mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04514  Cell adhesion molecules, mmu04620  Toll-like receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05166  Human T-cell leukemia virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05202  Transcriptional misregulation in cancer, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection, mmu05340  Primary immunodeficiency, mmu05416  Viral myocarditis, mmu05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04514 Cell adhesion molecules, 04620 Toll-like receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05169 Epstein-Barr virus infection, 05144 Malaria, 05145 Toxoplasmosis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05330 Allograft rejection, 05340 Primary immunodeficiency, 05417 Lipid and atherosclerosis, 05416 Viral myocarditis, 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], TNF receptor superfamily, Proteins'),('4777','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4778','mmu04060  Cytokine-cytokine receptor interaction, mmu04620  Toll-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4779',NULL,'04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('4780','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('4781','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04218  Cellular senescence, mmu04380  Osteoclast differentiation, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04668  TNF signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04917  Prolactin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04926  Relaxin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05212  Pancreatic cancer, mmu05215  Prostate cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:mmu03000], RHR (Rel homology region) Rel/Ankyrin'),('4782','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Hydroxy-carboxylic acid'),('4783','mmu04659  Th17 cell differentiation, mmu05321  Inflammatory bowel disease','04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix other regulators'),('4784','mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04514  Cell adhesion molecules, mmu04620  Toll-like receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05166  Human T-cell leukemia virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05202  Transcriptional misregulation in cancer, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection, mmu05340  Primary immunodeficiency, mmu05416  Viral myocarditis, mmu05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04514 Cell adhesion molecules, 04620 Toll-like receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05169 Epstein-Barr virus infection, 05144 Malaria, 05145 Toxoplasmosis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05330 Allograft rejection, 05340 Primary immunodeficiency, 05417 Lipid and atherosclerosis, 05416 Viral myocarditis, 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], TNF receptor superfamily, Proteins'),('4785','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4786','mmu04060  Cytokine-cytokine receptor interaction, mmu04620  Toll-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4787',NULL,'04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('4788','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('4789','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04218  Cellular senescence, mmu04380  Osteoclast differentiation, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04668  TNF signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04917  Prolactin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04926  Relaxin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05212  Pancreatic cancer, mmu05215  Prostate cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:mmu03000], RHR (Rel homology region) Rel/Ankyrin'),('4790','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Hydroxy-carboxylic acid'),('4791','mmu04659  Th17 cell differentiation, mmu05321  Inflammatory bowel disease','04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix other regulators'),('4792','mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04514  Cell adhesion molecules, mmu04620  Toll-like receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05166  Human T-cell leukemia virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05202  Transcriptional misregulation in cancer, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection, mmu05340  Primary immunodeficiency, mmu05416  Viral myocarditis, mmu05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04514 Cell adhesion molecules, 04620 Toll-like receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05169 Epstein-Barr virus infection, 05144 Malaria, 05145 Toxoplasmosis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05330 Allograft rejection, 05340 Primary immunodeficiency, 05417 Lipid and atherosclerosis, 05416 Viral myocarditis, 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], TNF receptor superfamily, Proteins'),('4793','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4794','mmu04060  Cytokine-cytokine receptor interaction, mmu04620  Toll-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4795',NULL,'04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('4796','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('4797','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04218  Cellular senescence, mmu04380  Osteoclast differentiation, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04668  TNF signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04917  Prolactin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04926  Relaxin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05212  Pancreatic cancer, mmu05215  Prostate cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:mmu03000], RHR (Rel homology region) Rel/Ankyrin'),('4798','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Hydroxy-carboxylic acid'),('4799','mmu04659  Th17 cell differentiation, mmu05321  Inflammatory bowel disease','04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix other regulators'),('4800','mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04514  Cell adhesion molecules, mmu04620  Toll-like receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05166  Human T-cell leukemia virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05202  Transcriptional misregulation in cancer, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection, mmu05340  Primary immunodeficiency, mmu05416  Viral myocarditis, mmu05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04514 Cell adhesion molecules, 04620 Toll-like receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05169 Epstein-Barr virus infection, 05144 Malaria, 05145 Toxoplasmosis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05330 Allograft rejection, 05340 Primary immunodeficiency, 05417 Lipid and atherosclerosis, 05416 Viral myocarditis, 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], TNF receptor superfamily, Proteins'),('4801','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4802','mmu04060  Cytokine-cytokine receptor interaction, mmu04620  Toll-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4803',NULL,'04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('4804','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('4805','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04218  Cellular senescence, mmu04380  Osteoclast differentiation, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04668  TNF signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04917  Prolactin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04926  Relaxin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05212  Pancreatic cancer, mmu05215  Prostate cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:mmu03000], RHR (Rel homology region) Rel/Ankyrin'),('4806','mmu04514  Cell adhesion molecules','04514 Cell adhesion molecules, 04090 CD molecules [BR:mmu04090], Proteins'),('4807','mmu04514  Cell adhesion molecules, mmu04620  Toll-like receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04940  Type I diabetes mellitus, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05202  Transcriptional misregulation in cancer, mmu05320  Autoimmune thyroid disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05416  Viral myocarditis','04514 Cell adhesion molecules, 04620 Toll-like receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05202 Transcriptional misregulation in cancer, 05167 Kaposi sarcoma-associated herpesvirus infection, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05320 Autoimmune thyroid disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05416 Viral myocarditis, 04940 Type I diabetes mellitus, 04147 Exosome [BR:mmu04147], 04090 CD molecules [BR:mmu04090], Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell), Proteins'),('4808','mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04514  Cell adhesion molecules, mmu04620  Toll-like receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05166  Human T-cell leukemia virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05202  Transcriptional misregulation in cancer, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection, mmu05340  Primary immunodeficiency, mmu05416  Viral myocarditis, mmu05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04514 Cell adhesion molecules, 04620 Toll-like receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05169 Epstein-Barr virus infection, 05144 Malaria, 05145 Toxoplasmosis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05330 Allograft rejection, 05340 Primary immunodeficiency, 05417 Lipid and atherosclerosis, 05416 Viral myocarditis, 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], TNF receptor superfamily, Proteins'),('4809','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('4810','mmu04060  Cytokine-cytokine receptor interaction, mmu04620  Toll-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('4811','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04630  JAK-STAT signaling pathway, mmu05145  Toxoplasmosis, mmu05152  Tuberculosis, mmu05163  Human cytomegalovirus infection','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 05163 Human cytomegalovirus infection, 05152 Tuberculosis, 05145 Toxoplasmosis, 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], IL10/28 receptor family, Proteins'),('4812','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04630  JAK-STAT signaling pathway, mmu05145  Toxoplasmosis, mmu05152  Tuberculosis, mmu05163  Human cytomegalovirus infection','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 05163 Human cytomegalovirus infection, 05152 Tuberculosis, 05145 Toxoplasmosis, 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], IL10/28 receptor family, Proteins'),('4813','mmu04659  Th17 cell differentiation, mmu04934  Cushing syndrome, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species','04659 Th17 cell differentiation, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 04934 Cushing syndrome, 03000 Transcription factors [BR:mmu03000], Factors with PAS domain'),('4814','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04630  JAK-STAT signaling pathway, mmu05145  Toxoplasmosis, mmu05152  Tuberculosis, mmu05163  Human cytomegalovirus infection','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 05163 Human cytomegalovirus infection, 05152 Tuberculosis, 05145 Toxoplasmosis, 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], IL10/28 receptor family, Proteins'),('4815','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04630  JAK-STAT signaling pathway, mmu05145  Toxoplasmosis, mmu05152  Tuberculosis, mmu05163  Human cytomegalovirus infection','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 05163 Human cytomegalovirus infection, 05152 Tuberculosis, 05145 Toxoplasmosis, 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], IL10/28 receptor family, Proteins'),('4816','mmu04659  Th17 cell differentiation, mmu04934  Cushing syndrome, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species','04659 Th17 cell differentiation, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 04934 Cushing syndrome, 03000 Transcription factors [BR:mmu03000], Factors with PAS domain'),('4817','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Hydroxy-carboxylic acid'),('4818','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Hydroxy-carboxylic acid'),('4819','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Hydroxy-carboxylic acid'),('4820','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Hydroxy-carboxylic acid'),('4821','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Hydroxy-carboxylic acid'),('4822','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01522  Endocrine resistance, mmu01524  Platinum drug resistance, mmu04010  MAPK signaling pathway, mmu04012  ErbB signaling pathway, mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04022  cGMP-PKG signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04072  Phospholipase D signaling pathway, mmu04114  Oocyte meiosis, mmu04140  Autophagy - animal, mmu04150  mTOR signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04218  Cellular senescence, mmu04261  Adrenergic signaling in cardiomyocytes, mmu04270  Vascular smooth muscle contraction, mmu04350  TGF-beta signaling pathway, mmu04360  Axon guidance, mmu04370  VEGF signaling pathway, mmu04371  Apelin signaling pathway, mmu04380  Osteoclast differentiation, mmu04510  Focal adhesion, mmu04520  Adherens junction, mmu04540  Gap junction, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04611  Platelet activation, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04666  Fc gamma R-mediated phagocytosis, mmu04668  TNF signaling pathway, mmu04713  Circadian entrainment, mmu04720  Long-term potentiation, mmu04722  Neurotrophin signaling pathway, mmu04723  Retrograde endocannabinoid signaling, mmu04724  Glutamatergic synapse, mmu04725  Cholinergic synapse, mmu04726  Serotonergic synapse, mmu04730  Long-term depression, mmu04810  Regulation of actin cytoskeleton, mmu04910  Insulin signaling pathway, mmu04912  GnRH signaling pathway, mmu04914  Progesterone-mediated oocyte maturation, mmu04915  Estrogen signaling pathway, mmu04916  Melanogenesis, mmu04917  Prolactin signaling pathway, mmu04919  Thyroid hormone signaling pathway, mmu04921  Oxytocin signaling pathway, mmu04926  Relaxin signaling pathway, mmu04928  Parathyroid hormone synthesis, secretion and action, mmu04929  GnRH secretion, mmu04930  Type II diabetes mellitus, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04934  Cushing syndrome, mmu04935  Growth hormone synthesis, secretion and action, mmu04960  Aldosterone-regulated sodium reabsorption, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05034  Alcoholism, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05210  Colorectal cancer, mmu05211  Renal cell carcinoma, mmu05212  Pancreatic cancer, mmu05213  Endometrial cancer, mmu05214  Glioma, mmu05215  Prostate cancer, mmu05216  Thyroid cancer, mmu05218  Melanoma, mmu05219  Bladder cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05223  Non-small cell lung cancer, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05230  Central carbon metabolism in cancer, mmu05231  Choline metabolism in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04350 TGF-beta signaling pathway, 04370 VEGF signaling pathway, 04371 Apelin signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04072 Phospholipase D signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04022 cGMP-PKG signaling pathway, 04151 PI3K-Akt signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04114 Oocyte meiosis, 04210 Apoptosis, 04218 Cellular senescence, 04510 Focal adhesion, 04520 Adherens junction, 04540 Gap junction, 04550 Signaling pathways regulating pluripotency of stem cells, 04810 Regulation of actin cytoskeleton, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04664 Fc epsilon RI signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04062 Chemokine signaling pathway, 04910 Insulin signaling pathway, 04929 GnRH secretion, 04912 GnRH signaling pathway, 04915 Estrogen signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 04916 Melanogenesis, 04261 Adrenergic signaling in cardiomyocytes, 04270 Vascular smooth muscle contraction, 04960 Aldosterone-regulated sodium reabsorption, 04724 Glutamatergic synapse, 04725 Cholinergic synapse, 04726 Serotonergic synapse, 04720 Long-term potentiation, 04730 Long-term depression, 04723 Retrograde endocannabinoid signaling, 04722 Neurotrophin signaling pathway, 04360 Axon guidance, 04380 Osteoclast differentiation, 04713 Circadian entrainment, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05211 Renal cell carcinoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05152 Tuberculosis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05034 Alcoholism, 05417 Lipid and atherosclerosis, 04930 Type II diabetes mellitus, 04933 AGE-RAGE signaling pathway in diabetic complications, 04934 Cushing syndrome, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01001 Protein kinases [BR:mmu01001], 03036 Chromosome and associated proteins [BR:mmu03036], 04147 Exosome [BR:mmu04147], 2.7.11.24  mitogen-activated protein kinase, MAPK family [OT], Protein kinases, Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)'),('4823','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01522  Endocrine resistance, mmu01524  Platinum drug resistance, mmu04010  MAPK signaling pathway, mmu04012  ErbB signaling pathway, mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04022  cGMP-PKG signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04072  Phospholipase D signaling pathway, mmu04114  Oocyte meiosis, mmu04140  Autophagy - animal, mmu04150  mTOR signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04218  Cellular senescence, mmu04261  Adrenergic signaling in cardiomyocytes, mmu04270  Vascular smooth muscle contraction, mmu04350  TGF-beta signaling pathway, mmu04360  Axon guidance, mmu04370  VEGF signaling pathway, mmu04371  Apelin signaling pathway, mmu04380  Osteoclast differentiation, mmu04510  Focal adhesion, mmu04520  Adherens junction, mmu04540  Gap junction, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04611  Platelet activation, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04666  Fc gamma R-mediated phagocytosis, mmu04668  TNF signaling pathway, mmu04713  Circadian entrainment, mmu04720  Long-term potentiation, mmu04722  Neurotrophin signaling pathway, mmu04723  Retrograde endocannabinoid signaling, mmu04724  Glutamatergic synapse, mmu04725  Cholinergic synapse, mmu04726  Serotonergic synapse, mmu04730  Long-term depression, mmu04810  Regulation of actin cytoskeleton, mmu04910  Insulin signaling pathway, mmu04912  GnRH signaling pathway, mmu04914  Progesterone-mediated oocyte maturation, mmu04915  Estrogen signaling pathway, mmu04916  Melanogenesis, mmu04917  Prolactin signaling pathway, mmu04919  Thyroid hormone signaling pathway, mmu04921  Oxytocin signaling pathway, mmu04926  Relaxin signaling pathway, mmu04928  Parathyroid hormone synthesis, secretion and action, mmu04929  GnRH secretion, mmu04930  Type II diabetes mellitus, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04934  Cushing syndrome, mmu04935  Growth hormone synthesis, secretion and action, mmu04960  Aldosterone-regulated sodium reabsorption, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05034  Alcoholism, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05210  Colorectal cancer, mmu05211  Renal cell carcinoma, mmu05212  Pancreatic cancer, mmu05213  Endometrial cancer, mmu05214  Glioma, mmu05215  Prostate cancer, mmu05216  Thyroid cancer, mmu05218  Melanoma, mmu05219  Bladder cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05223  Non-small cell lung cancer, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05230  Central carbon metabolism in cancer, mmu05231  Choline metabolism in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04350 TGF-beta signaling pathway, 04370 VEGF signaling pathway, 04371 Apelin signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04072 Phospholipase D signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04022 cGMP-PKG signaling pathway, 04151 PI3K-Akt signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04114 Oocyte meiosis, 04210 Apoptosis, 04218 Cellular senescence, 04510 Focal adhesion, 04520 Adherens junction, 04540 Gap junction, 04550 Signaling pathways regulating pluripotency of stem cells, 04810 Regulation of actin cytoskeleton, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04664 Fc epsilon RI signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04062 Chemokine signaling pathway, 04910 Insulin signaling pathway, 04929 GnRH secretion, 04912 GnRH signaling pathway, 04915 Estrogen signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 04916 Melanogenesis, 04261 Adrenergic signaling in cardiomyocytes, 04270 Vascular smooth muscle contraction, 04960 Aldosterone-regulated sodium reabsorption, 04724 Glutamatergic synapse, 04725 Cholinergic synapse, 04726 Serotonergic synapse, 04720 Long-term potentiation, 04730 Long-term depression, 04723 Retrograde endocannabinoid signaling, 04722 Neurotrophin signaling pathway, 04360 Axon guidance, 04380 Osteoclast differentiation, 04713 Circadian entrainment, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05211 Renal cell carcinoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05152 Tuberculosis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05034 Alcoholism, 05417 Lipid and atherosclerosis, 04930 Type II diabetes mellitus, 04933 AGE-RAGE signaling pathway in diabetic complications, 04934 Cushing syndrome, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01001 Protein kinases [BR:mmu01001], 03036 Chromosome and associated proteins [BR:mmu03036], 04147 Exosome [BR:mmu04147], 2.7.11.24  mitogen-activated protein kinase, MAPK family [OT], Protein kinases, Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)'),('4824','mmu03250  Viral life cycle - HIV-1, mmu04144  Endocytosis','03250 Viral life cycle - HIV-1, 04144 Endocytosis, 04131 Membrane trafficking [BR:mmu04131], 04147 Exosome [BR:mmu04147], ESCRT associated proteins, Proteins found in most exosomes'),('4825','mmu00510  N-Glycan biosynthesis, mmu00513  Various types of N-glycan biosynthesis, mmu01100  Metabolic pathways','00510 N-Glycan biosynthesis, 00513 Various types of N-glycan biosynthesis, 01003 Glycosyltransferases [BR:mmu01003], 2.4.1.260  dolichyl-P-Man:Man7GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase, Dol-linked oligosaccharide'),('4826','mmu00071  Fatty acid degradation, mmu00280  Valine, leucine and isoleucine degradation, mmu00592  alpha-Linolenic acid metabolism, mmu01040  Biosynthesis of unsaturated fatty acids, mmu01100  Metabolic pathways, mmu01212  Fatty acid metabolism, mmu03320  PPAR signaling pathway, mmu04146  Peroxisome','00071 Fatty acid degradation, 00592 alpha-Linolenic acid metabolism, 01040 Biosynthesis of unsaturated fatty acids, 00280 Valine, leucine and isoleucine degradation, 04146 Peroxisome, 03320 PPAR signaling pathway, 2.3.1.16  acetyl-CoA C-acyltransferase'),('4827','mmu00071  Fatty acid degradation, mmu00280  Valine, leucine and isoleucine degradation, mmu00592  alpha-Linolenic acid metabolism, mmu01040  Biosynthesis of unsaturated fatty acids, mmu01100  Metabolic pathways, mmu01212  Fatty acid metabolism, mmu03320  PPAR signaling pathway, mmu04146  Peroxisome','00071 Fatty acid degradation, 00592 alpha-Linolenic acid metabolism, 01040 Biosynthesis of unsaturated fatty acids, 00280 Valine, leucine and isoleucine degradation, 04146 Peroxisome, 03320 PPAR signaling pathway, 2.3.1.16  acetyl-CoA C-acyltransferase'),('4828','mmu00062  Fatty acid elongation, mmu00071  Fatty acid degradation, mmu00280  Valine, leucine and isoleucine degradation, mmu01100  Metabolic pathways, mmu01212  Fatty acid metabolism','00062 Fatty acid elongation, 00071 Fatty acid degradation, 00280 Valine, leucine and isoleucine degradation, 2.3.1.16  acetyl-CoA C-acyltransferase'),('4829','mmu00071  Fatty acid degradation, mmu00280  Valine, leucine and isoleucine degradation, mmu00410  beta-Alanine metabolism, mmu00640  Propanoate metabolism, mmu00650  Butanoate metabolism, mmu01100  Metabolic pathways, mmu01200  Carbon metabolism, mmu01212  Fatty acid metabolism','00640 Propanoate metabolism, 00650 Butanoate metabolism, 00071 Fatty acid degradation, 00280 Valine, leucine and isoleucine degradation, 00410 beta-Alanine metabolism, 1.3.8.1  short-chain acyl-CoA dehydrogenase'),('4830','mmu00380  Tryptophan metabolism, mmu01100  Metabolic pathways','00380 Tryptophan metabolism, 4.1.1.45  aminocarboxymuconate-semialdehyde decarboxylase'),('4831','mmu00062  Fatty acid elongation, mmu01040  Biosynthesis of unsaturated fatty acids, mmu01100  Metabolic pathways, mmu04913  Ovarian steroidogenesis','00062 Fatty acid elongation, 01040 Biosynthesis of unsaturated fatty acids, 04913 Ovarian steroidogenesis, 01004 Lipid biosynthesis proteins [BR:mmu01004], 3.1.2.2  palmitoyl-CoA hydrolase, Component type'),('4832','mmu00062  Fatty acid elongation, mmu01040  Biosynthesis of unsaturated fatty acids, mmu01100  Metabolic pathways, mmu04913  Ovarian steroidogenesis','00062 Fatty acid elongation, 01040 Biosynthesis of unsaturated fatty acids, 04913 Ovarian steroidogenesis, 01004 Lipid biosynthesis proteins [BR:mmu01004], 3.1.2.2  palmitoyl-CoA hydrolase, Component type'),('4833','mmu00062  Fatty acid elongation, mmu01040  Biosynthesis of unsaturated fatty acids','00062 Fatty acid elongation, 01040 Biosynthesis of unsaturated fatty acids, 01004 Lipid biosynthesis proteins [BR:mmu01004], 04147 Exosome [BR:mmu04147], 3.1.2.2  palmitoyl-CoA hydrolase, Component type, Exosomal proteins of other body fluids (saliva and urine)'),('4834','mmu00120  Primary bile acid biosynthesis, mmu01100  Metabolic pathways, mmu04146  Peroxisome','00120 Primary bile acid biosynthesis, 04146 Peroxisome, 3.1.2.27  choloyl-CoA hydrolase'),('4835','mmu00061  Fatty acid biosynthesis, mmu00071  Fatty acid degradation, mmu01100  Metabolic pathways, mmu01212  Fatty acid metabolism, mmu03320  PPAR signaling pathway, mmu04146  Peroxisome, mmu04216  Ferroptosis, mmu04714  Thermogenesis, mmu04920  Adipocytokine signaling pathway','00061 Fatty acid biosynthesis, 00071 Fatty acid degradation, 04146 Peroxisome, 04216 Ferroptosis, 04920 Adipocytokine signaling pathway, 03320 PPAR signaling pathway, 04714 Thermogenesis, 01004 Lipid biosynthesis proteins [BR:mmu01004], 04147 Exosome [BR:mmu04147], 6.2.1.3  long-chain-fatty-acid---CoA ligase, Long/very long chain acyl-CoA synthetase, Exosomal proteins of breast milk, Exosomal proteins of breast cancer cells'),('4836','mmu00010  Glycolysis / Gluconeogenesis, mmu00620  Pyruvate metabolism, mmu00630  Glyoxylate and dicarboxylate metabolism, mmu00640  Propanoate metabolism, mmu01100  Metabolic pathways, mmu01200  Carbon metabolism','00010 Glycolysis / Gluconeogenesis, 00620 Pyruvate metabolism, 00630 Glyoxylate and dicarboxylate metabolism, 00640 Propanoate metabolism, 01004 Lipid biosynthesis proteins [BR:mmu01004], 6.2.1.1  acetate---CoA ligase, Short/medium chain acyl-CoA synthetase'),('4837','mmu00620  Pyruvate metabolism, mmu01100  Metabolic pathways','00620 Pyruvate metabolism, 3.6.1.7  acylphosphatase'),('4838','mmu00230  Purine metabolism, mmu01100  Metabolic pathways, mmu01232  Nucleotide metabolism, mmu05340  Primary immunodeficiency','00230 Purine metabolism, 05340 Primary immunodeficiency, 3.5.4.4  adenosine deaminase'),('4839','mmu00561  Glycerolipid metabolism, mmu00564  Glycerophospholipid metabolism, mmu01100  Metabolic pathways, mmu04072  Phospholipase D signaling pathway, mmu04975  Fat digestion and absorption','00561 Glycerolipid metabolism, 00564 Glycerophospholipid metabolism, 04072 Phospholipase D signaling pathway, 04975 Fat digestion and absorption, 01004 Lipid biosynthesis proteins [BR:mmu01004], 2.3.1.51  1-acylglycerol-3-phosphate O-acyltransferase, LPAAT/LPLAT'),('4840','mmu00270  Cysteine and methionine metabolism, mmu01100  Metabolic pathways','00270 Cysteine and methionine metabolism, 01009 Protein phosphatases and associated proteins [BR:mmu01009], 04147 Exosome [BR:mmu04147], 3.3.1.1  adenosylhomocysteinase, PP1-interacting proteins (PIPs), Exosomal proteins of other body fluids (saliva and urine)'),('4841','mmu00040  Pentose and glucuronate interconversions, mmu00051  Fructose and mannose metabolism, mmu00052  Galactose metabolism, mmu00561  Glycerolipid metabolism, mmu00790  Folate biosynthesis, mmu01100  Metabolic pathways','00040 Pentose and glucuronate interconversions, 00051 Fructose and mannose metabolism, 00052 Galactose metabolism, 00561 Glycerolipid metabolism, 00790 Folate biosynthesis, 1.1.1.21  aldose reductase'),('4842','mmu00040  Pentose and glucuronate interconversions, mmu00051  Fructose and mannose metabolism, mmu00052  Galactose metabolism, mmu00561  Glycerolipid metabolism, mmu00790  Folate biosynthesis, mmu01100  Metabolic pathways','00040 Pentose and glucuronate interconversions, 00051 Fructose and mannose metabolism, 00052 Galactose metabolism, 00561 Glycerolipid metabolism, 00790 Folate biosynthesis, 1.1.1.21  aldose reductase'),('4843','mmu00260  Glycine, serine and threonine metabolism, mmu00860  Porphyrin metabolism, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors','00260 Glycine, serine and threonine metabolism, 00860 Porphyrin metabolism, 01007 Amino acid related enzymes [BR:mmu01007], 2.3.1.37  5-aminolevulinate synthase, Class II'),('4844','mmu00260  Glycine, serine and threonine metabolism, mmu00860  Porphyrin metabolism, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors','00260 Glycine, serine and threonine metabolism, 00860 Porphyrin metabolism, 01007 Amino acid related enzymes [BR:mmu01007], 2.3.1.37  5-aminolevulinate synthase, Class II'),('4845','mmu00010  Glycolysis / Gluconeogenesis, mmu00030  Pentose phosphate pathway, mmu00051  Fructose and mannose metabolism, mmu01100  Metabolic pathways, mmu01200  Carbon metabolism, mmu01230  Biosynthesis of amino acids, mmu04066  HIF-1 signaling pathway','00010 Glycolysis / Gluconeogenesis, 00030 Pentose phosphate pathway, 00051 Fructose and mannose metabolism, 04066 HIF-1 signaling pathway, 04131 Membrane trafficking [BR:mmu04131], 03036 Chromosome and associated proteins [BR:mmu03036], 04147 Exosome [BR:mmu04147], 4.1.2.13  fructose-bisphosphate aldolase, Selective cargos, Other centriole associated proteins, Proteins found in most exosomes'),('4846','mmu00510  N-Glycan biosynthesis, mmu00513  Various types of N-glycan biosynthesis, mmu01100  Metabolic pathways','00510 N-Glycan biosynthesis, 00513 Various types of N-glycan biosynthesis, 01003 Glycosyltransferases [BR:mmu01003], 2.4.1.260  dolichyl-P-Man:Man7GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase, Dol-linked oligosaccharide'),('4847','mmu00280  Valine, leucine and isoleucine degradation, mmu00350  Tyrosine metabolism, mmu00380  Tryptophan metabolism, mmu00750  Vitamin B6 metabolism, mmu00760  Nicotinate and nicotinamide metabolism, mmu00830  Retinol metabolism, mmu00982  Drug metabolism - cytochrome P450, mmu01100  Metabolic pathways, mmu04630  JAK-STAT signaling pathway','00280 Valine, leucine and isoleucine degradation, 00350 Tyrosine metabolism, 00380 Tryptophan metabolism, 00750 Vitamin B6 metabolism, 00760 Nicotinate and nicotinamide metabolism, 00830 Retinol metabolism, 00982 Drug metabolism - cytochrome P450, 04630 JAK-STAT signaling pathway, 1.2.3.1  aldehyde oxidase'),('4848','mmu00600  Sphingolipid metabolism, mmu01100  Metabolic pathways, mmu04142  Lysosome','00600 Sphingolipid metabolism, 04142 Lysosome, 3.1.6.8  cerebroside-sulfatase'),('4849','mmu00220  Arginine biosynthesis, mmu00250  Alanine, aspartate and glutamate metabolism, mmu01100  Metabolic pathways, mmu01230  Biosynthesis of amino acids','00250 Alanine, aspartate and glutamate metabolism, 00220 Arginine biosynthesis, 04147 Exosome [BR:mmu04147], 4.3.2.1  argininosuccinate lyase, Exosomal proteins of other body fluids (saliva and urine)'),('4850','mmu00250  Alanine, aspartate and glutamate metabolism, mmu01100  Metabolic pathways, mmu01230  Biosynthesis of amino acids','00250 Alanine, aspartate and glutamate metabolism, 01002 Peptidases and inhibitors [BR:mmu01002], 6.3.5.4  asparagine synthase (glutamine-hydrolysing), Family C44'),('4851','mmu00760  Nicotinate and nicotinamide metabolism, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors','00760 Nicotinate and nicotinamide metabolism, 1.4.1.21  aspartate dehydrogenase'),('4852','mmu00601  Glycosphingolipid biosynthesis - lacto and neolacto series, mmu01100  Metabolic pathways','00601 Glycosphingolipid biosynthesis - lacto and neolacto series, 01003 Glycosyltransferases [BR:mmu01003], 2.4.1.86  N-acetyl-beta-D-glucosaminide beta-(1,3)-galactosyltransferase, Type 1 chain'),('4853','mmu00601  Glycosphingolipid biosynthesis - lacto and neolacto series, mmu01100  Metabolic pathways','00601 Glycosphingolipid biosynthesis - lacto and neolacto series, 01003 Glycosyltransferases [BR:mmu01003], 2.4.1.86  N-acetyl-beta-D-glucosaminide beta-(1,3)-galactosyltransferase, Type 1 chain'),('4854','mmu00532  Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate, mmu00534  Glycosaminoglycan biosynthesis - heparan sulfate / heparin, mmu01100  Metabolic pathways','00532 Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate, 00534 Glycosaminoglycan biosynthesis - heparan sulfate / heparin, 01003 Glycosyltransferases [BR:mmu01003], 2.4.1.135  galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase, O-Glycan'),('4855','mmu00512  Mucin type O-glycan biosynthesis, mmu00601  Glycosphingolipid biosynthesis - lacto and neolacto series, mmu01100  Metabolic pathways','00512 Mucin type O-glycan biosynthesis, 00601 Glycosphingolipid biosynthesis - lacto and neolacto series, 01003 Glycosyltransferases [BR:mmu01003], 2.4.1.146  beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase, 2.4.1.149  N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase, Type 2 chain/Poly-N-acetyllactosamine'),('4856','mmu00600  Sphingolipid metabolism, mmu00604  Glycosphingolipid biosynthesis - ganglio series, mmu01100  Metabolic pathways','00600 Sphingolipid metabolism, 00604 Glycosphingolipid biosynthesis - ganglio series, 01003 Glycosyltransferases [BR:mmu01003], 2.4.1.92  (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase, Glycolipid'),('4857','mmu00780  Biotin metabolism, mmu01100  Metabolic pathways, mmu04977  Vitamin digestion and absorption','00780 Biotin metabolism, 04977 Vitamin digestion and absorption, 3.5.1.12  biotinidase'),('4858','mmu00100  Steroid biosynthesis, mmu00561  Glycerolipid metabolism, mmu01100  Metabolic pathways, mmu04972  Pancreatic secretion, mmu04975  Fat digestion and absorption','00100 Steroid biosynthesis, 00561 Glycerolipid metabolism, 04972 Pancreatic secretion, 04975 Fat digestion and absorption, 04147 Exosome [BR:mmu04147], 3.1.1.3  triacylglycerol lipase, 3.1.1.13  sterol esterase, Exosomal proteins of breast milk'),('4859','mmu00564  Glycerophospholipid metabolism, mmu01100  Metabolic pathways, mmu05231  Choline metabolism in cancer','00564 Glycerophospholipid metabolism, 05231 Choline metabolism in cancer, 2.7.1.32  choline kinase, 2.7.1.82  ethanolamine kinase'),('4860','mmu00564  Glycerophospholipid metabolism, mmu01100  Metabolic pathways, mmu05231  Choline metabolism in cancer','00564 Glycerophospholipid metabolism, 05231 Choline metabolism in cancer, 2.7.1.32  choline kinase, 2.7.1.82  ethanolamine kinase'),('4861','mmu00532  Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate, mmu01100  Metabolic pathways','00532 Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate, 01003 Glycosyltransferases [BR:mmu01003], 2.4.1.175  glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase, 2.4.1.226  N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase, O-Glycan'),('4862','mmu00532  Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate','00532 Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate, 01003 Glycosyltransferases [BR:mmu01003], 2.8.2.17  chondroitin 6-sulfotransferase, Sulfotransferases'),('4863','mmu00330  Arginine and proline metabolism, mmu01100  Metabolic pathways','00330 Arginine and proline metabolism, 04147 Exosome [BR:mmu04147], 2.7.3.2  creatine kinase, Exosomal proteins of epithelial cells'),('4864','mmu00410  beta-Alanine metabolism, mmu00430  Taurine and hypotaurine metabolism, mmu00770  Pantothenate and CoA biosynthesis, mmu01100  Metabolic pathways','00410 beta-Alanine metabolism, 00430 Taurine and hypotaurine metabolism, 00770 Pantothenate and CoA biosynthesis, 4.1.1.11  aspartate 1-decarboxylase, 4.1.1.29  sulfinoalanine decarboxylase'),('4865','mmu00140  Steroid hormone biosynthesis, mmu00380  Tryptophan metabolism, mmu00830  Retinol metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu01100  Metabolic pathways, mmu04913  Ovarian steroidogenesis, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05417  Lipid and atherosclerosis','00140 Steroid hormone biosynthesis, 00380 Tryptophan metabolism, 00830 Retinol metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 04913 Ovarian steroidogenesis, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05417 Lipid and atherosclerosis, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP1 family'),('4866','mmu00140  Steroid hormone biosynthesis, mmu00232  Caffeine metabolism, mmu00380  Tryptophan metabolism, mmu00591  Linoleic acid metabolism, mmu00830  Retinol metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu00982  Drug metabolism - cytochrome P450, mmu01100  Metabolic pathways, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species','00140 Steroid hormone biosynthesis, 00591 Linoleic acid metabolism, 00380 Tryptophan metabolism, 00830 Retinol metabolism, 00232 Caffeine metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP1 family'),('4867','mmu00140  Steroid hormone biosynthesis, mmu00232  Caffeine metabolism, mmu00380  Tryptophan metabolism, mmu00591  Linoleic acid metabolism, mmu00830  Retinol metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu00982  Drug metabolism - cytochrome P450, mmu01100  Metabolic pathways, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species','00140 Steroid hormone biosynthesis, 00591 Linoleic acid metabolism, 00380 Tryptophan metabolism, 00830 Retinol metabolism, 00232 Caffeine metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP1 family'),('4868','mmu00830  Retinol metabolism, mmu01100  Metabolic pathways','00830 Retinol metabolism, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('4869','mmu00830  Retinol metabolism, mmu01100  Metabolic pathways','00830 Retinol metabolism, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('4870','mmu00830  Retinol metabolism, mmu01100  Metabolic pathways','00830 Retinol metabolism, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('4871','mmu00830  Retinol metabolism, mmu01100  Metabolic pathways','00830 Retinol metabolism, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('4872','mmu00140  Steroid hormone biosynthesis, mmu00590  Arachidonic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu05207  Chemical carcinogenesis - receptor activation','00140 Steroid hormone biosynthesis, 00590 Arachidonic acid metabolism, 00830 Retinol metabolism, 05207 Chemical carcinogenesis - receptor activation, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('4873','mmu00140  Steroid hormone biosynthesis, mmu00590  Arachidonic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu05207  Chemical carcinogenesis - receptor activation','00140 Steroid hormone biosynthesis, 00590 Arachidonic acid metabolism, 00830 Retinol metabolism, 05207 Chemical carcinogenesis - receptor activation, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('4874','mmu00140  Steroid hormone biosynthesis, mmu00590  Arachidonic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu05207  Chemical carcinogenesis - receptor activation','00140 Steroid hormone biosynthesis, 00590 Arachidonic acid metabolism, 00830 Retinol metabolism, 05207 Chemical carcinogenesis - receptor activation, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('4875','mmu00140  Steroid hormone biosynthesis, mmu00590  Arachidonic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu05207  Chemical carcinogenesis - receptor activation','00140 Steroid hormone biosynthesis, 00590 Arachidonic acid metabolism, 00830 Retinol metabolism, 05207 Chemical carcinogenesis - receptor activation, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('4876','mmu00140  Steroid hormone biosynthesis, mmu00590  Arachidonic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu05207  Chemical carcinogenesis - receptor activation','00140 Steroid hormone biosynthesis, 00590 Arachidonic acid metabolism, 00830 Retinol metabolism, 05207 Chemical carcinogenesis - receptor activation, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('4877','mmu00140  Steroid hormone biosynthesis, mmu00590  Arachidonic acid metabolism, mmu00591  Linoleic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu04726  Serotonergic synapse, mmu04750  Inflammatory mediator regulation of TRP channels, mmu05204  Chemical carcinogenesis - DNA adducts','00140 Steroid hormone biosynthesis, 00590 Arachidonic acid metabolism, 00591 Linoleic acid metabolism, 00830 Retinol metabolism, 04726 Serotonergic synapse, 04750 Inflammatory mediator regulation of TRP channels, 05204 Chemical carcinogenesis - DNA adducts, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('4878','mmu00140  Steroid hormone biosynthesis, mmu00590  Arachidonic acid metabolism, mmu00591  Linoleic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu04726  Serotonergic synapse, mmu04750  Inflammatory mediator regulation of TRP channels, mmu05204  Chemical carcinogenesis - DNA adducts','00140 Steroid hormone biosynthesis, 00590 Arachidonic acid metabolism, 00591 Linoleic acid metabolism, 00830 Retinol metabolism, 04726 Serotonergic synapse, 04750 Inflammatory mediator regulation of TRP channels, 05204 Chemical carcinogenesis - DNA adducts, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('4879','mmu00140  Steroid hormone biosynthesis, mmu00590  Arachidonic acid metabolism, mmu00591  Linoleic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu04726  Serotonergic synapse, mmu04750  Inflammatory mediator regulation of TRP channels, mmu05204  Chemical carcinogenesis - DNA adducts','00140 Steroid hormone biosynthesis, 00590 Arachidonic acid metabolism, 00591 Linoleic acid metabolism, 00830 Retinol metabolism, 04726 Serotonergic synapse, 04750 Inflammatory mediator regulation of TRP channels, 05204 Chemical carcinogenesis - DNA adducts, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('4880','mmu00140  Steroid hormone biosynthesis, mmu00590  Arachidonic acid metabolism, mmu00591  Linoleic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu04726  Serotonergic synapse, mmu04750  Inflammatory mediator regulation of TRP channels, mmu05204  Chemical carcinogenesis - DNA adducts','00140 Steroid hormone biosynthesis, 00590 Arachidonic acid metabolism, 00591 Linoleic acid metabolism, 00830 Retinol metabolism, 04726 Serotonergic synapse, 04750 Inflammatory mediator regulation of TRP channels, 05204 Chemical carcinogenesis - DNA adducts, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('4881','mmu00140  Steroid hormone biosynthesis, mmu00590  Arachidonic acid metabolism, mmu00591  Linoleic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu04726  Serotonergic synapse, mmu04750  Inflammatory mediator regulation of TRP channels, mmu05204  Chemical carcinogenesis - DNA adducts','00140 Steroid hormone biosynthesis, 00590 Arachidonic acid metabolism, 00591 Linoleic acid metabolism, 00830 Retinol metabolism, 04726 Serotonergic synapse, 04750 Inflammatory mediator regulation of TRP channels, 05204 Chemical carcinogenesis - DNA adducts, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('4882','mmu00140  Steroid hormone biosynthesis, mmu00590  Arachidonic acid metabolism, mmu00591  Linoleic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu04726  Serotonergic synapse, mmu04750  Inflammatory mediator regulation of TRP channels, mmu05204  Chemical carcinogenesis - DNA adducts','00140 Steroid hormone biosynthesis, 00590 Arachidonic acid metabolism, 00591 Linoleic acid metabolism, 00830 Retinol metabolism, 04726 Serotonergic synapse, 04750 Inflammatory mediator regulation of TRP channels, 05204 Chemical carcinogenesis - DNA adducts, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('4883','mmu00140  Steroid hormone biosynthesis, mmu00590  Arachidonic acid metabolism, mmu00591  Linoleic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu04726  Serotonergic synapse, mmu04750  Inflammatory mediator regulation of TRP channels, mmu05204  Chemical carcinogenesis - DNA adducts','00140 Steroid hormone biosynthesis, 00590 Arachidonic acid metabolism, 00591 Linoleic acid metabolism, 00830 Retinol metabolism, 04726 Serotonergic synapse, 04750 Inflammatory mediator regulation of TRP channels, 05204 Chemical carcinogenesis - DNA adducts, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('4884','mmu00140  Steroid hormone biosynthesis, mmu04726  Serotonergic synapse','00140 Steroid hormone biosynthesis, 04726 Serotonergic synapse, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('4885','mmu00140  Steroid hormone biosynthesis, mmu04726  Serotonergic synapse','00140 Steroid hormone biosynthesis, 04726 Serotonergic synapse, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('4886','mmu00140  Steroid hormone biosynthesis, mmu04726  Serotonergic synapse','00140 Steroid hormone biosynthesis, 04726 Serotonergic synapse, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP2 family'),('4887','mmu00590  Arachidonic acid metabolism, mmu00591  Linoleic acid metabolism, mmu01100  Metabolic pathways, mmu04726  Serotonergic synapse, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04913  Ovarian steroidogenesis, mmu05417  Lipid and atherosclerosis','00590 Arachidonic acid metabolism, 00591 Linoleic acid metabolism, 04913 Ovarian steroidogenesis, 04726 Serotonergic synapse, 04750 Inflammatory mediator regulation of TRP channels, 05417 Lipid and atherosclerosis, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, 1.14.14.73  albendazole monooxygenase (sulfoxide-forming), 1.14.14.74  albendazole monooxygenase (hydroxylating), 1.14.14.75  fenbendazole monooxygenase (4\'-hydroxylating), CYP2 family'),('4888','mmu00590  Arachidonic acid metabolism, mmu00591  Linoleic acid metabolism, mmu01100  Metabolic pathways, mmu04726  Serotonergic synapse, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04913  Ovarian steroidogenesis, mmu05417  Lipid and atherosclerosis','00590 Arachidonic acid metabolism, 00591 Linoleic acid metabolism, 04913 Ovarian steroidogenesis, 04726 Serotonergic synapse, 04750 Inflammatory mediator regulation of TRP channels, 05417 Lipid and atherosclerosis, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, 1.14.14.73  albendazole monooxygenase (sulfoxide-forming), 1.14.14.74  albendazole monooxygenase (hydroxylating), 1.14.14.75  fenbendazole monooxygenase (4\'-hydroxylating), CYP2 family'),('4889','mmu00140  Steroid hormone biosynthesis, mmu00591  Linoleic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation','00140 Steroid hormone biosynthesis, 00591 Linoleic acid metabolism, 00830 Retinol metabolism, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP3 family'),('4890','mmu00140  Steroid hormone biosynthesis, mmu00591  Linoleic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation','00140 Steroid hormone biosynthesis, 00591 Linoleic acid metabolism, 00830 Retinol metabolism, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP3 family'),('4891','mmu00140  Steroid hormone biosynthesis, mmu00591  Linoleic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation','00140 Steroid hormone biosynthesis, 00591 Linoleic acid metabolism, 00830 Retinol metabolism, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP3 family'),('4892','mmu00140  Steroid hormone biosynthesis, mmu00591  Linoleic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation','00140 Steroid hormone biosynthesis, 00591 Linoleic acid metabolism, 00830 Retinol metabolism, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP3 family'),('4893','mmu00140  Steroid hormone biosynthesis, mmu00591  Linoleic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation','00140 Steroid hormone biosynthesis, 00591 Linoleic acid metabolism, 00830 Retinol metabolism, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP3 family'),('4894','mmu00071  Fatty acid degradation, mmu00590  Arachidonic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu03320  PPAR signaling pathway, mmu04270  Vascular smooth muscle contraction, mmu04750  Inflammatory mediator regulation of TRP channels','00071 Fatty acid degradation, 00590 Arachidonic acid metabolism, 00830 Retinol metabolism, 03320 PPAR signaling pathway, 04270 Vascular smooth muscle contraction, 04750 Inflammatory mediator regulation of TRP channels, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.80  long-chain fatty acid omega-monooxygenase, CYP4 family'),('4895','mmu00071  Fatty acid degradation, mmu00590  Arachidonic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu03320  PPAR signaling pathway, mmu04270  Vascular smooth muscle contraction, mmu04750  Inflammatory mediator regulation of TRP channels','00071 Fatty acid degradation, 00590 Arachidonic acid metabolism, 00830 Retinol metabolism, 03320 PPAR signaling pathway, 04270 Vascular smooth muscle contraction, 04750 Inflammatory mediator regulation of TRP channels, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.80  long-chain fatty acid omega-monooxygenase, CYP4 family'),('4896','mmu00071  Fatty acid degradation, mmu00590  Arachidonic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu03320  PPAR signaling pathway, mmu04270  Vascular smooth muscle contraction, mmu04750  Inflammatory mediator regulation of TRP channels','00071 Fatty acid degradation, 00590 Arachidonic acid metabolism, 00830 Retinol metabolism, 03320 PPAR signaling pathway, 04270 Vascular smooth muscle contraction, 04750 Inflammatory mediator regulation of TRP channels, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.80  long-chain fatty acid omega-monooxygenase, CYP4 family'),('4897',NULL,'00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP4 family'),('4898','mmu00120  Primary bile acid biosynthesis, mmu00140  Steroid hormone biosynthesis, mmu01100  Metabolic pathways, mmu03320  PPAR signaling pathway, mmu04976  Bile secretion, mmu04979  Cholesterol metabolism','00120 Primary bile acid biosynthesis, 00140 Steroid hormone biosynthesis, 03320 PPAR signaling pathway, 04976 Bile secretion, 04979 Cholesterol metabolism, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.23  cholesterol 7alpha-monooxygenase, CYP7 family'),('4899','mmu00120  Primary bile acid biosynthesis, mmu00140  Steroid hormone biosynthesis','00120 Primary bile acid biosynthesis, 00140 Steroid hormone biosynthesis, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.29  25/26-hydroxycholesterol 7alpha-hydroxylase, CYP7 family'),('4900','mmu00120  Primary bile acid biosynthesis, mmu01100  Metabolic pathways, mmu03320  PPAR signaling pathway','00120 Primary bile acid biosynthesis, 03320 PPAR signaling pathway, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.139  5beta-cholestane-3alpha,7alpha-diol 12alpha-hydroxylase, CYP8 family'),('4901','mmu00280  Valine, leucine and isoleucine degradation, mmu00640  Propanoate metabolism, mmu01100  Metabolic pathways','00640 Propanoate metabolism, 00280 Valine, leucine and isoleucine degradation, 2.3.1.168  dihydrolipoyllysine-residue (2-methylpropanoyl)transferase'),('4902','mmu00350  Tyrosine metabolism, mmu01100  Metabolic pathways, mmu04916  Melanogenesis','00350 Tyrosine metabolism, 04916 Melanogenesis, 5.3.3.12  L-dopachrome isomerase'),('4903','mmu00240  Pyrimidine metabolism, mmu01100  Metabolic pathways, mmu01232  Nucleotide metabolism','00240 Pyrimidine metabolism, 3.6.1.12  dCTP diphosphatase'),('4904','mmu00040  Pentose and glucuronate interconversions, mmu01100  Metabolic pathways','00040 Pentose and glucuronate interconversions, 1.1.1.10  L-xylulose reductase'),('4905','mmu00350  Tyrosine metabolism, mmu00360  Phenylalanine metabolism, mmu00380  Tryptophan metabolism, mmu01100  Metabolic pathways, mmu04726  Serotonergic synapse, mmu04728  Dopaminergic synapse, mmu05030  Cocaine addiction, mmu05031  Amphetamine addiction, mmu05034  Alcoholism','00350 Tyrosine metabolism, 00360 Phenylalanine metabolism, 00380 Tryptophan metabolism, 04728 Dopaminergic synapse, 04726 Serotonergic synapse, 05030 Cocaine addiction, 05031 Amphetamine addiction, 05034 Alcoholism, 04147 Exosome [BR:mmu04147], 4.1.1.28  aromatic-L-amino-acid decarboxylase, 4.1.1.105  L-tryptophan decarboxylase, Exosomal proteins of other body fluids (saliva and urine)'),('4906','mmu00010  Glycolysis / Gluconeogenesis, mmu00020  Citrate cycle (TCA cycle), mmu00260  Glycine, serine and threonine metabolism, mmu00280  Valine, leucine and isoleucine degradation, mmu00310  Lysine degradation, mmu00380  Tryptophan metabolism, mmu00620  Pyruvate metabolism, mmu00630  Glyoxylate and dicarboxylate metabolism, mmu00640  Propanoate metabolism, mmu01100  Metabolic pathways, mmu01200  Carbon metabolism, mmu01240  Biosynthesis of cofactors','00010 Glycolysis / Gluconeogenesis, 00020 Citrate cycle (TCA cycle), 00620 Pyruvate metabolism, 00630 Glyoxylate and dicarboxylate metabolism, 00640 Propanoate metabolism, 00260 Glycine, serine and threonine metabolism, 00280 Valine, leucine and isoleucine degradation, 00310 Lysine degradation, 00380 Tryptophan metabolism, 04147 Exosome [BR:mmu04147], 1.8.1.4  dihydrolipoyl dehydrogenase, Exosomal proteins of breast cancer cells'),('4907','mmu00640  Propanoate metabolism, mmu01100  Metabolic pathways','00640 Propanoate metabolism, 4.1.1.94  ethylmalonyl-CoA decarboxylase, 4.1.1.-'),('4908','mmu00062  Fatty acid elongation, mmu01040  Biosynthesis of unsaturated fatty acids, mmu01100  Metabolic pathways, mmu01212  Fatty acid metabolism','00062 Fatty acid elongation, 01040 Biosynthesis of unsaturated fatty acids, 01004 Lipid biosynthesis proteins [BR:mmu01004], 2.3.1.199  very-long-chain 3-oxoacyl-CoA synthase, Unclassified'),('4909','mmu00062  Fatty acid elongation, mmu01040  Biosynthesis of unsaturated fatty acids, mmu01100  Metabolic pathways, mmu01212  Fatty acid metabolism','00062 Fatty acid elongation, 01040 Biosynthesis of unsaturated fatty acids, 01004 Lipid biosynthesis proteins [BR:mmu01004], 2.3.1.199  very-long-chain 3-oxoacyl-CoA synthase, PUFA'),('4910','mmu00010  Glycolysis / Gluconeogenesis, mmu01100  Metabolic pathways, mmu01200  Carbon metabolism, mmu01230  Biosynthesis of amino acids, mmu03018  RNA degradation, mmu04066  HIF-1 signaling pathway','00010 Glycolysis / Gluconeogenesis, 03018 RNA degradation, 04066 HIF-1 signaling pathway, 03019 Messenger RNA biogenesis [BR:mmu03019], 04147 Exosome [BR:mmu04147], 4.2.1.11  phosphopyruvate hydratase, Other RNA degradosome components, Proteins found in most exosomes'),('4911','mmu00590  Arachidonic acid metabolism, mmu01100  Metabolic pathways, mmu04146  Peroxisome, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species','00590 Arachidonic acid metabolism, 04146 Peroxisome, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 01009 Protein phosphatases and associated proteins [BR:mmu01009], 01002 Peptidases and inhibitors [BR:mmu01002], 3.1.3.76  lipid-phosphate phosphatase, 3.3.2.10  soluble epoxide hydrolase, Other HAD phosphatases, Family S33'),('4912','mmu00564  Glycerophospholipid metabolism, mmu01100  Metabolic pathways','00564 Glycerophospholipid metabolism, 4.2.3.2  ethanolamine-phosphate phospho-lyase'),('4913','mmu00592  alpha-Linolenic acid metabolism, mmu01040  Biosynthesis of unsaturated fatty acids, mmu01100  Metabolic pathways, mmu01212  Fatty acid metabolism, mmu03320  PPAR signaling pathway','00592 alpha-Linolenic acid metabolism, 01040 Biosynthesis of unsaturated fatty acids, 03320 PPAR signaling pathway, 01004 Lipid biosynthesis proteins [BR:mmu01004], 1.14.19.3  acyl-CoA 6-desaturase, Front-end'),('4914','mmu00061  Fatty acid biosynthesis, mmu01100  Metabolic pathways, mmu01212  Fatty acid metabolism, mmu04152  AMPK signaling pathway, mmu04910  Insulin signaling pathway, mmu04936  Alcoholic liver disease','00061 Fatty acid biosynthesis, 04152 AMPK signaling pathway, 04910 Insulin signaling pathway, 04936 Alcoholic liver disease, 01004 Lipid biosynthesis proteins [BR:mmu01004], 04147 Exosome [BR:mmu04147], 2.3.1.85  fatty-acid synthase system, Animal type, Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell), Exosomal proteins of breast milk, Exosomal proteins of colorectal cancer cells, Exosomal proteins of bladder cancer cells'),('4915','mmu00511  Other glycan degradation, mmu04142  Lysosome','00511 Other glycan degradation, 04142 Lysosome, 04147 Exosome [BR:mmu04147], 3.2.1.51  alpha-L-fucosidase, Exosomal proteins of other body fluids (saliva and urine)'),('4916','mmu00860  Porphyrin metabolism','00860 Porphyrin metabolism, 03029 Mitochondrial biogenesis [BR:mmu03029], 1.16.3.1  ferroxidase, Proteins involved in Fe-S cluster biogenesis'),('4917','mmu00010  Glycolysis / Gluconeogenesis, mmu00052  Galactose metabolism, mmu00500  Starch and sucrose metabolism, mmu01100  Metabolic pathways, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04152  AMPK signaling pathway, mmu04910  Insulin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04973  Carbohydrate digestion and absorption','00010 Glycolysis / Gluconeogenesis, 00052 Galactose metabolism, 00500 Starch and sucrose metabolism, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04910 Insulin signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 04973 Carbohydrate digestion and absorption, 04931 Insulin resistance, 3.1.3.9  glucose-6-phosphatase'),('4918','mmu00565  Ether lipid metabolism, mmu00600  Sphingolipid metabolism, mmu01100  Metabolic pathways','00565 Ether lipid metabolism, 00600 Sphingolipid metabolism, 01003 Glycosyltransferases [BR:mmu01003], 2.8.2.11  galactosylceramide sulfotransferase, Sulfotransferases'),('4919','mmu00052  Galactose metabolism, mmu00520  Amino sugar and nucleotide sugar metabolism, mmu01100  Metabolic pathways, mmu01250  Biosynthesis of nucleotide sugars','00052 Galactose metabolism, 00520 Amino sugar and nucleotide sugar metabolism, 5.1.3.2  UDP-glucose 4-epimerase'),('4920','mmu00052  Galactose metabolism, mmu00520  Amino sugar and nucleotide sugar metabolism, mmu01100  Metabolic pathways, mmu01250  Biosynthesis of nucleotide sugars','00052 Galactose metabolism, 00520 Amino sugar and nucleotide sugar metabolism, 04147 Exosome [BR:mmu04147], 2.7.1.6  galactokinase, Exosomal proteins of other body fluids (saliva and urine)'),('4921','mmu00260  Glycine, serine and threonine metabolism, mmu01100  Metabolic pathways','00260 Glycine, serine and threonine metabolism, 01007 Amino acid related enzymes [BR:mmu01007], 2.3.1.29  glycine C-acetyltransferase, Class II'),('4922','mmu00010  Glycolysis / Gluconeogenesis, mmu00052  Galactose metabolism, mmu00500  Starch and sucrose metabolism, mmu00520  Amino sugar and nucleotide sugar metabolism, mmu00524  Neomycin, kanamycin and gentamicin biosynthesis, mmu01100  Metabolic pathways, mmu01200  Carbon metabolism, mmu01250  Biosynthesis of nucleotide sugars, mmu04910  Insulin signaling pathway, mmu04911  Insulin secretion, mmu04917  Prolactin signaling pathway, mmu04922  Glucagon signaling pathway, mmu04930  Type II diabetes mellitus, mmu04950  Maturity onset diabetes of the young, mmu05230  Central carbon metabolism in cancer','00010 Glycolysis / Gluconeogenesis, 00052 Galactose metabolism, 00500 Starch and sucrose metabolism, 00520 Amino sugar and nucleotide sugar metabolism, 00524 Neomycin, kanamycin and gentamicin biosynthesis, 04911 Insulin secretion, 04910 Insulin signaling pathway, 04922 Glucagon signaling pathway, 04917 Prolactin signaling pathway, 05230 Central carbon metabolism in cancer, 04930 Type II diabetes mellitus, 04950 Maturity onset diabetes of the young, 2.7.1.2  glucokinase'),('4923','mmu00270  Cysteine and methionine metabolism, mmu00480  Glutathione metabolism, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors, mmu04216  Ferroptosis','00270 Cysteine and methionine metabolism, 00480 Glutathione metabolism, 04216 Ferroptosis, 6.3.2.2  glutamate---cysteine ligase'),('4924','mmu00250  Alanine, aspartate and glutamate metabolism, mmu00520  Amino sugar and nucleotide sugar metabolism, mmu01100  Metabolic pathways, mmu01250  Biosynthesis of nucleotide sugars, mmu04931  Insulin resistance, mmu05415  Diabetic cardiomyopathy','00520 Amino sugar and nucleotide sugar metabolism, 00250 Alanine, aspartate and glutamate metabolism, 05415 Diabetic cardiomyopathy, 04931 Insulin resistance, 01002 Peptidases and inhibitors [BR:mmu01002], 2.6.1.16  glutamine---fructose-6-phosphate transaminase (isomerizing), Family C44'),('4925','mmu00051  Fructose and mannose metabolism, mmu00520  Amino sugar and nucleotide sugar metabolism, mmu01100  Metabolic pathways, mmu01250  Biosynthesis of nucleotide sugars','00051 Fructose and mannose metabolism, 00520 Amino sugar and nucleotide sugar metabolism, 4.2.1.47  GDP-mannose 4,6-dehydratase'),('4926','mmu00230  Purine metabolism, mmu01100  Metabolic pathways, mmu01232  Nucleotide metabolism','00230 Purine metabolism, 1.7.1.7  GMP reductase'),('4927','mmu00260  Glycine, serine and threonine metabolism, mmu01100  Metabolic pathways','00260 Glycine, serine and threonine metabolism, 2.1.1.20  glycine N-methyltransferase'),('4928','mmu00520  Amino sugar and nucleotide sugar metabolism, mmu01100  Metabolic pathways','00520 Amino sugar and nucleotide sugar metabolism, 3.5.99.6  glucosamine-6-phosphate deaminase'),('4929','mmu00564  Glycerophospholipid metabolism, mmu05231  Choline metabolism in cancer','00564 Glycerophospholipid metabolism, 05231 Choline metabolism in cancer, 3.1.4.2  glycerophosphocholine phosphodiesterase'),('4930','mmu00564  Glycerophospholipid metabolism, mmu05231  Choline metabolism in cancer','00564 Glycerophospholipid metabolism, 05231 Choline metabolism in cancer, 3.1.4.2  glycerophosphocholine phosphodiesterase'),('4931','mmu00564  Glycerophospholipid metabolism','00564 Glycerophospholipid metabolism, 1.1.1.8  glycerol-3-phosphate dehydrogenase (NAD+)'),('4932','mmu00480  Glutathione metabolism, mmu00590  Arachidonic acid metabolism, mmu01100  Metabolic pathways, mmu04918  Thyroid hormone synthesis, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05022  Pathways of neurodegeneration - multiple diseases','00590 Arachidonic acid metabolism, 00480 Glutathione metabolism, 04918 Thyroid hormone synthesis, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05022 Pathways of neurodegeneration - multiple diseases, 1.11.1.9  glutathione peroxidase'),('4933','mmu00480  Glutathione metabolism, mmu00590  Arachidonic acid metabolism, mmu01100  Metabolic pathways, mmu04918  Thyroid hormone synthesis, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05022  Pathways of neurodegeneration - multiple diseases','00590 Arachidonic acid metabolism, 00480 Glutathione metabolism, 04918 Thyroid hormone synthesis, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05022 Pathways of neurodegeneration - multiple diseases, 1.11.1.9  glutathione peroxidase'),('4934','mmu00480  Glutathione metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu00982  Drug metabolism - cytochrome P450, mmu00983  Drug metabolism - other enzymes, mmu01100  Metabolic pathways, mmu01524  Platinum drug resistance, mmu05200  Pathways in cancer, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05225  Hepatocellular carcinoma, mmu05418  Fluid shear stress and atherosclerosis','00480 Glutathione metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 00983 Drug metabolism - other enzymes, 05200 Pathways in cancer, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05418 Fluid shear stress and atherosclerosis, 01524 Platinum drug resistance, 02000 Transporters [BR:mmu02000], 2.5.1.18  glutathione transferase, Pores ion channels [TC:1]'),('4935','mmu00480  Glutathione metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu00982  Drug metabolism - cytochrome P450, mmu00983  Drug metabolism - other enzymes, mmu01100  Metabolic pathways, mmu01524  Platinum drug resistance, mmu05200  Pathways in cancer, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05225  Hepatocellular carcinoma, mmu05418  Fluid shear stress and atherosclerosis','00480 Glutathione metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 00983 Drug metabolism - other enzymes, 05200 Pathways in cancer, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05418 Fluid shear stress and atherosclerosis, 01524 Platinum drug resistance, 02000 Transporters [BR:mmu02000], 2.5.1.18  glutathione transferase, Pores ion channels [TC:1]'),('4936','mmu00480  Glutathione metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu00982  Drug metabolism - cytochrome P450, mmu00983  Drug metabolism - other enzymes, mmu01100  Metabolic pathways, mmu01524  Platinum drug resistance, mmu05200  Pathways in cancer, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05225  Hepatocellular carcinoma, mmu05418  Fluid shear stress and atherosclerosis','00480 Glutathione metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 00983 Drug metabolism - other enzymes, 05200 Pathways in cancer, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05418 Fluid shear stress and atherosclerosis, 01524 Platinum drug resistance, 02000 Transporters [BR:mmu02000], 2.5.1.18  glutathione transferase, Pores ion channels [TC:1]'),('4937','mmu00480  Glutathione metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu00982  Drug metabolism - cytochrome P450, mmu00983  Drug metabolism - other enzymes, mmu01100  Metabolic pathways, mmu01524  Platinum drug resistance, mmu05200  Pathways in cancer, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05225  Hepatocellular carcinoma, mmu05418  Fluid shear stress and atherosclerosis','00480 Glutathione metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 00983 Drug metabolism - other enzymes, 05200 Pathways in cancer, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05418 Fluid shear stress and atherosclerosis, 01524 Platinum drug resistance, 02000 Transporters [BR:mmu02000], 2.5.1.18  glutathione transferase, Pores ion channels [TC:1]'),('4938','mmu00480  Glutathione metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu00982  Drug metabolism - cytochrome P450, mmu00983  Drug metabolism - other enzymes, mmu01100  Metabolic pathways, mmu01524  Platinum drug resistance, mmu05200  Pathways in cancer, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05225  Hepatocellular carcinoma, mmu05418  Fluid shear stress and atherosclerosis','00480 Glutathione metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 00983 Drug metabolism - other enzymes, 05200 Pathways in cancer, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05418 Fluid shear stress and atherosclerosis, 01524 Platinum drug resistance, 02000 Transporters [BR:mmu02000], 2.5.1.18  glutathione transferase, Pores ion channels [TC:1]'),('4939','mmu00480  Glutathione metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu00982  Drug metabolism - cytochrome P450, mmu00983  Drug metabolism - other enzymes, mmu01100  Metabolic pathways, mmu01524  Platinum drug resistance, mmu05200  Pathways in cancer, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05225  Hepatocellular carcinoma, mmu05418  Fluid shear stress and atherosclerosis','00480 Glutathione metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 00983 Drug metabolism - other enzymes, 05200 Pathways in cancer, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05418 Fluid shear stress and atherosclerosis, 01524 Platinum drug resistance, 02000 Transporters [BR:mmu02000], 2.5.1.18  glutathione transferase, Pores ion channels [TC:1]'),('4940','mmu00480  Glutathione metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu00982  Drug metabolism - cytochrome P450, mmu00983  Drug metabolism - other enzymes, mmu01100  Metabolic pathways, mmu01524  Platinum drug resistance, mmu05200  Pathways in cancer, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05225  Hepatocellular carcinoma, mmu05418  Fluid shear stress and atherosclerosis','00480 Glutathione metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 00983 Drug metabolism - other enzymes, 05200 Pathways in cancer, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05418 Fluid shear stress and atherosclerosis, 01524 Platinum drug resistance, 02000 Transporters [BR:mmu02000], 2.5.1.18  glutathione transferase, Pores ion channels [TC:1]'),('4941','mmu00480  Glutathione metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu00982  Drug metabolism - cytochrome P450, mmu00983  Drug metabolism - other enzymes, mmu01100  Metabolic pathways, mmu01524  Platinum drug resistance, mmu05200  Pathways in cancer, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05225  Hepatocellular carcinoma, mmu05418  Fluid shear stress and atherosclerosis','00480 Glutathione metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 00983 Drug metabolism - other enzymes, 05200 Pathways in cancer, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05418 Fluid shear stress and atherosclerosis, 01524 Platinum drug resistance, 02000 Transporters [BR:mmu02000], 2.5.1.18  glutathione transferase, Pores ion channels [TC:1]'),('4942','mmu00480  Glutathione metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu00982  Drug metabolism - cytochrome P450, mmu00983  Drug metabolism - other enzymes, mmu01100  Metabolic pathways, mmu01524  Platinum drug resistance, mmu05200  Pathways in cancer, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05225  Hepatocellular carcinoma, mmu05418  Fluid shear stress and atherosclerosis','00480 Glutathione metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 00983 Drug metabolism - other enzymes, 05200 Pathways in cancer, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05418 Fluid shear stress and atherosclerosis, 01524 Platinum drug resistance, 02000 Transporters [BR:mmu02000], 2.5.1.18  glutathione transferase, Pores ion channels [TC:1]'),('4943','mmu00480  Glutathione metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu00982  Drug metabolism - cytochrome P450, mmu00983  Drug metabolism - other enzymes, mmu01100  Metabolic pathways, mmu01524  Platinum drug resistance, mmu05200  Pathways in cancer, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05225  Hepatocellular carcinoma, mmu05418  Fluid shear stress and atherosclerosis','00480 Glutathione metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 00983 Drug metabolism - other enzymes, 05200 Pathways in cancer, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05418 Fluid shear stress and atherosclerosis, 01524 Platinum drug resistance, 02000 Transporters [BR:mmu02000], 2.5.1.18  glutathione transferase, Pores ion channels [TC:1]'),('4944','mmu00480  Glutathione metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu00982  Drug metabolism - cytochrome P450, mmu00983  Drug metabolism - other enzymes, mmu01100  Metabolic pathways, mmu01524  Platinum drug resistance, mmu05200  Pathways in cancer, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05225  Hepatocellular carcinoma, mmu05418  Fluid shear stress and atherosclerosis','00480 Glutathione metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 00983 Drug metabolism - other enzymes, 05200 Pathways in cancer, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05418 Fluid shear stress and atherosclerosis, 01524 Platinum drug resistance, 02000 Transporters [BR:mmu02000], 2.5.1.18  glutathione transferase, Pores ion channels [TC:1]'),('4945','mmu00480  Glutathione metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu00982  Drug metabolism - cytochrome P450, mmu00983  Drug metabolism - other enzymes, mmu01100  Metabolic pathways, mmu01524  Platinum drug resistance, mmu05200  Pathways in cancer, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05225  Hepatocellular carcinoma, mmu05418  Fluid shear stress and atherosclerosis','00480 Glutathione metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 00983 Drug metabolism - other enzymes, 05200 Pathways in cancer, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05418 Fluid shear stress and atherosclerosis, 01524 Platinum drug resistance, 02000 Transporters [BR:mmu02000], 2.5.1.18  glutathione transferase, Pores ion channels [TC:1]'),('4946','mmu00053  Ascorbate and aldarate metabolism, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors','00053 Ascorbate and aldarate metabolism, 1.1.3.8  L-gulonolactone oxidase'),('4947','mmu00380  Tryptophan metabolism, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors','00380 Tryptophan metabolism, 1.13.11.6  3-hydroxyanthranilate 3,4-dioxygenase'),('4948','mmu00630  Glyoxylate and dicarboxylate metabolism, mmu01100  Metabolic pathways, mmu01200  Carbon metabolism, mmu04146  Peroxisome','00630 Glyoxylate and dicarboxylate metabolism, 04146 Peroxisome, 1.1.3.15  (S)-2-hydroxy-acid oxidase'),('4949','mmu00280  Valine, leucine and isoleucine degradation, mmu00650  Butanoate metabolism, mmu00900  Terpenoid backbone biosynthesis, mmu01100  Metabolic pathways, mmu03320  PPAR signaling pathway','00650 Butanoate metabolism, 00280 Valine, leucine and isoleucine degradation, 00900 Terpenoid backbone biosynthesis, 03320 PPAR signaling pathway, 2.3.3.10  hydroxymethylglutaryl-CoA synthase'),('4950','mmu00130  Ubiquinone and other terpenoid-quinone biosynthesis, mmu00350  Tyrosine metabolism, mmu00360  Phenylalanine metabolism, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors','00350 Tyrosine metabolism, 00360 Phenylalanine metabolism, 00130 Ubiquinone and other terpenoid-quinone biosynthesis, 04147 Exosome [BR:mmu04147], 1.13.11.27  4-hydroxyphenylpyruvate dioxygenase, Exosomal proteins of other body fluids (saliva and urine)'),('4951','mmu00280  Valine, leucine and isoleucine degradation, mmu01100  Metabolic pathways, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases','00280 Valine, leucine and isoleucine degradation, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 03029 Mitochondrial biogenesis [BR:mmu03029], 04147 Exosome [BR:mmu04147], 1.1.1.35  3-hydroxyacyl-CoA dehydrogenase, 1.1.1.178  3-hydroxy-2-methylbutyryl-CoA dehydrogenase, Mitochondrial ribonuclease P, Exosomal proteins of breast cancer cells'),('4952','mmu00140  Steroid hormone biosynthesis, mmu01100  Metabolic pathways, mmu04913  Ovarian steroidogenesis, mmu04925  Aldosterone synthesis and secretion, mmu04927  Cortisol synthesis and secretion, mmu04934  Cushing syndrome','00140 Steroid hormone biosynthesis, 04913 Ovarian steroidogenesis, 04925 Aldosterone synthesis and secretion, 04927 Cortisol synthesis and secretion, 04934 Cushing syndrome, 1.1.1.145  3beta-hydroxy-Delta5-steroid dehydrogenase, 5.3.3.1  steroid Delta-isomerase'),('4953','mmu00531  Glycosaminoglycan degradation, mmu01100  Metabolic pathways, mmu04142  Lysosome','00531 Glycosaminoglycan degradation, 04142 Lysosome, 02042 Bacterial toxins [BR:mmu02042], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], 00537 Glycosylphosphatidylinositol (GPI)-anchored proteins [BR:mmu00537], 3.2.1.35  hyaluronoglucosaminidase, Hyaluronidases/Collagenases, Enzymes, Enzymes'),('4954','mmu00562  Inositol phosphate metabolism, mmu01100  Metabolic pathways, mmu04070  Phosphatidylinositol signaling system','00562 Inositol phosphate metabolism, 04070 Phosphatidylinositol signaling system, 3.1.3.25  inositol-phosphate phosphatase'),('4955','mmu00562  Inositol phosphate metabolism, mmu01100  Metabolic pathways','00562 Inositol phosphate metabolism, 5.5.1.4  inositol-3-phosphate synthase'),('4956','mmu00051  Fructose and mannose metabolism, mmu01100  Metabolic pathways','00051 Fructose and mannose metabolism, 04147 Exosome [BR:mmu04147], 2.7.1.3  ketohexokinase, Exosomal proteins of other body fluids (saliva and urine)'),('4957','mmu00310  Lysine degradation, mmu01100  Metabolic pathways, mmu04934  Cushing syndrome, mmu05202  Transcriptional misregulation in cancer','00310 Lysine degradation, 05202 Transcriptional misregulation in cancer, 04934 Cushing syndrome, 03000 Transcription factors [BR:mmu03000], 03036 Chromosome and associated proteins [BR:mmu03036], 2.1.1.354  [histone H3]-lysine4 N-trimethyltransferase, CXXC CpG-binding proteins, HKMTs (histone lysine methyltransferases), MLL-HCF complex'),('4958','mmu00310  Lysine degradation, mmu01100  Metabolic pathways, mmu04934  Cushing syndrome, mmu05202  Transcriptional misregulation in cancer','00310 Lysine degradation, 05202 Transcriptional misregulation in cancer, 04934 Cushing syndrome, 03000 Transcription factors [BR:mmu03000], 03036 Chromosome and associated proteins [BR:mmu03036], 2.1.1.354  [histone H3]-lysine4 N-trimethyltransferase, CXXC CpG-binding proteins, HKMTs (histone lysine methyltransferases), MLL-HCF complex'),('4959','mmu00564  Glycerophospholipid metabolism, mmu04979  Cholesterol metabolism','00564 Glycerophospholipid metabolism, 04979 Cholesterol metabolism, 2.3.1.43  phosphatidylcholine---sterol O-acyltransferase'),('4960','mmu00010  Glycolysis / Gluconeogenesis, mmu00270  Cysteine and methionine metabolism, mmu00620  Pyruvate metabolism, mmu00640  Propanoate metabolism, mmu01100  Metabolic pathways, mmu04066  HIF-1 signaling pathway, mmu04922  Glucagon signaling pathway, mmu05230  Central carbon metabolism in cancer','00010 Glycolysis / Gluconeogenesis, 00620 Pyruvate metabolism, 00640 Propanoate metabolism, 00270 Cysteine and methionine metabolism, 04066 HIF-1 signaling pathway, 04922 Glucagon signaling pathway, 05230 Central carbon metabolism in cancer, 04147 Exosome [BR:mmu04147], 1.1.1.27  L-lactate dehydrogenase, Exosomal proteins of epithelial cells, Exosomal proteins of breast milk'),('4961','mmu00561  Glycerolipid metabolism, mmu03320  PPAR signaling pathway, mmu04979  Cholesterol metabolism, mmu05010  Alzheimer disease','00561 Glycerolipid metabolism, 03320 PPAR signaling pathway, 04979 Cholesterol metabolism, 05010 Alzheimer disease, 04147 Exosome [BR:mmu04147], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], 00537 Glycosylphosphatidylinositol (GPI)-anchored proteins [BR:mmu00537], 3.1.1.34  lipoprotein lipase, Exosomal proteins of microglial cells, Exosomal proteins of breast milk, Enzymes, Enzymes'),('4962','mmu00511  Other glycan degradation','00511 Other glycan degradation, 3.2.1.24  alpha-mannosidase'),('4963','mmu00061  Fatty acid biosynthesis, mmu01100  Metabolic pathways, mmu01212  Fatty acid metabolism','00061 Fatty acid biosynthesis, 00333 Prodigiosin biosynthesis, 01004 Lipid biosynthesis proteins [BR:mmu01004], 2.3.1.39  [acyl-carrier-protein] S-malonyltransferase, Component type'),('4964','mmu00510  N-Glycan biosynthesis, mmu00513  Various types of N-glycan biosynthesis, mmu01100  Metabolic pathways','00510 N-Glycan biosynthesis, 00513 Various types of N-glycan biosynthesis, 01003 Glycosyltransferases [BR:mmu01003], 2.4.1.145  alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase, N-Glycan'),('4965','mmu00561  Glycerolipid metabolism, mmu01100  Metabolic pathways, mmu04714  Thermogenesis, mmu04723  Retrograde endocannabinoid signaling, mmu04923  Regulation of lipolysis in adipocytes','00561 Glycerolipid metabolism, 04923 Regulation of lipolysis in adipocytes, 04723 Retrograde endocannabinoid signaling, 04714 Thermogenesis, 01002 Peptidases and inhibitors [BR:mmu01002], 3.1.1.23  acylglycerol lipase, Family S33'),('4966','mmu00350  Tyrosine metabolism, mmu00360  Phenylalanine metabolism, mmu01100  Metabolic pathways','00350 Tyrosine metabolism, 00360 Phenylalanine metabolism, 04147 Exosome [BR:mmu04147], 5.3.2.1  phenylpyruvate tautomerase, Exosomal proteins of breast milk'),('4967','mmu00410  beta-Alanine metabolism, mmu00640  Propanoate metabolism, mmu01100  Metabolic pathways, mmu04146  Peroxisome, mmu04152  AMPK signaling pathway, mmu04936  Alcoholic liver disease','00640 Propanoate metabolism, 00410 beta-Alanine metabolism, 04152 AMPK signaling pathway, 04146 Peroxisome, 04936 Alcoholic liver disease, 4.1.1.9  malonyl-CoA decarboxylase'),('4968','mmu00270  Cysteine and methionine metabolism, mmu00920  Sulfur metabolism, mmu01100  Metabolic pathways, mmu04122  Sulfur relay system','00920 Sulfur metabolism, 00270 Cysteine and methionine metabolism, 04122 Sulfur relay system, 2.8.1.1  thiosulfate sulfurtransferase, 2.8.1.2  3-mercaptopyruvate sulfurtransferase'),('4969','mmu00670  One carbon pool by folate, mmu01100  Metabolic pathways, mmu01523  Antifolate resistance','00670 One carbon pool by folate, 01523 Antifolate resistance, 1.5.1.53  methylenetetrahydrofolate reductase (NADPH)'),('4970','mmu00670  One carbon pool by folate, mmu01100  Metabolic pathways, mmu01523  Antifolate resistance','00670 One carbon pool by folate, 01523 Antifolate resistance, 1.5.1.53  methylenetetrahydrofolate reductase (NADPH)'),('4971','mmu00480  Glutathione metabolism, mmu01100  Metabolic pathways','00480 Glutathione metabolism, 2.3.1.80  cysteine-S-conjugate N-acetyltransferase, 2.3.1.-'),('4972','mmu00480  Glutathione metabolism, mmu01100  Metabolic pathways','00480 Glutathione metabolism, 2.3.1.80  cysteine-S-conjugate N-acetyltransferase, 2.3.1.-'),('4973','mmu00190  Oxidative phosphorylation, mmu01100  Metabolic pathways, mmu04714  Thermogenesis, mmu04723  Retrograde endocannabinoid signaling, mmu04932  Non-alcoholic fatty liver disease, mmu05010  Alzheimer disease, mmu05012  Parkinson disease, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05415  Diabetic cardiomyopathy','00190 Oxidative phosphorylation, 04723 Retrograde endocannabinoid signaling, 04714 Thermogenesis, 05208 Chemical carcinogenesis - reactive oxygen species, 05010 Alzheimer disease, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05415 Diabetic cardiomyopathy, 04932 Non-alcoholic fatty liver disease, 7.1.1.2  NADH:ubiquinone reductase (H+-translocating)'),('4974','mmu00190  Oxidative phosphorylation, mmu01100  Metabolic pathways, mmu04714  Thermogenesis, mmu04723  Retrograde endocannabinoid signaling, mmu04932  Non-alcoholic fatty liver disease, mmu05010  Alzheimer disease, mmu05012  Parkinson disease, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05415  Diabetic cardiomyopathy','00190 Oxidative phosphorylation, 04723 Retrograde endocannabinoid signaling, 04714 Thermogenesis, 05208 Chemical carcinogenesis - reactive oxygen species, 05010 Alzheimer disease, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05415 Diabetic cardiomyopathy, 04932 Non-alcoholic fatty liver disease, 7.1.1.2  NADH:ubiquinone reductase (H+-translocating)'),('4975','mmu00220  Arginine biosynthesis, mmu00330  Arginine and proline metabolism, mmu01100  Metabolic pathways, mmu04020  Calcium signaling pathway, mmu04022  cGMP-PKG signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04370  VEGF signaling pathway, mmu04371  Apelin signaling pathway, mmu04611  Platelet activation, mmu04915  Estrogen signaling pathway, mmu04921  Oxytocin signaling pathway, mmu04926  Relaxin signaling pathway, mmu04931  Insulin resistance, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','00220 Arginine biosynthesis, 00330 Arginine and proline metabolism, 04370 VEGF signaling pathway, 04371 Apelin signaling pathway, 04066 HIF-1 signaling pathway, 04020 Calcium signaling pathway, 04071 Sphingolipid signaling pathway, 04022 cGMP-PKG signaling pathway, 04151 PI3K-Akt signaling pathway, 04611 Platelet activation, 04915 Estrogen signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 1.14.13.39  nitric-oxide synthase (NADPH)'),('4976','mmu00130  Ubiquinone and other terpenoid-quinone biosynthesis, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors, mmu05200  Pathways in cancer, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05225  Hepatocellular carcinoma, mmu05418  Fluid shear stress and atherosclerosis','00130 Ubiquinone and other terpenoid-quinone biosynthesis, 05200 Pathways in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05418 Fluid shear stress and atherosclerosis, 1.6.5.2  NAD(P)H dehydrogenase (quinone)'),('4977','mmu00760  Nicotinate and nicotinamide metabolism, mmu01100  Metabolic pathways, mmu04146  Peroxisome','00760 Nicotinate and nicotinamide metabolism, 04146 Peroxisome, 3.6.1.22  NAD+ diphosphatase'),('4978','mmu00514  Other types of O-glycan biosynthesis, mmu04931  Insulin resistance','00514 Other types of O-glycan biosynthesis, 04931 Insulin resistance, 01003 Glycosyltransferases [BR:mmu01003], 03036 Chromosome and associated proteins [BR:mmu03036], 2.4.1.255  protein O-GlcNAc transferase, O-linked GlcNAc type, NSL complex'),('4979','mmu00514  Other types of O-glycan biosynthesis, mmu04931  Insulin resistance','00514 Other types of O-glycan biosynthesis, 04931 Insulin resistance, 01003 Glycosyltransferases [BR:mmu01003], 03036 Chromosome and associated proteins [BR:mmu03036], 2.4.1.255  protein O-GlcNAc transferase, O-linked GlcNAc type, NSL complex'),('4980','mmu00230  Purine metabolism, mmu00450  Selenocompound metabolism, mmu00920  Sulfur metabolism, mmu01100  Metabolic pathways','00920 Sulfur metabolism, 00230 Purine metabolism, 00450 Selenocompound metabolism, 00261 Monobactam biosynthesis, 2.7.1.25  adenylyl-sulfate kinase, 2.7.7.4  sulfate adenylyltransferase'),('4981','mmu00230  Purine metabolism, mmu01100  Metabolic pathways, mmu04022  cGMP-PKG signaling pathway, mmu04740  Olfactory transduction, mmu04925  Aldosterone synthesis and secretion, mmu05032  Morphine addiction','00230 Purine metabolism, 04022 cGMP-PKG signaling pathway, 04925 Aldosterone synthesis and secretion, 04740 Olfactory transduction, 05032 Morphine addiction, 3.1.4.17  3\',5\'-cyclic-nucleotide phosphodiesterase'),('4982','mmu00230  Purine metabolism, mmu01100  Metabolic pathways, mmu04024  cAMP signaling pathway, mmu04928  Parathyroid hormone synthesis, secretion and action, mmu05032  Morphine addiction','00230 Purine metabolism, 04024 cAMP signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 05032 Morphine addiction, 3.1.4.53  3\',5\'-cyclic-AMP phosphodiesterase'),('4983','mmu00564  Glycerophospholipid metabolism, mmu01100  Metabolic pathways','00564 Glycerophospholipid metabolism, 2.1.1.17  phosphatidylethanolamine N-methyltransferase, 2.1.1.71  phosphatidyl-N-methylethanolamine N-methyltransferase'),('4984','mmu00051  Fructose and mannose metabolism, mmu01100  Metabolic pathways, mmu04066  HIF-1 signaling pathway, mmu04152  AMPK signaling pathway','00051 Fructose and mannose metabolism, 04066 HIF-1 signaling pathway, 04152 AMPK signaling pathway, 2.7.1.105  6-phosphofructo-2-kinase, 3.1.3.46  fructose-2,6-bisphosphate 2-phosphatase'),('4985','mmu00051  Fructose and mannose metabolism, mmu01100  Metabolic pathways, mmu04066  HIF-1 signaling pathway, mmu04152  AMPK signaling pathway','00051 Fructose and mannose metabolism, 04066 HIF-1 signaling pathway, 04152 AMPK signaling pathway, 2.7.1.105  6-phosphofructo-2-kinase, 3.1.3.46  fructose-2,6-bisphosphate 2-phosphatase'),('4986','mmu00030  Pentose phosphate pathway, mmu01100  Metabolic pathways, mmu01200  Carbon metabolism','00030 Pentose phosphate pathway, 3.1.1.31  6-phosphogluconolactonase'),('4987','mmu00630  Glyoxylate and dicarboxylate metabolism, mmu01100  Metabolic pathways, mmu01200  Carbon metabolism','00630 Glyoxylate and dicarboxylate metabolism, 01009 Protein phosphatases and associated proteins [BR:mmu01009], 3.1.3.18  phosphoglycolate phosphatase, 3.1.3.48  protein-tyrosine-phosphatase, Other HAD phosphatases'),('4988','mmu00010  Glycolysis / Gluconeogenesis, mmu00620  Pyruvate metabolism, mmu01100  Metabolic pathways, mmu01200  Carbon metabolism, mmu01230  Biosynthesis of amino acids, mmu04910  Insulin signaling pathway, mmu04930  Type II diabetes mellitus, mmu04932  Non-alcoholic fatty liver disease, mmu04950  Maturity onset diabetes of the young','00010 Glycolysis / Gluconeogenesis, 00620 Pyruvate metabolism, 04910 Insulin signaling pathway, 04930 Type II diabetes mellitus, 04950 Maturity onset diabetes of the young, 04932 Non-alcoholic fatty liver disease, 04147 Exosome [BR:mmu04147], 2.7.1.40  pyruvate kinase, Exosomal proteins of other body fluids (saliva and urine)'),('4989','mmu00562  Inositol phosphate metabolism, mmu01100  Metabolic pathways, mmu04015  Rap1 signaling pathway, mmu04020  Calcium signaling pathway, mmu04022  cGMP-PKG signaling pathway, mmu04062  Chemokine signaling pathway, mmu04070  Phosphatidylinositol signaling system, mmu04071  Sphingolipid signaling pathway, mmu04072  Phospholipase D signaling pathway, mmu04261  Adrenergic signaling in cardiomyocytes, mmu04270  Vascular smooth muscle contraction, mmu04310  Wnt signaling pathway, mmu04371  Apelin signaling pathway, mmu04540  Gap junction, mmu04611  Platelet activation, mmu04613  Neutrophil extracellular trap formation, mmu04621  NOD-like receptor signaling pathway, mmu04713  Circadian entrainment, mmu04720  Long-term potentiation, mmu04723  Retrograde endocannabinoid signaling, mmu04724  Glutamatergic synapse, mmu04725  Cholinergic synapse, mmu04726  Serotonergic synapse, mmu04728  Dopaminergic synapse, mmu04730  Long-term depression, mmu04742  Taste transduction, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04911  Insulin secretion, mmu04912  GnRH signaling pathway, mmu04915  Estrogen signaling pathway, mmu04916  Melanogenesis, mmu04918  Thyroid hormone synthesis, mmu04919  Thyroid hormone signaling pathway, mmu04921  Oxytocin signaling pathway, mmu04922  Glucagon signaling pathway, mmu04924  Renin secretion, mmu04925  Aldosterone synthesis and secretion, mmu04926  Relaxin signaling pathway, mmu04927  Cortisol synthesis and secretion, mmu04928  Parathyroid hormone synthesis, secretion and action, mmu04929  GnRH secretion, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04934  Cushing syndrome, mmu04935  Growth hormone synthesis, secretion and action, mmu04961  Endocrine and other factor-regulated calcium reabsorption, mmu04970  Salivary secretion, mmu04971  Gastric acid secretion, mmu04972  Pancreatic secretion, mmu04973  Carbohydrate digestion and absorption, mmu05010  Alzheimer disease, mmu05016  Huntington disease, mmu05017  Spinocerebellar ataxia, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05146  Amoebiasis, mmu05163  Human cytomegalovirus infection, mmu05200  Pathways in cancer, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis','00562 Inositol phosphate metabolism, 04015 Rap1 signaling pathway, 04310 Wnt signaling pathway, 04371 Apelin signaling pathway, 04020 Calcium signaling pathway, 04070 Phosphatidylinositol signaling system, 04072 Phospholipase D signaling pathway, 04071 Sphingolipid signaling pathway, 04022 cGMP-PKG signaling pathway, 04540 Gap junction, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04621 NOD-like receptor signaling pathway, 04062 Chemokine signaling pathway, 04911 Insulin secretion, 04922 Glucagon signaling pathway, 04929 GnRH secretion, 04912 GnRH signaling pathway, 04915 Estrogen signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04918 Thyroid hormone synthesis, 04919 Thyroid hormone signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 04916 Melanogenesis, 04924 Renin secretion, 04925 Aldosterone synthesis and secretion, 04927 Cortisol synthesis and secretion, 04261 Adrenergic signaling in cardiomyocytes, 04270 Vascular smooth muscle contraction, 04970 Salivary secretion, 04971 Gastric acid secretion, 04972 Pancreatic secretion, 04973 Carbohydrate digestion and absorption, 04961 Endocrine and other factor-regulated calcium reabsorption, 04724 Glutamatergic synapse, 04725 Cholinergic synapse, 04728 Dopaminergic synapse, 04726 Serotonergic synapse, 04720 Long-term potentiation, 04730 Long-term depression, 04723 Retrograde endocannabinoid signaling, 04742 Taste transduction, 04750 Inflammatory mediator regulation of TRP channels, 04713 Circadian entrainment, 05200 Pathways in cancer, 05163 Human cytomegalovirus infection, 05146 Amoebiasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05010 Alzheimer disease, 05016 Huntington disease, 05017 Spinocerebellar ataxia, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05415 Diabetic cardiomyopathy, 04933 AGE-RAGE signaling pathway in diabetic complications, 04934 Cushing syndrome, 04131 Membrane trafficking [BR:mmu04131], 3.1.4.11  phosphoinositide phospholipase C, Phospholipases, Phospholipase C'),('4990','mmu00564  Glycerophospholipid metabolism, mmu00565  Ether lipid metabolism, mmu01100  Metabolic pathways','00564 Glycerophospholipid metabolism, 00565 Ether lipid metabolism, 04131 Membrane trafficking [BR:mmu04131], 3.1.4.4  phospholipase D, Phospholipases'),('4991','mmu00051  Fructose and mannose metabolism, mmu00520  Amino sugar and nucleotide sugar metabolism, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors, mmu01250  Biosynthesis of nucleotide sugars','00051 Fructose and mannose metabolism, 00520 Amino sugar and nucleotide sugar metabolism, 5.4.2.8  phosphomannomutase'),('4992','mmu00561  Glycerolipid metabolism, mmu01100  Metabolic pathways, mmu04972  Pancreatic secretion, mmu04975  Fat digestion and absorption, mmu04977  Vitamin digestion and absorption','00561 Glycerolipid metabolism, 04972 Pancreatic secretion, 04975 Fat digestion and absorption, 04977 Vitamin digestion and absorption, 3.1.1.3  triacylglycerol lipase'),('4993','mmu00561  Glycerolipid metabolism, mmu01100  Metabolic pathways, mmu04972  Pancreatic secretion, mmu04975  Fat digestion and absorption','00561 Glycerolipid metabolism, 04972 Pancreatic secretion, 04975 Fat digestion and absorption, 3.1.1.3  triacylglycerol lipase'),('4994','mmu03018  RNA degradation','03018 RNA degradation, 03019 Messenger RNA biogenesis [BR:mmu03019], 03016 Transfer RNA biogenesis [BR:mmu03016], 2.7.7.8  polyribonucleotide nucleotidyltransferase, Other RNA degradosome components, tRNA degradation factors'),('4995','mmu00515  Mannose type O-glycan biosynthesis, mmu01100  Metabolic pathways','00515 Mannose type O-glycan biosynthesis, 01003 Glycosyltransferases [BR:mmu01003], 2.4.1.312  protein O-mannose beta-1,4-N-acetylglucosaminyltransferase, O-Glycan'),('4996','mmu00062  Fatty acid elongation, mmu01100  Metabolic pathways, mmu01212  Fatty acid metabolism, mmu04142  Lysosome','00062 Fatty acid elongation, 04142 Lysosome, 01004 Lipid biosynthesis proteins [BR:mmu01004], 3.1.2.22  palmitoyl[protein] hydrolase, Component type'),('4997',NULL,'04147 Exosome [BR:mmu04147], 1.11.1.24  thioredoxin-dependent peroxiredoxin, Proteins found in most exosomes'),('4998',NULL,'04147 Exosome [BR:mmu04147], 1.11.1.24  thioredoxin-dependent peroxiredoxin, Proteins found in most exosomes'),('4999','mmu00330  Arginine and proline metabolism, mmu01100  Metabolic pathways','00330 Arginine and proline metabolism, 1.5.5.3  hydroxyproline dehydrogenase'),('5000','mmu00590  Arachidonic acid metabolism, mmu01100  Metabolic pathways','00590 Arachidonic acid metabolism, 5.3.99.2  prostaglandin-D synthase'),('5001','mmu00590  Arachidonic acid metabolism, mmu01100  Metabolic pathways','00590 Arachidonic acid metabolism, 5.3.99.3  prostaglandin-E synthase'),('5002','mmu00590  Arachidonic acid metabolism, mmu01100  Metabolic pathways','00590 Arachidonic acid metabolism, 00199 Cytochrome P450 [BR:mmu00199], 5.3.99.4  prostaglandin-I synthase, CYP8 family'),('5003','mmu00520  Amino sugar and nucleotide sugar metabolism, mmu01100  Metabolic pathways','00520 Amino sugar and nucleotide sugar metabolism, 5.1.3.8  N-acylglucosamine 2-epimerase'),('5004','mmu00830  Retinol metabolism','00830 Retinol metabolism, 1.3.99.23  all-trans-retinol 13,14-reductase'),('5005','mmu01524  Platinum drug resistance, mmu03460  Fanconi anemia pathway','03460 Fanconi anemia pathway, 01524 Platinum drug resistance, 03400 DNA repair and recombination proteins [BR:mmu03400], 2.7.7.7  DNA-directed DNA polymerase, B-family DNA polymerases'),('5006','mmu01040  Biosynthesis of unsaturated fatty acids, mmu01100  Metabolic pathways, mmu01212  Fatty acid metabolism, mmu03320  PPAR signaling pathway, mmu04152  AMPK signaling pathway, mmu04936  Alcoholic liver disease','01040 Biosynthesis of unsaturated fatty acids, 04152 AMPK signaling pathway, 03320 PPAR signaling pathway, 04936 Alcoholic liver disease, 01004 Lipid biosynthesis proteins [BR:mmu01004], 1.14.19.1  stearoyl-CoA 9-desaturase, First'),('5007','mmu00020  Citrate cycle (TCA cycle), mmu00190  Oxidative phosphorylation, mmu01100  Metabolic pathways, mmu01200  Carbon metabolism, mmu04714  Thermogenesis, mmu04932  Non-alcoholic fatty liver disease, mmu05010  Alzheimer disease, mmu05012  Parkinson disease, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05415  Diabetic cardiomyopathy','00020 Citrate cycle (TCA cycle), 00190 Oxidative phosphorylation, 04714 Thermogenesis, 05208 Chemical carcinogenesis - reactive oxygen species, 05010 Alzheimer disease, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05415 Diabetic cardiomyopathy, 04932 Non-alcoholic fatty liver disease, 1.3.5.1  succinate dehydrogenase'),('5008','mmu00600  Sphingolipid metabolism, mmu01100  Metabolic pathways','00600 Sphingolipid metabolism, 3.1.4.12  sphingomyelin phosphodiesterase'),('5009','mmu00600  Sphingolipid metabolism, mmu01100  Metabolic pathways','00600 Sphingolipid metabolism, 3.1.4.12  sphingomyelin phosphodiesterase'),('5010','mmu00601  Glycosphingolipid biosynthesis - lacto and neolacto series, mmu01100  Metabolic pathways','00601 Glycosphingolipid biosynthesis - lacto and neolacto series, 01003 Glycosyltransferases [BR:mmu01003], 2.4.99.4  beta-galactoside alpha-2,3-sialyltransferase, Sialyltransferase'),('5011','mmu00140  Steroid hormone biosynthesis, mmu01100  Metabolic pathways','00140 Steroid hormone biosynthesis, 2.8.2.4  estrone sulfotransferase'),('5012','mmu00590  Arachidonic acid metabolism, mmu01100  Metabolic pathways, mmu04611  Platelet activation','00590 Arachidonic acid metabolism, 04611 Platelet activation, 00199 Cytochrome P450 [BR:mmu00199], 5.3.99.5  thromboxane-A synthase, CYP5 family'),('5013','mmu00380  Tryptophan metabolism, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors','00380 Tryptophan metabolism, 1.13.11.11  tryptophan 2,3-dioxygenase'),('5014','mmu00062  Fatty acid elongation, mmu01040  Biosynthesis of unsaturated fatty acids, mmu01100  Metabolic pathways, mmu01212  Fatty acid metabolism','00062 Fatty acid elongation, 01040 Biosynthesis of unsaturated fatty acids, 01004 Lipid biosynthesis proteins [BR:mmu01004], 1.3.1.93  very-long-chain enoyl-CoA reductase, Component type'),('5015','mmu00100  Steroid biosynthesis, mmu01100  Metabolic pathways','00100 Steroid biosynthesis, 1.3.1.70  Delta14-sterol reductase'),('5016','mmu00500  Starch and sucrose metabolism, mmu01100  Metabolic pathways','00500 Starch and sucrose metabolism, 00537 Glycosylphosphatidylinositol (GPI)-anchored proteins [BR:mmu00537], 3.2.1.28  alpha,alpha-trehalase, Enzymes'),('5017','mmu00051  Fructose and mannose metabolism, mmu00520  Amino sugar and nucleotide sugar metabolism, mmu01100  Metabolic pathways, mmu01250  Biosynthesis of nucleotide sugars','00051 Fructose and mannose metabolism, 00520 Amino sugar and nucleotide sugar metabolism, 1.1.1.271  GDP-L-fucose synthase'),('5018','mmu00520  Amino sugar and nucleotide sugar metabolism, mmu01100  Metabolic pathways, mmu01250  Biosynthesis of nucleotide sugars','00520 Amino sugar and nucleotide sugar metabolism, 2.7.7.23  UDP-N-acetylglucosamine diphosphorylase, 2.7.7.83  UDP-N-acetylgalactosamine diphosphorylase'),('5019','mmu00040  Pentose and glucuronate interconversions, mmu00053  Ascorbate and aldarate metabolism, mmu00520  Amino sugar and nucleotide sugar metabolism, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors, mmu01250  Biosynthesis of nucleotide sugars','00040 Pentose and glucuronate interconversions, 00053 Ascorbate and aldarate metabolism, 00520 Amino sugar and nucleotide sugar metabolism, 1.1.1.22  UDP-glucose 6-dehydrogenase'),('5020','mmu00040  Pentose and glucuronate interconversions, mmu00053  Ascorbate and aldarate metabolism, mmu00140  Steroid hormone biosynthesis, mmu00830  Retinol metabolism, mmu00860  Porphyrin metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu00982  Drug metabolism - cytochrome P450, mmu00983  Drug metabolism - other enzymes, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors, mmu04976  Bile secretion, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation','00040 Pentose and glucuronate interconversions, 00053 Ascorbate and aldarate metabolism, 00140 Steroid hormone biosynthesis, 00830 Retinol metabolism, 00860 Porphyrin metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 00983 Drug metabolism - other enzymes, 04976 Bile secretion, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 01003 Glycosyltransferases [BR:mmu01003], 2.4.1.17  glucuronosyltransferase, Hydrophobic molecule'),('5021','mmu00040  Pentose and glucuronate interconversions, mmu00053  Ascorbate and aldarate metabolism, mmu00140  Steroid hormone biosynthesis, mmu00830  Retinol metabolism, mmu00860  Porphyrin metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu00982  Drug metabolism - cytochrome P450, mmu00983  Drug metabolism - other enzymes, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors, mmu04976  Bile secretion, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation','00040 Pentose and glucuronate interconversions, 00053 Ascorbate and aldarate metabolism, 00140 Steroid hormone biosynthesis, 00830 Retinol metabolism, 00860 Porphyrin metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 00983 Drug metabolism - other enzymes, 04976 Bile secretion, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 01003 Glycosyltransferases [BR:mmu01003], 2.4.1.17  glucuronosyltransferase, Hydrophobic molecule'),('5022','mmu00040  Pentose and glucuronate interconversions, mmu00053  Ascorbate and aldarate metabolism, mmu00140  Steroid hormone biosynthesis, mmu00830  Retinol metabolism, mmu00860  Porphyrin metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu00982  Drug metabolism - cytochrome P450, mmu00983  Drug metabolism - other enzymes, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors, mmu04976  Bile secretion, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation','00040 Pentose and glucuronate interconversions, 00053 Ascorbate and aldarate metabolism, 00140 Steroid hormone biosynthesis, 00830 Retinol metabolism, 00860 Porphyrin metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 00983 Drug metabolism - other enzymes, 04976 Bile secretion, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 01003 Glycosyltransferases [BR:mmu01003], 2.4.1.17  glucuronosyltransferase, Hydrophobic molecule'),('5023','mmu00240  Pyrimidine metabolism, mmu00983  Drug metabolism - other enzymes, mmu01100  Metabolic pathways, mmu01232  Nucleotide metabolism','00240 Pyrimidine metabolism, 00983 Drug metabolism - other enzymes, 2.4.2.3  uridine phosphorylase'),('5024','mmu00240  Pyrimidine metabolism, mmu00983  Drug metabolism - other enzymes, mmu01100  Metabolic pathways, mmu01232  Nucleotide metabolism','00240 Pyrimidine metabolism, 00983 Drug metabolism - other enzymes, 2.4.2.3  uridine phosphorylase'),('5025','mmu00240  Pyrimidine metabolism, mmu00983  Drug metabolism - other enzymes, mmu01100  Metabolic pathways, mmu01232  Nucleotide metabolism','00240 Pyrimidine metabolism, 00983 Drug metabolism - other enzymes, 2.4.2.3  uridine phosphorylase'),('5026','mmu04024  cAMP signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04714  Thermogenesis, mmu04911  Insulin secretion, mmu04922  Glucagon signaling pathway','04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04911 Insulin secretion, 04922 Glucagon signaling pathway, 04714 Thermogenesis'),('5027','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5028','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5029','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5030','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu05132  Salmonella infection, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05152  Tuberculosis, mmu05164  Influenza A, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis','04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 05164 Influenza A, 05132 Salmonella infection, 05135 Yersinia infection, 05134 Legionellosis, 05152 Tuberculosis, 05144 Malaria, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5031','mmu04614  Renin-angiotensin system, mmu04974  Protein digestion and absorption, mmu05171  Coronavirus disease - COVID-19','04614 Renin-angiotensin system, 04974 Protein digestion and absorption, 05171 Coronavirus disease - COVID-19, 01002 Peptidases and inhibitors [BR:mmu01002], 04147 Exosome [BR:mmu04147], 3.4.17.23  angiotensin-converting enzyme 2, Family M2, Exosomal proteins of other body fluids (saliva and urine)'),('5032','mmu04614  Renin-angiotensin system, mmu04974  Protein digestion and absorption, mmu05171  Coronavirus disease - COVID-19','04614 Renin-angiotensin system, 04974 Protein digestion and absorption, 05171 Coronavirus disease - COVID-19, 01002 Peptidases and inhibitors [BR:mmu01002], 04147 Exosome [BR:mmu04147], 3.4.17.23  angiotensin-converting enzyme 2, Family M2, Exosomal proteins of other body fluids (saliva and urine)'),('5033','mmu04614  Renin-angiotensin system, mmu04974  Protein digestion and absorption, mmu05171  Coronavirus disease - COVID-19','04614 Renin-angiotensin system, 04974 Protein digestion and absorption, 05171 Coronavirus disease - COVID-19, 01002 Peptidases and inhibitors [BR:mmu01002], 04147 Exosome [BR:mmu04147], 3.4.17.23  angiotensin-converting enzyme 2, Family M2, Exosomal proteins of other body fluids (saliva and urine)'),('5034','mmu04614  Renin-angiotensin system, mmu04974  Protein digestion and absorption, mmu05171  Coronavirus disease - COVID-19','04614 Renin-angiotensin system, 04974 Protein digestion and absorption, 05171 Coronavirus disease - COVID-19, 01002 Peptidases and inhibitors [BR:mmu01002], 04147 Exosome [BR:mmu04147], 3.4.17.23  angiotensin-converting enzyme 2, Family M2, Exosomal proteins of other body fluids (saliva and urine)'),('5035','mmu04614  Renin-angiotensin system, mmu04974  Protein digestion and absorption, mmu05171  Coronavirus disease - COVID-19','04614 Renin-angiotensin system, 04974 Protein digestion and absorption, 05171 Coronavirus disease - COVID-19, 01002 Peptidases and inhibitors [BR:mmu01002], 04147 Exosome [BR:mmu04147], 3.4.17.23  angiotensin-converting enzyme 2, Family M2, Exosomal proteins of other body fluids (saliva and urine)'),('5036','mmu04614  Renin-angiotensin system, mmu04974  Protein digestion and absorption, mmu05171  Coronavirus disease - COVID-19','04614 Renin-angiotensin system, 04974 Protein digestion and absorption, 05171 Coronavirus disease - COVID-19, 01002 Peptidases and inhibitors [BR:mmu01002], 04147 Exosome [BR:mmu04147], 3.4.17.23  angiotensin-converting enzyme 2, Family M2, Exosomal proteins of other body fluids (saliva and urine)'),('5040','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5041','mmu04060  Cytokine-cytokine receptor interaction, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04936  Alcoholic liver disease, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis','04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5042','mmu04060  Cytokine-cytokine receptor interaction, mmu04620  Toll-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5043','mmu04060  Cytokine-cytokine receptor interaction, mmu04620  Toll-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5044','mmu03050  Proteasome, mmu04060  Cytokine-cytokine receptor interaction, mmu04066  HIF-1 signaling pathway, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04630  JAK-STAT signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04940  Type I diabetes mellitus, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05200  Pathways in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:mmu03051], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Other assembling factors, Interferons, Cytokines'),('5045','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu04936  Alcoholic liver disease, mmu05134  Legionellosis, mmu05146  Amoebiasis, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05167 Kaposi sarcoma-associated herpesvirus infection, 05134 Legionellosis, 05146 Amoebiasis, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], Chemokines'),('5046','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu04936  Alcoholic liver disease, mmu05134  Legionellosis, mmu05146  Amoebiasis, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05167 Kaposi sarcoma-associated herpesvirus infection, 05134 Legionellosis, 05146 Amoebiasis, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], Chemokines'),('5049','mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu04976  Bile secretion, mmu05204  Chemical carcinogenesis - DNA adducts','00980 Metabolism of xenobiotics by cytochrome P450, 04976 Bile secretion, 05204 Chemical carcinogenesis - DNA adducts, 2.8.2.14  bile-salt sulfotransferase'),('5050',NULL,NULL),('5051','mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu04976  Bile secretion, mmu05204  Chemical carcinogenesis - DNA adducts','00980 Metabolism of xenobiotics by cytochrome P450, 04976 Bile secretion, 05204 Chemical carcinogenesis - DNA adducts, 2.8.2.14  bile-salt sulfotransferase'),('5052','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04218  Cellular senescence, mmu04380  Osteoclast differentiation, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04668  TNF signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04917  Prolactin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04926  Relaxin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05212  Pancreatic cancer, mmu05215  Prostate cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:mmu03000], RHR (Rel homology region) Rel/Ankyrin'),('5054','mmu03050  Proteasome, mmu04060  Cytokine-cytokine receptor interaction, mmu04066  HIF-1 signaling pathway, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04630  JAK-STAT signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04940  Type I diabetes mellitus, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05200  Pathways in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:mmu03051], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Other assembling factors, Interferons, Cytokines'),('5055','mmu04060  Cytokine-cytokine receptor interaction, mmu04151  PI3K-Akt signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05140  Leishmaniasis, mmu05200  Pathways in cancer, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04640 Hematopoietic cell lineage, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05140 Leishmaniasis, 05310 Asthma, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5060','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04218  Cellular senescence, mmu04380  Osteoclast differentiation, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04668  TNF signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04917  Prolactin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04926  Relaxin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05212  Pancreatic cancer, mmu05215  Prostate cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:mmu03000], RHR (Rel homology region) Rel/Ankyrin'),('5061','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04218  Cellular senescence, mmu04380  Osteoclast differentiation, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04668  TNF signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04917  Prolactin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04926  Relaxin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05212  Pancreatic cancer, mmu05215  Prostate cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:mmu03000], RHR (Rel homology region) Rel/Ankyrin'),('5062','mmu04060  Cytokine-cytokine receptor interaction, mmu04151  PI3K-Akt signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05140  Leishmaniasis, mmu05200  Pathways in cancer, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04640 Hematopoietic cell lineage, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05140 Leishmaniasis, 05310 Asthma, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5063','mmu03050  Proteasome, mmu04060  Cytokine-cytokine receptor interaction, mmu04066  HIF-1 signaling pathway, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04630  JAK-STAT signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04940  Type I diabetes mellitus, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05200  Pathways in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:mmu03051], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Other assembling factors, Interferons, Cytokines'),('5064','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5065','mmu04060  Cytokine-cytokine receptor interaction, mmu04151  PI3K-Akt signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05140  Leishmaniasis, mmu05200  Pathways in cancer, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04640 Hematopoietic cell lineage, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05140 Leishmaniasis, 05310 Asthma, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5066','mmu03050  Proteasome, mmu04060  Cytokine-cytokine receptor interaction, mmu04066  HIF-1 signaling pathway, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04630  JAK-STAT signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04940  Type I diabetes mellitus, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05200  Pathways in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:mmu03051], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Other assembling factors, Interferons, Cytokines'),('5067','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5068','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5070','mmu04060  Cytokine-cytokine receptor interaction, mmu04620  Toll-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5071','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5072','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu04936  Alcoholic liver disease, mmu05134  Legionellosis, mmu05146  Amoebiasis, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05167 Kaposi sarcoma-associated herpesvirus infection, 05134 Legionellosis, 05146 Amoebiasis, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], Chemokines'),('5073','mmu03050  Proteasome, mmu04060  Cytokine-cytokine receptor interaction, mmu04066  HIF-1 signaling pathway, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04630  JAK-STAT signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04940  Type I diabetes mellitus, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05200  Pathways in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:mmu03051], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Other assembling factors, Interferons, Cytokines'),('5074','mmu04060  Cytokine-cytokine receptor interaction, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04936  Alcoholic liver disease, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis','04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5075','mmu03320  PPAR signaling pathway, mmu04024  cAMP signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease, mmu05160  Hepatitis C, mmu05207  Chemical carcinogenesis - receptor activation, mmu05415  Diabetic cardiomyopathy','04024 cAMP signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 03320 PPAR signaling pathway, 05207 Chemical carcinogenesis - receptor activation, 05160 Hepatitis C, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 thyroid hormone receptor-like, 1C. Peroxisome proliferator-activated receptor (PPAR)'),('5076','mmu03320  PPAR signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04380  Osteoclast differentiation, mmu04714  Thermogenesis, mmu04932  Non-alcoholic fatty liver disease, mmu05016  Huntington disease, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05216  Thyroid cancer, mmu05417  Lipid and atherosclerosis','04152 AMPK signaling pathway, 03320 PPAR signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04714 Thermogenesis, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05216 Thyroid cancer, 05016 Huntington disease, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 thyroid hormone receptor-like, 1C. Peroxisome proliferator-activated receptor (PPAR)'),('5077','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5078','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04062  Chemokine signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05144  Malaria, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05135 Yersinia infection, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Chemokines, Chemokines'),('5079','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5080','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04151  PI3K-Akt signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04940  Type I diabetes mellitus, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05162  Measles, mmu05166  Human T-cell leukemia virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease','04630 JAK-STAT signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05166 Human T-cell leukemia virus 1 infection, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05135 Yersinia infection, 05142 Chagas disease, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 04940 Type I diabetes mellitus, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5081','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5082','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04068  FoxO signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5083','mmu04659  Th17 cell differentiation, mmu05321  Inflammatory bowel disease','04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix other regulators'),('5084','mmu04060  Cytokine-cytokine receptor interaction, mmu04151  PI3K-Akt signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05140  Leishmaniasis, mmu05200  Pathways in cancer, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04640 Hematopoietic cell lineage, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05140 Leishmaniasis, 05310 Asthma, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5085','mmu04060  Cytokine-cytokine receptor interaction, mmu04630  JAK-STAT signaling pathway, mmu04659  Th17 cell differentiation, mmu05321  Inflammatory bowel disease','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5086','mmu03050  Proteasome, mmu04060  Cytokine-cytokine receptor interaction, mmu04066  HIF-1 signaling pathway, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04630  JAK-STAT signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04940  Type I diabetes mellitus, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05200  Pathways in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:mmu03051], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Other assembling factors, Interferons, Cytokines'),('5087','mmu04060  Cytokine-cytokine receptor interaction, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04936  Alcoholic liver disease, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis','04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5088','mmu04022  cGMP-PKG signaling pathway, mmu04260  Cardiac muscle contraction, mmu04261  Adrenergic signaling in cardiomyocytes, mmu04919  Thyroid hormone signaling pathway, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05416  Viral myocarditis','04022 cGMP-PKG signaling pathway, 04919 Thyroid hormone signaling pathway, 04260 Cardiac muscle contraction, 04261 Adrenergic signaling in cardiomyocytes, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 05416 Viral myocarditis, 04812 Cytoskeleton proteins [BR:mmu04812], Myosins'),('5089','mmu04022  cGMP-PKG signaling pathway, mmu04024  cAMP signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04270  Vascular smooth muscle contraction, mmu04714  Thermogenesis, mmu04921  Oxytocin signaling pathway, mmu04923  Regulation of lipolysis in adipocytes, mmu04924  Renin secretion, mmu04925  Aldosterone synthesis and secretion, mmu05143  African trypanosomiasis','04066 HIF-1 signaling pathway, 04024 cAMP signaling pathway, 04022 cGMP-PKG signaling pathway, 04923 Regulation of lipolysis in adipocytes, 04921 Oxytocin signaling pathway, 04924 Renin secretion, 04925 Aldosterone synthesis and secretion, 04270 Vascular smooth muscle contraction, 04714 Thermogenesis, 05143 African trypanosomiasis'),('5091','mmu03320  PPAR signaling pathway, mmu04371  Apelin signaling pathway, mmu04714  Thermogenesis, mmu05016  Huntington disease','04371 Apelin signaling pathway, 03320 PPAR signaling pathway, 04714 Thermogenesis, 05016 Huntington disease, 02000 Transporters [BR:mmu02000], SLC25: Mitochondrial carrier'),('5092','mmu04020  Calcium signaling pathway, mmu04022  cGMP-PKG signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04714  Thermogenesis, mmu04923  Regulation of lipolysis in adipocytes, mmu04924  Renin secretion, mmu04970  Salivary secretion, mmu05207  Chemical carcinogenesis - receptor activation','04020 Calcium signaling pathway, 04022 cGMP-PKG signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04923 Regulation of lipolysis in adipocytes, 04924 Renin secretion, 04970 Salivary secretion, 04714 Thermogenesis, 05207 Chemical carcinogenesis - receptor activation, 04030 G protein-coupled receptors [BR:mmu04030], Adrenaline'),('5093','mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04371  Apelin signaling pathway, mmu04714  Thermogenesis, mmu04910  Insulin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04936  Alcoholic liver disease, mmu05016  Huntington disease','04371 Apelin signaling pathway, 04152 AMPK signaling pathway, 04910 Insulin signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 04211 Longevity regulating pathway, 04714 Thermogenesis, 05016 Huntington disease, 04936 Alcoholic liver disease, 04931 Insulin resistance, 03029 Mitochondrial biogenesis [BR:mmu03029], Coactivators'),('5094','mmu00071  Fatty acid degradation, mmu01212  Fatty acid metabolism, mmu03320  PPAR signaling pathway, mmu04152  AMPK signaling pathway, mmu04714  Thermogenesis, mmu04920  Adipocytokine signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04936  Alcoholic liver disease, mmu05415  Diabetic cardiomyopathy','00071 Fatty acid degradation, 04152 AMPK signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 03320 PPAR signaling pathway, 04714 Thermogenesis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04931 Insulin resistance, 03029 Mitochondrial biogenesis [BR:mmu03029], 2.3.1.21  carnitine O-palmitoyltransferase, Other regulator of mitochondrial biogenesis'),('5098','mmu03320  PPAR signaling pathway, mmu04371  Apelin signaling pathway, mmu04714  Thermogenesis, mmu05016  Huntington disease','04371 Apelin signaling pathway, 03320 PPAR signaling pathway, 04714 Thermogenesis, 05016 Huntington disease, 02000 Transporters [BR:mmu02000], SLC25: Mitochondrial carrier'),('5099','mmu04020  Calcium signaling pathway, mmu04022  cGMP-PKG signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04714  Thermogenesis, mmu04923  Regulation of lipolysis in adipocytes, mmu04924  Renin secretion, mmu04970  Salivary secretion, mmu05207  Chemical carcinogenesis - receptor activation','04020 Calcium signaling pathway, 04022 cGMP-PKG signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04923 Regulation of lipolysis in adipocytes, 04924 Renin secretion, 04970 Salivary secretion, 04714 Thermogenesis, 05207 Chemical carcinogenesis - receptor activation, 04030 G protein-coupled receptors [BR:mmu04030], Adrenaline'),('5100','mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04371  Apelin signaling pathway, mmu04714  Thermogenesis, mmu04910  Insulin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04936  Alcoholic liver disease, mmu05016  Huntington disease','04371 Apelin signaling pathway, 04152 AMPK signaling pathway, 04910 Insulin signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 04211 Longevity regulating pathway, 04714 Thermogenesis, 05016 Huntington disease, 04936 Alcoholic liver disease, 04931 Insulin resistance, 03029 Mitochondrial biogenesis [BR:mmu03029], Coactivators'),('5101','mmu00071  Fatty acid degradation, mmu01212  Fatty acid metabolism, mmu03320  PPAR signaling pathway, mmu04152  AMPK signaling pathway, mmu04714  Thermogenesis, mmu04920  Adipocytokine signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04936  Alcoholic liver disease, mmu05415  Diabetic cardiomyopathy','00071 Fatty acid degradation, 04152 AMPK signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 03320 PPAR signaling pathway, 04714 Thermogenesis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04931 Insulin resistance, 03029 Mitochondrial biogenesis [BR:mmu03029], 2.3.1.21  carnitine O-palmitoyltransferase, Other regulator of mitochondrial biogenesis'),('5104','mmu03320  PPAR signaling pathway, mmu04979  Cholesterol metabolism','03320 PPAR signaling pathway, 04979 Cholesterol metabolism, 04147 Exosome [BR:mmu04147], Exosomal proteins of breast milk'),('5105','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('5106','mmu04613  Neutrophil extracellular trap formation, mmu04919  Thyroid hormone signaling pathway, mmu05034  Alcoholism, mmu05203  Viral carcinogenesis','04613 Neutrophil extracellular trap formation, 04919 Thyroid hormone signaling pathway, 05203 Viral carcinogenesis, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:mmu03036], 3.5.1.98  histone deacetylase, Class I HDACs'),('5107','mmu04371  Apelin signaling pathway, mmu04613  Neutrophil extracellular trap formation, mmu05034  Alcoholism, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer','04371 Apelin signaling pathway, 04613 Neutrophil extracellular trap formation, 05206 MicroRNAs in cancer, 05203 Viral carcinogenesis, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:mmu03036], 3.5.1.98  histone deacetylase, Class II HDACs'),('5108','mmu03320  PPAR signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04380  Osteoclast differentiation, mmu04714  Thermogenesis, mmu04932  Non-alcoholic fatty liver disease, mmu05016  Huntington disease, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05216  Thyroid cancer, mmu05417  Lipid and atherosclerosis','04152 AMPK signaling pathway, 03320 PPAR signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04714 Thermogenesis, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05216 Thyroid cancer, 05016 Huntington disease, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 thyroid hormone receptor-like, 1C. Peroxisome proliferator-activated receptor (PPAR)'),('5109','mmu04613  Neutrophil extracellular trap formation, mmu04919  Thyroid hormone signaling pathway, mmu05034  Alcoholism, mmu05203  Viral carcinogenesis','04613 Neutrophil extracellular trap formation, 04919 Thyroid hormone signaling pathway, 05203 Viral carcinogenesis, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:mmu03036], 3.5.1.98  histone deacetylase, Class I HDACs'),('5110','mmu03320  PPAR signaling pathway, mmu04979  Cholesterol metabolism','03320 PPAR signaling pathway, 04979 Cholesterol metabolism, 04147 Exosome [BR:mmu04147], Exosomal proteins of breast milk'),('5111','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('5112','mmu04613  Neutrophil extracellular trap formation, mmu04919  Thyroid hormone signaling pathway, mmu05034  Alcoholism, mmu05203  Viral carcinogenesis','04613 Neutrophil extracellular trap formation, 04919 Thyroid hormone signaling pathway, 05203 Viral carcinogenesis, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:mmu03036], 3.5.1.98  histone deacetylase, Class I HDACs'),('5113','mmu04371  Apelin signaling pathway, mmu04613  Neutrophil extracellular trap formation, mmu05034  Alcoholism, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer','04371 Apelin signaling pathway, 04613 Neutrophil extracellular trap formation, 05206 MicroRNAs in cancer, 05203 Viral carcinogenesis, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:mmu03036], 3.5.1.98  histone deacetylase, Class II HDACs'),('5114','mmu03320  PPAR signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04380  Osteoclast differentiation, mmu04714  Thermogenesis, mmu04932  Non-alcoholic fatty liver disease, mmu05016  Huntington disease, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05216  Thyroid cancer, mmu05417  Lipid and atherosclerosis','04152 AMPK signaling pathway, 03320 PPAR signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04714 Thermogenesis, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05216 Thyroid cancer, 05016 Huntington disease, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 thyroid hormone receptor-like, 1C. Peroxisome proliferator-activated receptor (PPAR)'),('5115',NULL,'03000 Transcription factors [BR:mmu03000], Factors with PAS domain'),('5116','mmu04217  Necroptosis, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu05161  Hepatitis B, mmu05200  Pathways in cancer, mmu05321  Inflammatory bowel disease','04630 JAK-STAT signaling pathway, 04217 Necroptosis, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 05200 Pathways in cancer, 05161 Hepatitis B, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:mmu03000], STAT'),('5117','mmu04550  Signaling pathways regulating pluripotency of stem cells','04550 Signaling pathways regulating pluripotency of stem cells'),('5118',NULL,'03000 Transcription factors [BR:mmu03000], Tal/Twist/Atonal/Hen, Mesodermal Twist-like factors'),('5119','mmu04659  Th17 cell differentiation, mmu04915  Estrogen signaling pathway, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05221  Acute myeloid leukemia','04659 Th17 cell differentiation, 04915 Estrogen signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05221 Acute myeloid leukemia, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 thyroid hormone receptor-like, 1B. Retinoic acid receptor (RAR)'),('5120','mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05211  Renal cell carcinoma','05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05211 Renal cell carcinoma, 03000 Transcription factors [BR:mmu03000], Factors with PAS domain'),('5121','mmu04550  Signaling pathways regulating pluripotency of stem cells','04550 Signaling pathways regulating pluripotency of stem cells, 03000 Transcription factors [BR:mmu03000], Homeo domain LIM'),('5122','mmu04080  Neuroactive ligand-receptor interaction','04080 Neuroactive ligand-receptor interaction, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 estrogen receptor-like, 3C. 3-Ketosteroid receptor'),('5123',NULL,'01001 Protein kinases [BR:mmu01001], 04121 Ubiquitin system [BR:mmu04121], 2.3.2.27  RING-type E3 ubiquitin transferase, TIF1 family [OT], TRIM/RBCC proteins'),('5124',NULL,'01009 Protein phosphatases and associated proteins [BR:mmu01009], 03036 Chromosome and associated proteins [BR:mmu03036], 1.14.11.67  [histone H3]-trimethyl-L-lysine4 demethylase, PP1-interacting proteins (PIPs), Histone demethylases'),('5125','mmu04950  Maturity onset diabetes of the young','04950 Maturity onset diabetes of the young, 03000 Transcription factors [BR:mmu03000], Tal/Twist/Atonal/Hen, Atonal'),('5126','mmu04390  Hippo signaling pathway, mmu04550  Signaling pathways regulating pluripotency of stem cells','04390 Hippo signaling pathway, 04550 Signaling pathways regulating pluripotency of stem cells, 03000 Transcription factors [BR:mmu03000], HMG SOX'),('5127','mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04928  Parathyroid hormone synthesis, secretion and action, mmu05321  Inflammatory bowel disease','04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04928 Parathyroid hormone synthesis, secretion and action, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:mmu03000], Cys4 GATA-factors'),('5128','mmu04066  HIF-1 signaling pathway, mmu04934  Cushing syndrome, mmu05200  Pathways in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05211  Renal cell carcinoma','04066 HIF-1 signaling pathway, 05200 Pathways in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05211 Renal cell carcinoma, 04934 Cushing syndrome, 03000 Transcription factors [BR:mmu03000], Factors with PAS domain'),('5129','mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04950  Maturity onset diabetes of the young','04550 Signaling pathways regulating pluripotency of stem cells, 04950 Maturity onset diabetes of the young, 03000 Transcription factors [BR:mmu03000], Homeo domain CUT'),('5130','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu04062  Chemokine signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04217  Necroptosis, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04630  JAK-STAT signaling pathway, mmu04659  Th17 cell differentiation, mmu04917  Prolactin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04931  Insulin resistance, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04935  Growth hormone synthesis, secretion and action, mmu05145  Toxoplasmosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05212  Pancreatic cancer, mmu05221  Acute myeloid leukemia, mmu05223  Non-small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04217 Necroptosis, 04550 Signaling pathways regulating pluripotency of stem cells, 04659 Th17 cell differentiation, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05223 Non-small cell lung cancer, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05145 Toxoplasmosis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 03000 Transcription factors [BR:mmu03000], STAT'),('5131',NULL,'03000 Transcription factors [BR:mmu03000], HMG SOX'),('5132','mmu04010  MAPK signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04380  Osteoclast differentiation, mmu04625  C-type lectin receptor signaling pathway, mmu05166  Human T-cell leukemia virus 1 infection, mmu05169  Epstein-Barr virus infection','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04625 C-type lectin receptor signaling pathway, 04380 Osteoclast differentiation, 05166 Human T-cell leukemia virus 1 infection, 05169 Epstein-Barr virus infection, 03000 Transcription factors [BR:mmu03000], RHR (Rel homology region) Rel/Ankyrin'),('5133','mmu04022  cGMP-PKG signaling pathway, mmu04218  Cellular senescence, mmu04530  Tight junction, mmu04919  Thyroid hormone signaling pathway','04022 cGMP-PKG signaling pathway, 04218 Cellular senescence, 04530 Tight junction, 04919 Thyroid hormone signaling pathway, 03000 Transcription factors [BR:mmu03000], Cys4 GATA-factors'),('5134','mmu05226  Gastric cancer','05226 Gastric cancer, 03000 Transcription factors [BR:mmu03000], Homeo domain ANTP: HOXL'),('5135','mmu04014  Ras signaling pathway, mmu05166  Human T-cell leukemia virus 1 infection','04014 Ras signaling pathway, 05166 Human T-cell leukemia virus 1 infection, 03000 Transcription factors [BR:mmu03000], Tryptophan clusters Ets-type'),('5136','mmu04950  Maturity onset diabetes of the young','04950 Maturity onset diabetes of the young, 03000 Transcription factors [BR:mmu03000], Homeo domain POU'),('5137','mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04371  Apelin signaling pathway, mmu04714  Thermogenesis, mmu04910  Insulin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04936  Alcoholic liver disease, mmu05016  Huntington disease','04371 Apelin signaling pathway, 04152 AMPK signaling pathway, 04910 Insulin signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 04211 Longevity regulating pathway, 04714 Thermogenesis, 05016 Huntington disease, 04936 Alcoholic liver disease, 04931 Insulin resistance, 03029 Mitochondrial biogenesis [BR:mmu03029], Coactivators'),('5138','mmu01522  Endocrine resistance, mmu04330  Notch signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04919  Thyroid hormone signaling pathway, mmu05020  Prion disease, mmu05165  Human papillomavirus infection, mmu05200  Pathways in cancer, mmu05206  MicroRNAs in cancer, mmu05224  Breast cancer','04330 Notch signaling pathway, 04658 Th1 and Th2 cell differentiation, 04919 Thyroid hormone signaling pathway, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05224 Breast cancer, 05165 Human papillomavirus infection, 05020 Prion disease, 01522 Endocrine resistance'),('5139','mmu04659  Th17 cell differentiation, mmu04934  Cushing syndrome, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species','04659 Th17 cell differentiation, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 04934 Cushing syndrome, 03000 Transcription factors [BR:mmu03000], Factors with PAS domain'),('5140',NULL,'03000 Transcription factors [BR:mmu03000], 04147 Exosome [BR:mmu04147], Tryptophan clusters interferon-regulating factors, Exosomal proteins of other body fluids (saliva and urine)'),('5141','mmu04919  Thyroid hormone signaling pathway, mmu05016  Huntington disease, mmu05169  Epstein-Barr virus infection, mmu05202  Transcriptional misregulation in cancer','04919 Thyroid hormone signaling pathway, 05202 Transcriptional misregulation in cancer, 05169 Epstein-Barr virus infection, 05016 Huntington disease, 03036 Chromosome and associated proteins [BR:mmu03036], Sin3A-HDAC complex, Other heterochromatin formation proteins'),('5142','mmu05225  Hepatocellular carcinoma','05225 Hepatocellular carcinoma, 03036 Chromosome and associated proteins [BR:mmu03036], PBAF complex'),('5143',NULL,'03000 Transcription factors [BR:mmu03000], Ubiquitous (class A) factors'),('5144','mmu04218  Cellular senescence','04218 Cellular senescence, 03000 Transcription factors [BR:mmu03000], Tryptophan clusters Myb, Myb-factors'),('5145',NULL,NULL),('5146','mmu01522  Endocrine resistance, mmu04915  Estrogen signaling pathway, mmu04917  Prolactin signaling pathway, mmu04919  Thyroid hormone signaling pathway, mmu04961  Endocrine and other factor-regulated calcium reabsorption, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05224  Breast cancer','04915 Estrogen signaling pathway, 04917 Prolactin signaling pathway, 04919 Thyroid hormone signaling pathway, 04961 Endocrine and other factor-regulated calcium reabsorption, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05224 Breast cancer, 01522 Endocrine resistance, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 estrogen receptor-like, 3A. Estrogen receptor'),('5147','mmu04218  Cellular senescence','04218 Cellular senescence, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix other regulators'),('5148','mmu01522  Endocrine resistance, mmu04110  Cell cycle, mmu04218  Cellular senescence, mmu04934  Cushing syndrome, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05169  Epstein-Barr virus infection, mmu05200  Pathways in cancer, mmu05206  MicroRNAs in cancer, mmu05212  Pancreatic cancer, mmu05214  Glioma, mmu05215  Prostate cancer, mmu05218  Melanoma, mmu05219  Bladder cancer, mmu05220  Chronic myeloid leukemia, mmu05222  Small cell lung cancer, mmu05223  Non-small cell lung cancer, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer','04110 Cell cycle, 04218 Cellular senescence, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05219 Bladder cancer, 05215 Prostate cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 04934 Cushing syndrome, 01522 Endocrine resistance, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix cell cycle-controlling factors, E2F'),('5149','mmu01522  Endocrine resistance, mmu04110  Cell cycle, mmu04218  Cellular senescence, mmu04934  Cushing syndrome, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05169  Epstein-Barr virus infection, mmu05200  Pathways in cancer, mmu05206  MicroRNAs in cancer, mmu05212  Pancreatic cancer, mmu05214  Glioma, mmu05215  Prostate cancer, mmu05218  Melanoma, mmu05219  Bladder cancer, mmu05220  Chronic myeloid leukemia, mmu05222  Small cell lung cancer, mmu05223  Non-small cell lung cancer, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer','04110 Cell cycle, 04218 Cellular senescence, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05219 Bladder cancer, 05215 Prostate cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 04934 Cushing syndrome, 01522 Endocrine resistance, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix cell cycle-controlling factors, E2F'),('5150','mmu04110  Cell cycle, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05222  Small cell lung cancer','04110 Cell cycle, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05222 Small cell lung cancer, 03000 Transcription factors [BR:mmu03000], 04121 Ubiquitin system [BR:mmu04121], Cys2His2 BTB-ZF factors, Adoptor and target recognizing subunit (BTB)'),('5151','mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu05202  Transcriptional misregulation in cancer, mmu05206  MicroRNAs in cancer','04550 Signaling pathways regulating pluripotency of stem cells, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 03036 Chromosome and associated proteins [BR:mmu03036], PRC1 (polycomb repressive complex 1)'),('5152',NULL,'03000 Transcription factors [BR:mmu03000], 03036 Chromosome and associated proteins [BR:mmu03036], Cys4 GATA-factors, NuRD complex'),('5153',NULL,'03000 Transcription factors [BR:mmu03000], 03036 Chromosome and associated proteins [BR:mmu03036], Other zinc fingers, Other polycomb group proteins'),('5154',NULL,'03000 Transcription factors [BR:mmu03000], Fork head/winged helix tissue-specific regulators'),('5155','mmu04110  Cell cycle, mmu04144  Endocytosis, mmu04218  Cellular senescence, mmu04350  TGF-beta signaling pathway, mmu04371  Apelin signaling pathway, mmu04390  Hippo signaling pathway, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04659  Th17 cell differentiation, mmu04926  Relaxin signaling pathway, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05142  Chagas disease, mmu05166  Human T-cell leukemia virus 1 infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05210  Colorectal cancer, mmu05212  Pancreatic cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05321  Inflammatory bowel disease, mmu05415  Diabetic cardiomyopathy','04350 TGF-beta signaling pathway, 04390 Hippo signaling pathway, 04371 Apelin signaling pathway, 04144 Endocytosis, 04110 Cell cycle, 04218 Cellular senescence, 04550 Signaling pathways regulating pluripotency of stem cells, 04659 Th17 cell differentiation, 04926 Relaxin signaling pathway, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05166 Human T-cell leukemia virus 1 infection, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05415 Diabetic cardiomyopathy, 04933 AGE-RAGE signaling pathway in diabetic complications'),('5156','mmu04068  FoxO signaling pathway, mmu04110  Cell cycle, mmu04144  Endocytosis, mmu04218  Cellular senescence, mmu04310  Wnt signaling pathway, mmu04350  TGF-beta signaling pathway, mmu04371  Apelin signaling pathway, mmu04390  Hippo signaling pathway, mmu04520  Adherens junction, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04659  Th17 cell differentiation, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05161  Hepatitis B, mmu05166  Human T-cell leukemia virus 1 infection, mmu05200  Pathways in cancer, mmu05210  Colorectal cancer, mmu05212  Pancreatic cancer, mmu05220  Chronic myeloid leukemia, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05321  Inflammatory bowel disease, mmu05415  Diabetic cardiomyopathy','04310 Wnt signaling pathway, 04350 TGF-beta signaling pathway, 04390 Hippo signaling pathway, 04371 Apelin signaling pathway, 04068 FoxO signaling pathway, 04144 Endocytosis, 04110 Cell cycle, 04218 Cellular senescence, 04520 Adherens junction, 04550 Signaling pathways regulating pluripotency of stem cells, 04659 Th17 cell differentiation, 05200 Pathways in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05220 Chronic myeloid leukemia, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05321 Inflammatory bowel disease, 05415 Diabetic cardiomyopathy, 04933 AGE-RAGE signaling pathway in diabetic complications'),('5157','mmu04068  FoxO signaling pathway, mmu04110  Cell cycle, mmu04310  Wnt signaling pathway, mmu04350  TGF-beta signaling pathway, mmu04371  Apelin signaling pathway, mmu04390  Hippo signaling pathway, mmu04520  Adherens junction, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04659  Th17 cell differentiation, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05161  Hepatitis B, mmu05166  Human T-cell leukemia virus 1 infection, mmu05200  Pathways in cancer, mmu05210  Colorectal cancer, mmu05212  Pancreatic cancer, mmu05220  Chronic myeloid leukemia, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer','04310 Wnt signaling pathway, 04350 TGF-beta signaling pathway, 04390 Hippo signaling pathway, 04371 Apelin signaling pathway, 04068 FoxO signaling pathway, 04110 Cell cycle, 04520 Adherens junction, 04550 Signaling pathways regulating pluripotency of stem cells, 04659 Th17 cell differentiation, 05200 Pathways in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05220 Chronic myeloid leukemia, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 04933 AGE-RAGE signaling pathway in diabetic complications'),('5158','mmu04110  Cell cycle, mmu04350  TGF-beta signaling pathway','04350 TGF-beta signaling pathway, 04110 Cell cycle, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix cell cycle-controlling factors, DP'),('5159','mmu04114  Oocyte meiosis, mmu04914  Progesterone-mediated oocyte maturation, mmu04915  Estrogen signaling pathway, mmu05207  Chemical carcinogenesis - receptor activation, mmu05224  Breast cancer','04114 Oocyte meiosis, 04915 Estrogen signaling pathway, 04914 Progesterone-mediated oocyte maturation, 05207 Chemical carcinogenesis - receptor activation, 05224 Breast cancer, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 estrogen receptor-like, 3C. 3-Ketosteroid receptor'),('5160','mmu04710  Circadian rhythm, mmu04728  Dopaminergic synapse','04728 Dopaminergic synapse, 04710 Circadian rhythm, 03000 Transcription factors [BR:mmu03000], 03036 Chromosome and associated proteins [BR:mmu03036], 2.3.1.48  histone acetyltransferase, Factors with PAS domain, HATs (histone acetyltransferases)'),('5161','mmu04330  Notch signaling pathway, mmu05165  Human papillomavirus infection, mmu05200  Pathways in cancer, mmu05224  Breast cancer','04330 Notch signaling pathway, 05200 Pathways in cancer, 05224 Breast cancer, 05165 Human papillomavirus infection, 03000 Transcription factors [BR:mmu03000], Hairy, Hairy/E(SPL)'),('5162','mmu03320  PPAR signaling pathway, mmu04024  cAMP signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease, mmu05160  Hepatitis C, mmu05207  Chemical carcinogenesis - receptor activation, mmu05415  Diabetic cardiomyopathy','04024 cAMP signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 03320 PPAR signaling pathway, 05207 Chemical carcinogenesis - receptor activation, 05160 Hepatitis C, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 thyroid hormone receptor-like, 1C. Peroxisome proliferator-activated receptor (PPAR)'),('5163',NULL,'03000 Transcription factors [BR:mmu03000], Homeo domain ANTP: HOXL'),('5164',NULL,NULL),('5165','mmu04120  Ubiquitin mediated proteolysis, mmu04630  JAK-STAT signaling pathway','04120 Ubiquitin mediated proteolysis, 04630 JAK-STAT signaling pathway, 04121 Ubiquitin system [BR:mmu04121], 2.3.2.-, UBL E3 ligases'),('5166',NULL,'03000 Transcription factors [BR:mmu03000], Cys2His2 others'),('5167',NULL,'03000 Transcription factors [BR:mmu03000], bZIP/PAR'),('5168',NULL,'03000 Transcription factors [BR:mmu03000], AP-1(-like) components, Fos, AP-1(-like) components, CRE-BP/ATF'),('5169','mmu04120  Ubiquitin mediated proteolysis','04120 Ubiquitin mediated proteolysis, 04131 Membrane trafficking [BR:mmu04131], 04121 Ubiquitin system [BR:mmu04121], Other mitophagy associated  proteins, Target recognizing subunit (F-box)'),('5170',NULL,'04121 Ubiquitin system [BR:mmu04121], Adoptor and target recognizing subunit (BTB)'),('5171','mmu04110  Cell cycle, mmu04213  Longevity regulating pathway - multiple species, mmu04330  Notch signaling pathway, mmu04613  Neutrophil extracellular trap formation, mmu04919  Thyroid hormone signaling pathway, mmu05016  Huntington disease, mmu05031  Amphetamine addiction, mmu05034  Alcoholism, mmu05165  Human papillomavirus infection, mmu05169  Epstein-Barr virus infection, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05220  Chronic myeloid leukemia','04330 Notch signaling pathway, 04110 Cell cycle, 04613 Neutrophil extracellular trap formation, 04919 Thyroid hormone signaling pathway, 04213 Longevity regulating pathway - multiple species, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05203 Viral carcinogenesis, 05220 Chronic myeloid leukemia, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05016 Huntington disease, 05031 Amphetamine addiction, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:mmu03036], 3.5.1.98  histone deacetylase, Class I HDACs, Sin3A-HDAC complex, BRAF-HDAC complex, Other heterochromatin formation proteins, NuRD complex'),('5172','mmu04110  Cell cycle, mmu04218  Cellular senescence, mmu04350  TGF-beta signaling pathway, mmu05165  Human papillomavirus infection, mmu05203  Viral carcinogenesis','04350 TGF-beta signaling pathway, 04110 Cell cycle, 04218 Cellular senescence, 05203 Viral carcinogenesis, 05165 Human papillomavirus infection, 03000 Transcription factors [BR:mmu03000], Pocket domain Rb'),('5173','mmu05202  Transcriptional misregulation in cancer, mmu05206  MicroRNAs in cancer, mmu05215  Prostate cancer','05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05215 Prostate cancer, 03000 Transcription factors [BR:mmu03000], Homeo domain ZF'),('5174','mmu05206  MicroRNAs in cancer','05206 MicroRNAs in cancer, 03000 Transcription factors [BR:mmu03000], Homeo domain ZF'),('5175',NULL,'04121 Ubiquitin system [BR:mmu04121], 03036 Chromosome and associated proteins [BR:mmu03036], 2.3.2.27  RING-type E3 ubiquitin transferase, Other single Ring-finger type E3, PRC1 (polycomb repressive complex 1), AUTS2-polycomb complex'),('5176','mmu04371  Apelin signaling pathway, mmu04613  Neutrophil extracellular trap formation, mmu05034  Alcoholism, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer','04371 Apelin signaling pathway, 04613 Neutrophil extracellular trap formation, 05206 MicroRNAs in cancer, 05203 Viral carcinogenesis, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:mmu03036], 3.5.1.98  histone deacetylase, Class II HDACs'),('5177','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04137  Mitophagy - animal, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04218  Cellular senescence, mmu04380  Osteoclast differentiation, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04668  TNF signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04917  Prolactin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04926  Relaxin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05212  Pancreatic cancer, mmu05215  Prostate cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04137 Mitophagy - animal, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:mmu03000], RHR (Rel homology region) Rel/Ankyrin'),('5178','mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04210  Apoptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04668  TNF signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04926  Relaxin signaling pathway, mmu04931  Insulin resistance, mmu04936  Alcoholic liver disease, mmu05132  Salmonella infection, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05215  Prostate cancer, mmu05220  Chronic myeloid leukemia, mmu05222  Small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04024 cAMP signaling pathway, 04210 Apoptosis, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05134 Legionellosis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04931 Insulin resistance, 03000 Transcription factors [BR:mmu03000], 04131 Membrane trafficking [BR:mmu04131], RHR (Rel homology region) Ankyrin only, Selective cargos'),('5179',NULL,'03000 Transcription factors [BR:mmu03000], RHR (Rel homology region) Ankyrin only'),('5180','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu04062  Chemokine signaling pathway, mmu04068  FoxO signaling pathway, mmu04137  Mitophagy - animal, mmu04151  PI3K-Akt signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04213  Longevity regulating pathway - multiple species, mmu04218  Cellular senescence, mmu04722  Neurotrophin signaling pathway, mmu04917  Prolactin signaling pathway, mmu04936  Alcoholic liver disease, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05213  Endometrial cancer, mmu05223  Non-small cell lung cancer','04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04137 Mitophagy - animal, 04218 Cellular senescence, 04062 Chemokine signaling pathway, 04917 Prolactin signaling pathway, 04722 Neurotrophin signaling pathway, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 05208 Chemical carcinogenesis - reactive oxygen species, 05213 Endometrial cancer, 05223 Non-small cell lung cancer, 04936 Alcoholic liver disease, 01521 EGFR tyrosine kinase inhibitor resistance, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix other regulators'),('5181',NULL,'03000 Transcription factors [BR:mmu03000], Cys4 GATA-factors'),('5182','mmu03250  Viral life cycle - HIV-1, mmu04024  cAMP signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04110  Cell cycle, mmu04310  Wnt signaling pathway, mmu04330  Notch signaling pathway, mmu04350  TGF-beta signaling pathway, mmu04520  Adherens junction, mmu04630  JAK-STAT signaling pathway, mmu04720  Long-term potentiation, mmu04916  Melanogenesis, mmu04919  Thyroid hormone signaling pathway, mmu04922  Glucagon signaling pathway, mmu04935  Growth hormone synthesis, secretion and action, mmu05016  Huntington disease, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05211  Renal cell carcinoma, mmu05215  Prostate cancer','03250 Viral life cycle - HIV-1, 04310 Wnt signaling pathway, 04330 Notch signaling pathway, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04024 cAMP signaling pathway, 04110 Cell cycle, 04520 Adherens junction, 04922 Glucagon signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04916 Melanogenesis, 04720 Long-term potentiation, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05203 Viral carcinogenesis, 05211 Renal cell carcinoma, 05215 Prostate cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05164 Influenza A, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05152 Tuberculosis, 05016 Huntington disease, 03000 Transcription factors [BR:mmu03000], 03036 Chromosome and associated proteins [BR:mmu03036], 03029 Mitochondrial biogenesis [BR:mmu03029], 2.3.1.48  histone acetyltransferase, Pocket domain CBP, HATs (histone acetyltransferases), Coactivators'),('5183',NULL,'03000 Transcription factors [BR:mmu03000], AP-1(-like) components, NF-E2'),('5184','mmu01522  Endocrine resistance, mmu04010  MAPK signaling pathway, mmu04012  ErbB signaling pathway, mmu04024  cAMP signaling pathway, mmu04137  Mitophagy - animal, mmu04210  Apoptosis, mmu04310  Wnt signaling pathway, mmu04380  Osteoclast differentiation, mmu04510  Focal adhesion, mmu04530  Tight junction, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04668  TNF signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04912  GnRH signaling pathway, mmu04915  Estrogen signaling pathway, mmu04921  Oxytocin signaling pathway, mmu04926  Relaxin signaling pathway, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05030  Cocaine addiction, mmu05031  Amphetamine addiction, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05161  Hepatitis B, mmu05162  Measles, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05210  Colorectal cancer, mmu05211  Renal cell carcinoma, mmu05224  Breast cancer, mmu05231  Choline metabolism in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04310 Wnt signaling pathway, 04668 TNF signaling pathway, 04024 cAMP signaling pathway, 04137 Mitophagy - animal, 04210 Apoptosis, 04510 Focal adhesion, 04530 Tight junction, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04912 GnRH signaling pathway, 04915 Estrogen signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05211 Renal cell carcinoma, 05224 Breast cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05030 Cocaine addiction, 05031 Amphetamine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01522 Endocrine resistance, 03000 Transcription factors [BR:mmu03000], AP-1(-like) components, Jun'),('5185','mmu01522  Endocrine resistance, mmu04915  Estrogen signaling pathway, mmu04917  Prolactin signaling pathway, mmu04929  GnRH secretion, mmu05200  Pathways in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05224  Breast cancer','04929 GnRH secretion, 04915 Estrogen signaling pathway, 04917 Prolactin signaling pathway, 05200 Pathways in cancer, 05207 Chemical carcinogenesis - receptor activation, 05224 Breast cancer, 01522 Endocrine resistance, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 estrogen receptor-like, 3A. Estrogen receptor'),('5186','mmu04621  NOD-like receptor signaling pathway','04621 NOD-like receptor signaling pathway'),('5187','mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu05152  Tuberculosis, mmu05202  Transcriptional misregulation in cancer','04668 TNF signaling pathway, 04657 IL-17 signaling pathway, 05202 Transcriptional misregulation in cancer, 05152 Tuberculosis, 03000 Transcription factors [BR:mmu03000], C/EBP-like factors'),('5188','mmu04012  ErbB signaling pathway, mmu04062  Chemokine signaling pathway, mmu04217  Necroptosis, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04917  Prolactin signaling pathway, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04935  Growth hormone synthesis, secretion and action, mmu05161  Hepatitis B, mmu05162  Measles, mmu05166  Human T-cell leukemia virus 1 infection, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05207  Chemical carcinogenesis - receptor activation, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05223  Non-small cell lung cancer','04012 ErbB signaling pathway, 04630 JAK-STAT signaling pathway, 04217 Necroptosis, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04062 Chemokine signaling pathway, 04917 Prolactin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 05200 Pathways in cancer, 05207 Chemical carcinogenesis - receptor activation, 05203 Viral carcinogenesis, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05162 Measles, 04933 AGE-RAGE signaling pathway in diabetic complications, 03000 Transcription factors [BR:mmu03000], STAT'),('5189',NULL,'03000 Transcription factors [BR:mmu03000], Cys2His2 SP/KLF family and related proteins'),('5190',NULL,'03000 Transcription factors [BR:mmu03000], Homeo domain ANTP: HOXL'),('5191','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 03000 Transcription factors [BR:mmu03000], HMG SOX'),('5192','mmu04350  TGF-beta signaling pathway, mmu04390  Hippo signaling pathway','04350 TGF-beta signaling pathway, 04390 Hippo signaling pathway'),('5193','mmu04012  ErbB signaling pathway, mmu04217  Necroptosis, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04917  Prolactin signaling pathway, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04935  Growth hormone synthesis, secretion and action, mmu05161  Hepatitis B, mmu05162  Measles, mmu05166  Human T-cell leukemia virus 1 infection, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05207  Chemical carcinogenesis - receptor activation, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05223  Non-small cell lung cancer','04012 ErbB signaling pathway, 04630 JAK-STAT signaling pathway, 04217 Necroptosis, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04917 Prolactin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 05200 Pathways in cancer, 05207 Chemical carcinogenesis - receptor activation, 05203 Viral carcinogenesis, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05162 Measles, 04933 AGE-RAGE signaling pathway in diabetic complications, 03000 Transcription factors [BR:mmu03000], STAT'),('5194','mmu04137  Mitophagy - animal, mmu04140  Autophagy - animal, mmu04217  Necroptosis, mmu04218  Cellular senescence, mmu04380  Osteoclast differentiation, mmu05014  Amyotrophic lateral sclerosis, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05418  Fluid shear stress and atherosclerosis','04140 Autophagy - animal, 04137 Mitophagy - animal, 04217 Necroptosis, 04218 Cellular senescence, 04380 Osteoclast differentiation, 05014 Amyotrophic lateral sclerosis, 05022 Pathways of neurodegeneration - multiple diseases, 05418 Fluid shear stress and atherosclerosis, 04131 Membrane trafficking [BR:mmu04131], 03029 Mitochondrial biogenesis [BR:mmu03029], 04147 Exosome [BR:mmu04147], Cargo receptors, Pexophagy, Aggrephagy, Xenophagy, Midbophagy associated proteins, Parkin-dependent mechanism factors, Exosomal proteins of other body fluids (saliva and urine)'),('5195','mmu04928  Parathyroid hormone synthesis, secretion and action, mmu04961  Endocrine and other factor-regulated calcium reabsorption, mmu04978  Mineral absorption, mmu05152  Tuberculosis, mmu05207  Chemical carcinogenesis - receptor activation','04928 Parathyroid hormone synthesis, secretion and action, 04978 Mineral absorption, 04961 Endocrine and other factor-regulated calcium reabsorption, 05207 Chemical carcinogenesis - receptor activation, 05152 Tuberculosis, 01009 Protein phosphatases and associated proteins [BR:mmu01009], 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], PP1-interacting proteins (PIPs), Cys4 thyroid hormone receptor-like, 1I. Vitamin D3 like receptor'),('5196','mmu04927  Cortisol synthesis and secretion, mmu04934  Cushing syndrome','04927 Cortisol synthesis and secretion, 04934 Cushing syndrome, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 Fushi tarazu-F1-like, 5A. Fushi tarazu-F1 like receptor'),('5197','mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu05016  Huntington disease','04550 Signaling pathways regulating pluripotency of stem cells, 05016 Huntington disease, 03000 Transcription factors [BR:mmu03000], Cys2His2 others'),('5198',NULL,'03000 Transcription factors [BR:mmu03000], Tryptophan clusters Ets-type'),('5199','mmu04010  MAPK signaling pathway, mmu04141  Protein processing in endoplasmic reticulum, mmu04210  Apoptosis, mmu04932  Non-alcoholic fatty liver disease, mmu05010  Alzheimer disease, mmu05012  Parkinson disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05202  Transcriptional misregulation in cancer, mmu05417  Lipid and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 04010 MAPK signaling pathway, 04210 Apoptosis, 05202 Transcriptional misregulation in cancer, 05010 Alzheimer disease, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 03000 Transcription factors [BR:mmu03000], C/EBP-like factors'),('5200','mmu04371  Apelin signaling pathway, mmu05016  Huntington disease','04371 Apelin signaling pathway, 05016 Huntington disease, 03029 Mitochondrial biogenesis [BR:mmu03029], Nuclear respiratory factors'),('5201','mmu04010  MAPK signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04925  Aldosterone synthesis and secretion, mmu04927  Cortisol synthesis and secretion, mmu04934  Cushing syndrome','04010 MAPK signaling pathway, 04151 PI3K-Akt signaling pathway, 04925 Aldosterone synthesis and secretion, 04927 Cortisol synthesis and secretion, 04934 Cushing syndrome, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 nerve growth factor IB-like, 4A. Nerve growth factor IB like receptor'),('5202',NULL,'03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 thyroid hormone receptor-like, 1I. Vitamin D3 like receptor'),('5203','mmu04066  HIF-1 signaling pathway, mmu04137  Mitophagy - animal, mmu04140  Autophagy - animal, mmu04659  Th17 cell differentiation, mmu04919  Thyroid hormone signaling pathway, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05211  Renal cell carcinoma, mmu05230  Central carbon metabolism in cancer, mmu05231  Choline metabolism in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer','04066 HIF-1 signaling pathway, 04140 Autophagy - animal, 04137 Mitophagy - animal, 04659 Th17 cell differentiation, 04919 Thyroid hormone signaling pathway, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05211 Renal cell carcinoma, 05167 Kaposi sarcoma-associated herpesvirus infection, 03000 Transcription factors [BR:mmu03000], Factors with PAS domain'),('5204','mmu04066  HIF-1 signaling pathway, mmu04120  Ubiquitin mediated proteolysis, mmu05200  Pathways in cancer, mmu05211  Renal cell carcinoma','04120 Ubiquitin mediated proteolysis, 04066 HIF-1 signaling pathway, 05200 Pathways in cancer, 05211 Renal cell carcinoma, 04121 Ubiquitin system [BR:mmu04121], Target recognizing subunit (VHL box)'),('5205',NULL,'03000 Transcription factors [BR:mmu03000], 03036 Chromosome and associated proteins [BR:mmu03036], 03029 Mitochondrial biogenesis [BR:mmu03029], Cys2His2 others, Other polycomb group proteins, Ubiquitas transcription factors'),('5206','mmu01522  Endocrine resistance, mmu01524  Platinum drug resistance, mmu04010  MAPK signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04110  Cell cycle, mmu04115  p53 signaling pathway, mmu04137  Mitophagy - animal, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04216  Ferroptosis, mmu04218  Cellular senescence, mmu04310  Wnt signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04919  Thyroid hormone signaling pathway, mmu05012  Parkinson disease, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05210  Colorectal cancer, mmu05212  Pancreatic cancer, mmu05213  Endometrial cancer, mmu05214  Glioma, mmu05215  Prostate cancer, mmu05216  Thyroid cancer, mmu05217  Basal cell carcinoma, mmu05218  Melanoma, mmu05219  Bladder cancer, mmu05220  Chronic myeloid leukemia, mmu05222  Small cell lung cancer, mmu05223  Non-small cell lung cancer, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05230  Central carbon metabolism in cancer, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04310 Wnt signaling pathway, 04071 Sphingolipid signaling pathway, 04151 PI3K-Akt signaling pathway, 04137 Mitophagy - animal, 04110 Cell cycle, 04210 Apoptosis, 04216 Ferroptosis, 04115 p53 signaling pathway, 04218 Cellular senescence, 04919 Thyroid hormone signaling pathway, 04722 Neurotrophin signaling pathway, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05203 Viral carcinogenesis, 05230 Central carbon metabolism in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05220 Chronic myeloid leukemia, 05217 Basal cell carcinoma, 05218 Melanoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 01524 Platinum drug resistance, 01522 Endocrine resistance, 03000 Transcription factors [BR:mmu03000], 03036 Chromosome and associated proteins [BR:mmu03036], 03400 DNA repair and recombination proteins [BR:mmu03400], p53, Regulators of Aurora kinases, Other check point factors'),('5207','mmu04080  Neuroactive ligand-receptor interaction','04080 Neuroactive ligand-receptor interaction, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 estrogen receptor-like, 3C. 3-Ketosteroid receptor'),('5208','mmu04110  Cell cycle, mmu04114  Oocyte meiosis, mmu05166  Human T-cell leukemia virus 1 infection','04110 Cell cycle, 04114 Oocyte meiosis, 05166 Human T-cell leukemia virus 1 infection, 03036 Chromosome and associated proteins [BR:mmu03036], Securin'),('5209',NULL,'03000 Transcription factors [BR:mmu03000], Cys2His2 BTB-ZF factors'),('5210','mmu04115  p53 signaling pathway, mmu04390  Hippo signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu05162  Measles','04390 Hippo signaling pathway, 04115 p53 signaling pathway, 04722 Neurotrophin signaling pathway, 05162 Measles, 03000 Transcription factors [BR:mmu03000], p53'),('5211','mmu01522  Endocrine resistance, mmu04110  Cell cycle, mmu04218  Cellular senescence, mmu04934  Cushing syndrome, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05169  Epstein-Barr virus infection, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05207  Chemical carcinogenesis - receptor activation, mmu05212  Pancreatic cancer, mmu05214  Glioma, mmu05215  Prostate cancer, mmu05218  Melanoma, mmu05219  Bladder cancer, mmu05220  Chronic myeloid leukemia, mmu05222  Small cell lung cancer, mmu05223  Non-small cell lung cancer, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer','04110 Cell cycle, 04218 Cellular senescence, 05200 Pathways in cancer, 05207 Chemical carcinogenesis - receptor activation, 05203 Viral carcinogenesis, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05219 Bladder cancer, 05215 Prostate cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 04934 Cushing syndrome, 01522 Endocrine resistance, 01009 Protein phosphatases and associated proteins [BR:mmu01009], 03000 Transcription factors [BR:mmu03000], PP1-interacting proteins (PIPs), Pocket domain Rb'),('5212','mmu04014  Ras signaling pathway, mmu04068  FoxO signaling pathway','04014 Ras signaling pathway, 04068 FoxO signaling pathway, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix other regulators'),('5213','mmu03022  Basal transcription factors, mmu05016  Huntington disease','03022 Basal transcription factors, 05016 Huntington disease, 03021 Transcription machinery [BR:mmu03021], 03036 Chromosome and associated proteins [BR:mmu03036], TFIID, SAGA/TFTC/STAGA complex, TFTC complex'),('5214','mmu05202  Transcriptional misregulation in cancer','05202 Transcriptional misregulation in cancer, 03000 Transcription factors [BR:mmu03000], Tal/Twist/Atonal/Hen, Lymphoid factors'),('5215','mmu04261  Adrenergic signaling in cardiomyocytes','04261 Adrenergic signaling in cardiomyocytes, 03000 Transcription factors [BR:mmu03000], CREB'),('5216','mmu04310  Wnt signaling pathway, mmu04390  Hippo signaling pathway, mmu04520  Adherens junction, mmu04916  Melanogenesis, mmu04934  Cushing syndrome, mmu04936  Alcoholic liver disease, mmu05132  Salmonella infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05200  Pathways in cancer, mmu05210  Colorectal cancer, mmu05213  Endometrial cancer, mmu05215  Prostate cancer, mmu05216  Thyroid cancer, mmu05217  Basal cell carcinoma, mmu05221  Acute myeloid leukemia, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05412  Arrhythmogenic right ventricular cardiomyopathy','04310 Wnt signaling pathway, 04390 Hippo signaling pathway, 04520 Adherens junction, 04916 Melanogenesis, 05200 Pathways in cancer, 05210 Colorectal cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05217 Basal cell carcinoma, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05167 Kaposi sarcoma-associated herpesvirus infection, 05132 Salmonella infection, 05412 Arrhythmogenic right ventricular cardiomyopathy, 04936 Alcoholic liver disease, 04934 Cushing syndrome, 03000 Transcription factors [BR:mmu03000], HMG TCF-1'),('5217','mmu04010  MAPK signaling pathway, mmu04012  ErbB signaling pathway, mmu04110  Cell cycle, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04310  Wnt signaling pathway, mmu04350  TGF-beta signaling pathway, mmu04390  Hippo signaling pathway, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04630  JAK-STAT signaling pathway, mmu04919  Thyroid hormone signaling pathway, mmu05132  Salmonella infection, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05169  Epstein-Barr virus infection, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05210  Colorectal cancer, mmu05213  Endometrial cancer, mmu05216  Thyroid cancer, mmu05219  Bladder cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05230  Central carbon metabolism in cancer','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04310 Wnt signaling pathway, 04350 TGF-beta signaling pathway, 04390 Hippo signaling pathway, 04630 JAK-STAT signaling pathway, 04151 PI3K-Akt signaling pathway, 04110 Cell cycle, 04218 Cellular senescence, 04550 Signaling pathways regulating pluripotency of stem cells, 04919 Thyroid hormone signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05230 Central carbon metabolism in cancer, 05210 Colorectal cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05219 Bladder cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 03000 Transcription factors [BR:mmu03000], 03019 Messenger RNA biogenesis [BR:mmu03019], Cell cycle controlling factors, Myc, Factors that have mRNA localization signals'),('5218','mmu01522  Endocrine resistance, mmu04010  MAPK signaling pathway, mmu04024  cAMP signaling pathway, mmu04210  Apoptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04668  TNF signaling pathway, mmu04713  Circadian entrainment, mmu04725  Cholinergic synapse, mmu04728  Dopaminergic synapse, mmu04915  Estrogen signaling pathway, mmu04917  Prolactin signaling pathway, mmu04921  Oxytocin signaling pathway, mmu04926  Relaxin signaling pathway, mmu04928  Parathyroid hormone synthesis, secretion and action, mmu04932  Non-alcoholic fatty liver disease, mmu04935  Growth hormone synthesis, secretion and action, mmu05031  Amphetamine addiction, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05161  Hepatitis B, mmu05162  Measles, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05210  Colorectal cancer, mmu05224  Breast cancer, mmu05231  Choline metabolism in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04668 TNF signaling pathway, 04024 cAMP signaling pathway, 04210 Apoptosis, 04620 Toll-like receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04915 Estrogen signaling pathway, 04917 Prolactin signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04928 Parathyroid hormone synthesis, secretion and action, 04725 Cholinergic synapse, 04728 Dopaminergic synapse, 04380 Osteoclast differentiation, 04713 Circadian entrainment, 05200 Pathways in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05224 Breast cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05167 Kaposi sarcoma-associated herpesvirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05031 Amphetamine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 01522 Endocrine resistance, 03000 Transcription factors [BR:mmu03000], 04131 Membrane trafficking [BR:mmu04131], AP-1(-like) components, Fos, Selective cargos'),('5219',NULL,'03000 Transcription factors [BR:mmu03000], AP-2 (bHSH)'),('5220','mmu04062  Chemokine signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04917  Prolactin signaling pathway, mmu04919  Thyroid hormone signaling pathway, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04935  Growth hormone synthesis, secretion and action, mmu05140  Leishmaniasis, mmu05145  Toxoplasmosis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05212  Pancreatic cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease','04630 JAK-STAT signaling pathway, 04217 Necroptosis, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04062 Chemokine signaling pathway, 04917 Prolactin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05152 Tuberculosis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05321 Inflammatory bowel disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 03000 Transcription factors [BR:mmu03000], STAT'),('5221','mmu05207  Chemical carcinogenesis - receptor activation','05207 Chemical carcinogenesis - receptor activation, 03000 Transcription factors [BR:mmu03000], Cys2His2 SP/KLF family and related proteins'),('5222','mmu00310  Lysine degradation, mmu01100  Metabolic pathways, mmu05206  MicroRNAs in cancer','00310 Lysine degradation, 05206 MicroRNAs in cancer, 03036 Chromosome and associated proteins [BR:mmu03036], 2.1.1.356  [histone H3]-lysine27 N-trimethyltransferase, HKMTs (histone lysine methyltransferases), PRC2-EZH2 complex'),('5223',NULL,'03016 Transfer RNA biogenesis [BR:mmu03016], 03036 Chromosome and associated proteins [BR:mmu03036], Elongator complex, Elongator complex'),('5224','mmu04022  cGMP-PKG signaling pathway, mmu04024  cAMP signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04261  Adrenergic signaling in cardiomyocytes, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04668  TNF signaling pathway, mmu04710  Circadian rhythm, mmu04713  Circadian entrainment, mmu04714  Thermogenesis, mmu04725  Cholinergic synapse, mmu04728  Dopaminergic synapse, mmu04911  Insulin secretion, mmu04915  Estrogen signaling pathway, mmu04916  Melanogenesis, mmu04918  Thyroid hormone synthesis, mmu04922  Glucagon signaling pathway, mmu04924  Renin secretion, mmu04925  Aldosterone synthesis and secretion, mmu04926  Relaxin signaling pathway, mmu04927  Cortisol synthesis and secretion, mmu04928  Parathyroid hormone synthesis, secretion and action, mmu04931  Insulin resistance, mmu04934  Cushing syndrome, mmu04935  Growth hormone synthesis, secretion and action, mmu04962  Vasopressin-regulated water reabsorption, mmu05016  Huntington disease, mmu05020  Prion disease, mmu05030  Cocaine addiction, mmu05031  Amphetamine addiction, mmu05034  Alcoholism, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05203  Viral carcinogenesis, mmu05207  Chemical carcinogenesis - receptor activation, mmu05215  Prostate cancer','04668 TNF signaling pathway, 04024 cAMP signaling pathway, 04022 cGMP-PKG signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04612 Antigen processing and presentation, 04911 Insulin secretion, 04922 Glucagon signaling pathway, 04915 Estrogen signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04918 Thyroid hormone synthesis, 04928 Parathyroid hormone synthesis, secretion and action, 04916 Melanogenesis, 04924 Renin secretion, 04925 Aldosterone synthesis and secretion, 04927 Cortisol synthesis and secretion, 04261 Adrenergic signaling in cardiomyocytes, 04962 Vasopressin-regulated water reabsorption, 04725 Cholinergic synapse, 04728 Dopaminergic synapse, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04710 Circadian rhythm, 04713 Circadian entrainment, 04714 Thermogenesis, 05207 Chemical carcinogenesis - receptor activation, 05203 Viral carcinogenesis, 05215 Prostate cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05152 Tuberculosis, 05016 Huntington disease, 05020 Prion disease, 05030 Cocaine addiction, 05031 Amphetamine addiction, 05034 Alcoholism, 04931 Insulin resistance, 04934 Cushing syndrome, 03000 Transcription factors [BR:mmu03000], 03029 Mitochondrial biogenesis [BR:mmu03029], CREB, Ubiquitas transcription factors'),('5225','mmu04612  Antigen processing and presentation, mmu05017  Spinocerebellar ataxia, mmu05152  Tuberculosis','04612 Antigen processing and presentation, 05152 Tuberculosis, 05017 Spinocerebellar ataxia, 03000 Transcription factors [BR:mmu03000], Heteromeric CCAAT factors'),('5226','mmu01522  Endocrine resistance, mmu04110  Cell cycle, mmu04137  Mitophagy - animal, mmu04218  Cellular senescence, mmu04934  Cushing syndrome, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05169  Epstein-Barr virus infection, mmu05200  Pathways in cancer, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05212  Pancreatic cancer, mmu05214  Glioma, mmu05215  Prostate cancer, mmu05218  Melanoma, mmu05219  Bladder cancer, mmu05220  Chronic myeloid leukemia, mmu05222  Small cell lung cancer, mmu05223  Non-small cell lung cancer, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer','04137 Mitophagy - animal, 04110 Cell cycle, 04218 Cellular senescence, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05219 Bladder cancer, 05215 Prostate cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 04934 Cushing syndrome, 01522 Endocrine resistance, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix cell cycle-controlling factors, E2F'),('5227','mmu05206  MicroRNAs in cancer','05206 MicroRNAs in cancer, 03000 Transcription factors [BR:mmu03000], p53'),('5228','mmu04068  FoxO signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04213  Longevity regulating pathway - multiple species, mmu04218  Cellular senescence, mmu04910  Insulin signaling pathway, mmu04919  Thyroid hormone signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05165  Human papillomavirus infection, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05215  Prostate cancer','04068 FoxO signaling pathway, 04152 AMPK signaling pathway, 04218 Cellular senescence, 04910 Insulin signaling pathway, 04922 Glucagon signaling pathway, 04919 Thyroid hormone signaling pathway, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05215 Prostate cancer, 05165 Human papillomavirus infection, 04936 Alcoholic liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix other regulators'),('5229','mmu04068  FoxO signaling pathway, mmu04371  Apelin signaling pathway, mmu05418  Fluid shear stress and atherosclerosis','04371 Apelin signaling pathway, 04068 FoxO signaling pathway, 05418 Fluid shear stress and atherosclerosis, 03000 Transcription factors [BR:mmu03000], Cys2His2 SP/KLF family and related proteins'),('5230','mmu03018  RNA degradation','03018 RNA degradation, 03019 Messenger RNA biogenesis [BR:mmu03019], P-body specific factors, Other 3\'-5\' decay factors'),('5231','mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu05166  Human T-cell leukemia virus 1 infection, mmu05202  Transcriptional misregulation in cancer','04550 Signaling pathways regulating pluripotency of stem cells, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 03000 Transcription factors [BR:mmu03000], Ubiquitous (class A) factors'),('5232','mmu04217  Necroptosis, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu05161  Hepatitis B, mmu05200  Pathways in cancer, mmu05321  Inflammatory bowel disease','04630 JAK-STAT signaling pathway, 04217 Necroptosis, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05161 Hepatitis B, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:mmu03000], STAT'),('5233','mmu04068  FoxO signaling pathway, mmu05202  Transcriptional misregulation in cancer, mmu05207  Chemical carcinogenesis - receptor activation','04068 FoxO signaling pathway, 05202 Transcriptional misregulation in cancer, 05207 Chemical carcinogenesis - receptor activation, 03000 Transcription factors [BR:mmu03000], Cys2His2 BTB-ZF factors'),('5234','mmu04950  Maturity onset diabetes of the young','04950 Maturity onset diabetes of the young, 03000 Transcription factors [BR:mmu03000], Homeo domain POU'),('5235','mmu04141  Protein processing in endoplasmic reticulum, mmu05012  Parkinson disease, mmu05200  Pathways in cancer, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05225  Hepatocellular carcinoma, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 05200 Pathways in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05012 Parkinson disease, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 03000 Transcription factors [BR:mmu03000], 03029 Mitochondrial biogenesis [BR:mmu03029], AP-1(-like) components, NF-E2, Nuclear respiratory factors'),('5236','mmu04024  cAMP signaling pathway, mmu04340  Hedgehog signaling pathway, mmu05200  Pathways in cancer, mmu05217  Basal cell carcinoma','04340 Hedgehog signaling pathway, 04024 cAMP signaling pathway, 05200 Pathways in cancer, 05217 Basal cell carcinoma, 03000 Transcription factors [BR:mmu03000], Cys2His2 GLI-like'),('5237','mmu04950  Maturity onset diabetes of the young','04950 Maturity onset diabetes of the young, 03000 Transcription factors [BR:mmu03000], Tal/Twist/Atonal/Hen, Atonal'),('5238','mmu05202  Transcriptional misregulation in cancer','05202 Transcriptional misregulation in cancer, 03000 Transcription factors [BR:mmu03000], Tryptophan clusters Ets-type'),('5239','mmu04015  Rap1 signaling pathway, mmu04310  Wnt signaling pathway, mmu04390  Hippo signaling pathway, mmu04510  Focal adhesion, mmu04520  Adherens junction, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04670  Leukocyte transendothelial migration, mmu04916  Melanogenesis, mmu04919  Thyroid hormone signaling pathway, mmu04934  Cushing syndrome, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05100  Bacterial invasion of epithelial cells, mmu05132  Salmonella infection, mmu05160  Hepatitis C, mmu05163  Human cytomegalovirus infection, mmu05165  Human papillomavirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05210  Colorectal cancer, mmu05213  Endometrial cancer, mmu05215  Prostate cancer, mmu05216  Thyroid cancer, mmu05217  Basal cell carcinoma, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05412  Arrhythmogenic right ventricular cardiomyopathy, mmu05418  Fluid shear stress and atherosclerosis','04015 Rap1 signaling pathway, 04310 Wnt signaling pathway, 04390 Hippo signaling pathway, 04510 Focal adhesion, 04520 Adherens junction, 04550 Signaling pathways regulating pluripotency of stem cells, 04670 Leukocyte transendothelial migration, 04919 Thyroid hormone signaling pathway, 04916 Melanogenesis, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05210 Colorectal cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05216 Thyroid cancer, 05217 Basal cell carcinoma, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05160 Hepatitis C, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05100 Bacterial invasion of epithelial cells, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05418 Fluid shear stress and atherosclerosis, 05412 Arrhythmogenic right ventricular cardiomyopathy, 04936 Alcoholic liver disease, 04934 Cushing syndrome'),('5240','mmu04371  Apelin signaling pathway, mmu04912  GnRH signaling pathway, mmu04928  Parathyroid hormone synthesis, secretion and action, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05020  Prion disease, mmu05166  Human T-cell leukemia virus 1 infection','04371 Apelin signaling pathway, 04912 GnRH signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 05166 Human T-cell leukemia virus 1 infection, 05020 Prion disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 03000 Transcription factors [BR:mmu03000], Cys2His2 SP/KLF family and related proteins'),('5241','mmu03250  Viral life cycle - HIV-1, mmu04024  cAMP signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04110  Cell cycle, mmu04310  Wnt signaling pathway, mmu04330  Notch signaling pathway, mmu04350  TGF-beta signaling pathway, mmu04520  Adherens junction, mmu04630  JAK-STAT signaling pathway, mmu04720  Long-term potentiation, mmu04916  Melanogenesis, mmu04919  Thyroid hormone signaling pathway, mmu04922  Glucagon signaling pathway, mmu04935  Growth hormone synthesis, secretion and action, mmu05016  Huntington disease, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05211  Renal cell carcinoma, mmu05215  Prostate cancer','03250 Viral life cycle - HIV-1, 04310 Wnt signaling pathway, 04330 Notch signaling pathway, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04024 cAMP signaling pathway, 04110 Cell cycle, 04520 Adherens junction, 04922 Glucagon signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04916 Melanogenesis, 04720 Long-term potentiation, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05203 Viral carcinogenesis, 05211 Renal cell carcinoma, 05215 Prostate cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05164 Influenza A, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05152 Tuberculosis, 05016 Huntington disease, 03000 Transcription factors [BR:mmu03000], 03036 Chromosome and associated proteins [BR:mmu03036], 03029 Mitochondrial biogenesis [BR:mmu03029], 2.3.1.48  histone acetyltransferase, Pocket domain CBP, HATs (histone acetyltransferases), Coactivators'),('5242','mmu04911  Insulin secretion, mmu04930  Type II diabetes mellitus, mmu04950  Maturity onset diabetes of the young','04911 Insulin secretion, 04930 Type II diabetes mellitus, 04950 Maturity onset diabetes of the young, 03000 Transcription factors [BR:mmu03000], Homeo domain ANTP: HOXL'),('5243',NULL,'03000 Transcription factors [BR:mmu03000], Cys2His2 others'),('5244',NULL,'03000 Transcription factors [BR:mmu03000], Cell cycle controlling factors, Mad/Max'),('5245','mmu05202  Transcriptional misregulation in cancer','05202 Transcriptional misregulation in cancer, 03000 Transcription factors [BR:mmu03000], Tal/Twist/Atonal/Hen, Lymphoid factors'),('5246','mmu04310  Wnt signaling pathway','04310 Wnt signaling pathway, 03036 Chromosome and associated proteins [BR:mmu03036], 5.6.2.4  DNA 3\'-5\' helicase, TIP60 complex, SRCAP complex, INO80 complex, INO80 complex (yeast), SWR1 complex, ASTRA complex'),('5247','mmu03022  Basal transcription factors, mmu05016  Huntington disease','03022 Basal transcription factors, 05016 Huntington disease, 03021 Transcription machinery [BR:mmu03021], 03036 Chromosome and associated proteins [BR:mmu03036], TFIID, SAGA/TFTC/STAGA complex, TFTC complex'),('5248','mmu04014  Ras signaling pathway, mmu04068  FoxO signaling pathway','04014 Ras signaling pathway, 04068 FoxO signaling pathway, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix other regulators'),('5249','mmu01522  Endocrine resistance, mmu04110  Cell cycle, mmu04218  Cellular senescence, mmu04934  Cushing syndrome, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05169  Epstein-Barr virus infection, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05207  Chemical carcinogenesis - receptor activation, mmu05212  Pancreatic cancer, mmu05214  Glioma, mmu05215  Prostate cancer, mmu05218  Melanoma, mmu05219  Bladder cancer, mmu05220  Chronic myeloid leukemia, mmu05222  Small cell lung cancer, mmu05223  Non-small cell lung cancer, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer','04110 Cell cycle, 04218 Cellular senescence, 05200 Pathways in cancer, 05207 Chemical carcinogenesis - receptor activation, 05203 Viral carcinogenesis, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05219 Bladder cancer, 05215 Prostate cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 04934 Cushing syndrome, 01522 Endocrine resistance, 01009 Protein phosphatases and associated proteins [BR:mmu01009], 03000 Transcription factors [BR:mmu03000], PP1-interacting proteins (PIPs), Pocket domain Rb'),('5250','mmu04115  p53 signaling pathway, mmu04390  Hippo signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu05162  Measles','04390 Hippo signaling pathway, 04115 p53 signaling pathway, 04722 Neurotrophin signaling pathway, 05162 Measles, 03000 Transcription factors [BR:mmu03000], p53'),('5251',NULL,'03000 Transcription factors [BR:mmu03000], Cys2His2 BTB-ZF factors'),('5252',NULL,'03000 Transcription factors [BR:mmu03000], Cys2His2 BTB-ZF factors'),('5253','mmu04110  Cell cycle, mmu04114  Oocyte meiosis, mmu05166  Human T-cell leukemia virus 1 infection','04110 Cell cycle, 04114 Oocyte meiosis, 05166 Human T-cell leukemia virus 1 infection, 03036 Chromosome and associated proteins [BR:mmu03036], Securin'),('5254','mmu04080  Neuroactive ligand-receptor interaction','04080 Neuroactive ligand-receptor interaction, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 estrogen receptor-like, 3C. 3-Ketosteroid receptor'),('5255','mmu01522  Endocrine resistance, mmu01524  Platinum drug resistance, mmu04010  MAPK signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04110  Cell cycle, mmu04115  p53 signaling pathway, mmu04137  Mitophagy - animal, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04216  Ferroptosis, mmu04218  Cellular senescence, mmu04310  Wnt signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04919  Thyroid hormone signaling pathway, mmu05012  Parkinson disease, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05210  Colorectal cancer, mmu05212  Pancreatic cancer, mmu05213  Endometrial cancer, mmu05214  Glioma, mmu05215  Prostate cancer, mmu05216  Thyroid cancer, mmu05217  Basal cell carcinoma, mmu05218  Melanoma, mmu05219  Bladder cancer, mmu05220  Chronic myeloid leukemia, mmu05222  Small cell lung cancer, mmu05223  Non-small cell lung cancer, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05230  Central carbon metabolism in cancer, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04310 Wnt signaling pathway, 04071 Sphingolipid signaling pathway, 04151 PI3K-Akt signaling pathway, 04137 Mitophagy - animal, 04110 Cell cycle, 04210 Apoptosis, 04216 Ferroptosis, 04115 p53 signaling pathway, 04218 Cellular senescence, 04919 Thyroid hormone signaling pathway, 04722 Neurotrophin signaling pathway, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05203 Viral carcinogenesis, 05230 Central carbon metabolism in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05220 Chronic myeloid leukemia, 05217 Basal cell carcinoma, 05218 Melanoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 01524 Platinum drug resistance, 01522 Endocrine resistance, 03000 Transcription factors [BR:mmu03000], 03036 Chromosome and associated proteins [BR:mmu03036], 03400 DNA repair and recombination proteins [BR:mmu03400], p53, Regulators of Aurora kinases, Other check point factors'),('5256',NULL,'03000 Transcription factors [BR:mmu03000], 03036 Chromosome and associated proteins [BR:mmu03036], 03029 Mitochondrial biogenesis [BR:mmu03029], Cys2His2 others, Other polycomb group proteins, Ubiquitas transcription factors'),('5257','mmu04066  HIF-1 signaling pathway, mmu04137  Mitophagy - animal, mmu04140  Autophagy - animal, mmu04659  Th17 cell differentiation, mmu04919  Thyroid hormone signaling pathway, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05211  Renal cell carcinoma, mmu05230  Central carbon metabolism in cancer, mmu05231  Choline metabolism in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer','04066 HIF-1 signaling pathway, 04140 Autophagy - animal, 04137 Mitophagy - animal, 04659 Th17 cell differentiation, 04919 Thyroid hormone signaling pathway, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05211 Renal cell carcinoma, 05167 Kaposi sarcoma-associated herpesvirus infection, 03000 Transcription factors [BR:mmu03000], Factors with PAS domain'),('5258','mmu04066  HIF-1 signaling pathway, mmu04120  Ubiquitin mediated proteolysis, mmu05200  Pathways in cancer, mmu05211  Renal cell carcinoma','04120 Ubiquitin mediated proteolysis, 04066 HIF-1 signaling pathway, 05200 Pathways in cancer, 05211 Renal cell carcinoma, 04121 Ubiquitin system [BR:mmu04121], Target recognizing subunit (VHL box)'),('5259','mmu05200  Pathways in cancer, mmu05211  Renal cell carcinoma','05200 Pathways in cancer, 05211 Renal cell carcinoma, 03000 Transcription factors [BR:mmu03000], 04131 Membrane trafficking [BR:mmu04131], Factors with PAS domain, Other pexophagy associated proteins'),('5260','mmu05200  Pathways in cancer, mmu05211  Renal cell carcinoma','05200 Pathways in cancer, 05211 Renal cell carcinoma, 03000 Transcription factors [BR:mmu03000], 04131 Membrane trafficking [BR:mmu04131], Factors with PAS domain, Other pexophagy associated proteins'),('5261','mmu04710  Circadian rhythm, mmu04728  Dopaminergic synapse','04728 Dopaminergic synapse, 04710 Circadian rhythm, 03000 Transcription factors [BR:mmu03000], Factors with PAS domain'),('5262','mmu04710  Circadian rhythm, mmu04728  Dopaminergic synapse','04728 Dopaminergic synapse, 04710 Circadian rhythm, 03000 Transcription factors [BR:mmu03000], Factors with PAS domain'),('5263','mmu01522  Endocrine resistance, mmu01524  Platinum drug resistance, mmu04110  Cell cycle, mmu04115  p53 signaling pathway, mmu04218  Cellular senescence, mmu04934  Cushing syndrome, mmu05163  Human cytomegalovirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05212  Pancreatic cancer, mmu05214  Glioma, mmu05218  Melanoma, mmu05219  Bladder cancer, mmu05220  Chronic myeloid leukemia, mmu05223  Non-small cell lung cancer, mmu05225  Hepatocellular carcinoma','04110 Cell cycle, 04115 p53 signaling pathway, 04218 Cellular senescence, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05203 Viral carcinogenesis, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05214 Glioma, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05219 Bladder cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05163 Human cytomegalovirus infection, 04934 Cushing syndrome, 01524 Platinum drug resistance, 01522 Endocrine resistance'),('5264','mmu01522  Endocrine resistance, mmu01524  Platinum drug resistance, mmu04110  Cell cycle, mmu04115  p53 signaling pathway, mmu04218  Cellular senescence, mmu04934  Cushing syndrome, mmu05163  Human cytomegalovirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05212  Pancreatic cancer, mmu05214  Glioma, mmu05218  Melanoma, mmu05219  Bladder cancer, mmu05220  Chronic myeloid leukemia, mmu05223  Non-small cell lung cancer, mmu05225  Hepatocellular carcinoma','04110 Cell cycle, 04115 p53 signaling pathway, 04218 Cellular senescence, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05203 Viral carcinogenesis, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05214 Glioma, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05219 Bladder cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05163 Human cytomegalovirus infection, 04934 Cushing syndrome, 01524 Platinum drug resistance, 01522 Endocrine resistance'),('5265','mmu01522  Endocrine resistance, mmu04330  Notch signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04919  Thyroid hormone signaling pathway, mmu05020  Prion disease, mmu05165  Human papillomavirus infection, mmu05200  Pathways in cancer, mmu05206  MicroRNAs in cancer, mmu05224  Breast cancer','04330 Notch signaling pathway, 04658 Th1 and Th2 cell differentiation, 04919 Thyroid hormone signaling pathway, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05224 Breast cancer, 05165 Human papillomavirus infection, 05020 Prion disease, 01522 Endocrine resistance'),('5266','mmu01522  Endocrine resistance, mmu04330  Notch signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04919  Thyroid hormone signaling pathway, mmu05165  Human papillomavirus infection, mmu05200  Pathways in cancer, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05224  Breast cancer','04330 Notch signaling pathway, 04658 Th1 and Th2 cell differentiation, 04919 Thyroid hormone signaling pathway, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05224 Breast cancer, 05165 Human papillomavirus infection, 01522 Endocrine resistance'),('5267','mmu01522  Endocrine resistance, mmu04330  Notch signaling pathway, mmu04371  Apelin signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04919  Thyroid hormone signaling pathway, mmu05165  Human papillomavirus infection, mmu05200  Pathways in cancer, mmu05206  MicroRNAs in cancer, mmu05224  Breast cancer','04330 Notch signaling pathway, 04371 Apelin signaling pathway, 04658 Th1 and Th2 cell differentiation, 04919 Thyroid hormone signaling pathway, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05224 Breast cancer, 05165 Human papillomavirus infection, 01522 Endocrine resistance'),('5268','mmu01522  Endocrine resistance, mmu04330  Notch signaling pathway, mmu04919  Thyroid hormone signaling pathway, mmu05165  Human papillomavirus infection, mmu05200  Pathways in cancer, mmu05206  MicroRNAs in cancer, mmu05224  Breast cancer','04330 Notch signaling pathway, 04919 Thyroid hormone signaling pathway, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05224 Breast cancer, 05165 Human papillomavirus infection, 01522 Endocrine resistance'),('5269','mmu04010  MAPK signaling pathway, mmu04022  cGMP-PKG signaling pathway, mmu04137  Mitophagy - animal, mmu04141  Protein processing in endoplasmic reticulum, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04261  Adrenergic signaling in cardiomyocytes, mmu04668  TNF signaling pathway, mmu04720  Long-term potentiation, mmu04722  Neurotrophin signaling pathway, mmu04725  Cholinergic synapse, mmu04728  Dopaminergic synapse, mmu04911  Insulin secretion, mmu04912  GnRH signaling pathway, mmu04915  Estrogen signaling pathway, mmu04918  Thyroid hormone synthesis, mmu04922  Glucagon signaling pathway, mmu04925  Aldosterone synthesis and secretion, mmu04926  Relaxin signaling pathway, mmu04927  Cortisol synthesis and secretion, mmu04928  Parathyroid hormone synthesis, secretion and action, mmu04932  Non-alcoholic fatty liver disease, mmu04934  Cushing syndrome, mmu04935  Growth hormone synthesis, secretion and action, mmu05010  Alzheimer disease, mmu05012  Parkinson disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05031  Amphetamine addiction, mmu05034  Alcoholism, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05203  Viral carcinogenesis, mmu05207  Chemical carcinogenesis - receptor activation, mmu05215  Prostate cancer, mmu05417  Lipid and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 04010 MAPK signaling pathway, 04668 TNF signaling pathway, 04022 cGMP-PKG signaling pathway, 04151 PI3K-Akt signaling pathway, 04137 Mitophagy - animal, 04210 Apoptosis, 04911 Insulin secretion, 04922 Glucagon signaling pathway, 04912 GnRH signaling pathway, 04915 Estrogen signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04918 Thyroid hormone synthesis, 04928 Parathyroid hormone synthesis, secretion and action, 04925 Aldosterone synthesis and secretion, 04927 Cortisol synthesis and secretion, 04261 Adrenergic signaling in cardiomyocytes, 04725 Cholinergic synapse, 04728 Dopaminergic synapse, 04720 Long-term potentiation, 04722 Neurotrophin signaling pathway, 04211 Longevity regulating pathway, 05207 Chemical carcinogenesis - receptor activation, 05203 Viral carcinogenesis, 05215 Prostate cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05163 Human cytomegalovirus infection, 05010 Alzheimer disease, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05031 Amphetamine addiction, 05034 Alcoholism, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 04934 Cushing syndrome, 03000 Transcription factors [BR:mmu03000], AP-1(-like) components, CRE-BP/ATF'),('5270','mmu01524  Platinum drug resistance, mmu03440  Homologous recombination, mmu03460  Fanconi anemia pathway, mmu04120  Ubiquitin mediated proteolysis, mmu04151  PI3K-Akt signaling pathway, mmu05206  MicroRNAs in cancer, mmu05224  Breast cancer','04120 Ubiquitin mediated proteolysis, 03440 Homologous recombination, 03460 Fanconi anemia pathway, 04151 PI3K-Akt signaling pathway, 05206 MicroRNAs in cancer, 05224 Breast cancer, 01524 Platinum drug resistance, 01009 Protein phosphatases and associated proteins [BR:mmu01009], 04121 Ubiquitin system [BR:mmu04121], 03036 Chromosome and associated proteins [BR:mmu03036], 03400 DNA repair and recombination proteins [BR:mmu03400], 2.3.2.27  RING-type E3 ubiquitin transferase, PP1-interacting proteins (PIPs), Other single Ring-finger type E3, BRCC complex, Regulators of centriole replication, BRCA1-core complex, BRCA1-A complex, BRCA1-B complex, BRCA1-C complex, BRCA complex, Downstream FA components'),('5271','mmu04152  AMPK signaling pathway, mmu04950  Maturity onset diabetes of the young','04152 AMPK signaling pathway, 04950 Maturity onset diabetes of the young, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 hepatocyte nuclear factor 4-like, 2A. Hepatocyte nuclear factor 4 receptor'),('5272','mmu04152  AMPK signaling pathway, mmu04950  Maturity onset diabetes of the young','04152 AMPK signaling pathway, 04950 Maturity onset diabetes of the young, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 hepatocyte nuclear factor 4-like, 2A. Hepatocyte nuclear factor 4 receptor'),('5273',NULL,'03000 Transcription factors [BR:mmu03000], T-box'),('5274','mmu05202  Transcriptional misregulation in cancer','05202 Transcriptional misregulation in cancer'),('5275',NULL,'03000 Transcription factors [BR:mmu03000], Cell cycle controlling factors, Mad/Max'),('5276',NULL,'03000 Transcription factors [BR:mmu03000], Cys2His2 others'),('5277','mmu04911  Insulin secretion, mmu04930  Type II diabetes mellitus, mmu04950  Maturity onset diabetes of the young','04911 Insulin secretion, 04930 Type II diabetes mellitus, 04950 Maturity onset diabetes of the young, 03000 Transcription factors [BR:mmu03000], Homeo domain ANTP: HOXL'),('5278','mmu03250  Viral life cycle - HIV-1, mmu04024  cAMP signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04110  Cell cycle, mmu04310  Wnt signaling pathway, mmu04330  Notch signaling pathway, mmu04350  TGF-beta signaling pathway, mmu04520  Adherens junction, mmu04630  JAK-STAT signaling pathway, mmu04720  Long-term potentiation, mmu04916  Melanogenesis, mmu04919  Thyroid hormone signaling pathway, mmu04922  Glucagon signaling pathway, mmu04935  Growth hormone synthesis, secretion and action, mmu05016  Huntington disease, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05211  Renal cell carcinoma, mmu05215  Prostate cancer','03250 Viral life cycle - HIV-1, 04310 Wnt signaling pathway, 04330 Notch signaling pathway, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04024 cAMP signaling pathway, 04110 Cell cycle, 04520 Adherens junction, 04922 Glucagon signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04916 Melanogenesis, 04720 Long-term potentiation, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05203 Viral carcinogenesis, 05211 Renal cell carcinoma, 05215 Prostate cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05164 Influenza A, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05152 Tuberculosis, 05016 Huntington disease, 03000 Transcription factors [BR:mmu03000], 03036 Chromosome and associated proteins [BR:mmu03036], 03029 Mitochondrial biogenesis [BR:mmu03029], 2.3.1.48  histone acetyltransferase, Pocket domain CBP, HATs (histone acetyltransferases), Coactivators'),('5279','mmu04371  Apelin signaling pathway, mmu04912  GnRH signaling pathway, mmu04928  Parathyroid hormone synthesis, secretion and action, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05020  Prion disease, mmu05166  Human T-cell leukemia virus 1 infection','04371 Apelin signaling pathway, 04912 GnRH signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 05166 Human T-cell leukemia virus 1 infection, 05020 Prion disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 03000 Transcription factors [BR:mmu03000], Cys2His2 SP/KLF family and related proteins'),('5280','mmu04371  Apelin signaling pathway, mmu04912  GnRH signaling pathway, mmu04928  Parathyroid hormone synthesis, secretion and action, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05020  Prion disease, mmu05166  Human T-cell leukemia virus 1 infection','04371 Apelin signaling pathway, 04912 GnRH signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 05166 Human T-cell leukemia virus 1 infection, 05020 Prion disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 03000 Transcription factors [BR:mmu03000], Cys2His2 SP/KLF family and related proteins'),('5281','mmu04015  Rap1 signaling pathway, mmu04310  Wnt signaling pathway, mmu04390  Hippo signaling pathway, mmu04510  Focal adhesion, mmu04520  Adherens junction, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04670  Leukocyte transendothelial migration, mmu04916  Melanogenesis, mmu04919  Thyroid hormone signaling pathway, mmu04934  Cushing syndrome, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05100  Bacterial invasion of epithelial cells, mmu05132  Salmonella infection, mmu05160  Hepatitis C, mmu05163  Human cytomegalovirus infection, mmu05165  Human papillomavirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05210  Colorectal cancer, mmu05213  Endometrial cancer, mmu05215  Prostate cancer, mmu05216  Thyroid cancer, mmu05217  Basal cell carcinoma, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05412  Arrhythmogenic right ventricular cardiomyopathy, mmu05418  Fluid shear stress and atherosclerosis','04015 Rap1 signaling pathway, 04310 Wnt signaling pathway, 04390 Hippo signaling pathway, 04510 Focal adhesion, 04520 Adherens junction, 04550 Signaling pathways regulating pluripotency of stem cells, 04670 Leukocyte transendothelial migration, 04919 Thyroid hormone signaling pathway, 04916 Melanogenesis, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05210 Colorectal cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05216 Thyroid cancer, 05217 Basal cell carcinoma, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05160 Hepatitis C, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05100 Bacterial invasion of epithelial cells, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05418 Fluid shear stress and atherosclerosis, 05412 Arrhythmogenic right ventricular cardiomyopathy, 04936 Alcoholic liver disease, 04934 Cushing syndrome'),('5282','mmu05202  Transcriptional misregulation in cancer','05202 Transcriptional misregulation in cancer, 03000 Transcription factors [BR:mmu03000], Tryptophan clusters Ets-type'),('5283','mmu04950  Maturity onset diabetes of the young','04950 Maturity onset diabetes of the young, 03000 Transcription factors [BR:mmu03000], Tal/Twist/Atonal/Hen, Atonal'),('5284','mmu04024  cAMP signaling pathway, mmu04340  Hedgehog signaling pathway, mmu05200  Pathways in cancer, mmu05217  Basal cell carcinoma','04340 Hedgehog signaling pathway, 04024 cAMP signaling pathway, 05200 Pathways in cancer, 05217 Basal cell carcinoma, 03000 Transcription factors [BR:mmu03000], Cys2His2 GLI-like'),('5285',NULL,'03000 Transcription factors [BR:mmu03000], Homeo domain ANTP: NKL'),('5286','mmu04950  Maturity onset diabetes of the young','04950 Maturity onset diabetes of the young, 03000 Transcription factors [BR:mmu03000], Homeo domain POU'),('5287','mmu04217  Necroptosis, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu05161  Hepatitis B, mmu05200  Pathways in cancer, mmu05321  Inflammatory bowel disease','04630 JAK-STAT signaling pathway, 04217 Necroptosis, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05161 Hepatitis B, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:mmu03000], STAT'),('5288','mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu05166  Human T-cell leukemia virus 1 infection, mmu05202  Transcriptional misregulation in cancer','04550 Signaling pathways regulating pluripotency of stem cells, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 03000 Transcription factors [BR:mmu03000], Ubiquitous (class A) factors'),('5289','mmu03018  RNA degradation','03018 RNA degradation, 03019 Messenger RNA biogenesis [BR:mmu03019], P-body specific factors, Other 3\'-5\' decay factors'),('5290','mmu04068  FoxO signaling pathway, mmu04371  Apelin signaling pathway, mmu05418  Fluid shear stress and atherosclerosis','04371 Apelin signaling pathway, 04068 FoxO signaling pathway, 05418 Fluid shear stress and atherosclerosis, 03000 Transcription factors [BR:mmu03000], Cys2His2 SP/KLF family and related proteins'),('5291','mmu05206  MicroRNAs in cancer','05206 MicroRNAs in cancer, 03000 Transcription factors [BR:mmu03000], p53'),('5292','mmu01522  Endocrine resistance, mmu04110  Cell cycle, mmu04137  Mitophagy - animal, mmu04218  Cellular senescence, mmu04934  Cushing syndrome, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05169  Epstein-Barr virus infection, mmu05200  Pathways in cancer, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05212  Pancreatic cancer, mmu05214  Glioma, mmu05215  Prostate cancer, mmu05218  Melanoma, mmu05219  Bladder cancer, mmu05220  Chronic myeloid leukemia, mmu05222  Small cell lung cancer, mmu05223  Non-small cell lung cancer, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer','04137 Mitophagy - animal, 04110 Cell cycle, 04218 Cellular senescence, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05219 Bladder cancer, 05215 Prostate cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 04934 Cushing syndrome, 01522 Endocrine resistance, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix cell cycle-controlling factors, E2F'),('5293','mmu04612  Antigen processing and presentation, mmu05017  Spinocerebellar ataxia, mmu05152  Tuberculosis','04612 Antigen processing and presentation, 05152 Tuberculosis, 05017 Spinocerebellar ataxia, 03000 Transcription factors [BR:mmu03000], Heteromeric CCAAT factors'),('5294','mmu04022  cGMP-PKG signaling pathway, mmu04024  cAMP signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04261  Adrenergic signaling in cardiomyocytes, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04668  TNF signaling pathway, mmu04710  Circadian rhythm, mmu04713  Circadian entrainment, mmu04714  Thermogenesis, mmu04725  Cholinergic synapse, mmu04728  Dopaminergic synapse, mmu04911  Insulin secretion, mmu04915  Estrogen signaling pathway, mmu04916  Melanogenesis, mmu04918  Thyroid hormone synthesis, mmu04922  Glucagon signaling pathway, mmu04924  Renin secretion, mmu04925  Aldosterone synthesis and secretion, mmu04926  Relaxin signaling pathway, mmu04927  Cortisol synthesis and secretion, mmu04928  Parathyroid hormone synthesis, secretion and action, mmu04931  Insulin resistance, mmu04934  Cushing syndrome, mmu04935  Growth hormone synthesis, secretion and action, mmu04962  Vasopressin-regulated water reabsorption, mmu05016  Huntington disease, mmu05020  Prion disease, mmu05030  Cocaine addiction, mmu05031  Amphetamine addiction, mmu05034  Alcoholism, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05203  Viral carcinogenesis, mmu05207  Chemical carcinogenesis - receptor activation, mmu05215  Prostate cancer','04668 TNF signaling pathway, 04024 cAMP signaling pathway, 04022 cGMP-PKG signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04612 Antigen processing and presentation, 04911 Insulin secretion, 04922 Glucagon signaling pathway, 04915 Estrogen signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04918 Thyroid hormone synthesis, 04928 Parathyroid hormone synthesis, secretion and action, 04916 Melanogenesis, 04924 Renin secretion, 04925 Aldosterone synthesis and secretion, 04927 Cortisol synthesis and secretion, 04261 Adrenergic signaling in cardiomyocytes, 04962 Vasopressin-regulated water reabsorption, 04725 Cholinergic synapse, 04728 Dopaminergic synapse, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04710 Circadian rhythm, 04713 Circadian entrainment, 04714 Thermogenesis, 05207 Chemical carcinogenesis - receptor activation, 05203 Viral carcinogenesis, 05215 Prostate cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05152 Tuberculosis, 05016 Huntington disease, 05020 Prion disease, 05030 Cocaine addiction, 05031 Amphetamine addiction, 05034 Alcoholism, 04931 Insulin resistance, 04934 Cushing syndrome, 03000 Transcription factors [BR:mmu03000], 03029 Mitochondrial biogenesis [BR:mmu03029], CREB, Ubiquitas transcription factors'),('5295',NULL,'03016 Transfer RNA biogenesis [BR:mmu03016], 03036 Chromosome and associated proteins [BR:mmu03036], Elongator complex, Elongator complex'),('5296','mmu00310  Lysine degradation, mmu01100  Metabolic pathways, mmu05206  MicroRNAs in cancer','00310 Lysine degradation, 05206 MicroRNAs in cancer, 03036 Chromosome and associated proteins [BR:mmu03036], 2.1.1.356  [histone H3]-lysine27 N-trimethyltransferase, HKMTs (histone lysine methyltransferases), PRC2-EZH2 complex'),('5297','mmu05207  Chemical carcinogenesis - receptor activation','05207 Chemical carcinogenesis - receptor activation, 03000 Transcription factors [BR:mmu03000], Cys2His2 SP/KLF family and related proteins'),('5298','mmu04062  Chemokine signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04917  Prolactin signaling pathway, mmu04919  Thyroid hormone signaling pathway, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04935  Growth hormone synthesis, secretion and action, mmu05140  Leishmaniasis, mmu05145  Toxoplasmosis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05212  Pancreatic cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease','04630 JAK-STAT signaling pathway, 04217 Necroptosis, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04062 Chemokine signaling pathway, 04917 Prolactin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05152 Tuberculosis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05321 Inflammatory bowel disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 03000 Transcription factors [BR:mmu03000], STAT'),('5299',NULL,'03000 Transcription factors [BR:mmu03000], AP-2 (bHSH)'),('5300','mmu01522  Endocrine resistance, mmu04010  MAPK signaling pathway, mmu04024  cAMP signaling pathway, mmu04210  Apoptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04668  TNF signaling pathway, mmu04713  Circadian entrainment, mmu04725  Cholinergic synapse, mmu04728  Dopaminergic synapse, mmu04915  Estrogen signaling pathway, mmu04917  Prolactin signaling pathway, mmu04921  Oxytocin signaling pathway, mmu04926  Relaxin signaling pathway, mmu04928  Parathyroid hormone synthesis, secretion and action, mmu04932  Non-alcoholic fatty liver disease, mmu04935  Growth hormone synthesis, secretion and action, mmu05031  Amphetamine addiction, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05161  Hepatitis B, mmu05162  Measles, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05210  Colorectal cancer, mmu05224  Breast cancer, mmu05231  Choline metabolism in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04668 TNF signaling pathway, 04024 cAMP signaling pathway, 04210 Apoptosis, 04620 Toll-like receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04915 Estrogen signaling pathway, 04917 Prolactin signaling pathway, 04921 Oxytocin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04928 Parathyroid hormone synthesis, secretion and action, 04725 Cholinergic synapse, 04728 Dopaminergic synapse, 04380 Osteoclast differentiation, 04713 Circadian entrainment, 05200 Pathways in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05224 Breast cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05167 Kaposi sarcoma-associated herpesvirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05031 Amphetamine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 01522 Endocrine resistance, 03000 Transcription factors [BR:mmu03000], 04131 Membrane trafficking [BR:mmu04131], AP-1(-like) components, Fos, Selective cargos'),('5301','mmu04010  MAPK signaling pathway, mmu04012  ErbB signaling pathway, mmu04110  Cell cycle, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04310  Wnt signaling pathway, mmu04350  TGF-beta signaling pathway, mmu04390  Hippo signaling pathway, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04630  JAK-STAT signaling pathway, mmu04919  Thyroid hormone signaling pathway, mmu05132  Salmonella infection, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05169  Epstein-Barr virus infection, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05210  Colorectal cancer, mmu05213  Endometrial cancer, mmu05216  Thyroid cancer, mmu05219  Bladder cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05230  Central carbon metabolism in cancer','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04310 Wnt signaling pathway, 04350 TGF-beta signaling pathway, 04390 Hippo signaling pathway, 04630 JAK-STAT signaling pathway, 04151 PI3K-Akt signaling pathway, 04110 Cell cycle, 04218 Cellular senescence, 04550 Signaling pathways regulating pluripotency of stem cells, 04919 Thyroid hormone signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05230 Central carbon metabolism in cancer, 05210 Colorectal cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05219 Bladder cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 03000 Transcription factors [BR:mmu03000], 03019 Messenger RNA biogenesis [BR:mmu03019], Cell cycle controlling factors, Myc, Factors that have mRNA localization signals'),('5302','mmu04310  Wnt signaling pathway, mmu04390  Hippo signaling pathway, mmu04520  Adherens junction, mmu04916  Melanogenesis, mmu04934  Cushing syndrome, mmu04936  Alcoholic liver disease, mmu05132  Salmonella infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05200  Pathways in cancer, mmu05210  Colorectal cancer, mmu05213  Endometrial cancer, mmu05215  Prostate cancer, mmu05216  Thyroid cancer, mmu05217  Basal cell carcinoma, mmu05221  Acute myeloid leukemia, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05412  Arrhythmogenic right ventricular cardiomyopathy','04310 Wnt signaling pathway, 04390 Hippo signaling pathway, 04520 Adherens junction, 04916 Melanogenesis, 05200 Pathways in cancer, 05210 Colorectal cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05217 Basal cell carcinoma, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05167 Kaposi sarcoma-associated herpesvirus infection, 05132 Salmonella infection, 05412 Arrhythmogenic right ventricular cardiomyopathy, 04936 Alcoholic liver disease, 04934 Cushing syndrome, 03000 Transcription factors [BR:mmu03000], HMG TCF-1'),('5303','mmu04261  Adrenergic signaling in cardiomyocytes','04261 Adrenergic signaling in cardiomyocytes, 03000 Transcription factors [BR:mmu03000], CREB'),('5307','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Hydroxy-carboxylic acid'),('5308','mmu05202  Transcriptional misregulation in cancer','05202 Transcriptional misregulation in cancer, 03000 Transcription factors [BR:mmu03000], Cys2His2 SP/KLF family and related proteins'),('5309','mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04068  FoxO signaling pathway, mmu04110  Cell cycle, mmu04218  Cellular senescence, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04390  Hippo signaling pathway, mmu04659  Th17 cell differentiation, mmu04672  Intestinal immune network for IgA production, mmu04926  Relaxin signaling pathway, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05166  Human T-cell leukemia virus 1 infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05210  Colorectal cancer, mmu05211  Renal cell carcinoma, mmu05212  Pancreatic cancer, mmu05220  Chronic myeloid leukemia, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05415  Diabetic cardiomyopathy','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04390 Hippo signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04110 Cell cycle, 04218 Cellular senescence, 04659 Th17 cell differentiation, 04672 Intestinal immune network for IgA production, 04926 Relaxin signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05220 Chronic myeloid leukemia, 05211 Renal cell carcinoma, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 05415 Diabetic cardiomyopathy, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 03110 Chaperones and folding catalysts [BR:mmu03110], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Others, Transforming growth factors (RSTK binding), Growth factors/receptors'),('5310',NULL,'04990 Domain-containing proteins not elsewhere classified [BR:mmu04990], S100 proteins'),('5311','mmu04151  PI3K-Akt signaling pathway, mmu04510  Focal adhesion, mmu04512  ECM-receptor interaction, mmu04926  Relaxin signaling pathway, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04974  Protein digestion and absorption, mmu05146  Amoebiasis, mmu05165  Human papillomavirus infection, mmu05200  Pathways in cancer, mmu05222  Small cell lung cancer','04151 PI3K-Akt signaling pathway, 04512 ECM-receptor interaction, 04510 Focal adhesion, 04926 Relaxin signaling pathway, 04974 Protein digestion and absorption, 05200 Pathways in cancer, 05222 Small cell lung cancer, 05165 Human papillomavirus infection, 05146 Amoebiasis, 04933 AGE-RAGE signaling pathway in diabetic complications, 04147 Exosome [BR:mmu04147], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Exosomal proteins of other cancer cells, Extracellular matrix molecules'),('5312','mmu01522  Endocrine resistance, mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu04670  Leukocyte transendothelial migration, mmu04915  Estrogen signaling pathway, mmu04926  Relaxin signaling pathway, mmu05161  Hepatitis B, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05215  Prostate cancer, mmu05219  Bladder cancer, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04668 TNF signaling pathway, 04657 IL-17 signaling pathway, 04670 Leukocyte transendothelial migration, 04915 Estrogen signaling pathway, 04926 Relaxin signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05219 Bladder cancer, 05215 Prostate cancer, 05161 Hepatitis B, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 01522 Endocrine resistance, 01002 Peptidases and inhibitors [BR:mmu01002], 3.4.24.35  gelatinase B, Family M10'),('5313','mmu04066  HIF-1 signaling pathway','04066 HIF-1 signaling pathway, 01002 Peptidases and inhibitors [BR:mmu01002], Family I35: timp family'),('5314','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04062  Chemokine signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05144  Malaria, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05135 Yersinia infection, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Chemokines, Chemokines'),('5315','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04062  Chemokine signaling pathway, mmu04620  Toll-like receptor signaling pathway, mmu05142  Chagas disease, mmu05163  Human cytomegalovirus infection, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis','04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04620 Toll-like receptor signaling pathway, 04062 Chemokine signaling pathway, 05163 Human cytomegalovirus infection, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Chemokines, Chemokines'),('5316','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5317','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5318',NULL,'03036 Chromosome and associated proteins [BR:mmu03036], ATAC complex'),('5319',NULL,'01001 Protein kinases [BR:mmu01001], 03036 Chromosome and associated proteins [BR:mmu03036], 2.7.11.1  non-specific serine/threonine protein kinase, AUR family [OT], Protein kinases, Aurora kinases'),('5320','mmu00310  Lysine degradation, mmu01100  Metabolic pathways, mmu05202  Transcriptional misregulation in cancer','00310 Lysine degradation, 05202 Transcriptional misregulation in cancer, 03036 Chromosome and associated proteins [BR:mmu03036], 2.1.1.360  [histone H3]-lysine79 N-trimethyltransferase, HKMTs (histone lysine methyltransferases), Dot1-containing complex'),('5321','mmu05017  Spinocerebellar ataxia, mmu05166  Human T-cell leukemia virus 1 infection','05166 Human T-cell leukemia virus 1 infection, 05017 Spinocerebellar ataxia, 03000 Transcription factors [BR:mmu03000], 03036 Chromosome and associated proteins [BR:mmu03036], 2.3.1.48  histone acetyltransferase, Cys2HisCys zinc factors, HATs (histone acetyltransferases), TIP60 complex, NuA4 complex'),('5322','mmu04613  Neutrophil extracellular trap formation, mmu05014  Amyotrophic lateral sclerosis, mmu05034  Alcoholism, mmu05203  Viral carcinogenesis','04613 Neutrophil extracellular trap formation, 05203 Viral carcinogenesis, 05014 Amyotrophic lateral sclerosis, 05034 Alcoholism, 01009 Protein phosphatases and associated proteins [BR:mmu01009], 03019 Messenger RNA biogenesis [BR:mmu03019], 04131 Membrane trafficking [BR:mmu04131], 03036 Chromosome and associated proteins [BR:mmu03036], 3.5.1.98  histone deacetylase, PP1-interacting proteins (PIPs), Stress granule specific factors, Other aggrephagy associated proteins, Class II HDACs'),('5323',NULL,'04990 Domain-containing proteins not elsewhere classified [BR:mmu04990], Fibronectin type III domain-containing proteins'),('5324',NULL,NULL),('5325','mmu04530  Tight junction','04530 Tight junction'),('5326','mmu04360  Axon guidance, mmu04929  GnRH secretion','04929 GnRH secretion, 04360 Axon guidance, 01009 Protein phosphatases and associated proteins [BR:mmu01009], 04040 Ion channels [BR:mmu04040], PP1-interacting proteins (PIPs), Transient receptor potential channel (TRP)'),('5327','mmu04022  cGMP-PKG signaling pathway, mmu04360  Axon guidance','04022 cGMP-PKG signaling pathway, 04360 Axon guidance, 04040 Ion channels [BR:mmu04040], Transient receptor potential channel (TRP)'),('5328','mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04145  Phagosome, mmu04151  PI3K-Akt signaling pathway, mmu04310  Wnt signaling pathway, mmu04360  Axon guidance, mmu04370  VEGF signaling pathway, mmu04380  Osteoclast differentiation, mmu04510  Focal adhesion, mmu04520  Adherens junction, mmu04530  Tight junction, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04662  B cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04666  Fc gamma R-mediated phagocytosis, mmu04670  Leukocyte transendothelial migration, mmu04722  Neurotrophin signaling pathway, mmu04810  Regulation of actin cytoskeleton, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04972  Pancreatic secretion, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05100  Bacterial invasion of epithelial cells, mmu05132  Salmonella infection, mmu05135  Yersinia infection, mmu05163  Human cytomegalovirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05205  Proteoglycans in cancer, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05210  Colorectal cancer, mmu05211  Renal cell carcinoma, mmu05212  Pancreatic cancer, mmu05231  Choline metabolism in cancer, mmu05415  Diabetic cardiomyopathy, mmu05416  Viral myocarditis, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04310 Wnt signaling pathway, 04370 VEGF signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04145 Phagosome, 04510 Focal adhesion, 04520 Adherens junction, 04530 Tight junction, 04810 Regulation of actin cytoskeleton, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04662 B cell receptor signaling pathway, 04664 Fc epsilon RI signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04670 Leukocyte transendothelial migration, 04062 Chemokine signaling pathway, 04972 Pancreatic secretion, 04722 Neurotrophin signaling pathway, 04360 Axon guidance, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05231 Choline metabolism in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05211 Renal cell carcinoma, 05170 Human immunodeficiency virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05100 Bacterial invasion of epithelial cells, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 05416 Viral myocarditis, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04131 Membrane trafficking [BR:mmu04131], 04147 Exosome [BR:mmu04147], 04031 GTP-binding proteins [BR:mmu04031], Rho GTPases, Arf6-dependent endocytosis, Ras GTPases, Nox associated proteins, Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell), Exosomal proteins of other body fluids (saliva and urine), Exosomal proteins of colorectal cancer cells, Exosomal proteins of bladder cancer cells, Rac/Cdc42 [OT]'),('5329','mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04062  Chemokine signaling pathway, mmu04144  Endocytosis, mmu04360  Axon guidance, mmu04370  VEGF signaling pathway, mmu04510  Focal adhesion, mmu04520  Adherens junction, mmu04530  Tight junction, mmu04660  T cell receptor signaling pathway, mmu04666  Fc gamma R-mediated phagocytosis, mmu04670  Leukocyte transendothelial migration, mmu04722  Neurotrophin signaling pathway, mmu04810  Regulation of actin cytoskeleton, mmu04912  GnRH signaling pathway, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05100  Bacterial invasion of epithelial cells, mmu05132  Salmonella infection, mmu05135  Yersinia infection, mmu05165  Human papillomavirus infection, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05205  Proteoglycans in cancer, mmu05211  Renal cell carcinoma, mmu05212  Pancreatic cancer, mmu05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04370 VEGF signaling pathway, 04144 Endocytosis, 04510 Focal adhesion, 04520 Adherens junction, 04530 Tight junction, 04810 Regulation of actin cytoskeleton, 04660 T cell receptor signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04670 Leukocyte transendothelial migration, 04062 Chemokine signaling pathway, 04912 GnRH signaling pathway, 04722 Neurotrophin signaling pathway, 04360 Axon guidance, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05203 Viral carcinogenesis, 05212 Pancreatic cancer, 05211 Renal cell carcinoma, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05100 Bacterial invasion of epithelial cells, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04131 Membrane trafficking [BR:mmu04131], 03036 Chromosome and associated proteins [BR:mmu03036], 04147 Exosome [BR:mmu04147], 04031 GTP-binding proteins [BR:mmu04031], Rho GTPases, GRAF1-dependent endocytosis, Ras GTPases, Other centriole associated proteins, Exosomal proteins of microglial cells, Exosomal proteins of breast milk, Rac/Cdc42 [OT]'),('5330','mmu04020  Calcium signaling pathway, mmu04024  cAMP signaling pathway, mmu04611  Platelet activation, mmu04924  Renin secretion, mmu04925  Aldosterone synthesis and secretion, mmu04927  Cortisol synthesis and secretion, mmu04934  Cushing syndrome, mmu05340  Primary immunodeficiency','04020 Calcium signaling pathway, 04024 cAMP signaling pathway, 04611 Platelet activation, 04924 Renin secretion, 04925 Aldosterone synthesis and secretion, 04927 Cortisol synthesis and secretion, 05340 Primary immunodeficiency, 04934 Cushing syndrome, 04040 Ion channels [BR:mmu04040], Calcium channel, calcium release-activated (Orai)'),('5331','mmu04020  Calcium signaling pathway, mmu04611  Platelet activation','04020 Calcium signaling pathway, 04611 Platelet activation, 02000 Transporters [BR:mmu02000], Pores ion channels [TC:1]'),('5332','mmu04020  Calcium signaling pathway','04020 Calcium signaling pathway, 02000 Transporters [BR:mmu02000], Pores ion channels [TC:1]'),('5333','mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05418  Fluid shear stress and atherosclerosis','05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05418 Fluid shear stress and atherosclerosis, 03100 Non-coding RNAs [BR:mmu03100], Micro RNA'),('5334','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04068  FoxO signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5335','mmu04060  Cytokine-cytokine receptor interaction, mmu04620  Toll-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5336','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5337','mmu00120  Primary bile acid biosynthesis, mmu00140  Steroid hormone biosynthesis, mmu01100  Metabolic pathways, mmu03320  PPAR signaling pathway, mmu04976  Bile secretion, mmu04979  Cholesterol metabolism','00120 Primary bile acid biosynthesis, 00140 Steroid hormone biosynthesis, 03320 PPAR signaling pathway, 04976 Bile secretion, 04979 Cholesterol metabolism, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.23  cholesterol 7alpha-monooxygenase, CYP7 family'),('5338','mmu04976  Bile secretion','04976 Bile secretion, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 thyroid hormone receptor-like, 1H. Liver X receptor like receptor'),('5339','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5340','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu05014  Amyotrophic lateral sclerosis, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05170  Human immunodeficiency virus 1 infection','04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04920 Adipocytokine signaling pathway, 05170 Human immunodeficiency virus 1 infection, 05014 Amyotrophic lateral sclerosis, 05022 Pathways of neurodegeneration - multiple diseases, 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], TNF receptor superfamily, Proteins'),('5341','mmu04911  Insulin secretion','04911 Insulin secretion, 04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('5342','mmu04060  Cytokine-cytokine receptor interaction, mmu04062  Chemokine signaling pathway','04060 Cytokine-cytokine receptor interaction, 04062 Chemokine signaling pathway, 04052 Cytokines and growth factors [BR:mmu04052], Chemokines'),('5343','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('5344','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 04147 Exosome [BR:mmu04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('5345','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 01009 Protein phosphatases and associated proteins [BR:mmu01009], PP1-interacting proteins (PIPs)'),('5346','mmu04020  Calcium signaling pathway, mmu04022  cGMP-PKG signaling pathway, mmu04270  Vascular smooth muscle contraction, mmu04371  Apelin signaling pathway, mmu04510  Focal adhesion, mmu04611  Platelet activation, mmu04810  Regulation of actin cytoskeleton, mmu04921  Oxytocin signaling pathway, mmu04971  Gastric acid secretion','04371 Apelin signaling pathway, 04020 Calcium signaling pathway, 04022 cGMP-PKG signaling pathway, 04510 Focal adhesion, 04810 Regulation of actin cytoskeleton, 04611 Platelet activation, 04921 Oxytocin signaling pathway, 04270 Vascular smooth muscle contraction, 04971 Gastric acid secretion, 01001 Protein kinases [BR:mmu01001], 2.7.11.18  myosin-light-chain kinase, MLCK family'),('5347','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04137  Mitophagy - animal, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04218  Cellular senescence, mmu04380  Osteoclast differentiation, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04668  TNF signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04917  Prolactin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04926  Relaxin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05212  Pancreatic cancer, mmu05215  Prostate cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04137 Mitophagy - animal, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:mmu03000], RHR (Rel homology region) Rel/Ankyrin'),('5348','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('5349','mmu04060  Cytokine-cytokine receptor interaction, mmu04062  Chemokine signaling pathway','04060 Cytokine-cytokine receptor interaction, 04062 Chemokine signaling pathway, 04052 Cytokines and growth factors [BR:mmu04052], Chemokines'),('5350','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04062  Chemokine signaling pathway, mmu04072  Phospholipase D signaling pathway, mmu04144  Endocytosis','04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04144 Endocytosis, 04062 Chemokine signaling pathway, 04030 G protein-coupled receptors [BR:mmu04030], 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], CXC Chemokine, CXC Chemokine, Proteins'),('5351','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04062  Chemokine signaling pathway, mmu04072  Phospholipase D signaling pathway, mmu04144  Endocytosis, mmu05163  Human cytomegalovirus infection','04072 Phospholipase D signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04144 Endocytosis, 04062 Chemokine signaling pathway, 05163 Human cytomegalovirus infection, 04030 G protein-coupled receptors [BR:mmu04030], 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], CXC Chemokine, CXC Chemokine, Proteins'),('5352','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5353','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu04936  Alcoholic liver disease, mmu05134  Legionellosis, mmu05146  Amoebiasis, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05167 Kaposi sarcoma-associated herpesvirus infection, 05134 Legionellosis, 05146 Amoebiasis, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], Chemokines'),('5354','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5355','mmu01522  Endocrine resistance, mmu01524  Platinum drug resistance, mmu04012  ErbB signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04110  Cell cycle, mmu04115  p53 signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04630  JAK-STAT signaling pathway, mmu04921  Oxytocin signaling pathway, mmu04928  Parathyroid hormone synthesis, secretion and action, mmu04934  Cushing syndrome, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05169  Epstein-Barr virus infection, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05210  Colorectal cancer, mmu05211  Renal cell carcinoma, mmu05212  Pancreatic cancer, mmu05213  Endometrial cancer, mmu05214  Glioma, mmu05215  Prostate cancer, mmu05216  Thyroid cancer, mmu05217  Basal cell carcinoma, mmu05218  Melanoma, mmu05219  Bladder cancer, mmu05220  Chronic myeloid leukemia, mmu05222  Small cell lung cancer, mmu05223  Non-small cell lung cancer, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer','04012 ErbB signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04110 Cell cycle, 04115 p53 signaling pathway, 04218 Cellular senescence, 04921 Oxytocin signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05203 Viral carcinogenesis, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05220 Chronic myeloid leukemia, 05217 Basal cell carcinoma, 05218 Melanoma, 05211 Renal cell carcinoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 04934 Cushing syndrome, 01524 Platinum drug resistance, 01522 Endocrine resistance'),('5356','mmu01522  Endocrine resistance, mmu01524  Platinum drug resistance, mmu04110  Cell cycle, mmu04115  p53 signaling pathway, mmu04218  Cellular senescence, mmu04934  Cushing syndrome, mmu05163  Human cytomegalovirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05212  Pancreatic cancer, mmu05214  Glioma, mmu05218  Melanoma, mmu05219  Bladder cancer, mmu05220  Chronic myeloid leukemia, mmu05223  Non-small cell lung cancer, mmu05225  Hepatocellular carcinoma','04110 Cell cycle, 04115 p53 signaling pathway, 04218 Cellular senescence, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05203 Viral carcinogenesis, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05214 Glioma, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05219 Bladder cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05163 Human cytomegalovirus infection, 04934 Cushing syndrome, 01524 Platinum drug resistance, 01522 Endocrine resistance'),('5357','mmu00590  Arachidonic acid metabolism, mmu01100  Metabolic pathways, mmu04064  NF-kappa B signaling pathway, mmu04370  VEGF signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu04723  Retrograde endocannabinoid signaling, mmu04726  Serotonergic synapse, mmu04913  Ovarian steroidogenesis, mmu04921  Oxytocin signaling pathway, mmu04923  Regulation of lipolysis in adipocytes, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05140  Leishmaniasis, mmu05163  Human cytomegalovirus infection, mmu05165  Human papillomavirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05200  Pathways in cancer, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05206  MicroRNAs in cancer, mmu05222  Small cell lung cancer','00590 Arachidonic acid metabolism, 04370 VEGF signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04625 C-type lectin receptor signaling pathway, 04657 IL-17 signaling pathway, 04923 Regulation of lipolysis in adipocytes, 04913 Ovarian steroidogenesis, 04921 Oxytocin signaling pathway, 04726 Serotonergic synapse, 04723 Retrograde endocannabinoid signaling, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05204 Chemical carcinogenesis - DNA adducts, 05222 Small cell lung cancer, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05140 Leishmaniasis, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 1.14.99.1  prostaglandin-endoperoxide synthase'),('5358','mmu03050  Proteasome, mmu04060  Cytokine-cytokine receptor interaction, mmu04066  HIF-1 signaling pathway, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04630  JAK-STAT signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04940  Type I diabetes mellitus, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05200  Pathways in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:mmu03051], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Other assembling factors, Interferons, Cytokines'),('5359','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5360','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04068  FoxO signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5361','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5362','mmu04080  Neuroactive ligand-receptor interaction, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04924  Renin secretion, mmu05163  Human cytomegalovirus infection, mmu05165  Human papillomavirus infection, mmu05200  Pathways in cancer','04080 Neuroactive ligand-receptor interaction, 04924 Renin secretion, 04750 Inflammatory mediator regulation of TRP channels, 05200 Pathways in cancer, 05163 Human cytomegalovirus infection, 05165 Human papillomavirus infection, 04030 G protein-coupled receptors [BR:mmu04030], Prostaglandin'),('5363',NULL,'03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 thyroid hormone receptor-like, 1I. Vitamin D3 like receptor'),('5364','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5365','mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04145  Phagosome, mmu04151  PI3K-Akt signaling pathway, mmu04217  Necroptosis, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04936  Alcoholic liver disease, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05164  Influenza A, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04066 HIF-1 signaling pathway, 04151 PI3K-Akt signaling pathway, 04145 Phagosome, 04217 Necroptosis, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 05205 Proteoglycans in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04131 Membrane trafficking [BR:mmu04131], 04054 Pattern recognition receptors [BR:mmu04054], 04090 CD molecules [BR:mmu04090], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Toll-like receptors, Toll-like receptors, Proteins, Cell surface receptors'),('5366','mmu02010  ABC transporters, mmu04976  Bile secretion, mmu05206  MicroRNAs in cancer, mmu05226  Gastric cancer','02010 ABC transporters, 04976 Bile secretion, 05206 MicroRNAs in cancer, 05226 Gastric cancer, 02000 Transporters [BR:mmu02000], 04147 Exosome [BR:mmu04147], 04090 CD molecules [BR:mmu04090], 7.6.2.2  ABC-type xenobiotic transporter, ABCB1, 4, 5 subgroups, Exosomal proteins of other body fluids (saliva and urine), Proteins'),('5367','mmu00140  Steroid hormone biosynthesis, mmu00591  Linoleic acid metabolism, mmu00830  Retinol metabolism, mmu01100  Metabolic pathways, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation','00140 Steroid hormone biosynthesis, 00591 Linoleic acid metabolism, 00830 Retinol metabolism, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 00199 Cytochrome P450 [BR:mmu00199], 1.14.14.1  unspecific monooxygenase, CYP3 family'),('5368','mmu00040  Pentose and glucuronate interconversions, mmu00053  Ascorbate and aldarate metabolism, mmu00140  Steroid hormone biosynthesis, mmu00830  Retinol metabolism, mmu00860  Porphyrin metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu00982  Drug metabolism - cytochrome P450, mmu00983  Drug metabolism - other enzymes, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors, mmu04976  Bile secretion, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05207  Chemical carcinogenesis - receptor activation','00040 Pentose and glucuronate interconversions, 00053 Ascorbate and aldarate metabolism, 00140 Steroid hormone biosynthesis, 00830 Retinol metabolism, 00860 Porphyrin metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 00983 Drug metabolism - other enzymes, 04976 Bile secretion, 05204 Chemical carcinogenesis - DNA adducts, 05207 Chemical carcinogenesis - receptor activation, 01003 Glycosyltransferases [BR:mmu01003], 2.4.1.17  glucuronosyltransferase, Hydrophobic molecule'),('5373','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04068  FoxO signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5374','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5375','mmu04137  Mitophagy - animal, mmu04140  Autophagy - animal, mmu04217  Necroptosis, mmu04218  Cellular senescence, mmu04380  Osteoclast differentiation, mmu05014  Amyotrophic lateral sclerosis, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05418  Fluid shear stress and atherosclerosis','04140 Autophagy - animal, 04137 Mitophagy - animal, 04217 Necroptosis, 04218 Cellular senescence, 04380 Osteoclast differentiation, 05014 Amyotrophic lateral sclerosis, 05022 Pathways of neurodegeneration - multiple diseases, 05418 Fluid shear stress and atherosclerosis, 04131 Membrane trafficking [BR:mmu04131], 03029 Mitochondrial biogenesis [BR:mmu03029], 04147 Exosome [BR:mmu04147], Cargo receptors, Pexophagy, Aggrephagy, Xenophagy, Midbophagy associated proteins, Parkin-dependent mechanism factors, Exosomal proteins of other body fluids (saliva and urine)'),('5376','mmu04141  Protein processing in endoplasmic reticulum, mmu05012  Parkinson disease, mmu05200  Pathways in cancer, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05225  Hepatocellular carcinoma, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 05200 Pathways in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05012 Parkinson disease, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 03000 Transcription factors [BR:mmu03000], 03029 Mitochondrial biogenesis [BR:mmu03029], AP-1(-like) components, NF-E2, Nuclear respiratory factors'),('5377','mmu00860  Porphyrin metabolism, mmu01100  Metabolic pathways, mmu04066  HIF-1 signaling pathway, mmu04216  Ferroptosis, mmu04978  Mineral absorption, mmu05200  Pathways in cancer, mmu05206  MicroRNAs in cancer, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05225  Hepatocellular carcinoma, mmu05418  Fluid shear stress and atherosclerosis','00860 Porphyrin metabolism, 04066 HIF-1 signaling pathway, 04216 Ferroptosis, 04978 Mineral absorption, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05418 Fluid shear stress and atherosclerosis, 1.14.14.18  heme oxygenase (biliverdin-producing)'),('5378','mmu00130  Ubiquinone and other terpenoid-quinone biosynthesis, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors, mmu05200  Pathways in cancer, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05225  Hepatocellular carcinoma, mmu05418  Fluid shear stress and atherosclerosis','00130 Ubiquinone and other terpenoid-quinone biosynthesis, 05200 Pathways in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05418 Fluid shear stress and atherosclerosis, 1.6.5.2  NAD(P)H dehydrogenase (quinone)'),('5379','mmu00480  Glutathione metabolism, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu00982  Drug metabolism - cytochrome P450, mmu00983  Drug metabolism - other enzymes, mmu01100  Metabolic pathways, mmu01524  Platinum drug resistance, mmu05200  Pathways in cancer, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05215  Prostate cancer, mmu05225  Hepatocellular carcinoma, mmu05418  Fluid shear stress and atherosclerosis','00480 Glutathione metabolism, 00980 Metabolism of xenobiotics by cytochrome P450, 00982 Drug metabolism - cytochrome P450, 00983 Drug metabolism - other enzymes, 05200 Pathways in cancer, 05204 Chemical carcinogenesis - DNA adducts, 05225 Hepatocellular carcinoma, 05215 Prostate cancer, 05418 Fluid shear stress and atherosclerosis, 01524 Platinum drug resistance, 02000 Transporters [BR:mmu02000], 2.5.1.18  glutathione transferase, Pores ion channels [TC:1]'),('5381','mmu04012  ErbB signaling pathway, mmu04020  Calcium signaling pathway, mmu04024  cAMP signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04114  Oocyte meiosis, mmu04217  Necroptosis, mmu04261  Adrenergic signaling in cardiomyocytes, mmu04310  Wnt signaling pathway, mmu04360  Axon guidance, mmu04713  Circadian entrainment, mmu04720  Long-term potentiation, mmu04722  Neurotrophin signaling pathway, mmu04725  Cholinergic synapse, mmu04728  Dopaminergic synapse, mmu04740  Olfactory transduction, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04911  Insulin secretion, mmu04912  GnRH signaling pathway, mmu04916  Melanogenesis, mmu04921  Oxytocin signaling pathway, mmu04922  Glucagon signaling pathway, mmu04925  Aldosterone synthesis and secretion, mmu04934  Cushing syndrome, mmu04971  Gastric acid secretion, mmu05012  Parkinson disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05031  Amphetamine addiction, mmu05152  Tuberculosis, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05214  Glioma, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04012 ErbB signaling pathway, 04310 Wnt signaling pathway, 04066 HIF-1 signaling pathway, 04020 Calcium signaling pathway, 04024 cAMP signaling pathway, 04114 Oocyte meiosis, 04217 Necroptosis, 04911 Insulin secretion, 04922 Glucagon signaling pathway, 04912 GnRH signaling pathway, 04921 Oxytocin signaling pathway, 04916 Melanogenesis, 04925 Aldosterone synthesis and secretion, 04261 Adrenergic signaling in cardiomyocytes, 04971 Gastric acid secretion, 04725 Cholinergic synapse, 04728 Dopaminergic synapse, 04720 Long-term potentiation, 04722 Neurotrophin signaling pathway, 04740 Olfactory transduction, 04750 Inflammatory mediator regulation of TRP channels, 04360 Axon guidance, 04713 Circadian entrainment, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05214 Glioma, 05152 Tuberculosis, 05012 Parkinson disease, 05022 Pathways of neurodegeneration - multiple diseases, 05031 Amphetamine addiction, 05417 Lipid and atherosclerosis, 05415 Diabetic cardiomyopathy, 04934 Cushing syndrome, 01001 Protein kinases [BR:mmu01001], 2.7.11.17  Ca2+/calmodulin-dependent protein kinase, CAMK2 family'),('5382','mmu04961  Endocrine and other factor-regulated calcium reabsorption','04961 Endocrine and other factor-regulated calcium reabsorption, 04990 Domain-containing proteins not elsewhere classified [BR:mmu04990], Other EF-hand domain-containing proteins'),('5384','mmu04659  Th17 cell differentiation, mmu05321  Inflammatory bowel disease','04659 Th17 cell differentiation, 05321 Inflammatory bowel disease, 03000 Transcription factors [BR:mmu03000], Fork head/winged helix other regulators'),('5387','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu04062  Chemokine signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04217  Necroptosis, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04630  JAK-STAT signaling pathway, mmu04659  Th17 cell differentiation, mmu04917  Prolactin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04931  Insulin resistance, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04935  Growth hormone synthesis, secretion and action, mmu05145  Toxoplasmosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05212  Pancreatic cancer, mmu05221  Acute myeloid leukemia, mmu05223  Non-small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04217 Necroptosis, 04550 Signaling pathways regulating pluripotency of stem cells, 04659 Th17 cell differentiation, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05223 Non-small cell lung cancer, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05145 Toxoplasmosis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 03000 Transcription factors [BR:mmu03000], STAT'),('5388','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01522  Endocrine resistance, mmu04012  ErbB signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04072  Phospholipase D signaling pathway, mmu04136  Autophagy - other, mmu04140  Autophagy - animal, mmu04150  mTOR signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04213  Longevity regulating pathway - multiple species, mmu04218  Cellular senescence, mmu04371  Apelin signaling pathway, mmu04613  Neutrophil extracellular trap formation, mmu04630  JAK-STAT signaling pathway, mmu04659  Th17 cell differentiation, mmu04714  Thermogenesis, mmu04910  Insulin signaling pathway, mmu04919  Thyroid hormone signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04935  Growth hormone synthesis, secretion and action, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05017  Spinocerebellar ataxia, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05163  Human cytomegalovirus infection, mmu05165  Human papillomavirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05210  Colorectal cancer, mmu05212  Pancreatic cancer, mmu05214  Glioma, mmu05215  Prostate cancer, mmu05221  Acute myeloid leukemia, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05230  Central carbon metabolism in cancer, mmu05231  Choline metabolism in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05415  Diabetic cardiomyopathy','04012 ErbB signaling pathway, 04371 Apelin signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04072 Phospholipase D signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04136 Autophagy - other, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04659 Th17 cell differentiation, 04910 Insulin signaling pathway, 04920 Adipocytokine signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 04714 Thermogenesis, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05221 Acute myeloid leukemia, 05215 Prostate cancer, 05224 Breast cancer, 05170 Human immunodeficiency virus 1 infection, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05017 Spinocerebellar ataxia, 05022 Pathways of neurodegeneration - multiple diseases, 05415 Diabetic cardiomyopathy, 04930 Type II diabetes mellitus, 04931 Insulin resistance, 01521 EGFR tyrosine kinase inhibitor resistance, 01522 Endocrine resistance, 01001 Protein kinases [BR:mmu01001], 04131 Membrane trafficking [BR:mmu04131], 2.7.11.1  non-specific serine/threonine protein kinase, PIKK family [OT], mTORC1 complex, mTORC2 complex'),('5389',NULL,'03000 Transcription factors [BR:mmu03000], 2.1.1.-, Cys2His2 PRDM'),('5390','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04068  FoxO signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5391',NULL,'04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('5392','mmu00220  Arginine biosynthesis, mmu00330  Arginine and proline metabolism, mmu01100  Metabolic pathways, mmu01230  Biosynthesis of amino acids, mmu05146  Amoebiasis','00220 Arginine biosynthesis, 00330 Arginine and proline metabolism, 05146 Amoebiasis, 3.5.3.1  arginase'),('5393','mmu00220  Arginine biosynthesis, mmu00330  Arginine and proline metabolism, mmu01100  Metabolic pathways, mmu01230  Biosynthesis of amino acids, mmu05146  Amoebiasis','00220 Arginine biosynthesis, 00330 Arginine and proline metabolism, 05146 Amoebiasis, 3.5.3.1  arginase'),('5394','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01522  Endocrine resistance, mmu01524  Platinum drug resistance, mmu04010  MAPK signaling pathway, mmu04012  ErbB signaling pathway, mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04022  cGMP-PKG signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04072  Phospholipase D signaling pathway, mmu04140  Autophagy - animal, mmu04150  mTOR signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04152  AMPK signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04213  Longevity regulating pathway - multiple species, mmu04218  Cellular senescence, mmu04261  Adrenergic signaling in cardiomyocytes, mmu04370  VEGF signaling pathway, mmu04371  Apelin signaling pathway, mmu04380  Osteoclast differentiation, mmu04510  Focal adhesion, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04611  Platelet activation, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04666  Fc gamma R-mediated phagocytosis, mmu04668  TNF signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04725  Cholinergic synapse, mmu04728  Dopaminergic synapse, mmu04910  Insulin signaling pathway, mmu04914  Progesterone-mediated oocyte maturation, mmu04915  Estrogen signaling pathway, mmu04917  Prolactin signaling pathway, mmu04919  Thyroid hormone signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04922  Glucagon signaling pathway, mmu04923  Regulation of lipolysis in adipocytes, mmu04926  Relaxin signaling pathway, mmu04929  GnRH secretion, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04935  Growth hormone synthesis, secretion and action, mmu04936  Alcoholic liver disease, mmu04973  Carbohydrate digestion and absorption, mmu05010  Alzheimer disease, mmu05017  Spinocerebellar ataxia, mmu05132  Salmonella infection, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05210  Colorectal cancer, mmu05211  Renal cell carcinoma, mmu05212  Pancreatic cancer, mmu05213  Endometrial cancer, mmu05214  Glioma, mmu05215  Prostate cancer, mmu05218  Melanoma, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05223  Non-small cell lung cancer, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05230  Central carbon metabolism in cancer, mmu05231  Choline metabolism in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04370 VEGF signaling pathway, 04371 Apelin signaling pathway, 04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04072 Phospholipase D signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04022 cGMP-PKG signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04150 mTOR signaling pathway, 04140 Autophagy - animal, 04210 Apoptosis, 04218 Cellular senescence, 04510 Focal adhesion, 04550 Signaling pathways regulating pluripotency of stem cells, 04611 Platelet activation, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04662 B cell receptor signaling pathway, 04664 Fc epsilon RI signaling pathway, 04666 Fc gamma R-mediated phagocytosis, 04062 Chemokine signaling pathway, 04910 Insulin signaling pathway, 04922 Glucagon signaling pathway, 04923 Regulation of lipolysis in adipocytes, 04920 Adipocytokine signaling pathway, 04929 GnRH secretion, 04915 Estrogen signaling pathway, 04914 Progesterone-mediated oocyte maturation, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04935 Growth hormone synthesis, secretion and action, 04919 Thyroid hormone signaling pathway, 04261 Adrenergic signaling in cardiomyocytes, 04973 Carbohydrate digestion and absorption, 04725 Cholinergic synapse, 04728 Dopaminergic synapse, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05230 Central carbon metabolism in cancer, 05231 Choline metabolism in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05211 Renal cell carcinoma, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05152 Tuberculosis, 05145 Toxoplasmosis, 05142 Chagas disease, 05010 Alzheimer disease, 05017 Spinocerebellar ataxia, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01001 Protein kinases [BR:mmu01001], 2.7.11.1  non-specific serine/threonine protein kinase, AKT/PKB family'),('5395','mmu01524  Platinum drug resistance, mmu04010  MAPK signaling pathway, mmu04115  p53 signaling pathway, mmu04210  Apoptosis, mmu04215  Apoptosis - multiple species, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu04726  Serotonergic synapse, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05012  Parkinson disease, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05210  Colorectal cancer, mmu05222  Small cell lung cancer, mmu05416  Viral myocarditis, mmu05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04668 TNF signaling pathway, 04210 Apoptosis, 04215 Apoptosis - multiple species, 04115 p53 signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04657 IL-17 signaling pathway, 04726 Serotonergic synapse, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05203 Viral carcinogenesis, 05210 Colorectal cancer, 05222 Small cell lung cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05010 Alzheimer disease, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05416 Viral myocarditis, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01524 Platinum drug resistance, 01002 Peptidases and inhibitors [BR:mmu01002], 3.4.22.56  caspase-3, Family C14: caspase family'),('5396','mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04024  cAMP signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu05016  Huntington disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05034  Alcoholism','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04722 Neurotrophin signaling pathway, 05016 Huntington disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05034 Alcoholism, 04052 Cytokines and growth factors [BR:mmu04052], Growth factors (RTK binding)'),('5397','mmu04024  cAMP signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04714  Thermogenesis, mmu04911  Insulin secretion, mmu04922  Glucagon signaling pathway','04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04911 Insulin secretion, 04922 Glucagon signaling pathway, 04714 Thermogenesis'),('5398',NULL,'04030 G protein-coupled receptors [BR:mmu04030], Free fatty acid'),('5399','mmu04371  Apelin signaling pathway, mmu05016  Huntington disease','04371 Apelin signaling pathway, 05016 Huntington disease, 03029 Mitochondrial biogenesis [BR:mmu03029], Nuclear respiratory factors'),('5400','mmu04371  Apelin signaling pathway, mmu05016  Huntington disease','04371 Apelin signaling pathway, 05016 Huntington disease, 03029 Mitochondrial biogenesis [BR:mmu03029], Nuclear respiratory factors'),('5401','mmu04146  Peroxisome, mmu04213  Longevity regulating pathway - multiple species, mmu05012  Parkinson disease, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05208  Chemical carcinogenesis - reactive oxygen species','04146 Peroxisome, 04213 Longevity regulating pathway - multiple species, 05208 Chemical carcinogenesis - reactive oxygen species, 05012 Parkinson disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 1.15.1.1  superoxide dismutase'),('5402','mmu00380  Tryptophan metabolism, mmu00630  Glyoxylate and dicarboxylate metabolism, mmu01100  Metabolic pathways, mmu01200  Carbon metabolism, mmu04068  FoxO signaling pathway, mmu04146  Peroxisome, mmu04211  Longevity regulating pathway, mmu04213  Longevity regulating pathway - multiple species, mmu05014  Amyotrophic lateral sclerosis, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05208  Chemical carcinogenesis - reactive oxygen species','00630 Glyoxylate and dicarboxylate metabolism, 00380 Tryptophan metabolism, 04068 FoxO signaling pathway, 04146 Peroxisome, 04211 Longevity regulating pathway, 04213 Longevity regulating pathway - multiple species, 05208 Chemical carcinogenesis - reactive oxygen species, 05014 Amyotrophic lateral sclerosis, 05022 Pathways of neurodegeneration - multiple diseases, 1.11.1.6  catalase'),('5403','mmu04141  Protein processing in endoplasmic reticulum, mmu05012  Parkinson disease, mmu05200  Pathways in cancer, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05225  Hepatocellular carcinoma, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 05200 Pathways in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05012 Parkinson disease, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 03000 Transcription factors [BR:mmu03000], 03029 Mitochondrial biogenesis [BR:mmu03029], AP-1(-like) components, NF-E2, Nuclear respiratory factors'),('5404','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5405','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5406','mmu04015  Rap1 signaling pathway, mmu04145  Phagosome, mmu04514  Cell adhesion molecules, mmu04610  Complement and coagulation cascades, mmu04613  Neutrophil extracellular trap formation, mmu04640  Hematopoietic cell lineage, mmu04670  Leukocyte transendothelial migration, mmu04810  Regulation of actin cytoskeleton, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05140  Leishmaniasis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05202  Transcriptional misregulation in cancer, mmu05221  Acute myeloid leukemia','04015 Rap1 signaling pathway, 04514 Cell adhesion molecules, 04145 Phagosome, 04810 Regulation of actin cytoskeleton, 04640 Hematopoietic cell lineage, 04610 Complement and coagulation cascades, 04613 Neutrophil extracellular trap formation, 04670 Leukocyte transendothelial migration, 05202 Transcriptional misregulation in cancer, 05221 Acute myeloid leukemia, 05133 Pertussis, 05134 Legionellosis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05140 Leishmaniasis, 04131 Membrane trafficking [BR:mmu04131], 04147 Exosome [BR:mmu04147], 04515 Cell adhesion molecules [BR:mmu04515], 04090 CD molecules [BR:mmu04090], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Integrins (complement receptors), Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell), Integrin alpha subunits, Proteins, Adhesion molecules of cell surface'),('5407','mmu04020  Calcium signaling pathway, mmu04024  cAMP signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04726  Serotonergic synapse','04020 Calcium signaling pathway, 04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04726 Serotonergic synapse, 04030 G protein-coupled receptors [BR:mmu04030], Serotonin'),('5408','mmu04020  Calcium signaling pathway, mmu04024  cAMP signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04726  Serotonergic synapse','04020 Calcium signaling pathway, 04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04726 Serotonergic synapse, 04030 G protein-coupled receptors [BR:mmu04030], Serotonin'),('5409','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5410','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5411','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu04936  Alcoholic liver disease, mmu05134  Legionellosis, mmu05146  Amoebiasis, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05167 Kaposi sarcoma-associated herpesvirus infection, 05134 Legionellosis, 05146 Amoebiasis, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], Chemokines'),('5412','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5413','mmu04060  Cytokine-cytokine receptor interaction, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04936  Alcoholic liver disease, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis','04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5414','mmu03050  Proteasome, mmu04060  Cytokine-cytokine receptor interaction, mmu04066  HIF-1 signaling pathway, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04630  JAK-STAT signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04940  Type I diabetes mellitus, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05200  Pathways in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:mmu03051], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Other assembling factors, Interferons, Cytokines'),('5415','mmu04060  Cytokine-cytokine receptor interaction, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05200  Pathways in cancer, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04640 Hematopoietic cell lineage, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05310 Asthma, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5416','mmu00380  Tryptophan metabolism, mmu00790  Folate biosynthesis, mmu01100  Metabolic pathways, mmu04726  Serotonergic synapse','00380 Tryptophan metabolism, 00790 Folate biosynthesis, 04726 Serotonergic synapse, 1.14.16.4  tryptophan 5-monooxygenase'),('5417','mmu00380  Tryptophan metabolism, mmu00790  Folate biosynthesis, mmu01100  Metabolic pathways, mmu04726  Serotonergic synapse','00380 Tryptophan metabolism, 00790 Folate biosynthesis, 04726 Serotonergic synapse, 1.14.16.4  tryptophan 5-monooxygenase'),('5418','mmu00380  Tryptophan metabolism, mmu00790  Folate biosynthesis, mmu01100  Metabolic pathways, mmu04726  Serotonergic synapse','00380 Tryptophan metabolism, 00790 Folate biosynthesis, 04726 Serotonergic synapse, 1.14.16.4  tryptophan 5-monooxygenase'),('5419','mmu00380  Tryptophan metabolism, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors, mmu05143  African trypanosomiasis','00380 Tryptophan metabolism, 05143 African trypanosomiasis, 1.13.11.52  indoleamine 2,3-dioxygenase'),('5420','mmu00010  Glycolysis / Gluconeogenesis, mmu00052  Galactose metabolism, mmu00500  Starch and sucrose metabolism, mmu01100  Metabolic pathways, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04152  AMPK signaling pathway, mmu04910  Insulin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04973  Carbohydrate digestion and absorption','00010 Glycolysis / Gluconeogenesis, 00052 Galactose metabolism, 00500 Starch and sucrose metabolism, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04910 Insulin signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 04973 Carbohydrate digestion and absorption, 04931 Insulin resistance, 3.1.3.9  glucose-6-phosphatase'),('5421','mmu03320  PPAR signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04380  Osteoclast differentiation, mmu04714  Thermogenesis, mmu04932  Non-alcoholic fatty liver disease, mmu05016  Huntington disease, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05216  Thyroid cancer, mmu05417  Lipid and atherosclerosis','04152 AMPK signaling pathway, 03320 PPAR signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04714 Thermogenesis, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05216 Thyroid cancer, 05016 Huntington disease, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 thyroid hormone receptor-like, 1C. Peroxisome proliferator-activated receptor (PPAR)'),('5422','mmu00071  Fatty acid degradation, mmu01212  Fatty acid metabolism, mmu03320  PPAR signaling pathway, mmu04152  AMPK signaling pathway, mmu04714  Thermogenesis, mmu04920  Adipocytokine signaling pathway, mmu04922  Glucagon signaling pathway, mmu04931  Insulin resistance, mmu04936  Alcoholic liver disease','00071 Fatty acid degradation, 04152 AMPK signaling pathway, 04922 Glucagon signaling pathway, 04920 Adipocytokine signaling pathway, 03320 PPAR signaling pathway, 04714 Thermogenesis, 04936 Alcoholic liver disease, 04931 Insulin resistance, 03029 Mitochondrial biogenesis [BR:mmu03029], 2.3.1.21  carnitine O-palmitoyltransferase, Other regulator of mitochondrial biogenesis'),('5423','mmu04141  Protein processing in endoplasmic reticulum, mmu05012  Parkinson disease, mmu05200  Pathways in cancer, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05225  Hepatocellular carcinoma, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 05200 Pathways in cancer, 05208 Chemical carcinogenesis - reactive oxygen species, 05225 Hepatocellular carcinoma, 05012 Parkinson disease, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 03000 Transcription factors [BR:mmu03000], 03029 Mitochondrial biogenesis [BR:mmu03029], AP-1(-like) components, NF-E2, Nuclear respiratory factors'),('5424','mmu04068  FoxO signaling pathway, mmu04152  AMPK signaling pathway, mmu04910  Insulin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu05415  Diabetic cardiomyopathy','04068 FoxO signaling pathway, 04152 AMPK signaling pathway, 04910 Insulin signaling pathway, 04920 Adipocytokine signaling pathway, 05415 Diabetic cardiomyopathy, 04930 Type II diabetes mellitus, 04931 Insulin resistance, 02000 Transporters [BR:mmu02000], SLC2: Facilitative GLUT transporter, Sugar porter (SP) family [TC:2.A.1.1]'),('5425','mmu03320  PPAR signaling pathway, mmu04371  Apelin signaling pathway, mmu04714  Thermogenesis, mmu05016  Huntington disease','04371 Apelin signaling pathway, 03320 PPAR signaling pathway, 04714 Thermogenesis, 05016 Huntington disease, 02000 Transporters [BR:mmu02000], SLC25: Mitochondrial carrier'),('5427','mmu04060  Cytokine-cytokine receptor interaction, mmu04659  Th17 cell differentiation','04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5428','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5429','mmu04514  Cell adhesion molecules, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer','04514 Cell adhesion molecules, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 04090 CD molecules [BR:mmu04090], Proteins'),('5430','mmu00230  Purine metabolism, mmu00240  Pyrimidine metabolism, mmu01100  Metabolic pathways, mmu01232  Nucleotide metabolism, mmu05169  Epstein-Barr virus infection','00230 Purine metabolism, 00240 Pyrimidine metabolism, 05169 Epstein-Barr virus infection, 04090 CD molecules [BR:mmu04090], 3.6.1.5  apyrase, Proteins'),('5431','mmu00380  Tryptophan metabolism, mmu01100  Metabolic pathways, mmu01240  Biosynthesis of cofactors, mmu05143  African trypanosomiasis','00380 Tryptophan metabolism, 05143 African trypanosomiasis, 1.13.11.52  indoleamine 2,3-dioxygenase'),('5432','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('5433','mmu04530  Tight junction','04530 Tight junction'),('5434','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 01009 Protein phosphatases and associated proteins [BR:mmu01009], PP1-interacting proteins (PIPs)'),('5435','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 04090 CD molecules [BR:mmu04090], Proteins'),('5436','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 04147 Exosome [BR:mmu04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('5437','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5438','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5439','mmu04060  Cytokine-cytokine receptor interaction, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04936  Alcoholic liver disease, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis','04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5440','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5441','mmu03050  Proteasome, mmu04060  Cytokine-cytokine receptor interaction, mmu04066  HIF-1 signaling pathway, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04630  JAK-STAT signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04940  Type I diabetes mellitus, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05200  Pathways in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:mmu03051], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Other assembling factors, Interferons, Cytokines'),('5442','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('5443','mmu04530  Tight junction','04530 Tight junction'),('5444','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 01009 Protein phosphatases and associated proteins [BR:mmu01009], PP1-interacting proteins (PIPs)'),('5445','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 04090 CD molecules [BR:mmu04090], Proteins'),('5446','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 04147 Exosome [BR:mmu04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('5447','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5448','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5449','mmu04060  Cytokine-cytokine receptor interaction, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04936  Alcoholic liver disease, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis','04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5450','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5451','mmu03050  Proteasome, mmu04060  Cytokine-cytokine receptor interaction, mmu04066  HIF-1 signaling pathway, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04630  JAK-STAT signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04940  Type I diabetes mellitus, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05200  Pathways in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:mmu03051], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Other assembling factors, Interferons, Cytokines'),('5452','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('5453','mmu04530  Tight junction','04530 Tight junction'),('5454','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 01009 Protein phosphatases and associated proteins [BR:mmu01009], PP1-interacting proteins (PIPs)'),('5455','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 04090 CD molecules [BR:mmu04090], Proteins'),('5456','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 04147 Exosome [BR:mmu04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('5457','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5458','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5459','mmu04060  Cytokine-cytokine receptor interaction, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04936  Alcoholic liver disease, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis','04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5460','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5461','mmu03050  Proteasome, mmu04060  Cytokine-cytokine receptor interaction, mmu04066  HIF-1 signaling pathway, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04630  JAK-STAT signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04940  Type I diabetes mellitus, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05200  Pathways in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:mmu03051], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Other assembling factors, Interferons, Cytokines'),('5462','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('5463','mmu04530  Tight junction','04530 Tight junction'),('5464','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 01009 Protein phosphatases and associated proteins [BR:mmu01009], PP1-interacting proteins (PIPs)'),('5465','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 04090 CD molecules [BR:mmu04090], Proteins'),('5466','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 04147 Exosome [BR:mmu04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('5467','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5468','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5469','mmu04060  Cytokine-cytokine receptor interaction, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04936  Alcoholic liver disease, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis','04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5470','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5471','mmu03050  Proteasome, mmu04060  Cytokine-cytokine receptor interaction, mmu04066  HIF-1 signaling pathway, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04630  JAK-STAT signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04940  Type I diabetes mellitus, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05200  Pathways in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:mmu03051], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Other assembling factors, Interferons, Cytokines'),('5472','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('5473','mmu04530  Tight junction','04530 Tight junction'),('5474','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 01009 Protein phosphatases and associated proteins [BR:mmu01009], PP1-interacting proteins (PIPs)'),('5475','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 04090 CD molecules [BR:mmu04090], Proteins'),('5476','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 04147 Exosome [BR:mmu04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('5477','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5478','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5479','mmu04060  Cytokine-cytokine receptor interaction, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04936  Alcoholic liver disease, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis','04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5480','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5481','mmu03050  Proteasome, mmu04060  Cytokine-cytokine receptor interaction, mmu04066  HIF-1 signaling pathway, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04630  JAK-STAT signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04940  Type I diabetes mellitus, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05200  Pathways in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:mmu03051], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Other assembling factors, Interferons, Cytokines'),('5482','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('5483','mmu04530  Tight junction','04530 Tight junction'),('5484','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 01009 Protein phosphatases and associated proteins [BR:mmu01009], PP1-interacting proteins (PIPs)'),('5485','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 04090 CD molecules [BR:mmu04090], Proteins'),('5486','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 04147 Exosome [BR:mmu04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('5487','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5488','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5489','mmu04060  Cytokine-cytokine receptor interaction, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04936  Alcoholic liver disease, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis','04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5490','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5491','mmu03050  Proteasome, mmu04060  Cytokine-cytokine receptor interaction, mmu04066  HIF-1 signaling pathway, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04630  JAK-STAT signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04940  Type I diabetes mellitus, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05200  Pathways in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:mmu03051], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Other assembling factors, Interferons, Cytokines'),('5492','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5493','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04062  Chemokine signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05144  Malaria, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05135 Yersinia infection, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Chemokines, Chemokines'),('5494','mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04145  Phagosome, mmu04151  PI3K-Akt signaling pathway, mmu04217  Necroptosis, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04936  Alcoholic liver disease, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05164  Influenza A, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04066 HIF-1 signaling pathway, 04151 PI3K-Akt signaling pathway, 04145 Phagosome, 04217 Necroptosis, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 05205 Proteoglycans in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04131 Membrane trafficking [BR:mmu04131], 04054 Pattern recognition receptors [BR:mmu04054], 04090 CD molecules [BR:mmu04090], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Toll-like receptors, Toll-like receptors, Proteins, Cell surface receptors'),('5495','mmu04010  MAPK signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04936  Alcoholic liver disease, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease'),('5496','mmu03320  PPAR signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04380  Osteoclast differentiation, mmu04714  Thermogenesis, mmu04932  Non-alcoholic fatty liver disease, mmu05016  Huntington disease, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05216  Thyroid cancer, mmu05417  Lipid and atherosclerosis','04152 AMPK signaling pathway, 03320 PPAR signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04714 Thermogenesis, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05216 Thyroid cancer, 05016 Huntington disease, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 thyroid hormone receptor-like, 1C. Peroxisome proliferator-activated receptor (PPAR)'),('5498','mmu04020  Calcium signaling pathway, mmu04024  cAMP signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04726  Serotonergic synapse','04020 Calcium signaling pathway, 04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04726 Serotonergic synapse, 04030 G protein-coupled receptors [BR:mmu04030], Serotonin'),('5499','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5500','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5501','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5502','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 04147 Exosome [BR:mmu04147], Exosomal proteins of ovarian cancer cells, Exosomal proteins of colorectal cancer cells'),('5503','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 01009 Protein phosphatases and associated proteins [BR:mmu01009], PP1-interacting proteins (PIPs)'),('5504','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('5505','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04068  FoxO signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5506','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5507','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5508','mmu04060  Cytokine-cytokine receptor interaction, mmu04630  JAK-STAT signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04664  Fc epsilon RI signaling pathway, mmu05200  Pathways in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04658 Th1 and Th2 cell differentiation, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 05200 Pathways in cancer, 05310 Asthma, 05321 Inflammatory bowel disease, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5509','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04218  Cellular senescence, mmu04380  Osteoclast differentiation, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04668  TNF signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04917  Prolactin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04926  Relaxin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05212  Pancreatic cancer, mmu05215  Prostate cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:mmu03000], RHR (Rel homology region) Rel/Ankyrin'),('5510','mmu00430  Taurine and hypotaurine metabolism, mmu00480  Glutathione metabolism, mmu00590  Arachidonic acid metabolism, mmu01100  Metabolic pathways','00590 Arachidonic acid metabolism, 00430 Taurine and hypotaurine metabolism, 00480 Glutathione metabolism, 01002 Peptidases and inhibitors [BR:mmu01002], 04090 CD molecules [BR:mmu04090], 2.3.2.2  gamma-glutamyltransferase, 3.4.19.13  glutathione gamma-glutamate hydrolase, 3.4.19.14  leukotriene-C4 hydrolase, Family T3: gamma-glutamyltransferase family, Proteins'),('5511','mmu04142  Lysosome','04142 Lysosome, 02000 Transporters [BR:mmu02000], SLC17: Vesicular glutamate transporter, Anion:cation symporter (ACS) family [TC:2.A.1.14]'),('5512','mmu00220  Arginine biosynthesis, mmu00250  Alanine, aspartate and glutamate metabolism, mmu01100  Metabolic pathways, mmu01200  Carbon metabolism, mmu01210  2-Oxocarboxylic acid metabolism, mmu01230  Biosynthesis of amino acids','00250 Alanine, aspartate and glutamate metabolism, 00220 Arginine biosynthesis, 01007 Amino acid related enzymes [BR:mmu01007], 2.6.1.2  alanine transaminase, Class I'),('5513','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5514','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5515','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5516','mmu03320  PPAR signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04380  Osteoclast differentiation, mmu04714  Thermogenesis, mmu04932  Non-alcoholic fatty liver disease, mmu05016  Huntington disease, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05216  Thyroid cancer, mmu05417  Lipid and atherosclerosis','04152 AMPK signaling pathway, 03320 PPAR signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04714 Thermogenesis, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05216 Thyroid cancer, 05016 Huntington disease, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 thyroid hormone receptor-like, 1C. Peroxisome proliferator-activated receptor (PPAR)'),('5517','mmu04152  AMPK signaling pathway, mmu04910  Insulin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease','04152 AMPK signaling pathway, 04910 Insulin signaling pathway, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 03000 Transcription factors [BR:mmu03000], 04131 Membrane trafficking [BR:mmu04131], Ubiquitous bHLH-ZIP factors, Other mitophagy associated  proteins'),('5518','mmu03320  PPAR signaling pathway, mmu04145  Phagosome, mmu04152  AMPK signaling pathway, mmu04512  ECM-receptor interaction, mmu04640  Hematopoietic cell lineage, mmu04920  Adipocytokine signaling pathway, mmu04931  Insulin resistance, mmu04975  Fat digestion and absorption, mmu04979  Cholesterol metabolism, mmu05144  Malaria, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04152 AMPK signaling pathway, 04512 ECM-receptor interaction, 04145 Phagosome, 04640 Hematopoietic cell lineage, 04920 Adipocytokine signaling pathway, 03320 PPAR signaling pathway, 04975 Fat digestion and absorption, 04979 Cholesterol metabolism, 05144 Malaria, 05417 Lipid and atherosclerosis, 05415 Diabetic cardiomyopathy, 04931 Insulin resistance, 04131 Membrane trafficking [BR:mmu04131], 04147 Exosome [BR:mmu04147], 04090 CD molecules [BR:mmu04090], Scavenger receptors, Exosomal proteins of breast milk, Proteins'),('5520','mmu00430  Taurine and hypotaurine metabolism, mmu00480  Glutathione metabolism, mmu00590  Arachidonic acid metabolism, mmu01100  Metabolic pathways','00590 Arachidonic acid metabolism, 00430 Taurine and hypotaurine metabolism, 00480 Glutathione metabolism, 01002 Peptidases and inhibitors [BR:mmu01002], 04090 CD molecules [BR:mmu04090], 2.3.2.2  gamma-glutamyltransferase, 3.4.19.13  glutathione gamma-glutamate hydrolase, 3.4.19.14  leukotriene-C4 hydrolase, Family T3: gamma-glutamyltransferase family, Proteins'),('5521','mmu04142  Lysosome','04142 Lysosome, 02000 Transporters [BR:mmu02000], SLC17: Vesicular glutamate transporter, Anion:cation symporter (ACS) family [TC:2.A.1.14]'),('5522','mmu00220  Arginine biosynthesis, mmu00250  Alanine, aspartate and glutamate metabolism, mmu01100  Metabolic pathways, mmu01200  Carbon metabolism, mmu01210  2-Oxocarboxylic acid metabolism, mmu01230  Biosynthesis of amino acids','00250 Alanine, aspartate and glutamate metabolism, 00220 Arginine biosynthesis, 01007 Amino acid related enzymes [BR:mmu01007], 2.6.1.2  alanine transaminase, Class I'),('5523','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5524','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5525','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5526','mmu03320  PPAR signaling pathway, mmu04152  AMPK signaling pathway, mmu04211  Longevity regulating pathway, mmu04380  Osteoclast differentiation, mmu04714  Thermogenesis, mmu04932  Non-alcoholic fatty liver disease, mmu05016  Huntington disease, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05216  Thyroid cancer, mmu05417  Lipid and atherosclerosis','04152 AMPK signaling pathway, 03320 PPAR signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 04714 Thermogenesis, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05216 Thyroid cancer, 05016 Huntington disease, 05417 Lipid and atherosclerosis, 04932 Non-alcoholic fatty liver disease, 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], Cys4 thyroid hormone receptor-like, 1C. Peroxisome proliferator-activated receptor (PPAR)'),('5527','mmu04152  AMPK signaling pathway, mmu04910  Insulin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease','04152 AMPK signaling pathway, 04910 Insulin signaling pathway, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 03000 Transcription factors [BR:mmu03000], 04131 Membrane trafficking [BR:mmu04131], Ubiquitous bHLH-ZIP factors, Other mitophagy associated  proteins'),('5528','mmu03320  PPAR signaling pathway, mmu04145  Phagosome, mmu04152  AMPK signaling pathway, mmu04512  ECM-receptor interaction, mmu04640  Hematopoietic cell lineage, mmu04920  Adipocytokine signaling pathway, mmu04931  Insulin resistance, mmu04975  Fat digestion and absorption, mmu04979  Cholesterol metabolism, mmu05144  Malaria, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04152 AMPK signaling pathway, 04512 ECM-receptor interaction, 04145 Phagosome, 04640 Hematopoietic cell lineage, 04920 Adipocytokine signaling pathway, 03320 PPAR signaling pathway, 04975 Fat digestion and absorption, 04979 Cholesterol metabolism, 05144 Malaria, 05417 Lipid and atherosclerosis, 05415 Diabetic cardiomyopathy, 04931 Insulin resistance, 04131 Membrane trafficking [BR:mmu04131], 04147 Exosome [BR:mmu04147], 04090 CD molecules [BR:mmu04090], Scavenger receptors, Exosomal proteins of breast milk, Proteins'),('5530','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04068  FoxO signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5531','mmu04060  Cytokine-cytokine receptor interaction, mmu04620  Toll-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5532','mmu04060  Cytokine-cytokine receptor interaction, mmu04620  Toll-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5533','mmu04060  Cytokine-cytokine receptor interaction, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04936  Alcoholic liver disease, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis','04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5534','mmu00220  Arginine biosynthesis, mmu00250  Alanine, aspartate and glutamate metabolism, mmu01100  Metabolic pathways, mmu01200  Carbon metabolism, mmu01210  2-Oxocarboxylic acid metabolism, mmu01230  Biosynthesis of amino acids','00250 Alanine, aspartate and glutamate metabolism, 00220 Arginine biosynthesis, 01007 Amino acid related enzymes [BR:mmu01007], 2.6.1.2  alanine transaminase, Class I'),('5535','mmu04142  Lysosome','04142 Lysosome, 02000 Transporters [BR:mmu02000], SLC17: Vesicular glutamate transporter, Anion:cation symporter (ACS) family [TC:2.A.1.14]'),('5536','mmu03050  Proteasome, mmu04060  Cytokine-cytokine receptor interaction, mmu04066  HIF-1 signaling pathway, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04630  JAK-STAT signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04940  Type I diabetes mellitus, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05200  Pathways in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:mmu03051], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Other assembling factors, Interferons, Cytokines'),('5537','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04151  PI3K-Akt signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04940  Type I diabetes mellitus, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05162  Measles, mmu05166  Human T-cell leukemia virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease','04630 JAK-STAT signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05166 Human T-cell leukemia virus 1 infection, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05135 Yersinia infection, 05142 Chagas disease, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 04940 Type I diabetes mellitus, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5538','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04062  Chemokine signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05144  Malaria, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05135 Yersinia infection, 05144 Malaria, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04933 AGE-RAGE signaling pathway in diabetic complications, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Chemokines, Chemokines'),('5539','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04062  Chemokine signaling pathway, mmu05163  Human cytomegalovirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection','04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04062 Chemokine signaling pathway, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 04030 G protein-coupled receptors [BR:mmu04030], 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], CC Chemokine, CC Chemokine, Proteins'),('5540','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04620  Toll-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu05163  Human cytomegalovirus infection','04064 NF-kappa B signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04620 Toll-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04062 Chemokine signaling pathway, 05163 Human cytomegalovirus infection, 04052 Cytokines and growth factors [BR:mmu04052], Chemokines'),('5541','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5542','mmu04060  Cytokine-cytokine receptor interaction, mmu04620  Toll-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5543','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01522  Endocrine resistance, mmu01524  Platinum drug resistance, mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04115  p53 signaling pathway, mmu04140  Autophagy - animal, mmu04141  Protein processing in endoplasmic reticulum, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04215  Apoptosis - multiple species, mmu04217  Necroptosis, mmu04261  Adrenergic signaling in cardiomyocytes, mmu04340  Hedgehog signaling pathway, mmu04510  Focal adhesion, mmu04621  NOD-like receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04725  Cholinergic synapse, mmu04915  Estrogen signaling pathway, mmu04928  Parathyroid hormone synthesis, secretion and action, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05014  Amyotrophic lateral sclerosis, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05145  Toxoplasmosis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05200  Pathways in cancer, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05210  Colorectal cancer, mmu05215  Prostate cancer, mmu05222  Small cell lung cancer, mmu05226  Gastric cancer, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04141 Protein processing in endoplasmic reticulum, 04340 Hedgehog signaling pathway, 04630 JAK-STAT signaling pathway, 04064 NF-kappa B signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04151 PI3K-Akt signaling pathway, 04140 Autophagy - animal, 04210 Apoptosis, 04215 Apoptosis - multiple species, 04217 Necroptosis, 04115 p53 signaling pathway, 04510 Focal adhesion, 04621 NOD-like receptor signaling pathway, 04915 Estrogen signaling pathway, 04928 Parathyroid hormone synthesis, secretion and action, 04261 Adrenergic signaling in cardiomyocytes, 04725 Cholinergic synapse, 04722 Neurotrophin signaling pathway, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05210 Colorectal cancer, 05226 Gastric cancer, 05215 Prostate cancer, 05222 Small cell lung cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05152 Tuberculosis, 05145 Toxoplasmosis, 05014 Amyotrophic lateral sclerosis, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01524 Platinum drug resistance, 01522 Endocrine resistance, 01009 Protein phosphatases and associated proteins [BR:mmu01009], PP1-interacting proteins (PIPs)'),('5544','mmu01524  Platinum drug resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04115  p53 signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04650  Natural killer cell mediated cytotoxicity, mmu04668  TNF signaling pathway, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05320  Autoimmune thyroid disease, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04210 Apoptosis, 04217 Necroptosis, 04115 p53 signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05142 Chagas disease, 05143 African trypanosomiasis, 05320 Autoimmune thyroid disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 01524 Platinum drug resistance, 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], TNF receptor superfamily, Proteins'),('5545','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04115  p53 signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04650  Natural killer cell mediated cytotoxicity, mmu05132  Salmonella infection, mmu05164  Influenza A, mmu05417  Lipid and atherosclerosis','04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04115 p53 signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 05164 Influenza A, 05132 Salmonella infection, 05417 Lipid and atherosclerosis, 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], TNF receptor superfamily, Proteins'),('5546','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 01009 Protein phosphatases and associated proteins [BR:mmu01009], PP1-interacting proteins (PIPs)'),('5547','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('5548','mmu04015  Rap1 signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04714  Thermogenesis, mmu04723  Retrograde endocannabinoid signaling','04015 Rap1 signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04723 Retrograde endocannabinoid signaling, 04714 Thermogenesis, 04030 G protein-coupled receptors [BR:mmu04030], Cannabinoid'),('5549','mmu03250  Viral life cycle - HIV-1','03250 Viral life cycle - HIV-1, 03021 Transcription machinery [BR:mmu03021], NELF complex'),('5550','mmu04060  Cytokine-cytokine receptor interaction, mmu04620  Toll-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5551','mmu04060  Cytokine-cytokine receptor interaction, mmu04620  Toll-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04620 Toll-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 05200 Pathways in cancer, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5552','mmu03050  Proteasome, mmu04060  Cytokine-cytokine receptor interaction, mmu04066  HIF-1 signaling pathway, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04630  JAK-STAT signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04940  Type I diabetes mellitus, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05200  Pathways in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:mmu03051], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Other assembling factors, Interferons, Cytokines'),('5553','mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04068  FoxO signaling pathway, mmu04110  Cell cycle, mmu04218  Cellular senescence, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04390  Hippo signaling pathway, mmu04659  Th17 cell differentiation, mmu04672  Intestinal immune network for IgA production, mmu04926  Relaxin signaling pathway, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05166  Human T-cell leukemia virus 1 infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05210  Colorectal cancer, mmu05211  Renal cell carcinoma, mmu05212  Pancreatic cancer, mmu05220  Chronic myeloid leukemia, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05415  Diabetic cardiomyopathy','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04390 Hippo signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04110 Cell cycle, 04218 Cellular senescence, 04659 Th17 cell differentiation, 04672 Intestinal immune network for IgA production, 04926 Relaxin signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05220 Chronic myeloid leukemia, 05211 Renal cell carcinoma, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 05415 Diabetic cardiomyopathy, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 03110 Chaperones and folding catalysts [BR:mmu03110], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Others, Transforming growth factors (RSTK binding), Growth factors/receptors'),('5554','mmu01522  Endocrine resistance, mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu04670  Leukocyte transendothelial migration, mmu04915  Estrogen signaling pathway, mmu04926  Relaxin signaling pathway, mmu05161  Hepatitis B, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05215  Prostate cancer, mmu05219  Bladder cancer, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04668 TNF signaling pathway, 04657 IL-17 signaling pathway, 04670 Leukocyte transendothelial migration, 04915 Estrogen signaling pathway, 04926 Relaxin signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05219 Bladder cancer, 05215 Prostate cancer, 05161 Hepatitis B, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 01522 Endocrine resistance, 01002 Peptidases and inhibitors [BR:mmu01002], 3.4.24.35  gelatinase B, Family M10'),('5555','mmu04964  Proximal tubule bicarbonate reclamation, mmu04974  Protein digestion and absorption, mmu04976  Bile secretion, mmu04978  Mineral absorption','04976 Bile secretion, 04974 Protein digestion and absorption, 04978 Mineral absorption, 04964 Proximal tubule bicarbonate reclamation, 02000 Transporters [BR:mmu02000], SLC9: Na+/H+ exchanger'),('5556','mmu04972  Pancreatic secretion, mmu04978  Mineral absorption','04972 Pancreatic secretion, 04978 Mineral absorption, 02000 Transporters [BR:mmu02000], SLC26: Multifunctional anion exchanger'),('5557','mmu04141  Protein processing in endoplasmic reticulum, mmu04918  Thyroid hormone synthesis','04141 Protein processing in endoplasmic reticulum, 04918 Thyroid hormone synthesis, 03110 Chaperones and folding catalysts [BR:mmu03110], 04131 Membrane trafficking [BR:mmu04131], 5.3.4.1  protein disulfide-isomerase, Protein disulfide isomerase, PDI family proteins'),('5558','mmu00910  Nitrogen metabolism, mmu01100  Metabolic pathways, mmu04964  Proximal tubule bicarbonate reclamation, mmu04966  Collecting duct acid secretion, mmu04971  Gastric acid secretion, mmu04972  Pancreatic secretion, mmu04976  Bile secretion','00910 Nitrogen metabolism, 04971 Gastric acid secretion, 04972 Pancreatic secretion, 04976 Bile secretion, 04964 Proximal tubule bicarbonate reclamation, 04966 Collecting duct acid secretion, 04147 Exosome [BR:mmu04147], 4.2.1.1  carbonic anhydrase, Exosomal proteins of other body fluids (saliva and urine)'),('5559',NULL,'04990 Domain-containing proteins not elsewhere classified [BR:mmu04990], Other PDZ domain-containing proteins'),('5560','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5561','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu04936  Alcoholic liver disease, mmu05134  Legionellosis, mmu05146  Amoebiasis, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis','04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04657 IL-17 signaling pathway, 04062 Chemokine signaling pathway, 05167 Kaposi sarcoma-associated herpesvirus infection, 05134 Legionellosis, 05146 Amoebiasis, 05323 Rheumatoid arthritis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], Chemokines'),('5562','mmu03050  Proteasome, mmu04060  Cytokine-cytokine receptor interaction, mmu04066  HIF-1 signaling pathway, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04630  JAK-STAT signaling pathway, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04940  Type I diabetes mellitus, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05200  Pathways in cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05418  Fluid shear stress and atherosclerosis','03050 Proteasome, 04350 TGF-beta signaling pathway, 04630 JAK-STAT signaling pathway, 04066 HIF-1 signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04380 Osteoclast differentiation, 05200 Pathways in cancer, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05160 Hepatitis C, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 03051 Proteasome [BR:mmu03051], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Other assembling factors, Interferons, Cytokines'),('5563','mmu04972  Pancreatic secretion, mmu04978  Mineral absorption','04972 Pancreatic secretion, 04978 Mineral absorption, 02000 Transporters [BR:mmu02000], SLC26: Multifunctional anion exchanger'),('5564','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5565','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu05132  Salmonella infection, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05152  Tuberculosis, mmu05164  Influenza A, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05417  Lipid and atherosclerosis','04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 05164 Influenza A, 05132 Salmonella infection, 05135 Yersinia infection, 05134 Legionellosis, 05152 Tuberculosis, 05144 Malaria, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05417 Lipid and atherosclerosis, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5566','mmu05146  Amoebiasis, mmu05226  Gastric cancer','05226 Gastric cancer, 05146 Amoebiasis, 04131 Membrane trafficking [BR:mmu04131], Secretory mucins'),('5567','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('5573','mmu04310  Wnt signaling pathway, mmu04390  Hippo signaling pathway, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04934  Cushing syndrome, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05165  Human papillomavirus infection, mmu05200  Pathways in cancer, mmu05210  Colorectal cancer, mmu05213  Endometrial cancer, mmu05217  Basal cell carcinoma, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer','04310 Wnt signaling pathway, 04390 Hippo signaling pathway, 04550 Signaling pathways regulating pluripotency of stem cells, 05200 Pathways in cancer, 05210 Colorectal cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05217 Basal cell carcinoma, 05213 Endometrial cancer, 05224 Breast cancer, 05165 Human papillomavirus infection, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 04934 Cushing syndrome, 03036 Chromosome and associated proteins [BR:mmu03036], Other centriole associated proteins'),('5574','mmu04512  ECM-receptor interaction, mmu04640  Hematopoietic cell lineage, mmu05169  Epstein-Barr virus infection, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer','04512 ECM-receptor interaction, 04640 Hematopoietic cell lineage, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05169 Epstein-Barr virus infection, 04147 Exosome [BR:mmu04147], 04090 CD molecules [BR:mmu04090], 00535 Proteoglycans [BR:mmu00535], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell), Exosomal proteins of other body fluids (saliva and urine), Exosomal proteins of colorectal cancer cells, Exosomal proteins of bladder cancer cells, Proteins, Others, Cell surface receptors'),('5575','mmu04010  MAPK signaling pathway, mmu04012  ErbB signaling pathway, mmu04110  Cell cycle, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04310  Wnt signaling pathway, mmu04350  TGF-beta signaling pathway, mmu04390  Hippo signaling pathway, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04630  JAK-STAT signaling pathway, mmu04919  Thyroid hormone signaling pathway, mmu05132  Salmonella infection, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05169  Epstein-Barr virus infection, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05210  Colorectal cancer, mmu05213  Endometrial cancer, mmu05216  Thyroid cancer, mmu05219  Bladder cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05230  Central carbon metabolism in cancer','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04310 Wnt signaling pathway, 04350 TGF-beta signaling pathway, 04390 Hippo signaling pathway, 04630 JAK-STAT signaling pathway, 04151 PI3K-Akt signaling pathway, 04110 Cell cycle, 04218 Cellular senescence, 04550 Signaling pathways regulating pluripotency of stem cells, 04919 Thyroid hormone signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05230 Central carbon metabolism in cancer, 05210 Colorectal cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05219 Bladder cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 03000 Transcription factors [BR:mmu03000], 03019 Messenger RNA biogenesis [BR:mmu03019], Cell cycle controlling factors, Myc, Factors that have mRNA localization signals'),('5576','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 03000 Transcription factors [BR:mmu03000], HMG SOX'),('5577','mmu04360  Axon guidance','04360 Axon guidance, 01001 Protein kinases [BR:mmu01001], 2.7.10.1  receptor protein-tyrosine kinase, EPH family [OT]'),('5578','mmu01522  Endocrine resistance, mmu04068  FoxO signaling pathway, mmu04110  Cell cycle, mmu04115  p53 signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04152  AMPK signaling pathway, mmu04218  Cellular senescence, mmu04310  Wnt signaling pathway, mmu04340  Hedgehog signaling pathway, mmu04371  Apelin signaling pathway, mmu04390  Hippo signaling pathway, mmu04510  Focal adhesion, mmu04530  Tight junction, mmu04630  JAK-STAT signaling pathway, mmu04917  Prolactin signaling pathway, mmu04919  Thyroid hormone signaling pathway, mmu04921  Oxytocin signaling pathway, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04934  Cushing syndrome, mmu04936  Alcoholic liver disease, mmu05160  Hepatitis C, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05169  Epstein-Barr virus infection, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05210  Colorectal cancer, mmu05212  Pancreatic cancer, mmu05213  Endometrial cancer, mmu05214  Glioma, mmu05215  Prostate cancer, mmu05216  Thyroid cancer, mmu05218  Melanoma, mmu05219  Bladder cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05223  Non-small cell lung cancer, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05416  Viral myocarditis','04310 Wnt signaling pathway, 04340 Hedgehog signaling pathway, 04390 Hippo signaling pathway, 04371 Apelin signaling pathway, 04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04110 Cell cycle, 04115 p53 signaling pathway, 04218 Cellular senescence, 04510 Focal adhesion, 04530 Tight junction, 04917 Prolactin signaling pathway, 04921 Oxytocin signaling pathway, 04919 Thyroid hormone signaling pathway, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05203 Viral carcinogenesis, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05160 Hepatitis C, 05162 Measles, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05416 Viral myocarditis, 04936 Alcoholic liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04934 Cushing syndrome, 01522 Endocrine resistance'),('5579','mmu04310  Wnt signaling pathway, mmu04390  Hippo signaling pathway, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04934  Cushing syndrome, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05165  Human papillomavirus infection, mmu05200  Pathways in cancer, mmu05210  Colorectal cancer, mmu05213  Endometrial cancer, mmu05217  Basal cell carcinoma, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer','04310 Wnt signaling pathway, 04390 Hippo signaling pathway, 04550 Signaling pathways regulating pluripotency of stem cells, 05200 Pathways in cancer, 05210 Colorectal cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05217 Basal cell carcinoma, 05213 Endometrial cancer, 05224 Breast cancer, 05165 Human papillomavirus infection, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 04934 Cushing syndrome, 03036 Chromosome and associated proteins [BR:mmu03036], Other centriole associated proteins'),('5580','mmu04512  ECM-receptor interaction, mmu04640  Hematopoietic cell lineage, mmu05169  Epstein-Barr virus infection, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer','04512 ECM-receptor interaction, 04640 Hematopoietic cell lineage, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05169 Epstein-Barr virus infection, 04147 Exosome [BR:mmu04147], 04090 CD molecules [BR:mmu04090], 00535 Proteoglycans [BR:mmu00535], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Exosomal proteins of haemopoietic cells  (B-cell, T-cell, DC-cell, reticulocyte, and mast cell), Exosomal proteins of other body fluids (saliva and urine), Exosomal proteins of colorectal cancer cells, Exosomal proteins of bladder cancer cells, Proteins, Others, Cell surface receptors'),('5581','mmu04010  MAPK signaling pathway, mmu04012  ErbB signaling pathway, mmu04110  Cell cycle, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04310  Wnt signaling pathway, mmu04350  TGF-beta signaling pathway, mmu04390  Hippo signaling pathway, mmu04550  Signaling pathways regulating pluripotency of stem cells, mmu04630  JAK-STAT signaling pathway, mmu04919  Thyroid hormone signaling pathway, mmu05132  Salmonella infection, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05169  Epstein-Barr virus infection, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05210  Colorectal cancer, mmu05213  Endometrial cancer, mmu05216  Thyroid cancer, mmu05219  Bladder cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05230  Central carbon metabolism in cancer','04010 MAPK signaling pathway, 04012 ErbB signaling pathway, 04310 Wnt signaling pathway, 04350 TGF-beta signaling pathway, 04390 Hippo signaling pathway, 04630 JAK-STAT signaling pathway, 04151 PI3K-Akt signaling pathway, 04110 Cell cycle, 04218 Cellular senescence, 04550 Signaling pathways regulating pluripotency of stem cells, 04919 Thyroid hormone signaling pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05230 Central carbon metabolism in cancer, 05210 Colorectal cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05219 Bladder cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 03000 Transcription factors [BR:mmu03000], 03019 Messenger RNA biogenesis [BR:mmu03019], Cell cycle controlling factors, Myc, Factors that have mRNA localization signals'),('5582','mmu04024  cAMP signaling pathway','04024 cAMP signaling pathway, 03000 Transcription factors [BR:mmu03000], HMG SOX'),('5583','mmu04360  Axon guidance','04360 Axon guidance, 01001 Protein kinases [BR:mmu01001], 2.7.10.1  receptor protein-tyrosine kinase, EPH family [OT]'),('5584','mmu01522  Endocrine resistance, mmu04068  FoxO signaling pathway, mmu04110  Cell cycle, mmu04115  p53 signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04152  AMPK signaling pathway, mmu04218  Cellular senescence, mmu04310  Wnt signaling pathway, mmu04340  Hedgehog signaling pathway, mmu04371  Apelin signaling pathway, mmu04390  Hippo signaling pathway, mmu04510  Focal adhesion, mmu04530  Tight junction, mmu04630  JAK-STAT signaling pathway, mmu04917  Prolactin signaling pathway, mmu04919  Thyroid hormone signaling pathway, mmu04921  Oxytocin signaling pathway, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04934  Cushing syndrome, mmu04936  Alcoholic liver disease, mmu05160  Hepatitis C, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05169  Epstein-Barr virus infection, mmu05200  Pathways in cancer, mmu05203  Viral carcinogenesis, mmu05205  Proteoglycans in cancer, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05210  Colorectal cancer, mmu05212  Pancreatic cancer, mmu05213  Endometrial cancer, mmu05214  Glioma, mmu05215  Prostate cancer, mmu05216  Thyroid cancer, mmu05218  Melanoma, mmu05219  Bladder cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05223  Non-small cell lung cancer, mmu05224  Breast cancer, mmu05225  Hepatocellular carcinoma, mmu05226  Gastric cancer, mmu05416  Viral myocarditis','04310 Wnt signaling pathway, 04340 Hedgehog signaling pathway, 04390 Hippo signaling pathway, 04371 Apelin signaling pathway, 04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04152 AMPK signaling pathway, 04110 Cell cycle, 04115 p53 signaling pathway, 04218 Cellular senescence, 04510 Focal adhesion, 04530 Tight junction, 04917 Prolactin signaling pathway, 04921 Oxytocin signaling pathway, 04919 Thyroid hormone signaling pathway, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05205 Proteoglycans in cancer, 05207 Chemical carcinogenesis - receptor activation, 05203 Viral carcinogenesis, 05210 Colorectal cancer, 05212 Pancreatic cancer, 05225 Hepatocellular carcinoma, 05226 Gastric cancer, 05214 Glioma, 05216 Thyroid cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05218 Melanoma, 05219 Bladder cancer, 05215 Prostate cancer, 05213 Endometrial cancer, 05224 Breast cancer, 05222 Small cell lung cancer, 05223 Non-small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05160 Hepatitis C, 05162 Measles, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05416 Viral myocarditis, 04936 Alcoholic liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 04934 Cushing syndrome, 01522 Endocrine resistance'),('5585','mmu04613  Neutrophil extracellular trap formation, mmu04919  Thyroid hormone signaling pathway, mmu05034  Alcoholism, mmu05203  Viral carcinogenesis','04613 Neutrophil extracellular trap formation, 04919 Thyroid hormone signaling pathway, 05203 Viral carcinogenesis, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:mmu03036], 3.5.1.98  histone deacetylase, Class I HDACs'),('5586','mmu04613  Neutrophil extracellular trap formation, mmu04919  Thyroid hormone signaling pathway, mmu05034  Alcoholism, mmu05203  Viral carcinogenesis','04613 Neutrophil extracellular trap formation, 04919 Thyroid hormone signaling pathway, 05203 Viral carcinogenesis, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:mmu03036], 3.5.1.98  histone deacetylase, Class I HDACs'),('5587','mmu04613  Neutrophil extracellular trap formation, mmu04919  Thyroid hormone signaling pathway, mmu05034  Alcoholism, mmu05203  Viral carcinogenesis','04613 Neutrophil extracellular trap formation, 04919 Thyroid hormone signaling pathway, 05203 Viral carcinogenesis, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:mmu03036], 3.5.1.98  histone deacetylase, Class I HDACs'),('5588','mmu04613  Neutrophil extracellular trap formation, mmu04919  Thyroid hormone signaling pathway, mmu05034  Alcoholism, mmu05203  Viral carcinogenesis','04613 Neutrophil extracellular trap formation, 04919 Thyroid hormone signaling pathway, 05203 Viral carcinogenesis, 05034 Alcoholism, 03036 Chromosome and associated proteins [BR:mmu03036], 3.5.1.98  histone deacetylase, Class I HDACs'),('5589','mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04020  Calcium signaling pathway, mmu04024  cAMP signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04713  Circadian entrainment, mmu04720  Long-term potentiation, mmu04724  Glutamatergic synapse, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05017  Spinocerebellar ataxia, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05031  Amphetamine addiction, mmu05033  Nicotine addiction, mmu05034  Alcoholism','04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04020 Calcium signaling pathway, 04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04724 Glutamatergic synapse, 04720 Long-term potentiation, 04713 Circadian entrainment, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05017 Spinocerebellar ataxia, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05031 Amphetamine addiction, 05033 Nicotine addiction, 05034 Alcoholism, 04040 Ion channels [BR:mmu04040], Glutamate (ionotropic)'),('5590','mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04020  Calcium signaling pathway, mmu04024  cAMP signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04713  Circadian entrainment, mmu04720  Long-term potentiation, mmu04724  Glutamatergic synapse, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05017  Spinocerebellar ataxia, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05031  Amphetamine addiction, mmu05033  Nicotine addiction, mmu05034  Alcoholism','04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04020 Calcium signaling pathway, 04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04724 Glutamatergic synapse, 04720 Long-term potentiation, 04713 Circadian entrainment, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05017 Spinocerebellar ataxia, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05031 Amphetamine addiction, 05033 Nicotine addiction, 05034 Alcoholism, 04040 Ion channels [BR:mmu04040], Glutamate (ionotropic)'),('5591','mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04020  Calcium signaling pathway, mmu04024  cAMP signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04713  Circadian entrainment, mmu04720  Long-term potentiation, mmu04724  Glutamatergic synapse, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05017  Spinocerebellar ataxia, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05031  Amphetamine addiction, mmu05033  Nicotine addiction, mmu05034  Alcoholism','04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04020 Calcium signaling pathway, 04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04724 Glutamatergic synapse, 04720 Long-term potentiation, 04713 Circadian entrainment, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05017 Spinocerebellar ataxia, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05031 Amphetamine addiction, 05033 Nicotine addiction, 05034 Alcoholism, 04040 Ion channels [BR:mmu04040], Glutamate (ionotropic)'),('5592','mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04020  Calcium signaling pathway, mmu04024  cAMP signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04713  Circadian entrainment, mmu04720  Long-term potentiation, mmu04724  Glutamatergic synapse, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05017  Spinocerebellar ataxia, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05031  Amphetamine addiction, mmu05033  Nicotine addiction, mmu05034  Alcoholism','04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04020 Calcium signaling pathway, 04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04724 Glutamatergic synapse, 04720 Long-term potentiation, 04713 Circadian entrainment, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05017 Spinocerebellar ataxia, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05031 Amphetamine addiction, 05033 Nicotine addiction, 05034 Alcoholism, 04040 Ion channels [BR:mmu04040], Glutamate (ionotropic)'),('5593','mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04020  Calcium signaling pathway, mmu04024  cAMP signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04713  Circadian entrainment, mmu04720  Long-term potentiation, mmu04724  Glutamatergic synapse, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05017  Spinocerebellar ataxia, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05031  Amphetamine addiction, mmu05033  Nicotine addiction, mmu05034  Alcoholism','04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04020 Calcium signaling pathway, 04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04724 Glutamatergic synapse, 04720 Long-term potentiation, 04713 Circadian entrainment, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05017 Spinocerebellar ataxia, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05031 Amphetamine addiction, 05033 Nicotine addiction, 05034 Alcoholism, 04040 Ion channels [BR:mmu04040], Glutamate (ionotropic)'),('5594','mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04020  Calcium signaling pathway, mmu04024  cAMP signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04713  Circadian entrainment, mmu04720  Long-term potentiation, mmu04724  Glutamatergic synapse, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05017  Spinocerebellar ataxia, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05031  Amphetamine addiction, mmu05033  Nicotine addiction, mmu05034  Alcoholism','04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04020 Calcium signaling pathway, 04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04724 Glutamatergic synapse, 04720 Long-term potentiation, 04713 Circadian entrainment, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05017 Spinocerebellar ataxia, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05031 Amphetamine addiction, 05033 Nicotine addiction, 05034 Alcoholism, 04040 Ion channels [BR:mmu04040], Glutamate (ionotropic)'),('5595','mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04020  Calcium signaling pathway, mmu04024  cAMP signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04713  Circadian entrainment, mmu04720  Long-term potentiation, mmu04724  Glutamatergic synapse, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05017  Spinocerebellar ataxia, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05031  Amphetamine addiction, mmu05033  Nicotine addiction, mmu05034  Alcoholism','04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04020 Calcium signaling pathway, 04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04724 Glutamatergic synapse, 04720 Long-term potentiation, 04713 Circadian entrainment, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05017 Spinocerebellar ataxia, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05031 Amphetamine addiction, 05033 Nicotine addiction, 05034 Alcoholism, 04040 Ion channels [BR:mmu04040], Glutamate (ionotropic)'),('5596','mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04020  Calcium signaling pathway, mmu04024  cAMP signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04713  Circadian entrainment, mmu04720  Long-term potentiation, mmu04724  Glutamatergic synapse, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05017  Spinocerebellar ataxia, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05031  Amphetamine addiction, mmu05033  Nicotine addiction, mmu05034  Alcoholism','04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04020 Calcium signaling pathway, 04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04724 Glutamatergic synapse, 04720 Long-term potentiation, 04713 Circadian entrainment, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05017 Spinocerebellar ataxia, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05031 Amphetamine addiction, 05033 Nicotine addiction, 05034 Alcoholism, 04040 Ion channels [BR:mmu04040], Glutamate (ionotropic)'),('5597','mmu04014  Ras signaling pathway, mmu04015  Rap1 signaling pathway, mmu04020  Calcium signaling pathway, mmu04024  cAMP signaling pathway, mmu04080  Neuroactive ligand-receptor interaction, mmu04713  Circadian entrainment, mmu04720  Long-term potentiation, mmu04724  Glutamatergic synapse, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05016  Huntington disease, mmu05017  Spinocerebellar ataxia, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05031  Amphetamine addiction, mmu05033  Nicotine addiction, mmu05034  Alcoholism','04014 Ras signaling pathway, 04015 Rap1 signaling pathway, 04020 Calcium signaling pathway, 04024 cAMP signaling pathway, 04080 Neuroactive ligand-receptor interaction, 04724 Glutamatergic synapse, 04720 Long-term potentiation, 04713 Circadian entrainment, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05016 Huntington disease, 05017 Spinocerebellar ataxia, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05031 Amphetamine addiction, 05033 Nicotine addiction, 05034 Alcoholism, 04040 Ion channels [BR:mmu04040], Glutamate (ionotropic)'),('5598','mmu04010  MAPK signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04936  Alcoholic liver disease, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05417 Lipid and atherosclerosis, 04936 Alcoholic liver disease'),('5599','mmu04060  Cytokine-cytokine receptor interaction, mmu04622  RIG-I-like receptor signaling pathway, mmu04630  JAK-STAT signaling pathway','04630 JAK-STAT signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04622 RIG-I-like receptor signaling pathway, 04052 Cytokines and growth factors [BR:mmu04052], Interferons'),('5601','mmu00140  Steroid hormone biosynthesis, mmu01100  Metabolic pathways, mmu04913  Ovarian steroidogenesis, mmu04925  Aldosterone synthesis and secretion, mmu04927  Cortisol synthesis and secretion, mmu04934  Cushing syndrome','00140 Steroid hormone biosynthesis, 04913 Ovarian steroidogenesis, 04925 Aldosterone synthesis and secretion, 04927 Cortisol synthesis and secretion, 04934 Cushing syndrome, 00199 Cytochrome P450 [BR:mmu00199], 1.14.15.6  cholesterol monooxygenase (side-chain-cleaving), CYP11 family'),('5602','mmu00140  Steroid hormone biosynthesis, mmu01100  Metabolic pathways, mmu04927  Cortisol synthesis and secretion, mmu04934  Cushing syndrome','00140 Steroid hormone biosynthesis, 04927 Cortisol synthesis and secretion, 04934 Cushing syndrome, 00199 Cytochrome P450 [BR:mmu00199], 1.14.15.4  steroid 11beta-monooxygenase, CYP11 family'),('5603','mmu00140  Steroid hormone biosynthesis, mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu01100  Metabolic pathways, mmu05204  Chemical carcinogenesis - DNA adducts','00140 Steroid hormone biosynthesis, 00980 Metabolism of xenobiotics by cytochrome P450, 05204 Chemical carcinogenesis - DNA adducts, 1.1.1.146  11beta-hydroxysteroid dehydrogenase'),('5604','mmu00140  Steroid hormone biosynthesis, mmu01100  Metabolic pathways, mmu04960  Aldosterone-regulated sodium reabsorption','00140 Steroid hormone biosynthesis, 04960 Aldosterone-regulated sodium reabsorption, 1.1.1.-'),('5605','mmu04928  Parathyroid hormone synthesis, secretion and action, mmu04961  Endocrine and other factor-regulated calcium reabsorption, mmu04978  Mineral absorption, mmu05152  Tuberculosis, mmu05207  Chemical carcinogenesis - receptor activation','04928 Parathyroid hormone synthesis, secretion and action, 04978 Mineral absorption, 04961 Endocrine and other factor-regulated calcium reabsorption, 05207 Chemical carcinogenesis - receptor activation, 05152 Tuberculosis, 01009 Protein phosphatases and associated proteins [BR:mmu01009], 03000 Transcription factors [BR:mmu03000], 03310 Nuclear receptors [BR:mmu03310], PP1-interacting proteins (PIPs), Cys4 thyroid hormone receptor-like, 1I. Vitamin D3 like receptor'),('5606','mmu00980  Metabolism of xenobiotics by cytochrome P450, mmu04976  Bile secretion, mmu05204  Chemical carcinogenesis - DNA adducts','00980 Metabolism of xenobiotics by cytochrome P450, 04976 Bile secretion, 05204 Chemical carcinogenesis - DNA adducts, 2.8.2.14  bile-salt sulfotransferase'),('5607',NULL,'04030 G protein-coupled receptors [BR:mmu04030], Bile acid'),('5608',NULL,'03000 Transcription factors [BR:mmu03000], Cys4 GATA-factors'),('5609','mmu04976  Bile secretion','04976 Bile secretion, 02000 Transporters [BR:mmu02000], SLC10: Sodium bile salt cotransporter'),('5610','mmu04976  Bile secretion','04976 Bile secretion, 02000 Transporters [BR:mmu02000], SLC51: Transporter of steroid-derived molecules'),('5611','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5612','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5613','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5614','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04068  FoxO signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5615','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04218  Cellular senescence, mmu04380  Osteoclast differentiation, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04668  TNF signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04917  Prolactin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04926  Relaxin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05212  Pancreatic cancer, mmu05215  Prostate cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:mmu03000], RHR (Rel homology region) Rel/Ankyrin'),('5616','mmu04657  IL-17 signaling pathway','04657 IL-17 signaling pathway'),('5617','mmu04659  Th17 cell differentiation, mmu04934  Cushing syndrome, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species','04659 Th17 cell differentiation, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 04934 Cushing syndrome, 03000 Transcription factors [BR:mmu03000], Factors with PAS domain'),('5618','mmu04659  Th17 cell differentiation, mmu04934  Cushing syndrome, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species','04659 Th17 cell differentiation, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 04934 Cushing syndrome, 03000 Transcription factors [BR:mmu03000], Factors with PAS domain'),('5619','mmu04659  Th17 cell differentiation, mmu04934  Cushing syndrome, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species','04659 Th17 cell differentiation, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 04934 Cushing syndrome, 03000 Transcription factors [BR:mmu03000], Factors with PAS domain'),('5620','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5621','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5622','mmu00220  Arginine biosynthesis, mmu00330  Arginine and proline metabolism, mmu01100  Metabolic pathways, mmu04020  Calcium signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04146  Peroxisome, mmu04371  Apelin signaling pathway, mmu04926  Relaxin signaling pathway, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05133  Pertussis, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05200  Pathways in cancer, mmu05222  Small cell lung cancer','00220 Arginine biosynthesis, 00330 Arginine and proline metabolism, 04371 Apelin signaling pathway, 04066 HIF-1 signaling pathway, 04020 Calcium signaling pathway, 04146 Peroxisome, 04926 Relaxin signaling pathway, 05200 Pathways in cancer, 05222 Small cell lung cancer, 05133 Pertussis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05022 Pathways of neurodegeneration - multiple diseases, 1.14.13.39  nitric-oxide synthase (NADPH)'),('5623','mmu00590  Arachidonic acid metabolism, mmu01100  Metabolic pathways, mmu04064  NF-kappa B signaling pathway, mmu04370  VEGF signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04668  TNF signaling pathway, mmu04723  Retrograde endocannabinoid signaling, mmu04726  Serotonergic synapse, mmu04913  Ovarian steroidogenesis, mmu04921  Oxytocin signaling pathway, mmu04923  Regulation of lipolysis in adipocytes, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05140  Leishmaniasis, mmu05163  Human cytomegalovirus infection, mmu05165  Human papillomavirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05200  Pathways in cancer, mmu05204  Chemical carcinogenesis - DNA adducts, mmu05206  MicroRNAs in cancer, mmu05222  Small cell lung cancer','00590 Arachidonic acid metabolism, 04370 VEGF signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04625 C-type lectin receptor signaling pathway, 04657 IL-17 signaling pathway, 04923 Regulation of lipolysis in adipocytes, 04913 Ovarian steroidogenesis, 04921 Oxytocin signaling pathway, 04726 Serotonergic synapse, 04723 Retrograde endocannabinoid signaling, 05200 Pathways in cancer, 05206 MicroRNAs in cancer, 05204 Chemical carcinogenesis - DNA adducts, 05222 Small cell lung cancer, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05165 Human papillomavirus infection, 05140 Leishmaniasis, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 1.14.99.1  prostaglandin-endoperoxide synthase'),('5624','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5625','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04218  Cellular senescence, mmu04380  Osteoclast differentiation, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04668  TNF signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04917  Prolactin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04926  Relaxin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05212  Pancreatic cancer, mmu05215  Prostate cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:mmu03000], RHR (Rel homology region) Rel/Ankyrin'),('5626','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04064  NF-kappa B signaling pathway, mmu04217  Necroptosis, mmu04380  Osteoclast differentiation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04750  Inflammatory mediator regulation of TRP channels, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05168  Herpes simplex virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04750 Inflammatory mediator regulation of TRP channels, 04380 Osteoclast differentiation, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5627','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04151  PI3K-Akt signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04940  Type I diabetes mellitus, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05162  Measles, mmu05166  Human T-cell leukemia virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease','04630 JAK-STAT signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05166 Human T-cell leukemia virus 1 infection, 05171 Coronavirus disease - COVID-19, 05162 Measles, 05135 Yersinia infection, 05142 Chagas disease, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 04940 Type I diabetes mellitus, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5628','mmu01521  EGFR tyrosine kinase inhibitor resistance, mmu01523  Antifolate resistance, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04066  HIF-1 signaling pathway, mmu04068  FoxO signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04218  Cellular senescence, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04668  TNF signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05417  Lipid and atherosclerosis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04068 FoxO signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04218 Cellular senescence, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04672 Intestinal immune network for IgA production, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05166 Human T-cell leukemia virus 1 infection, 05161 Hepatitis B, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05142 Chagas disease, 05143 African trypanosomiasis, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01521 EGFR tyrosine kinase inhibitor resistance, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5629','mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04068  FoxO signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04672  Intestinal immune network for IgA production, mmu05133  Pertussis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05150  Staphylococcus aureus infection, mmu05152  Tuberculosis, mmu05310  Asthma, mmu05320  Autoimmune thyroid disease, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05330  Allograft rejection','04630 JAK-STAT signaling pathway, 04068 FoxO signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04672 Intestinal immune network for IgA production, 05135 Yersinia infection, 05133 Pertussis, 05150 Staphylococcus aureus infection, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05320 Autoimmune thyroid disease, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Interleukins, Cytokines'),('5630','mmu04060  Cytokine-cytokine receptor interaction, mmu04151  PI3K-Akt signaling pathway, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04657  IL-17 signaling pathway, mmu05144  Malaria, mmu05171  Coronavirus disease - COVID-19','04630 JAK-STAT signaling pathway, 04151 PI3K-Akt signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04640 Hematopoietic cell lineage, 04657 IL-17 signaling pathway, 05171 Coronavirus disease - COVID-19, 05144 Malaria, 04052 Cytokines and growth factors [BR:mmu04052], CSF and other factors'),('5631','mmu04060  Cytokine-cytokine receptor interaction, mmu04630  JAK-STAT signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu05146  Amoebiasis, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05171  Coronavirus disease - COVID-19, mmu05202  Transcriptional misregulation in cancer, mmu05221  Acute myeloid leukemia, mmu05323  Rheumatoid arthritis','04630 JAK-STAT signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04640 Hematopoietic cell lineage, 04650 Natural killer cell mediated cytotoxicity, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 05202 Transcriptional misregulation in cancer, 05221 Acute myeloid leukemia, 05166 Human T-cell leukemia virus 1 infection, 05171 Coronavirus disease - COVID-19, 05167 Kaposi sarcoma-associated herpesvirus infection, 05146 Amoebiasis, 05323 Rheumatoid arthritis, 03019 Messenger RNA biogenesis [BR:mmu03019], 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Other 3\'-5\' decay factors, CSF and other factors, Cytokines'),('5632','mmu00350  Tyrosine metabolism, mmu01100  Metabolic pathways','00350 Tyrosine metabolism, 2.1.1.28  phenylethanolamine N-methyltransferase'),('5633','mmu04152  AMPK signaling pathway, mmu04910  Insulin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease','04152 AMPK signaling pathway, 04910 Insulin signaling pathway, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 03000 Transcription factors [BR:mmu03000], 04131 Membrane trafficking [BR:mmu04131], Ubiquitous bHLH-ZIP factors, Other mitophagy associated  proteins'),('5634','mmu01524  Platinum drug resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04115  p53 signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04650  Natural killer cell mediated cytotoxicity, mmu04668  TNF signaling pathway, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05320  Autoimmune thyroid disease, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04210 Apoptosis, 04217 Necroptosis, 04115 p53 signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05142 Chagas disease, 05143 African trypanosomiasis, 05320 Autoimmune thyroid disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 01524 Platinum drug resistance, 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], TNF receptor superfamily, Proteins'),('5636','mmu00561  Glycerolipid metabolism, mmu00564  Glycerophospholipid metabolism, mmu01100  Metabolic pathways','00561 Glycerolipid metabolism, 00564 Glycerophospholipid metabolism, 01004 Lipid biosynthesis proteins [BR:mmu01004], 2.3.1.15  glycerol-3-phosphate 1-O-acyltransferase, GPAT'),('5637','mmu01040  Biosynthesis of unsaturated fatty acids, mmu01100  Metabolic pathways, mmu01212  Fatty acid metabolism, mmu03320  PPAR signaling pathway, mmu04152  AMPK signaling pathway, mmu04936  Alcoholic liver disease','01040 Biosynthesis of unsaturated fatty acids, 04152 AMPK signaling pathway, 03320 PPAR signaling pathway, 04936 Alcoholic liver disease, 01004 Lipid biosynthesis proteins [BR:mmu01004], 1.14.19.1  stearoyl-CoA 9-desaturase, First'),('5638','mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease','04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 03000 Transcription factors [BR:mmu03000], Cell cycle controlling factors, Mad/Max'),('5639',NULL,'03000 Transcription factors [BR:mmu03000], Ubiquitous bHLH-ZIP factors'),('5640','mmu00900  Terpenoid backbone biosynthesis, mmu01100  Metabolic pathways, mmu04152  AMPK signaling pathway, mmu04976  Bile secretion','00900 Terpenoid backbone biosynthesis, 04152 AMPK signaling pathway, 04976 Bile secretion, 1.1.1.34  hydroxymethylglutaryl-CoA reductase (NADPH)'),('5641','mmu04152  AMPK signaling pathway, mmu04910  Insulin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease','04152 AMPK signaling pathway, 04910 Insulin signaling pathway, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 03000 Transcription factors [BR:mmu03000], 04131 Membrane trafficking [BR:mmu04131], Ubiquitous bHLH-ZIP factors, Other mitophagy associated  proteins'),('5642','mmu01524  Platinum drug resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04115  p53 signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04650  Natural killer cell mediated cytotoxicity, mmu04668  TNF signaling pathway, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05320  Autoimmune thyroid disease, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04210 Apoptosis, 04217 Necroptosis, 04115 p53 signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05142 Chagas disease, 05143 African trypanosomiasis, 05320 Autoimmune thyroid disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 01524 Platinum drug resistance, 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], TNF receptor superfamily, Proteins'),('5643',NULL,'03000 Transcription factors [BR:mmu03000], Ubiquitous bHLH-ZIP factors'),('5644','mmu00900  Terpenoid backbone biosynthesis, mmu01100  Metabolic pathways, mmu04152  AMPK signaling pathway, mmu04976  Bile secretion','00900 Terpenoid backbone biosynthesis, 04152 AMPK signaling pathway, 04976 Bile secretion, 1.1.1.34  hydroxymethylglutaryl-CoA reductase (NADPH)'),('5645','mmu04152  AMPK signaling pathway, mmu04910  Insulin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease','04152 AMPK signaling pathway, 04910 Insulin signaling pathway, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 03000 Transcription factors [BR:mmu03000], 04131 Membrane trafficking [BR:mmu04131], Ubiquitous bHLH-ZIP factors, Other mitophagy associated  proteins'),('5646','mmu01524  Platinum drug resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04115  p53 signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04650  Natural killer cell mediated cytotoxicity, mmu04668  TNF signaling pathway, mmu04932  Non-alcoholic fatty liver disease, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05200  Pathways in cancer, mmu05205  Proteoglycans in cancer, mmu05320  Autoimmune thyroid disease, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05417  Lipid and atherosclerosis','04010 MAPK signaling pathway, 04668 TNF signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04210 Apoptosis, 04217 Necroptosis, 04115 p53 signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 05200 Pathways in cancer, 05205 Proteoglycans in cancer, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05142 Chagas disease, 05143 African trypanosomiasis, 05320 Autoimmune thyroid disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 01524 Platinum drug resistance, 04050 Cytokine receptors [BR:mmu04050], 04090 CD molecules [BR:mmu04090], TNF receptor superfamily, Proteins'),('5647',NULL,'03000 Transcription factors [BR:mmu03000], Ubiquitous bHLH-ZIP factors'),('5648','mmu00900  Terpenoid backbone biosynthesis, mmu01100  Metabolic pathways, mmu04152  AMPK signaling pathway, mmu04976  Bile secretion','00900 Terpenoid backbone biosynthesis, 04152 AMPK signaling pathway, 04976 Bile secretion, 1.1.1.34  hydroxymethylglutaryl-CoA reductase (NADPH)'),('5654','mmu04060  Cytokine-cytokine receptor interaction, mmu04657  IL-17 signaling pathway, mmu04659  Th17 cell differentiation, mmu04936  Alcoholic liver disease, mmu05321  Inflammatory bowel disease, mmu05323  Rheumatoid arthritis','04060 Cytokine-cytokine receptor interaction, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 04936 Alcoholic liver disease, 04052 Cytokines and growth factors [BR:mmu04052], Interleukins'),('5655','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04060  Cytokine-cytokine receptor interaction, mmu04061  Viral protein interaction with cytokine and cytokine receptor, mmu04064  NF-kappa B signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04150  mTOR signaling pathway, mmu04210  Apoptosis, mmu04217  Necroptosis, mmu04350  TGF-beta signaling pathway, mmu04380  Osteoclast differentiation, mmu04612  Antigen processing and presentation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04640  Hematopoietic cell lineage, mmu04650  Natural killer cell mediated cytotoxicity, mmu04657  IL-17 signaling pathway, mmu04660  T cell receptor signaling pathway, mmu04664  Fc epsilon RI signaling pathway, mmu04668  TNF signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04930  Type II diabetes mellitus, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu04940  Type I diabetes mellitus, mmu05010  Alzheimer disease, mmu05014  Amyotrophic lateral sclerosis, mmu05020  Prion disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05143  African trypanosomiasis, mmu05144  Malaria, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05205  Proteoglycans in cancer, mmu05310  Asthma, mmu05321  Inflammatory bowel disease, mmu05322  Systemic lupus erythematosus, mmu05323  Rheumatoid arthritis, mmu05330  Allograft rejection, mmu05332  Graft-versus-host disease, mmu05410  Hypertrophic cardiomyopathy, mmu05414  Dilated cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04350 TGF-beta signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04071 Sphingolipid signaling pathway, 04150 mTOR signaling pathway, 04060 Cytokine-cytokine receptor interaction, 04061 Viral protein interaction with cytokine and cytokine receptor, 04210 Apoptosis, 04217 Necroptosis, 04640 Hematopoietic cell lineage, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04625 C-type lectin receptor signaling pathway, 04650 Natural killer cell mediated cytotoxicity, 04612 Antigen processing and presentation, 04660 T cell receptor signaling pathway, 04657 IL-17 signaling pathway, 04664 Fc epsilon RI signaling pathway, 04920 Adipocytokine signaling pathway, 04380 Osteoclast differentiation, 05205 Proteoglycans in cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05144 Malaria, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05143 African trypanosomiasis, 05310 Asthma, 05322 Systemic lupus erythematosus, 05323 Rheumatoid arthritis, 05321 Inflammatory bowel disease, 05330 Allograft rejection, 05332 Graft-versus-host disease, 05010 Alzheimer disease, 05014 Amyotrophic lateral sclerosis, 05020 Prion disease, 05022 Pathways of neurodegeneration - multiple diseases, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05410 Hypertrophic cardiomyopathy, 05414 Dilated cardiomyopathy, 04930 Type II diabetes mellitus, 04940 Type I diabetes mellitus, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 04052 Cytokines and growth factors [BR:mmu04052], 00536 Glycosaminoglycan binding proteins [BR:mmu00536], Tumor necrosis fators, Cytokines'),('5656','mmu01523  Antifolate resistance, mmu04010  MAPK signaling pathway, mmu04014  Ras signaling pathway, mmu04024  cAMP signaling pathway, mmu04062  Chemokine signaling pathway, mmu04064  NF-kappa B signaling pathway, mmu04066  HIF-1 signaling pathway, mmu04071  Sphingolipid signaling pathway, mmu04151  PI3K-Akt signaling pathway, mmu04210  Apoptosis, mmu04211  Longevity regulating pathway, mmu04218  Cellular senescence, mmu04380  Osteoclast differentiation, mmu04613  Neutrophil extracellular trap formation, mmu04620  Toll-like receptor signaling pathway, mmu04621  NOD-like receptor signaling pathway, mmu04622  RIG-I-like receptor signaling pathway, mmu04623  Cytosolic DNA-sensing pathway, mmu04625  C-type lectin receptor signaling pathway, mmu04657  IL-17 signaling pathway, mmu04658  Th1 and Th2 cell differentiation, mmu04659  Th17 cell differentiation, mmu04660  T cell receptor signaling pathway, mmu04662  B cell receptor signaling pathway, mmu04668  TNF signaling pathway, mmu04722  Neurotrophin signaling pathway, mmu04917  Prolactin signaling pathway, mmu04920  Adipocytokine signaling pathway, mmu04926  Relaxin signaling pathway, mmu04931  Insulin resistance, mmu04932  Non-alcoholic fatty liver disease, mmu04933  AGE-RAGE signaling pathway in diabetic complications, mmu04936  Alcoholic liver disease, mmu05010  Alzheimer disease, mmu05022  Pathways of neurodegeneration - multiple diseases, mmu05030  Cocaine addiction, mmu05132  Salmonella infection, mmu05133  Pertussis, mmu05134  Legionellosis, mmu05135  Yersinia infection, mmu05140  Leishmaniasis, mmu05142  Chagas disease, mmu05145  Toxoplasmosis, mmu05146  Amoebiasis, mmu05152  Tuberculosis, mmu05160  Hepatitis C, mmu05161  Hepatitis B, mmu05162  Measles, mmu05163  Human cytomegalovirus infection, mmu05164  Influenza A, mmu05165  Human papillomavirus infection, mmu05166  Human T-cell leukemia virus 1 infection, mmu05167  Kaposi sarcoma-associated herpesvirus infection, mmu05168  Herpes simplex virus 1 infection, mmu05169  Epstein-Barr virus infection, mmu05170  Human immunodeficiency virus 1 infection, mmu05171  Coronavirus disease - COVID-19, mmu05200  Pathways in cancer, mmu05202  Transcriptional misregulation in cancer, mmu05203  Viral carcinogenesis, mmu05206  MicroRNAs in cancer, mmu05207  Chemical carcinogenesis - receptor activation, mmu05208  Chemical carcinogenesis - reactive oxygen species, mmu05212  Pancreatic cancer, mmu05215  Prostate cancer, mmu05220  Chronic myeloid leukemia, mmu05221  Acute myeloid leukemia, mmu05222  Small cell lung cancer, mmu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer, mmu05321  Inflammatory bowel disease, mmu05415  Diabetic cardiomyopathy, mmu05417  Lipid and atherosclerosis, mmu05418  Fluid shear stress and atherosclerosis','04010 MAPK signaling pathway, 04014 Ras signaling pathway, 04064 NF-kappa B signaling pathway, 04668 TNF signaling pathway, 04066 HIF-1 signaling pathway, 04071 Sphingolipid signaling pathway, 04024 cAMP signaling pathway, 04151 PI3K-Akt signaling pathway, 04210 Apoptosis, 04218 Cellular senescence, 04613 Neutrophil extracellular trap formation, 04620 Toll-like receptor signaling pathway, 04621 NOD-like receptor signaling pathway, 04622 RIG-I-like receptor signaling pathway, 04623 Cytosolic DNA-sensing pathway, 04625 C-type lectin receptor signaling pathway, 04660 T cell receptor signaling pathway, 04658 Th1 and Th2 cell differentiation, 04659 Th17 cell differentiation, 04657 IL-17 signaling pathway, 04662 B cell receptor signaling pathway, 04062 Chemokine signaling pathway, 04920 Adipocytokine signaling pathway, 04917 Prolactin signaling pathway, 04926 Relaxin signaling pathway, 04722 Neurotrophin signaling pathway, 04380 Osteoclast differentiation, 04211 Longevity regulating pathway, 05200 Pathways in cancer, 05202 Transcriptional misregulation in cancer, 05206 MicroRNAs in cancer, 05207 Chemical carcinogenesis - receptor activation, 05208 Chemical carcinogenesis - reactive oxygen species, 05203 Viral carcinogenesis, 05235 PD-L1 expression and PD-1 checkpoint pathway in cancer, 05212 Pancreatic cancer, 05221 Acute myeloid leukemia, 05220 Chronic myeloid leukemia, 05215 Prostate cancer, 05222 Small cell lung cancer, 05166 Human T-cell leukemia virus 1 infection, 05170 Human immunodeficiency virus 1 infection, 05161 Hepatitis B, 05160 Hepatitis C, 05171 Coronavirus disease - COVID-19, 05164 Influenza A, 05162 Measles, 05168 Herpes simplex virus 1 infection, 05163 Human cytomegalovirus infection, 05167 Kaposi sarcoma-associated herpesvirus infection, 05169 Epstein-Barr virus infection, 05165 Human papillomavirus infection, 05132 Salmonella infection, 05135 Yersinia infection, 05133 Pertussis, 05134 Legionellosis, 05152 Tuberculosis, 05146 Amoebiasis, 05145 Toxoplasmosis, 05140 Leishmaniasis, 05142 Chagas disease, 05321 Inflammatory bowel disease, 05010 Alzheimer disease, 05022 Pathways of neurodegeneration - multiple diseases, 05030 Cocaine addiction, 05417 Lipid and atherosclerosis, 05418 Fluid shear stress and atherosclerosis, 05415 Diabetic cardiomyopathy, 04936 Alcoholic liver disease, 04932 Non-alcoholic fatty liver disease, 04931 Insulin resistance, 04933 AGE-RAGE signaling pathway in diabetic complications, 01523 Antifolate resistance, 03000 Transcription factors [BR:mmu03000], RHR (Rel homology region) Rel/Ankyrin'),('5657','mmu04520  Adherens junction, mmu04530  Tight junction, mmu04540  Gap junction','04520 Adherens junction, 04530 Tight junction, 04540 Gap junction, 04812 Cytoskeleton proteins [BR:mmu04812], Others'),('5658','mmu04514  Cell adhesion molecules, mmu04530  Tight junction, mmu04670  Leukocyte transendothelial migration, mmu05160  Hepatitis C','04514 Cell adhesion molecules, 04530 Tight junction, 04670 Leukocyte transendothelial migration, 05160 Hepatitis C, 01009 Protein phosphatases and associated proteins [BR:mmu01009], PP1-interacting proteins (PIPs)');
/*!40000 ALTER TABLE `gene_kegg_info` ENABLE KEYS */;
UNLOCK TABLES;
/*!40103 SET TIME_ZONE=@OLD_TIME_ZONE */;

/*!40101 SET SQL_MODE=@OLD_SQL_MODE */;
/*!40014 SET FOREIGN_KEY_CHECKS=@OLD_FOREIGN_KEY_CHECKS */;
/*!40014 SET UNIQUE_CHECKS=@OLD_UNIQUE_CHECKS */;
/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
/*!40111 SET SQL_NOTES=@OLD_SQL_NOTES */;

-- Dump completed on 2022-10-25 15:23:25
